Live Feed

Feed to the latest filings at the SEC

 

Innovative Eyewear Inc

Date Filed : Dec 13, 2021

S-11innovativeeyewear_s1.htmS-1

Asfiled with the U.S. Securities and Exchange Commission onDecember 13, 2021

RegistrationNumber 333-        

  

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

___________________

FORMS-1

REGISTRATIONSTATEMENT
UNDER THE SECURITIES ACT OF 1933

___________________

InnovativeEyewear, Inc.

(ExactName of Registrant as Specified in its Charter)

___________________

Delaware

 

5995

 

84-2794274

(State or other jurisdiction of
incorporation or organization)

 

(Primary Standard Industrial
Classification Code Number)

 

(I.R.S. Employer
Identification No.)

8101Biscayne Blvd., Suite 705

Miami,Florida, 33138

(954)826-0329
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

___________________

HarrisonGross

ChiefExecutive Officer 8101 Biscayne Blvd., Suite 705

Miami,Florida, 33138

(954) 826-0329
(Name, Address, Including Zip Code, and Telephone Number,Including Area Code, of Agent for Service)

___________________

withCopies to:

Barry I. Grossman, Esq.
Sarah W. Williams, Esq.
Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY 10105
Phone: (212) 370
-1300
Fax: (212) 370
-7889

 

Leslie Marlow, Esq.
Hank Gracin, Esq.
Patrick J. Egan, Esq.
Gracin & Marlow, LLP
405 Lexington Avenue, 26
th Floor
New York, NY 10174
Phone: (212) 907
-6457
Fax: (212) 208
-4657

___________________

Approximatedate of commencement of proposed sale to public:

Assoon as practicable after the effective date hereof.

Ifany of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415under the Securities Act, check the following box. ☒

Ifthis Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, checkthe following box and list the Securities Act registration statement number of the earlier effective registration statement for the sameoffering. ☐

Ifthis Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the followingbox and list the Securities Act registration number of the earlier effective registration statement for the same offering. ☐

Ifthis Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the followingbox and list the Securities Act registration number of the earlier effective registration statement for the same offering. ☐

Indicateby check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer    ☐

 

Accelerated filer    ☐

 

Non-accelerated filer    ☒

 

Smaller reporting company    ☒

           

Emerging growth company    ☒

Ifan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. ☐

 

CALCULATIONOF REGISTRATION FEE

Title of each class of securities to be registered

 

Proposed
maximum
aggregate
offering
price
(1)

 

Amount of
registration
fee
(2)

Units consisting of:

 

 

   

 

 

(i) Shares of common stock, par value $0.00001 per share(3)

 

$

17,250,000.00

 

$

 1,599.08

(ii) Warrants to purchase shares of common stock(4)

 

 

 

 

Common stock issuable upon exercise of the Warrants

 

$

17,250,000.00

 

$

1,599.08

Representative’s warrant(4)

 

 

 

 

Common stock underlying the Representative’s warrant(5)

 

$

1,138,500.00

 

$

105.54

Total

 

$

35,638,500.00 

 

$

3,303.70

____________

(1)      Estimatedsolely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the“Securities Act”).

(2)      Calculatedpursuant to Rule 457(o) based on an estimate of the proposed maximum aggregate offering price.

(3)      Includesshares of common stock which may be issued on exercise of a 45-day option granted to the underwriters to coverover-allotments, if any.

(4)      Noseparate registration fee required pursuant to Rule 457(g) under the Securities Act.

(5)      Estimatedsolely for the purposes of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. We have agreed to issue,upon the closing of this offering, representative’s warrants to Maxim Group LLC (or its designees) entitling it to purchase up to6% of the aggregate shares of Common Stock in this offering. We have calculated the proposed maximum aggregate offering price of the commonstock underlying the representative’s warrants by assuming that such warrants are exercisable at a price per share equal to 110%of the price per share sold in this offering.

Theregistrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrantshall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordancewith Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission,acting pursuant to Section 8(a), may determine.

 

 

Theinformation contained in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registrationstatement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securitiesand it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

PRELIMINARY PROSPECTUS

 

SUBJECT TO COMPLETION

 

DATED DECEMBER 13, 2021

InnovativeEyewear, Inc.

Unitsconsisting of
Shares of Common Stock and
Warrants to purchase               
Shares of Common Stock

Thisis a firm commitment underwritten public offering by Innovative Eyewear, Inc., a Delaware corporation (after we redomicile from a Floridacorporation to a Delaware corporation) (the “Company”) of units (the “Units”), each of which consisting of oneshare of the Company’s common stock, par value $0.00001 per share and one warrant (the “Warrant”) to purchase one shareof common stock. Prior to this offering, there has been no public market for our Common Stock or Warrants, comprising the Units. We anticipatethat the initial public offering price of our Units will be between $         and $        ,and the number of Units offered hereby is based upon an assumed offering price of $          per Unit, the midpoint of such estimated price range.

TheUnits have no stand-alone rights and will not be certificated or issued as stand-alone securities. The Warrantsand common stock are immediately separable and will be issued separately in this offering. Each Warrant offered hereby is immediatelyexercisable on the date of issuance at an exercise price of $           per Warrant(which shall not be less than       % of the public offering price per share of common stock) and will expirefive years from the date of issuance. The Warrants will not be listed for trading.

Wehave applied to have our shares of common stock listed on the Nasdaq Capital Market (“NASDAQ”) under the symbol “LUCY”.No assurance can be given that our application will be approved. If our common stock is not approved for listing on NASDAQ, we will notconsummate this offering. There is no established trading market for any of the Warrants, and we do not expect a market to develop. Wedo not intend to apply for a listing for any of the Warrants on any securities exchange or other nationally recognized trading system.Without an active trading system, the liquidity of the Warrants will be limited.

Weare an emerging growth company under the Jumpstart our Business Startups Act of 2012, or JOBS Act, and, as such, may elect to comply withcertain reduced public company reporting requirements for this prospectus and future filings. See “Summary — Implicationsof Being an Emerging Growth Company.”

Investingin our common stock involves a high degree of risk. See “Risk Factors” beginning on page 14.

Neitherthe Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determinedif this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

Per Share

 

Total

Initial public offering price

 

$

   

$

 

Underwriting discounts and commissions(1)

 

$

   

$

 

Proceeds to us, before expenses

 

$

   

$

 

____________

(1)      Doesnot include the reimbursement of certain expenses of the underwriters and warrants that we have agreed to issue to the representativeof the underwriters as additional compensation. We refer you to “Underwriting” beginning on page 106 for additional informationregarding underwriters’ compensation.

Wehave granted a 45-day option to the representative of the underwriters to purchase up to         additional shares of common stock at a price of $           per share and/or up to anadditional            Warrants to purchase up to           shares of Common Stock at a price per Warrant of $        , in any combination thereof, less,in each case, the underwriting discounts and commissions, solely to cover over-allotments, if any. If the representativeof the underwriters exercises the option in full, the total underwriting discounts and commissions will be $        and the additional proceeds to us, before expenses, from the over-allotment option exercise will be $        .

Theunderwriters expect to deliver the securities comprising the Units to purchasers on or about        ,2022.

SoleBook-Running Manager

MaximGroup LLC

Thedate of this prospectus is        , 2022

 

 

 

 

 

 

i

Aboutthis Prospectus

Weand the underwriters have not authorized anyone to provide any information or to make any representations other than those contained inthis prospectus or in any free writing prospectuses prepared by us or on our behalf or to which we have referred you. We take no responsibilityfor, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offerto sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. We are notmaking an offer to sell these securities in any jurisdiction where the offer or sale is not permitted or where the person making the offeror sale is not qualified to do so or to any person to whom it is not permitted to make such offer or sale. The information contained inthis prospectus is current only as of the date on the front cover of the prospectus. Our business, financial condition, results of operationsand prospects may have changed since that date.

Personswho come into possession of this prospectus and any applicable free writing prospectus in jurisdictions outside the United Statesare required to inform themselves about and to observe any restrictions as to this offering and the distribution of this prospectus andany such free writing prospectus applicable to that jurisdiction. See “Underwriting” for additional information on these restrictions.

Industryand Market Data

Unlessotherwise indicated, information in this prospectus concerning economic conditions, our industry, our markets and our competitive positionis based on a variety of sources, including information from third-party industry analysts and publications and our own estimatesand research. Some of the industry and market data contained in this prospectus are based on third-party industry publications.This information involves a number of assumptions, estimates and limitations.

Theindustry publications, surveys and forecasts and other public information generally indicate or suggest that their information has beenobtained from sources believed to be reliable. None of the third-party industry publications used in this prospectus wereprepared on our behalf. The industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors,including those described in “Risk Factors” in this prospectus. These and other factors could cause results to differ materiallyfrom those expressed in these publications.

Trademarks

Thisprospectus contains references to our trademarks and service marks and to those belonging to other entities. Solely for convenience, trademarksand trade names referred to in this prospectus may appear without the ®or TM symbols, but such references are not intended to indicate,in any way, that we will not assert, to the fullest extent possible under applicable law, our rights or the rights of the applicable licensorto these trademarks and trade names. We do not intend our use or display of other companies’ trade names, trademarks or servicemarks to imply a relationship with, or endorsement or sponsorship of us by any other companies.

1

ProspectusSummary

Thissummary highlights certain information appearing elsewhere in this prospectus. Because it is only a summary, it does not contain all ofthe information that you should consider before investing in our securitiesand it is qualified in its entirety by, and should be read in conjunction with, the more detailedinformation appearing elsewhere in this prospectus. Before you decide to invest in our securities,you should read the entire prospectus carefully, including “Risk Factors” beginning on page 14 and the financial statementsand related notes included in this prospectus. Except where the historical context specifically requires otherwise, disclosures in thisprospectus reflect our redomicile from a Florida corporation to a Delaware corporation on             ,2021.

Unlessthe context indicates otherwise, as used in this prospectus, the terms “we,” “us,” “our,” “theCompany,” “Innovative Eyewear” and “our business” refer to Innovative Eyewear, Inc.

Thisprospectus includes trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and tradenames included in this prospectus are the property of their respective owners.

OurCompany

InnovativeEyewear develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connectedto their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd. (the “Parent”),a portfolio company of Tekcapital. Tekcapital is a U.K. based university intellectual property accelerator. Tekcapital builds portfoliocompanies around new technologies. Innovative Eyewear licensed the exclusive rights to the Lucyd®brand (“Lucyd”), from Lucyd Ltd., which includes the exclusive use of all of Lucyd Ltd.’s intellectual property,including our main product, Lucyd Lyte® glasses (“Lucyd Lyte”).

InJanuary 2021, Innovative Eyewear fully launched its first commercial product, Lucyd Lyte. This initial product embodies our goalof creating smart eyewear for all day wear that looks like and is priced similarly to designer eyewear, but is also light weight and comfortable,and enables the wearer to remain connected to their digital lives. The product was initially launched with six styles. In September 2021,an additional six styles were added. These twelve styles are each available with 56 different lens types, resulting in 668 variationsof products currently available.

LucydLyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone taskshands-free. Some of the many things our customers can do with their Lucyd Lyte glasses include:

1.      “Senda voice message to (contact)”: this command begins the recording of an audio message to be sent to named contact.

2.      “Senda text to (contact)”: begins recording of a speech-to-text message to be sent by SMS to named contact.

3.      “Call(contact)”: speed-dials the named contact.

4.      “Send$___ to (contact)”: this command allows our user to send money to a contact via Venmo or Apple Pay. Follow the digital assistant’sprompts to confirm.

5.      “Checkmy messages”: this command reads out our user’s latest incoming text messages and offers a prompt to reply to each. Closeout the digital assistant to end the readout.

6.      “Checkmy mailbox”: this command announces the number of unread emails, and reads them out with a prompt to continue after each one. Inthe prompt after each one, our customers can tell their digital assistant “Reply” and dictate an email response to the previousemail.

7.      “Find(cuisine type) food nearby”: this command reads through a list of nearby restaurants and their ratings, and prompts our user fordirections or to call after each one.

8.      “Callme an Uber”: this command prompts our user on which type of Uber ride they want, then asks to confirm to send a car to our user’slocation.

9.      “Whattime is it?”: announces the current time.

2

10.    “Play(song/album/artist)”: this command begins playing the requested song, album or artist via Apple Music.

11.    “Getme directions to (location)”: this command begins navigating on phone, with audible directions on glasses.

12.    “Takea memo”: this command begins recording a speech-to-text memo in Notes. Say “Read my Notes” to play back.

Webelieve that our Upgrade Your Eyewear® approach will set the pace and pavethe way for the future of the eyewear industry (“Upgrade Your Eyewear”). We also believe that traditional frames, no matterhow attractive, do not possess the functionality many eyeglass wearers need and want. Smart eyewear is part of a fast-growing,technology-enhanced ecosystem, consisting of traditional eyewear, electronic in-ear devices (“hearables”)and digital assistants. Lucyd Lyte sits at the intersection of these market drivers. We view proper eyewear design and construction asa core competency for competing in this new sector. Understanding the technological capabilities of hearables and digital assistants,and our ability to effectively integrate these technologies into eyewear, is a critical element for our long-term successin the eyewear market.

Additionally,we believe smart eyewear should also enable customers to freely interact with social media. While digital assistants, once enabled, canprovide some of this interaction, we believe that the ability to receive and send social media posts with your voice will greatly enhanceease of use of these platforms on the go. To facilitate this, Innovative Eyewear has been developing a full stack social media applicationcalled Vyrb™ (“Vyrb”) which enables the user to receive and send posts through Lucyd Lyte smart glasses with your voice.The application is slated to launch out of beta in the fourth quarter of 2021, and we are aiming to roll out software upgrades to Vyrbin the fourth quarter of 2022, which are currently planned to include new features like: monetization, ad-buying modules,an itemized upgrade system, and content selling capabilities for social media creators.

InnovativeEyewear believes that Vyrb will enhance the utility of current and future Lyte glasses by enabling users to keep their smart phones intheir pockets and still be able to hear and make social media posts on Vyrb, which other Vyrb users will be able hear. Additionally, Vyrbwill offer Lucyd Lyte users external social sharing features, which will allow posts made on Vyrb to be exported to other platforms suchas Facebook, Twitter and Instagram. The app can be

3

alsoused entirely with its visual interface on a phone or tablet and does not require Lucyd Lyte or another “hearable” to use,however, we believe it will enhance Lucyd Lyte and other hearables by enabling new voice commands that can be used through virtual assistants,such as Siri, and allowing users to interact with Vyrb and other social media platforms without looking at their phone or tablet.

Additionally,we are designing Vyrb to host audiobooks, podcasts and entire music albums on the platform. With Vyrb, Lucyd Lyte customers will be ableto hear their social media feeds, post messages, hold gatherings and musical performances, and enjoy social media with the authenticityof their own voice: all through their eyewear and without taking their phone out of their pocket.

OurMarket Opportunity

Accordingto Statista, the total addressable market for eyewear in the U.S. is projected to be $28.3 billion in 2021. The market fordigital assistants like Siri, Google Voice, Bixby and Alexa has grown rapidly in North America, and had $2.5 billion in revenuein 2020. In the U.S., our primary market, the hearables market is projected to be $5.1 billion in 2021. We view the popularityof hearables and digital assistants as important catalysts for the smart eyewear market.

Thecommon denominator among markets for the hearables and digital assistant is that they facilitate real-time access to digitaldata, whether it is through music, calls, navigational directions, or information, among other uses. The combination of hearables anddigital assistants provides a transparent, ergonomic interface between the users and their digital lives. At Innovative Eyewear, we arededicated to a touch-free interface and untethering your eyes from your smartphone’s screen, all with the simplicityand elegance of our carefully designed eyewear.

Thesynergistic fusion of these three markets enables, in our view, an opportunity to create a completely new experience of connected eyewear,which smoothly delivers the functionality of both optical glasses and headphones, eliminating the need for either on its own. Nevertheless,we believe that several orthodoxies of the eyewear industry still hold, namely: if you want to sell a lot of eyewear, it should be attractive,comfortable (e.g., light weight, which we believe to be approximately 1 oz.) and cost roughly the same as traditional eyewear. This iswhat we sought to achieve, and in our view accomplished with the introduction of Lucyd Lyte eyewear.

____________

1         https://www.statista.com/outlook/cmo/eyewear/united-states

          https://www.grandviewresearch.com/industry-analysis/intelligent-virtual-assistant-industry

          https://www.globenewswire.com/news-release/2021/07/29/2270984/0/en/Global-Wireless-Headphones-Market-to-
Reach-45-7-Billion-by-2026.html

4

OurBusiness Strategy

Whenwe started Innovative Eyewear, we believed that there were no attractive smart glasses that addressed the basic consumer need for goodlooking designer glasses that were comfortable, lightweight, and provided the functionality of hearables, and priced around the same asregular glasses. To meet this need, we decided to create products that we believed addressed all of these areas.

Allof our products are designed in Miami, manufactured in China and sold through multiple ecommerce channels, including on our website (Lucyd.co),BestBuy.com and Amazon.com, or through optical retailers. We believe this capital light approach is highly scalable and efficient in thedeployment of resources.

Sincewe understand that customers are particular about what they wear on their faces, and because customers come in every shape, size and designsensibility, we aim to continuously introduce new models in an effort to offer a wide variety of designs for myriad applications.

Competition

Thesmart eyewear industry in which we operate is highly competitive and rapidly evolving. While we believe that our products, which are anamalgam of optical quality eyeglasses and Bluetooth audio technology, provide a unique, designer format that is feature rich and competitivelypriced, we face competition from many different entities currently and likely will in the future. Our competitors’ products mayhave attributes and structural capabilities that we are unable to currently duplicate. Specifically, these may include:

Experiencein designing, producing, and selling smart eyewear and consumer electronic products.    All of our key competitorshave significantly longer experience designing and selling smart eyewear. As a result they are likely to have better developed design,manufacturing and production experience.

Brandawareness and marketing know-how.    Mostof our competitors have storied brands that they can leverage to accelerate market awareness and encourage early adopters to evaluateand purchase their products.

Channeldevelopment and product placement.    Many of our competitors have long-standing relationshipswith retail and ecommerce distribution channels which gives them an advantage for market penetration, certainly in the near-termand perhaps over time as well.

Captiveretail distribution.    At least one of our competitors has their own company-owned retail distributionchannel which enhances their ability to bring smart eyewear to a large audience at an incremental cost.

Financialresources.    All of our competitors have significantly greater financial resources which they can put in harnesstowards research and development and sales and marketing to develop and sell an enhanced product at a favorable price.

OurCompetitive Strengths

AUnique Solution to a Common Problem.    We believe that the distraction created by smartphones originates intwo forms: (1) via headphones or earbuds, where the user is deprived of full audible situational awareness; and, (2) via thevisual interface of the phone, which distracts the user completely from their surroundings. Many of our competitors have relatively bulkyspeakers enclosed within the temples, while Lucyd Lyte’s speakers and temples are thin, which allows them to look similar to traditionaldesigner glasses.

AffordablePrice Point.    The manufacturer’s suggested retail price for Lucyd Lyte eyewear starts at $149. Mostof our U.S. based competitors are significantly more expensive, starting at $249 or higher.

Quality.All of our frames can be outfitted in-house or by optical resellers with any combination of the following: prescription,sunglass, readers and blue light formats. Our frame fronts are made with what we believe are high quality optical materials to ensureeasy lens fitting by any optician.

CustomizableProduct Offering.    There are 56 lens types available for Lucyd Lyte, making it one of the most customizablesmart eyewear in the world. Innovative Eyewear has a long-standing partnership with a high-quality optical labin Boston to produce prescription and custom lenses for our frames quickly and affordably. Our contract with a third-partylab also allows us to offer direct fulfillment to our customers.

5

Comfort.    Atjust 1.0-1.45 ounces, our eyewear has a feather-light fit, suitable for all day vision correction.

Longbattery life.    At 6.5-8 hours of playback per charge, Lucyd eyewear outpaces most if not allof the competition on battery life.

Capitallight business model.    All of our products are sold through multiple ecommerce channels, including on ourwebsite (Lucyd.co), BestBuy.com and Amazon.com, or through optical or other retailers that maintain traditional brick and mortar retailstores. We believe this capital light approach is highly scalable and efficient in the deployment of resources. We view “capitallight” as being more efficient, by obviating the need to build factories and retail stores, but rather contract with both.

Multi-channelapproach.    We sell our products both through multiple online channels and multiple categories of brick-and-mortarretail stores. We believe this multi-channel approach provides us with an advantage against our competitors who either solelysell their products online or in brick-and-mortar retail stores.

Experiencedmanagement team.    We have an experienced board of directors with more than 80 years of combined experiencein the eyewear industry and a management team with substantial experience with operating eyewear and technology companies.

RisksAssociated with our Business

Ourbusiness and ability to execute our business strategy are subject to a number of risks of which you should be aware before you decideto buy our common stock. In particular, you should carefully consider the following risks, which are discussed more fully in the sectionentitled “Risk Factors” in this prospectus:

•        Theoptical industry is highly competitive, and if we do not compete successfully, our business may be adversely impacted.

•        Wehave a history of losses, and we may be unable to achieve or sustain profitability.

•        Thereports of our independent registered public accounting firm for the fiscal years ended December 31, 2019 and 2020 containan explanatory paragraph regarding substantial doubt about our ability to continue as a going concern.

•        Wehave limited experience in scaling a smart eyewear business. If we are unable to manage our expected growth effectively, our brand, andfinancial performance may suffer, which may have a material adverse effect on our business, financial condition, and operating results.

•        Increasesin component costs, shipping costs, long lead times, supply shortages, and supply changes could disrupt our supply chain; factors suchas wage rate increases and inflation can have a material adverse effect on our business, financial condition, and operating results.

•        Wecurrently derive all of our revenue from sales of our glasses. A decline in sales of our eyewear would negatively affect our business,financial condition, and results of operation.

•        Weface significant risks due to our dependency on foreign supply and manufacturing chains, geopolitical and economic changes, and changesin public perception about internationally sourced and manufactured products.

•        Werely on a limited number of contract manufacturers and logistics partners for our products. A loss of any of these partners could negativelyaffect our business.

•        Ifwe fail to cost-effectively retain our existing customers or to acquire new customers, our business, financial condition,and results of operations would be harmed.

•        Eyeglassesare regulated as medical devices by the FDA, and our failure, or the failure of any third-party manufacturer or optical laboratory,to obtain and maintain the necessary marketing authorizations for our products could have a material adverse effect on our business.

•        Ourprofitability and cash flows may be negatively affected if we are not successful in managing our supply chain and customer demands forproduct deliveries.

6

•        Ifwe fail to maintain and enhance our brand, our ability to engage or expand our base of customers will be impaired, and our business, financialcondition, and results of operations may suffer.

•        Werely heavily on our information technology systems, as well as those of our third-party vendors, business partners, and serviceproviders, for our business to effectively operate and to safeguard confidential information; any significant failure, inadequacy, interruption,or data security incident could adversely affect our business, financial condition, and operations.

•        Ourmultichannel channel business faces distinct risks, and our failure to successfully manage it could have a negative impact on our profitability.

•        TheCOVID-19 pandemic has had, and may in the future continue to have, a material adverse impact on our business.

•        Ifwe fail to adapt and respond effectively to rapidly changing technology, evolving industry standards and changing customer needs or requirements,our solutions may become less competitive.

•        Wedepend on highly skilled personnel to grow and operate our business, and if we are unable to hire, retain, and motivate our personnel,we may not be able to grow effectively.

•        Adecline in sales of our eyewear would negatively affect our business, financial condition, and results of operations.

•        Wecould be adversely affected by product liability, product recall or personal injury issues.

•        Welicense our technology from Lucyd Ltd., the majority stockholder of the Company, and our inability to maintain this license could materiallyaffect our business, financial condition, and operating results.

•        Failureto adequately maintain and protect our intellectual property and proprietary rights could harm our brand, devalue our proprietary content,and adversely affect our ability to compete effectively.

•        Wemay incur costs to defend against, face liability or for being vulnerable to intellectual property infringement claims brought againstus by others.

•        Weface risks associated with suppliers from whom our products are sourced and are dependent on a limited number of suppliers.

•        Ourprojects could be hindered due to our dependence on third parties to complete many of our contracts.

•        Wedepend on search engines, social media platforms, digital application stores, content-based online advertising, and otheronline sources to attract consumers to and promote our website and our mobile applications, which may be affected by third-partyinterference beyond our control; and, as we grow, our the cost of acquiring new customers may continue to rise and become uneconomical.

•        Ourdirectors, executive officers and principal stockholders will continue to have substantial control over our company after this offering,which could limit your ability to influence the outcome of key transactions, including a change of control.

CorporateInformation

Wewere initially organized as a limited liability company under the laws of the State of Florida on August 15, 2019. We converted theCompany from a Florida limited liability company into a Florida corporation on March 25, 2020. Prior to the effectivenessof the registration statement, we plan on redomiciling from a Florida corporation to a Delaware corporation. Our principal executive officeis located at 8101 Biscayne Blvd., Suite 705, Miami, FL, 33126, and our phone number is (954) 826-0329. We maintain a websiteat www.lucyd.co. Following the effectiveness of the registration statement of which this prospectusis a part, we intend to announce material information to the public through filings with the SEC, the investor relations page of our website,as well as press releases, public conference calls, and investor conferences.

7

Thereference to our website is intended to be an inactive textual reference only. The information contained on, or that can be accessed through,our website is not part of this prospectus and investors should not rely on such information in deciding whether to purchase shares ofour common stock.

Our“Lucyd” logo, the Lucyd Lyte name and the slogan “Upgrade your Eyewear” and our other registered or common lawtrademarks mentioned in this prospectus are the exclusive licensed property of Innovative Eyewear Inc. Other trade names, trademarks,and service used in this prospectus are the property of their respective owners.

Implicationsof Being an Emerging Growth Company

Wequalify as an “emerging growth company” as defined under the Securities Act of 1933, as amended (the “Securities Act”).As a result, we are permitted to, and intend to, rely on exemptions from certain disclosure requirements that are otherwise applicableto public companies. These provisions include, but are not limited to:

•        beingpermitted to present only two years of audited financial statements and only two years of related “Management’s Discussionand Analysis of Financial Condition and Results of Operations” in this prospectus;

•        notbeing required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002,as amended (or the Sarbanes-Oxley Act);

•        reduceddisclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration statements; and

•        exemptionsfrom the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachutepayments not previously approved.

Inaddition, an emerging growth company can take advantage of an extended transition period for complying with new or revised accountingstandards. This provision allows an emerging growth company to delay the adoption of some accounting standards until those standards wouldotherwise apply to private companies. We have elected to avail ourselves of this extended transition period. We will remain an emerginggrowth company until the earliest to occur of: (i) our reporting $1.07 billion or more in annual gross revenues; (ii) theend of fiscal year 2026; (iii) our issuance, in a three year period, of more than $1 billion in non-convertibledebt; and (iv) the end of the fiscal year in which the market value of our common stock held by non-affiliates exceeded$700 million on the last business day of our second fiscal quarter.

Wehave elected to take advantage of certain of the reduced disclosure obligations and may elect to take advantage of other reduced reportingrequirements in future filings. As a result, the information that we provide to our stockholders may be different than the informationyou might receive from other public reporting companies in which you hold equity interests.

Tothe extent that we continue to qualify as a “smaller reporting company,” as such term is defined in Rule 12b-2under the Securities Exchange Act of 1934, as amended, after we cease to qualify as an “emerging growth company,” certainof the exemptions available to us as an “emerging growth company” may continue to be available to us as a smaller reportingcompany, including: (1) not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-OxleyAct; (2) scaled executive compensation disclosures; and (3) the ability to provide only two years of audited financial statements,instead of three years.

8

TheOffering

Units offered by us

 

               Units, assuming a public offering price of $       per Unit, the midpoint of the initial public offering price range reflected on the cover page of this prospectus. Each Unit will consist of one share of common stock and one Warrant to purchase one share of common stock. The Units have no stand-alone rights and will not be certificated or issued as stand-alone securities. The shares of common stock and Warrants are immediately separable and will be issued separately in this offering.

Common stock outstanding immediately before this offering

 


               shares of common stock

Common stock to be outstanding after this offering(1)

 


               shares of common stock (or                shares of common stock if the underwriters exercise their option to purchase additional shares of common stock and/or additional Warrants in full, and assuming in each case no exercise of the Warrants).

Option to purchase additional shares of common stock and/or Warrants

 


We have granted to the underwriters an option exercisable for a period of 45 days from the date of this prospectus to purchase an aggregate of up to an additional                shares of common stock at the initial public offering price per share less the underwriting discounts and commissions and/or up to                additional Warrants to purchase up to                shares of common stock, in any combination thereof.

Use of proceeds

 

We estimate that the net proceeds to us from this offering, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, will be approximately $         million, based on the assumed initial public offering price of $         per share, which is the midpoint of the price range set forth on the cover page of this prospectus. Approximately $         million of the net proceeds received by us from this offering will be used for (i) sales and marketing, (ii) expanding our inventory, (iii) updating and producing our in-store displays, (iv) development of new styles and sizes of our smart eyewear and (v) working capital and general purposes. We may also use a portion of the net proceeds to acquire, license and invest in complementary products, technologies or additional businesses; however, we currently have no agreements or commitments to complete any such transaction. See “Use of Proceeds.”

Description of the Warrants

 

The Warrants will have an exercise price of $         per share of common stock, will be immediately exercisable and will expire five years from the date of issuance. Each Warrant is exercisable for one share of common stock, subject to adjustment in the event of stock dividends, stock splits, stock combinations, reclassifications, reorganizations or similar events affecting our common stock. A holder may not exercise any portion of a Warrant to the extent that the holder, together with its affiliates and any other person or entity acting as a group, would own more than 4.99% of our outstanding shares of common stock after exercise, as such ownership percentage is determined in accordance with the terms of the Warrants, except that upon notice from the holder to us, the holder may waive such limitation up to a percentage, not in excess of 9.99%. This prospectus also relates to the offering of the common stock issuable upon exercise of the Warrants. To better understand the terms of the Warrants, you should carefully read the “Description of Capital Stock” section of this prospectus. You should also read the form of Warrant, which is filed as an exhibit to the registration statement that includes this prospectus.

9

Concentration of ownership

 

Upon completion of this offering, our executive officers and directors, and Lucyd Ltd. will beneficially own, in the aggregate, approximately               % of the outstanding shares of our common stock.

Nasdaq Symbol and Trading

 

We have applied to list our common stock on the Nasdaq Capital Market under the ticker symbol “LUCY.” No assurance can be given that our application will be approved. We do not intend to apply for a listing for any of the Warrants on any securities exchange or other nationally recognized trading system.

Risk Factors

 

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 14 and the other information in this prospectus for a discussion of the factors you should consider carefully before you decide to invest in our Common Stock and warrants.

Lock-Up

 

In connection with this offering, we, our directors, executive officers, and certain stockholders holding one percent (1%) or more of our common stock have agreed not to offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any of our securities for a period of six (6) months following the closing of the offering of the shares. See “Underwriting” for more information.

Representative’s warrants

 

We will issue to Maxim Group LLC, as the representative of the underwriters, upon closing of this offering compensation warrants entitling the underwriters or their designees to purchase up to six percent (6%) of the aggregate number of shares of our Common Stock that we issue to investors in this offering. The warrants are exercisable for a four-and-one-half year period commencing 180 days following the commencement of sales of the common stock in this offering. The warrants will have an exercise price per share equal to 110% of the public offering price of our shares of Common Stock offered hereby. See “Underwriting — Representative’s Warrants.”

____________

(1)      Thenumber of shares of our common stock to be outstanding immediately after this offering is based on shares of our common stock outstandingas of             , 2021, which giveseffect to the conversion of outstanding convertible promissory notes, or the Notes, into shares of common stock, and exclude:

•        2,332,500shares of common stock issuable upon exercise of stock options, at a weighted average exercise price of $2.59 per share; and

•                    shares of our common stock reserved for future issuance under our 2021 Equity Incentive Plan (which is equal to 20% of our issued andoutstanding common stock immediately after the consummation of this offering, less the number of outstanding option grants).

Unlessotherwise indicated, this prospectus reflects and assumes the following:

•        Conversionof the Notes upon the closing of this offering into an aggregate of             shares of our common stock at a conversion price of $             per share;

•        Noexercise of the Warrants included in the Units offered hereby; and

•        Noexercise by the underwriters of its over-allotment option; and

•        Noexercise of the Representative’s warrants.

10

Summaryof Financial Information

Thefollowing tables present our summary financial data and should be read together with our financial statements and accompanying notes and“Management’s Discussion and Analysis of Financial Condition and Results of Operations” appearing elsewhere in thisprospectus. The summary financial data for the years ended December 31, 2020 and 2019 are derived from our audited annual financialstatements, which are included elsewhere in this prospectus. The unaudited summary financial data as of September 30, 2021and for the nine months ended September 30, 2021 have been derived from our unaudited interim financial statements, whichare included elsewhere in this prospectus, and include all adjustments, consisting of normal recurring adjustments, necessary for a fairpresentation of our financial position and results of operations for these periods.

Statementof Operations Data:

 

Nine months
ended
September 30,
2021

 

Year ended
December 31,
2020

 

Nine months
ended
September 30,
2020

   

(unaudited)

 

(audited)

 

(unaudited)

Revenues, net

 

415,185

 

 

56,997

 

 

33,592

 

Less: Cost of Goods Sold

 

(332,378

)

 

(74,266

)

 

(34,783

)

Gross Profit (Loss)

 

82,807

 

 

(17,269

)

 

(1,191

)

     

 

   

 

   

 

Operating expenses:

   

 

   

 

   

 

General & administrative

 

(883,356

)

 

(316,115

)

 

(210,509

)

Impairment expense

 

 

 

(112,329

)

 

(112,329

)

Sales and marketing

 

(903,795

)

 

(152,731

)

 

(98,789

)

Related party management fee

 

(84,975

)

 

(130,000

)

 

(102,475

)

Research and development

 

(36,121

)

 

(36,894

)

 

(30,822

)

Total Operating Expenses

 

(1,908,247

)

 

(748,070

)

 

(554,924

)

     

 

   

 

   

 

Other Income

 

 

 

2,120

 

 

 

Interest Expense

 

(33,654

)

 

(4,966

)

 

 

Total Other Income/(Expense)

 

(33,654

)

 

(2,846

)

 

 

     

 

   

 

   

 

Net Loss

 

(1,859,094

)

 

(768,184

)

 

(556,115

)

     

 

   

 

   

 

Weighted average number of shares outstanding

 

5,033,823

 

 

2,960,289

 

 

2,602,987

 

Earnings per share, basic and diluted

 

(0.37

)

 

(0.26

)

 

(0.21

)

CashFlow Data:

 

Nine months
ended
September 30,
2021

 

Nine months
ended
September 30,
2020

   

(unaudited)

 

(unaudited)

Net cash flows from operating activities

 

(810,446

)

 

(3,672

)

Net cash flows from investing activities

 

(87,246

)

 

(29,634

)

Net cash flows from financing activities

 

935,725

 

 

62,769

 

Net Change in Cash

 

38,033

 

 

29,463

 

11

BalanceSheet Data:

 

As of
September 30,
2021

 

As of
December 31,
2020

   

(unaudited)

 

(audited)

Non Current Assets

 

150,241

 

 

69,213

 

Current Assets

 

546,223

 

 

141,803

 

Current Liabilities

 

(665,593

)

 

(765,853

)

Total Equity/(Deficit)

 

30,871

 

 

(554,837

)

12

CautionaryNote Regarding Forward-Looking Statements

Certainstatements in this prospectus may contain “forward-looking statements” within the meaning of the federal securitieslaws. Our forward-looking statements include, but are not limited to, statements about us and our industry, as well as statementsregarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. Additionally,any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlyingassumptions, are forward-looking statements. We intend the forward-looking statements to be covered by the safeharbor provisions of the federal securities laws. Words such as “may,” “should,” “could,” “would,”“predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,”“intends,” “plans,” “believes,” “estimates,” and similar expressions, as well as statementsin future tense, may identify forward-looking statements, but the absence of these words does not mean that a statement isnot forward-looking.

Forward-lookingstatements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performanceor results will be achieved. Forward-looking statements are based on information we have when those statements are made ormanagement’s good faith belief as of that time with respect to future events, and are subject to significant risks and uncertaintiesthat could cause actual performance or results to differ materially from those expressed in or suggested by the forward-lookingstatements. Important factors that could cause such differences include, but are not limited to:

•        ourlack of operating history;

•        ourexpected use of proceeds from this offering and relationships with our current customers;

•        ourexpectations regarding the time during which we will be an emerging growth company under the JOBS Act;

•        ourestimates regarding future revenue, expenses and needs for additional financing;

•        ourability to compete in our industry;

•        ourability to expand the number of retail stores that sell our products;

•        ourability to expand the production of our products;

•        theimpact of governmental laws and regulation;

•        difficultieswith certain vendors, suppliers and distributors we rely on or will rely on;

•        failureto maintain our corporate culture as we grow and changes in consumer recognition of our brand;

•        changesin senior management, loss of one or more key personnel or an inability to attract, hire, integrate and retain highly skilled personnel;

•        thesuccessful launch of our new application, Vyrb;

•        theability of our product to perform in a safe and efficient manner; and

•        ourability to adapt and respond effectively to rapidly changing technology, evolving industry standards and changing customer needs or requirements.

Theforegoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements containedherein or risk factors that we are faced with. Forward-looking statements necessarily involve risks and uncertainties, andour actual results could differ materially from those anticipated in the forward-looking statements due to a number of factors,including those set forth under the section of this prospectus entitled “Risk Factors” elsewhere in this prospectus. The factorsset forth under the “Risk Factors” section and other cautionary statements made in this prospectus should be read and understoodas being applicable to all related forward-looking statements wherever they appear in this prospectus. The forward-lookingstatements contained in this prospectus represent our judgment as of the date of this prospectus. We caution readers not to place unduereliance on such statements. Except as required by law, we undertake no obligation to update publicly any forward-lookingstatements for any reason, even if new information becomes available or other events occur in the future. All subsequent written and oralforward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety bythe cautionary statements contained above and throughout this prospectus.

13

RiskFactors

Anyinvestment in our securities involves a high degree ofrisk. You should carefully consider the risks described below, which we believe represent certain of the material risks to our business,together with the information contained elsewhere in this prospectus, before you make a decision to invest in our securities.Please note that the risks highlighted here are not the only ones that we may face. For example, additional risks presently unknown tous or that we currently consider immaterial or unlikely to occur could also impair our operations. If any of the following events occuror any additional risks presently unknown to us actually occur, our business, financial condition and operating results may be materiallyadversely affected. In that event, the trading price of our securities could decline and you could lose all or part of your investment.

RisksRelating to Our Business, Strategy and Industry

Theoptical industry is highly competitive, and if we do not compete successfully, our business may be adversely impacted.

Wecompete directly with large, integrated optical players that sell both at the retail level and online such as Ray-Ban®that have multiple products, well regarded brands and retail banners, as well as established and well-regarded consumer electronicscompanies such as Bose®. This diversified and capable competition takesplace both in physical retail locations as well as online, for smart glasses. To compete effectively, we must continue to create, investin, or acquire, advanced technology, incorporate this technology into our products, obtain regulatory approvals in a timely manner whererequired, and process and successfully market our products.

Mostif not all of our competitors have significantly greater financial and operational resources, longer operating histories, greater brandrecognition, and broader geographic presence than we do. As a result, they may be able to outmaneuver us in the marketplace and offercapable products at more competitive prices, which may adversely affect our business. They also are able to spend far more than we dofor advertising. We may be at a substantial disadvantage to larger competitors with greater economies of scale. If our costs are greatercompared to those of our competitors, the pricing of our products may not be as attractive, thus depressing sales or the profitabilityof our products and services. Our competitors may expand into markets in which we currently operate and we remain vulnerable to the marketingpower and high level of customer recognition of these larger competitors and to the risk that these competitors or others could attractour customer base. Some of our competitors are vertically integrated and are also engaged in the manufacture and distribution of glassesand many of our competitors operate under a variety of brands and price points. These competitors can advantageously leverage this structureto better compete and access the market with significant market power could to make it more difficult for us to compete. We purchase someof our product components from suppliers who may be affiliates of one or more competitors or may compete with ourselves in the future.

Wemay not continue to be able to successfully compete against existing or future competitors. Our inability to respond effectively to competitivepressures, improved performance by our competitors, and changes in the retail and ecommerce markets could result in lost market shareand have a material adverse effect on our business, financial condition, and results of operations.

Wehave a history of losses, and we may be unable to achieve or sustain profitability.

Wehad a net loss of $768,184 for the year ended December 31, 2020 and $1,859,094 for the nine months ended September30, 2021 and have in the past had net losses. As of September 30, 2021, we had an accumulated deficit of $3,238,742.Because we have a short operating history it is difficult for us to predict our future operating results. We will need to generate andsustain increased revenue and manage our costs to achieve profitability. Even if we do, we may not be able become or increase our profitability.

Ourability to generate profit depends on our ability to strengthen and expand our brand, continue to provide exciting products customerslove, expand sales and improve margins. We are aiming to achieve profitability in the next two years, and between now and then we planto efficiently invest in the business to bring it to scale by:

•        enhancingour products with new designs, functionality, and technology to widen our appeal and delight customers in a wide variety of demographicgroups; and,

14

•        investingin our product development, supply chain and sales and marketing capabilities to leverage external resources as efficiently as possibleto ensure that smart glasses are affordable for the majority of the world’s population who need them.

However,we may not succeed in any of the foregoing, and the planned investments may not result in profitability.

Thereports of our independent registered public accounting firm for the fiscal years ended December 31, 2019 and 2020 contain an explanatoryparagraph regarding substantial doubt about our ability to continue as a going concern.

Dueto the uncertainty of our ability to meet our current operating and capital expenses, in their report on our audited annual financialstatements as of and for the years ended December 31, 2019 and December 31, 2020, our independent auditors includedan explanatory paragraph regarding concerns about our ability to continue as a going concern. Substantial doubt about our ability to continueas a going concern may materially and adversely affect the price per share of our common stock and we may have a more difficult time obtainingfinancing. Further, the perception that we may be unable to continue as a going concern may impede our ability to raise additional fundsor operate our business due to concerns regarding our ability to discharge our contractual obligations.

Wehave limited experience in the smart eyewear space. If we are unable to manage our growth effectively, our brand “Lucyd”,and our financial performance may suffer, which may have a material adverse effect on our business, financial condition, and operatingresults.

Thesmart eyewear industry is newly emerging. Whilst our directors have more than 80 years of combined experience in the eyewear industry,the smart eyewear market presents numerous new challenges. To effectively manage these challenges and continue to grow, we must continueto invest in the design of new frames and technology, expand our product line and effectively integrate several new technologies intoeyewear. Achieving this could strain our existing resources, and we could experience ongoing operating difficulties in managing our businessand bringing it to scale. Failure to scale could harm our competitive position and future success, including our ability to retain andrecruit personnel and to effectively execute our corporate objectives.

Ourability to generate net revenue will depend upon many factors, some of which we may have no control over.

Theindustry for stylish, affordable smart glasses, is rapidly evolving and may not develop as we expect. Even if our net revenue continuesto increase, our net revenue growth rates may decline in the future as a result of a variety of factors, including macroeconomic factors,increased competition, and the maturation of our business. As a result, you should not rely on our net revenue growth rate for any priorperiod as an indication of our future performance. Overall growth of our net revenue will depend on a number of factors, including ourability to:

•        Increaseexogenous distribution of our products in optical stores, big box retailers, specialty retailers and through multiple ecommerce channels;

•        Priceour products so that we are able to attract new customers, and expand our relationships with existing customers;

•        Accuratelyforecast our net revenue and plan our operating expenses accordingly;

•        Successfullycompete with other companies that are currently in, or may in the future enter, the smart eyewear industry or the markets in which wecompete, and respond to developments from these competitors such as pricing changes and the introduction of new products and features,noting that most, if not all, of our competitors have stronger balance sheets and larger staffs to devote to their products;

•        Complywith existing and new laws and regulations applicable to our business;

•        Developnew product offerings, with services and features, including in response to new trends, competitive dynamics, or the needs of customers;

•        Successfullyidentify and acquire or invest in businesses, products, or technologies that we believe could complement or expand our business;

•        Avoidinterruptions or disruptions in our supply chain from natural disasters and political uncertainty;

15

•        Providecustomers with a high-quality experience and customer service and support that meets their needs;

•        Hire,integrate, and retain talented sales, customer experience, product design, and development and other personnel;

•        Effectivelymanage growth of our business, personnel, and operations;

•        Effectivelymanage our costs related to our business and operations; and,

•        Enhanceour reputation and the value of the Lucyd brand.

Becausewe have a limited history operating our business, it is difficult to evaluate our current business and future prospects, including ourability to plan for and model future growth. Our limited operating experience combined with the rapidly evolving nature of the marketin which we sell our products and services, substantial uncertainty concerning how these markets may develop, and other economic factorsbeyond our control, reduces our ability to accurately forecast quarterly or annual revenue. Failure to manage our future growth effectivelycould have an adverse effect on our business, financial condition, and operating results.

Wealso expect to continue to expend substantial financial and other resources to grow our business, and we may fail to allocate our resourcesin a manner that results in increased net revenue growth in our business. Additionally, we may encounter unforeseen operating expenses,difficulties, complications, delays, and other unknown factors that may result in losses in future periods. If our net revenue growthdoes not meet our expectations in future periods, our business, financial condition, and results of operations may be harmed, and we maynot achieve or sustain profitability in the future.

Increasesin component costs, shipping costs, long lead times, supply shortages, and supply changes could disrupt our supply chain and factors suchas wage rate increases and inflation can have a material adverse effect on our business, financial condition, and operating results.

Meetingcustomer demand partially depends on our ability to obtain timely and adequate delivery of components for our products and services. Allof the components that go into the manufacturing of our products and services are sourced from a limited number of third-partysuppliers predominantly in the U.S., and China. Our contract manufacturers purchase and provide many of these components on our behalf,including sun lenses, demo lenses, hinge and chip sets and other electronic components, and we do not have long-term arrangementswith most of our component suppliers. We are therefore subject to the risk of shortages and long lead times in the supply of these componentsand the risk that our suppliers discontinue or modify components used in our products. In addition, the lead times associated with certaincomponents are lengthy and may preclude rapid changes in design, quantities, and delivery schedules. Our ability to meet temporary unforeseenincreases in demand has been, and may in the future be, impacted by our reliance on the availability of components from these suppliers.We may in the future experience component shortages, and the predictability of the availability of these components may be limited, whichmay be heightened in light of the ongoing COVID-19 pandemic. In the event of a component shortage or supply interruptionfrom suppliers of these components, we may not be able to develop alternate sources in a timely manner. Developing alternate sources ofsupply for these components may be time-consuming, difficult, and costly, and we may not be able to source these componentson terms that are acceptable to us, or at all, which may undermine our ability to fill our orders in a timely manner. Any interruptionor delay in the supply of any of these parts or components, or the inability to obtain these parts or components from alternate sourcesat acceptable prices and within a reasonable amount of time, would harm our ability to timely ship our products to our customers.

Inaddition, substantially all of our components are shipped directly from our contract manufacturers to our warehouse facility in Miamior to a third party optical laboratory in the United States, where lenses are cut and mounted into frames. These laboratories processmost of the glasses ordered by our customers. Once processed at the laboratories, the finished products are then sorted and shipped usingthird-party carriers to our customers. Our eyeglasses are also shipped directly to our third-party distributioncenter in the United States for shipment directly to our customers and resellers. We depend in large part on the orderly operation ofthis distribution process, which depends, in turn, on adherence to shipping schedules and effective management of our optical laboratorynetwork and third-party distribution center. Increases in transportation costs (including increases in fuel costs), issueswith overseas shipments,

16

supplier-sidedelays, as well as reductions in the transportation capacity of carriers, labor strikes or shortages in the transportation industry, disruptionsto the national and international transportation infrastructure, and unexpected delivery interruptions or delays also have the potentialto derail our distribution process.

Moreover,volatile economic conditions may make it more likely that our suppliers and logistics providers may be unable to timely deliver supplies,or at all, and there is no guarantee that we will be able to timely locate alternative suppliers of comparable quality at an acceptableprice. In addition, international supply chains may be impacted by events outside of our control, including but not limited to the COVID-19pandemic, and limit our ability to procure timely delivery of supplies or finished goods and services. We face additional risks relatedto the manufacturing facility we contract with in China and suppliers in China, including port of entry risks such as longshoremen strikes,import restrictions, foreign government regulations, trade restrictions, customs, and duties.

Wesource components from suppliers located in China. Effective September 1, 2019, the U.S. government implemented a 15% tariffon specified products imported into the U.S. from China and effective February 14, 2020, the 15% tariff was reduced to 7.5%.In June 2020, the U.S. government granted a temporary exclusion for plastic and metal frames with a retroactive effective date of September1, 2019, and such exclusion expired in September 2020. Given the recent change in the U.S. presidential administration, there isuncertainty whether there will be, and the resulting impacts of, any changes to U.S. government trade policy. If we are unable to mitigatethe full impact of the enacted tariffs or if there is a further escalation of tariffs, costs on a significant portion of our productsmay increase further and our financial results may be negatively affected. While it is too early to predict how the current and futureChina tariffs will impact our business, our financial results may also be impacted by any resulting economic slowdown.

Theinability to fulfill, or any delays in processing, customer orders through third party optical laboratory optical laboratory could resultin the loss of customers, issuances of refunds or credits, and may also adversely affect our income and reputation. The success of ourretail and e-commerce sales depends on the timely receipt of products by our customers and any repeated, intermittent orlong-term disruption in, or failures of, the operations of our distribution center and/or optical laboratories could resultin lower sales and profitability, a loss of loyalty to our brands, and excess inventory.

Furthermore,increases in compensation, wage pressure, and other expenses for our employees, may adversely affect our profitability. Increases in minimumwages and other wage and hour regulations can exacerbate this risk. These cost increases may be the result of inflationary pressures whichcould further reduce our sales or profitability. Increases in other operating costs, may increase our cost of products sold or selling,general, and administrative expenses. Our competitive price model and pricing pressures in the optical retail industry may inhibit ourability to reflect these increased costs in the prices of our products, in which case such increased costs could have a material adverseeffect on our business, financial condition, and results of operations.

Wecurrently derive all of our revenue from sales of our glasses. A decline in sales of our eyewear would negatively affect our business,financial condition, and results of operations.

Wederive all of our revenue from the sale of one product line, our Lucyd Lyte smart eyewear. Our glasses are sold in highly competitivemarkets with limited barriers to entry. Introduction by competitors of comparable products at lower price points, a maturing product lifecycle,a decline in consumer spending, or other factors could result in a material decline in our revenue. Because we derive most of our revenuefrom the sale of our glasses, any material decline in sales of our glasses would have a material adverse impact on our business, financialcondition, and operating results.

Weface significant risks due to our dependency on foreign supply and manufacturing chains, geopolitical and economic changes, and changesin public perception about internationally sourced and manufactured products.

Sinceour component materials are sourced in China, our production may face additional risks such as, but not limited to: increased shippingcosts, imposition of additional import or trade restrictions, increased custom duties and tariffs, legal or economic restrictions on oursupplier and manufacturer’s ability to meet our needs, unforeseen delays in customs clearance of goods, transportation delays, issueswith ports of entry, new and adverse foreign government regulations, political instability, war, natural disasters, and overall economicuncertainty. Our overseas sourcing and manufacturing could also suffer due to health-related concerns surrounding infectiousdiseases, such the ongoing COVID-19 pandemic. Public opinion about internationally sourced and manufactured products couldbe changed by negative press, which could have an impact on our customers’ confidence and satisfaction, and could also have a negativeimpact on our public image and brand perception.

17

Ifwe fail to cost-effectively retain our existing customers or to acquire new customers, our business, financial condition, and resultsof operations would be harmed.

Thegrowth of our business is dependent upon our ability to continue to grow by cost-effectively retaining our existing customersand adding new customers. Although we believe that many customers originate from word-of-mouth and paid and non-paidreferrals, we expect to continue to expend resources and run marketing campaigns to acquire additional customers, all of which could impactour overall profitability. If we are not able to continue to expand our customer base, or fail to retain customers, our net revenue willgrow slower than expected or decline.

Thegrowth of our e-commerce channel is critical to our continued customer retention and growth. Historically, consumers havebeen slower to adopt online shopping for glasses than e-commerce offerings in other industries such as consumer electronicsand apparel. Improving upon the consumer in-store experience through an online platform is difficult due to broad consumerdemands on selection, quality, convenience, and affordability. Changing traditional optical retail habits is difficult, and if consumersand retailers do not embrace smart eyewear as we expect, our business and operations could be harmed.

Ourability to attract new customers and increase net revenue from existing customers also depends in large part on our ability to enhanceand improve our existing products and to introduce new products and services, in each case, in a timely manner. We also must be able toidentify and originate styles and trends as well as to anticipate and react to changing consumer demands in a timely manner. The successof new and/or enhanced products and services depends on several factors, including their timely introduction and completion, sufficientdemand, and cost-effectiveness. New products that we develop may not be well received and could negatively impact our financialperformance.

Ournumber of customers may decline materially or fluctuate as a result of many factors, including, among other things:

•        thequality, consumer appeal, price, and reliability of products and services offered by us;

•        intensecompetition in the optical retail industry by better financed participants;

•        negativepublicity related to our brand or brand influencers;

•        theimpact of the COVID-19 pandemic or a future outbreak of disease or similar public health concern;

•        customerdissatisfaction with changes we make to our products and services.

Inaddition, if we are unable to provide high-quality support to customers or help resolve issues in a timely and acceptablemanner, our ability to attract new customers and retain customers could be adversely affected. If our number of customers declines orfluctuates for any of these reasons among others, our business would suffer.

Ourprofitability and cash flows may be negatively affected if we are not successful in managing our inventory balances and inventory shrinkage.

Efficientinventory management is a key component of our business success and profitability. To be successful, we must maintain sufficient inventorylevels to meet our customers’ demands without allowing those levels to increase to such an extent that the costs to hold the goodsunduly impact our financial results. We must balance the need to maintain inventory levels that are sufficient to ensure competitive leadtimes against the risk of inventory obsolescence because of changing customer requirements, fluctuating commodity prices, changes to ourproducts, product transfers, or the life cycle of our products. If we fail to adequately forecast demand for any product, or fail to determinethe optimal product mix for production purposes, we may face production capacity issues in processing sufficient quantities of a givenproduct. If our buying and distribution decisions do not accurately predict customer trends or spending levels in general or if we inappropriatelyprice products, we may have to record potential write-downs relating to the value of obsolete or excess inventory. Conversely,if we underestimate future demand for a particular product or do not respond quickly enough to replenish our best performing products,we may have a shortfall in inventory of such products, likely leading to unfulfilled orders, reduced net revenue, and customer dissatisfaction.In addition, because we source components from suppliers located in China, our inventory management may be impacted by enactment or furtherescalation of tariffs, import restrictions, foreign government regulations, trade restrictions, customs, and duties.

18

Maintainingadequate inventory requires significant attention and monitoring of market trends, local markets, developments with suppliers, and ourdistribution network, and it is not certain that we will be effective in our inventory management.

Ifwe fail to maintain and enhance our brand, our ability to engage or expand our base of customers will be impaired, and our business, financialcondition, and results of operations may suffer.

Maintainingand enhancing our appeal and reputation as a stylish, innovative, and coveted brand is critical to attracting and expanding our relationshipswith customers. The successful promotion of our brand and the market’s awareness of our products and services will depend on a numberof factors, including our marketing efforts, ability to continue to develop our products and services, and ability to successfully differentiateour offerings from competitive offerings. We expect to invest substantial resources to promote and maintain our brand, but there is noguarantee that our brand development strategies will enhance the recognition of our brand or lead to increased sales. The strength ofour brand will depend largely on our ability to provide stylish, technologically enhanced products and quality services at competitiveprices. Brand promotion activities may not yield increased net revenue, and even if they do, the increased net revenue may not offsetthe expenses we incur in promoting and maintaining our brand and reputation. In order to protect our brand, we also plan to expend substantialresources to register and defend our trademarks and to prevent others from using the same or substantially similar marks. Despite theseefforts, we and Lucyd Ltd. may not always be successful in protecting the trademarks we license from Lucyd Ltd. Our trademarks may bediluted, and we may suffer harm to our reputation, or other harm to our brand. If our efforts to cost-effectively promoteand maintain our brand are not successful, our results of operations and our ability to attract and engage customers, partners, and employeesmay be adversely affected.

Unfavorablepublicity regarding our products, customer service, or privacy and security practices could also harm our reputation and diminish confidencein, and the use of, our products and services. In addition, negative publicity related to key brands that we have partnered with may damageour reputation, even if the publicity is not directly related to us. If we fail to maintain, protect, and enhance our brand successfullyor to maintain loyalty among customers, or if we incur substantial expenses in unsuccessful attempts to maintain, protect, and enhanceour brand, we may fail to attract or increase the engagement of customers, and our business, financial condition, and results of operationsmay suffer.

Werely heavily on our information technology systems, as well as those of our third-party vendors, business partners, and service providers,for our business to effectively operate and to safeguard confidential information; any significant failure, inadequacy, interruption,or data security incident could adversely affect our business, financial condition, and operations.

Werely heavily on our in-house information technology and enterprise resource planning systems for many functions across ouroperations, including managing our supply chain and inventory, processing customer transactions in our stores, allocating lens processingjobs to the appropriate laboratories, our financial accounting and reporting, compensating our employees, and operating our website, mobileapplications and in-store systems. Our ability to effectively manage our business and coordinate the manufacturing, sourcing,distribution, and sale of our products depends significantly on the reliability and capacity of these systems. We are critically dependenton the integrity, security, and consistent operations of these systems, which are highly reliant on the coordination of our internal businessand engineering teams. We also collect, process, and store sensitive and confidential information, including our proprietary businessinformation and that of our customers, employees, suppliers, and business partners. The secure processing, maintenance, and transmissionof this information is critical to our operations.

Oursystems may be subject to damage or interruption from power outages or damages, telecommunications problems, data corruption, softwareerrors, network failures, acts of war or terrorist attacks, fire, flood, global pandemics, and natural disasters; our existing safetysystems, data backup, access protection, user management, and information technology emergency planning may not be sufficient to preventdata loss or long-term network outages. In addition, we may have to upgrade our existing information technology systems orchoose to incorporate new technology systems from time to time in order for such systems to support the increasing needs of our expandingbusiness. Costs and potential problems and interruptions associated with the implementation of new or upgraded systems and technologyor with maintenance or adequate support of existing systems could disrupt or reduce the efficiency of our operations.

19

Oursystems and those of our third-party service providers and business partners may be vulnerable to security incidents, attacksby hackers, acts of vandalism, computer viruses, misplaced or lost data, human errors or other similar events. If unauthorized partiesgain access to our networks or databases, or those of our third-party service providers or business partners, they may beable to steal, publish, delete, use inappropriately, or modify our private and sensitive third-party information includingpersonal health information, credit card information, and personal identification information. In addition, employees may intentionallyor inadvertently cause data or security incidents that result in unauthorized release of personal or confidential information. Becausethe techniques used to circumvent security systems can be highly sophisticated, change frequently, are often not recognized until launchedagainst a target, and may originate from less regulated and remote areas around the world, we may be unable to proactively address allpossible techniques or implement adequate preventive measures for all situations.

Securityincidents compromising the confidentiality, integrity, and availability of this information and our systems could result from cyber-attacks,computer malware, viruses, social engineering (including spear phishing and ransomware attacks), credential stuffing, supply chain attacks,efforts by individuals or groups of hackers and sophisticated organizations, including state-sponsored organizations, errorsor malfeasance of our personnel, and security vulnerabilities in the software or systems on which we rely. We anticipate that these threatswill continue to grow in scope and complexity over time and such incidents have occurred in the past, and may occur in the future, resultingin unauthorized, unlawful, or inappropriate access to, inability to access, disclosure of, or loss of the sensitive, proprietary and confidentialinformation that we handle.

Wealso rely on a number of third-party service providers to operate our critical business systems, provide us with software,and process confidential and personal information, such as the payment processors that process customer credit card payments, which exposeus to security risks outside of our direct control and our ability to monitor these third-party service providers’data security is limited. These service providers could experience a security incident that compromises the confidentiality, integrity,or availability of the systems they operate for us or the information they process on our behalf. Cybercrime and hacking techniques areconstantly evolving, and we or our third-party service providers may be unable to anticipate attempted security breaches,react in a timely manner, or implement adequate preventative measures, particularly given the increasing use of hacking techniques designedto circumvent controls, avoid detection, and remove or obfuscate forensic artifacts. While we have taken measures designed to protectthe security of the confidential and personal information under our control, we cannot assure you that any security measures that we orour third-party service providers have implemented will be effective against current or future security threats. Moreover,we or our third-party service providers may be more vulnerable to such attacks in remote work environments, which have increasedin response to the COVID-19 pandemic.

Asecurity breach may also cause us to breach our contractual obligations. Our agreements with certain customers, business partners, orother stakeholders may require us to use industry-standard or reasonable measures to safeguard personal information. We alsomay be subject to laws that require us to use industry-standard or reasonable security measures to safeguard personal information.A security incident could lead to claims by our customers, business partners, or other relevant stakeholders that we have failed to complywith such legal or contractual obligations. In addition, our inability to comply with data privacy obligations in our contracts or ourinability to flow down such obligations to our vendors, collaborators, other contractors, or consultants may cause us to breach our contracts.As a result, we could be subject to legal action or our customers or business partners could end their relationships with us. There canbe no assurance that the limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us fromliabilities or damages.

Inaddition, any such access, disclosure or other loss or unauthorized use of information or data, whether actual or perceived, could resultin legal claims or proceedings, regulatory investigations or actions, and other types of liability under laws that protect the privacyand security of personal information, including federal, state and foreign data protection and privacy regulations, violations of whichcould result in significant penalties and fines in the EU and United States. In addition, although we seek to detect and investigate alldata security incidents, security breaches, and other incidents of unauthorized access to our information technology systems and datacan be difficult to detect and any delay in identifying such breaches or incidents may lead to increased harm and legal exposure of thetype described above.

Thecost of investigating, mitigating, and responding to potential security breaches and complying with applicable breach notification obligationsto individuals, regulators, partners, and others can be significant. Further, defending a suit, regardless of its merit, could be costly,divert management attention, and harm our reputation. The successful

20

assertionof one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies,including premium increases or the imposition of large deductible or co-insurance requirements, could adversely affect ourreputation, business, financial condition, revenues, results of operations, or cash flows. Any material disruption or slowdown of oursystems or those of our third-party service providers and business partners, could have a material adverse effect on ourbusiness, financial condition, and results of operations. Our risks are likely to increase as we continue to expand, grow our customerbase, and process, store, and transmit increasing amounts of proprietary and sensitive data.

Oure-commerce and multichannel channel business faces distinct risks, and our failure to successfully manage it could have a negative impacton our profitability.

Asan e-commerce and multichannel retailer, we encounter risks and difficulties frequently experienced by businesses with significantonline and in-store sales. The successful operation of our business as well as our ability to provide a positive shoppingexperience that will generate orders and drive subsequent visits depends on efficient and uninterrupted operation of our e-commerceorder-taking and fulfillment operations. If we are unable to allow real-time and accurate visibility to productavailability when customers are ready to purchase, quickly and efficiently fulfill our customers’ orders using the fulfillment andpayment methods they demand, provide a convenient and consistent experience for our customers regardless of the ultimate sales channel,or effectively manage our online sales, our ability to compete and our results of operations could be adversely affected. Risks associatedwith our e-commerce and multichannel business include:

•        uncertaintiesassociated with our websites, mobile applications and in-store virtual try-on kiosks including changes in requiredtechnology interfaces, website downtime and other technical failures, costs and technical issues as we upgrade our systems software, inadequatesystem capacity, computer viruses, human error, security breaches, legal claims related to our systems operations, and fulfillment;

•        ourpartnership with select third-party apps, through which we sell a portion of our products, are subject to changes in theirtechnology interfaces, website downtime and other technical failures, costs, and issues;

•        disruptionsin internet service or power outages;

•        relianceon third parties for computer hardware and software, as well as delivery of merchandise to our customers;

•        rapidtechnology changes;

•        creditor debit card fraud and other payment processing related issues;

•        cybersecurityand consumer privacy; and

•        naturaldisasters or adverse weather conditions.

Inaddition, we must keep up to date with competitive technology trends, including the use of new or improved technology, creative user interfaces,virtual and augmented reality, and other e-commerce marketing tools such as paid search and mobile application, among others,which may increase our costs and which may not increase sales or attract customers. Our competitors, most of whom have significantly greaterresources than we do, may also be able to benefit from changes in e-commerce technologies, which could harm our competitiveposition.

TheCOVID-19 pandemic has had, and may in the future continue to have, a material adverse impact on our business.

TheCOVID-19 pandemic and the travel restrictions, quarantines, other and related public health measures and actions taken bygovernments and the private sector have adversely affected global economies, financial markets, and the overall environment for our business,and the extent to which it may continue to impact our future results of operations and overall financial performance remains uncertain.The global macroeconomic effects of the pandemic, including the Delta variant and other new variants may persist for an indefinite periodof time, even after the initial waves of the pandemic have subsided.

21

COVID-19and related governmental reactions have had and may continue to have a negative impact on our financial condition, business, and resultsof operations due to the occurrence of some or all of the following events or circumstances, among others:

•        ourinability to manage our business effectively due to key employees becoming ill or being unable to travel to our third-partysuppliers’, contract manufacturers’, logistics providers’, and other business partners’ inability to operate worksitesat full capacity or at all, including manufacturing facilities and shipping and fulfillment centers, due to employee illness or reluctanceto appear at work, or “stay-at-home” regulations;

•        longerwait times and delayed responses to customer support inquiries and requests;

•        ourinability to meet consumer demand and delays in the delivery of our products to our customers, resulting in reputational harm and damagedcustomer relationships;

•        decreasein consumer discretionary spending;

•        inventoryshortages caused by a combination of increased demand that has been difficult to predict with accuracy, and longer lead-timesand component shortages in the manufacturing of our products, due to work restrictions related to COVID-19, shut-down,or disruption of international suppliers, import/export conditions such as port congestion, and local government orders;

•        interruptionsin manufacturing, receiving and making shipments of our products; and

•        disruptionsof the operations of our third-party suppliers, which could impact our ability to purchase components at efficient pricesand in sufficient amounts.

Thescope and duration of the pandemic, including the current resurgences as a result of the Delta variant in various regions in the UnitedStates and globally and other future resurgences, the pace at which government restrictions are lifted or whether additional actions maybe taken to contain the virus, the impact on our customers and suppliers, the speed and extent to which markets fully recover from thedisruptions caused by the pandemic, and the impact of these factors on our business, will depend on future developments that are highlyuncertain and cannot be predicted with confidence. It is possible that changes in economic conditions and steps taken by the federal governmentand the Federal Reserve in response to the COVID-19 pandemic could lead to higher inflation than we had anticipated, whichcould in turn lead to an increase in our costs of products and services and other operating expenses. In addition, to the extent COVID-19continues, it may adversely affect our operations, because people like to try on glasses in stores and in a pandemic, they may be lesslikely to do so.

Pleasesee “Results of Operations” for more details on the potential impact of the COVID-19 pandemic and associatedeconomic disruptions, and the actual operational and financial impacts that we have experienced to date.

Ifwe fail to adapt and respond effectively to rapidly changing technology, evolving industry standards and changing customer needs or requirements,our solutions may become less competitive.

Oursuccess depends on our customers’ willingness to adopt and use our products, as well as our ability to adapt and enhance our products.To attract new customers and increase revenue from existing customers, we need to continue to enhance and improve our products and tomeet customer needs at prices that customers are willing to pay. Such efforts will require adding new features, expanding related applicationsand responding to technological advancements, which will increase our research and development costs. If we are unable to develop solutionsthat address customers’ needs or enhance and improve our platform in a timely manner, we may not be able to increase or maintainmarket acceptance of our products. Further, we may make changes to our products that customers do not find useful. We may also face unexpectedproblems or challenges in connection with new applications or feature introductions.

Moreover,many competitors expend a considerably greater amount of funds on their research and development programs, and those that do not may beacquired by larger companies that would allocate greater resources to competitors’ research and development programs. If we failto compete effectively with the research and development programs of competitors, our business could be harmed. Our ability to grow isalso subject to the risk of future disruptive technologies. If new technologies emerge that are able to deliver smart eyewear productsat lower prices, more efficiently, more conveniently or more securely, such technologies could adversely affect our ability to compete.

22

Wedepend on highly skilled personnel to grow and operate our business, and if we are unable to hire, retain, and motivate our personnel,we may not be able to grow effectively.

Oursuccess and future growth depend largely upon the continued services of our management team, including our Chief Executive Officer HarrisonGross. From time to time, there may be changes in our executive management team resulting from the hiring or departure of our executives.Our executive officers are employed on an at-will basis, which means they may terminate their employment with us at any time.The loss of one or more of our executive officers, or the failure by our executive team to effectively work with our employees and leadour company, could harm our business. We do not maintain key person life insurance with respect to any member of management or other employee.

Inaddition, our future success will depend, in part, upon our continued ability to identify and hire skilled employees with the skills andtechnical knowledge that we require, including software design and programming, eyewear design, marketing, merchandising, operations,and other key management skills and knowledge. Such efforts will require significant time, expense, and attention as there is intensecompetition for such individuals.

Certaintechnological advances, greater availability of, or increased consumer preferences for, vision correction alternatives to prescriptioneyeglasses or contact lenses, and future drug development for the correction of vision-relatedproblems may reduce the demand for our products and adversely impact our business and profitability.

Technologicaladvances in vision care, including the development of new or improved products, as well as future drug development for the correctionof vision-related problems, could significantly change how vision care may be conducted and make our existing products lessattractive or even obsolete. The greater availability and acceptance, or reductions in the cost, of vision correction alternatives toprescription eyeglasses and contact lenses, such as corneal refractive surgery procedures, including radial keratotomy, photorefractivekeratotomy, or PRK, and LASIK, may reduce the demand for our products, lower our sales, and thereby adversely impact our business andprofitability.

Wecould be adversely affected by product liability, product recall or personal injury issues.

Wecould be adversely impacted by the supply of defective products, including the infiltration of counterfeit products into the supply chainor product mishandling issues. Product liability or personal injury claims may be asserted against us with respect to any of the productswe sell or services we provide.

Ifthe products that we sell, including those that we process, package, or label, are defective or otherwise result in product liabilityor personal injury claims against us, our business could be adversely affected and we could be subject to adverse regulatory action. Ifour products or services do not meet applicable governmental safety standards or our customers’ expectations regarding quality orsafety, we could experience lost sales and increased costs, be exposed to legal and reputational risk, and face fines or penalties whichcould materially adversely affect our financial results.

Refunds,cancellations, and warranty claims could harm our business.

Weallow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reasonwithin the first 7 days of their purchase and receive a full refund. At the time of sale, we establish a reserve for returns, based onhistorical experience and expected future returns, which is recorded as a reduction of sales. If we experience a substantial increasein refunds, our cancellation reserve levels might not be sufficient and our business, financial condition, and results of operations couldbe harmed.

Weexpect a number of factors to cause our results of operations and operating cash flows to fluctuate on a quarterly and annual basis, whichmay make it difficult to predict our future performance.

Ourresults of operations could vary significantly from quarter to quarter and year to year because of a variety of factors, many of whichare outside of our control. As a result, comparing our results of operations on a period-to-period basis may not be meaningful.In addition to other risk factors discussed in this section, factors that may contribute to the variability of our quarterly and annualresults include:

•        ourability to accurately forecast and achieve net revenues and appropriately plan our expenses;

•        changesto financial accounting standards and the interpretation of those standards, which may affect the way we recognize and report our financialresults;

23

•        theeffectiveness of our internal controls;

•        theearly-stage nature of our business and the need to scale our operations and,

•        theimpact of the COVID-19 pandemic on our business.

Theimpact of one or more of the foregoing and other factors may cause our results of operations to vary significantly. As such, quarter-to-quarterand year-over-year comparisons of our results of operations may not be meaningful and should not be relied upon as an indicationof future performance.

Wemay require additional capital to support the growth of our business, and this capital might not be available on acceptable terms, ifat all.

Wehave funded our operations since inception primarily through net proceeds from the sale of convertible loan notes and common stock salesthrough two registered crowdfunds and cash flows generated from operating activities. We cannot be certain when, or if, our operationswill generate sufficient cash to fully fund our ongoing operations or the growth of our business. We intend to continue to make investmentsto support the development of our products and services and will require additional funds for such development. We may need additionalfunding for marketing expenses and to develop and expand sales resources, develop new products and improve existing products with newfeatures or enhance our products and services with new technology, improve our operating infrastructure, or acquire complementary businessesand technologies. Accordingly, we might need or may want to engage in future equity or debt financings to secure additional funds. Additionalfinancing may not be available on terms favorable to us, if at all. If adequate funds are not available on acceptable terms, we may beunable to invest in future growth opportunities, which could harm our business, financial condition, and results of operations. In particular,the ongoing COVID-19 pandemic has caused disruption in the credit and financial markets in the United States and worldwide,which may reduce our ability to access capital and negatively affect our liquidity in the future. If we are unable to obtain adequatefinancing or financing on terms satisfactory to us, our ability to develop our products and services, support our business growth, andrespond to business challenges could be significantly impaired, and our business may be adversely affected.

Ifwe incur additional debt, the debt holders would have rights senior to holders of common stock to make claims on our assets, and the termsof any additional debt could include restrictive covenants that restrict our operations, including our ability to pay dividends on ourcommon stock. Furthermore, if we issue additional equity securities, stockholders will experience dilution, and the new equity securitiescould have rights senior to those of our common stock. Because our decision to issue securities in the future will depend on numerousconsiderations, including factors beyond our control, we cannot predict or estimate the amount, timing, or nature of any future issuancesof debt or equity securities. As a result, our stockholders bear the risk of future issuances of debt or equity securities reducing thevalue of our common stock and diluting their interests.

Theoccurrence of any of these foregoing risks could adversely affect our business, financial condition, and results of operations and exposeus to unknown risks or liabilities.

Eyeglassesare regulated as medical devices by the FDA, and our failure, or the failure of any third-party manufacturer or optical laboratory, toobtain and maintain the necessary marketing authorizations for our products could have a material adverse effect on our business.

Weare a FDA registered eyewear importer and we also engage in certain manufacturing, packaging, shipping and labeling activities that subjectus to direct oversight by the FDA under the FDCA and its implementing regulations. The FDA regulates, among other things, with respectto medical devices: design, development and manufacturing, testing, labeling, content, and language of instructions for use and storage;clinical trials; product safety; establishment registration and device listing; marketing, sales and distribution; premarket clearance,classification and approval; recordkeeping procedures; advertising and promotion; recalls and field safety corrective actions; post marketsurveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or seriousinjury; post-market approval studies; and product import and export. The regulations to which we are subject are complexand have tended to become more stringent over time. Regulatory changes could result in restrictions on our ability to carry on or expandour operations, higher than anticipated costs, or lower than anticipated sales. The FDA enforces its regulatory requirements through,among other means, periodic unannounced inspections. Failure to comply with applicable regulations could jeopardize our or our contractmanufacturers’ ability to manufacture and

24

sellour products and result in FDA enforcement actions such as: warning letters; fines; injunctions; civil penalties; termination of distribution;recalls or seizures of products; delays in the introduction of products into the market; total or partial suspension of production; refusalto grant future clearances or approvals; withdrawals or suspensions of clearances or approvals, resulting in prohibitions on sales ofour products; and in the most serious cases, criminal penalties.

Weare subject to rapidly changing and increasingly stringent laws, regulations, contractual obligations, and industry standards relatingto privacy, data security, and data protection. The restrictions and costs imposed by these laws and other obligations, or our actualor perceived failure to comply with them, could subject us to liabilities that adversely affect our business, operations, and financialperformance.

Wecollect, process, store, and use a wide variety of data from current and prospective customers, including personal information, such ashome addresses and geolocation, and health information related to their ophthalmic prescriptions. These activities are regulated by avariety of federal, state, local, and foreign privacy, data security, and data protection laws and regulations, which have become increasinglystringent in recent years.

Domesticprivacy and data security laws are complex and changing rapidly. Many states have enacted laws regulating the online collection, use,and disclosure of personal information and requiring that companies implement reasonable data security measures. Laws in all states andU.S. territories also require businesses to notify affected individuals, governmental entities, and/or credit reporting agencies of certainsecurity incidents affecting personal information. These laws are not consistent, and compliance with them in the event of a widespreaddata breach is complex and costly.

Further,the California Consumer Privacy Act (CCPA) took effect on January 1, 2020. The CCPA gives California residents expanded rightsrelated to their personal information, including the right to access and delete their personal information, and receive detailed informationabout how their personal information is used and shared. The CCPA also created restrictions on “sales” of personal informationthat allow California residents to opt-out of certain sharing of their personal information and may restrict the use of cookiesand similar technologies for advertising purposes. Our e-commerce platform, including our websites and mobile applications,rely on these technologies and could be adversely affected by the CCPA’s restrictions. The CCPA prohibits discrimination againstindividuals who exercise their privacy rights, provides for civil penalties for violations, and creates a private right of action fordata breaches that is expected to increase data breach litigation. Additionally, a new California ballot initiative, the California PrivacyRights Act, or CPRA, was recently passed in California. The CPRA will restrict use of certain categories of sensitive personal informationthat we handle; further restrict the use of cross-context behavioral advertising techniques on which our products may relyin the future; establish restrictions on the retention of personal information; expand the types of data breaches subject to the privateright of action; and establish the California Privacy Protection Agency to implement and enforce the new law, as well as impose administrativefines. The majority of the CPRA’s provisions will go into effect on January 1, 2023, and additional compliance investmentand potential business process changes will likely be required. Similar laws have been proposed in other states and at the federal level,reflecting a trend toward more stringent privacy legislation in the United States. Compliance with such laws could be difficult and costlyto achieve and we could be subject to fines and penalties in the event of non-compliance.

Additionally,we are subject to certain health information privacy and security laws as a result of the health information that we receive in connectionwith our products and services. These laws and regulations include not be adequate to indemnify us for the full extent of our potentialliabilities.

Ourbusiness could be adversely impacted by changes in the internet and mobile device accessibility of users. Companies and governmental agenciesmay restrict access to our products and services, our mobile applications, website, application stores, or the internet generally, whichcould negatively impact our operations.

Ourbusiness depends on customers accessing our products and services via a mobile device or a personal computer, and the internet. We mayoperate in jurisdictions that provide limited internet connectivity. Internet access and access to a mobile device or personal computerare frequently provided by companies with significant market power that could take actions that degrade, disrupt, or increase the costof consumers’ ability to access our products and services. In addition, the internet infrastructure that we and our customers relyon in any particular geographic area may be

25

unableto support the demands placed upon it and could interfere with the speed and availability of our products and services. Any such failurein internet or mobile device or computer accessibility, even for a short period of time, could adversely affect our results of operations.

Governmentalagencies in any of the countries in which we or our customers are located could block access to or require a license for our mobile applications,website, or the internet generally for a number of reasons, including security, confidentiality, or regulatory concerns. In addition,companies may adopt policies that prohibit their employees from using our products and services. If companies or governmental entitiesblock, limit, or otherwise restrict customers from accessing our products and services, our business could be negatively impacted, thenumber of customers could decline or grow more slowly, and our results of operations could be adversely affected.

Wecould incur significant liabilities related to, and significant costs in complying with, environmental, health, and safety laws and regulations.

Ouroperations are subject to various national, state, and local environmental, health, and safety laws and regulations that govern, amongother things, the health and safety of our employees and the end-users of our products and the materials used in, and therecycling of, our products and their packaging. Non-compliance with, or liability related to, these laws and regulations,which tend to become more stringent over time, could result in substantial fines or penalties, injunctive relief, civil, or criminal sanctions,and could expose us to costs of investigation or remediation, as well as tort claims for property damage or personal injury.

Inaddition, a number of governmental authorities, both in the United States and abroad, have considered, and are expected to consider, legislationaimed at reducing the amount of plastic non-recyclable waste. Programs have included banning certain types of products, mandatingcertain rates of recycling and/or the use of recycled materials, imposing deposits or taxes on single-use plastic bags, paperbags, reusable bags, and packaging materials. Such legislation, as well as voluntary initiatives, aimed at reducing the level of plasticwastes could result in increased cost of packaging for our products or otherwise require us to alter our current packaging and baggingpractices. Additional regulatory efforts addressing other environmental or safety concerns in the future could similarly impact our business,financial condition, and results of operations.

Fromtime to time, we may be subject to legal proceedings, regulatory disputes, and governmental inquiries that could cause us to incur significantexpenses, divert our management’s attention, and materially harm our business, financial condition, and operating results.

Fromtime to time, we may be subject to claims, lawsuits, government investigations, and other proceedings involving products liability, competitionand antitrust, intellectual property, privacy, false advertising, consumer protection, securities, tax, labor and employment, commercialdisputes, and other matters that could adversely affect our business operations and financial condition. As we grow, we may see a risein the number and significance of these disputes and inquiries. Litigation and regulatory proceedings may be protracted and expensive,and the results are difficult to predict. Certain of these matters include speculative claims for substantial or indeterminate amountsof damages and include claims for injunctive relief. Additionally, our litigation costs could be significant. Adverse outcomes with respectto litigation or any of these legal proceedings may result in significant settlement costs or judgments, penalties and fines, or requireus to modify our products or services, all of which could negatively affect our revenue growth. The results of litigation, investigations,claims, and regulatory proceedings cannot be predicted with certainty, and determining reserves for pending litigation and other legaland regulatory matters requires significant judgment. There can be no assurance that our expectations will prove correct, and even ifthese matters are resolved in our favor or without significant cash settlements, these matters, and the time and resources necessary tolitigate or resolve them, could harm our business, financial condition, and results of operations.

RisksRelated to Intellectual Property

Welicense our technology from Lucyd Ltd., the majority stockholder of the Company, and our inability to maintain this license could materiallyaffect our business, financial condition, and operating results.

Allour current intellectual property is licensed from Lucyd Ltd., the majority stockholder of the Company, pursuant to a license agreementwe entered into with Lucyd Ltd. on April 1, 2020 (the “License Agreement”). Pursuant to the License Agreement,we acquired an exclusive, worldwide license that is royalty-free, fully paid up, and perpetual

26

licensefor the exclusive use of certain assets of Lucyd Ltd. related to Innovative Eyewear current products and trademarks. There can be no assurancethat the license will not be terminated by Lucyd Ltd. and if we are unable to continue to license the technology (because of, for example,intellectual property infringement claims brought by third-parties against us or against Lucyd Ltd.) then our business, financialcondition and operating results would be adversely affected. If we are unable to continue the License Agreement, our ability to continuedeveloping, designing, manufacturing, distributing, and selling our products would be limited and may require us to stop selling our products.If the License Agreement is terminated for any reason, we may be forced to acquire or develop alternative technology, which we may beunable to do in a commercially feasible manner, if at all, and may require us to use alternative technology of lower quality or performancestandards. This could, in turn, limit, delay or disrupt our ability to offer new or competitive solutions and could also increase ourcosts, which could adversely affect our margins, market share, business, financial condition, and operating results. Please see “Business—MaterialAgreements” for a more complete description of the License Agreement.

Failureto adequately maintain and protect our intellectual property and proprietary rights could harm our brand, devalue our proprietary content,and adversely affect our ability to compete effectively.

Oursuccess depends to a significant degree on Lucyd Ltd.’s ability to obtain, maintain, protect, and enforce our licensed intellectualproperty rights, including those in our proprietary technologies, know-how, and brand. To protect our rights to our intellectualproperty, we rely on a combination of patent, trademark, copyright and trade secret laws, domain name registrations, confidentiality agreements,and other contractual arrangements with our employees, affiliates, clients, strategic partners, and others. However, the protective stepswe have taken and plan to take may be inadequate to deter misappropriation or other violation of or otherwise protect our intellectualproperty rights. We may be unable to detect the unauthorized use of, or take appropriate steps to enforce, our intellectual property rights.Effective patent, trademark, copyright, and trade secret protection may not be available to us or available in every jurisdiction in whichwe offer or intend to offer our services. Failure to adequately protect our intellectual property could harm our brand, devalue our proprietarytechnology and content, and adversely affect our ability to compete effectively. Further, even if we are successful, defending our intellectualproperty rights could result in the expenditure of significant financial and managerial resources, which could adversely affect our business,financial condition, and results of operations.

Ifwe fail to protect our intellectual property rights adequately, our competitors may gain access to our licensed intellectual propertyand proprietary technology and develop and commercialize substantially identical offerings or technologies. Any patents, trademarks, copyrights,or other intellectual property rights that we have or may obtain may be challenged or circumvented by others or invalidated or held unenforceablethrough administrative process, including re-examinationinter partes review,interference and derivation proceedings, and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings), or litigation.There can be no assurance that our patent applications will result in issued patents and we may be unable to obtain or maintain patentprotection for our technology. In addition, any patents issued from pending or future patent applications or licensed to us in the futuremay not provide us with claims sufficiently broad to provide meaningful competitive advantages or may be successfully challenged by thirdparties. There is also no guarantee that our pending trademark applications for any mark will proceed to registration; our pending applicationsmay be opposed by a third party prior to registration; and even those trademarks that are registered could be challenged by a third party,including by way of revocation or invalidity actions. For example, we have registrations in a number of foreign countries in which weare not currently offering goods or services, and those registrations could be subject to invalidation proceedings if we cannot demonstrateuse of the marks by the applicable use deadlines in those countries. In addition, because patent applications in the United States arecurrently maintained in secrecy for a period of time prior to issuance, and patent applications in certain other countries generally arenot published until more than 18 months after they are first filed, and because publication of discoveries in scientificor patent literature often lags behind actual discoveries, we cannot be certain that we were the first creator of inventions covered byour pending patent applications or that we were the first to file patent applications on such inventions. To maintain a proprietary marketposition in foreign countries, we may seek to protect some of our proprietary inventions through foreign counterpart patent applications.Statutory differences in patentable subject matter may limit the protection we can obtain on some of our inventions outside of the UnitedStates. The diversity of patent laws may make our expenses associated with the development and maintenance of intellectual property inforeign jurisdictions more expensive than we anticipate. We probably will not be able to obtain the same patent protection in every marketin which we may otherwise be able to potentially generate revenue. Further, the laws of some foreign countries may not be as protectiveof intellectual property rights as those in the United States, and mechanisms for enforcement

27

ofintellectual property rights may be inadequate. Moreover, policing unauthorized use of our technologies, trade secrets, and intellectualproperty may be difficult, expensive, and time-consuming. Despite our precautions, it may be possible for unauthorized thirdparties to copy our offerings and capabilities and use information that we regard as proprietary to create offerings that compete withours. Third parties may apply to register our trademarks or other trademarks similar to our trademarks in jurisdictions before us, therebycreating risks relating to our ability to use and register our trademarks in those jurisdictions. In addition, there could be potentialtrade name or trademark ownership or infringement claims brought by owners of other rights, including registered trademarks, in our marksor marks similar to ours. Any claims of infringement, brand dilution, or consumer confusion related to our brand (including our trademarks)or any failure to renew key license agreements on acceptable terms could damage our reputation and brand identity and substantially harmour business and results of operations. The value of our intellectual property could diminish if others assert rights in or ownershipof our trademarks and other intellectual property rights, or trademarks that are similar to our trademarks. We may be unable to successfullyresolve these types of conflicts to our satisfaction. In some cases, litigation or other actions may be necessary to protect or enforceour trademarks and other intellectual property rights.

Wegenerally enter into confidentiality and invention assignment agreements with our employees and consultants, as well as confidentialityagreements with other third parties, including suppliers and other partners. However, we cannot guarantee that we have entered into suchagreements with each party that has or may have had access to our proprietary information, know-how, and trade secrets. Moreover,no assurance can be given that these agreements will be effective in controlling access to our proprietary information or the distribution,use, misuse, misappropriation, reverse engineering, or disclosure of our proprietary information, know-how, and trade secrets.Further, these agreements may not prevent our competitors from independently developing technologies that are substantially equivalentor superior to our offerings and capabilities. These agreements may be breached, and we may not have adequate remedies for any such breach.

Wemay be required to spend significant resources to monitor and protect our intellectual property rights. Litigation may be necessary inthe future to enforce our intellectual property rights and to protect our trade secrets. Litigation brought to protect and enforce ourintellectual property rights could be costly, time-consuming, and distracting to management, and could result in the impairmentor loss of portions of our intellectual property rights. Further, our efforts to enforce our intellectual property rights may be met withdefenses, counterclaims, and countersuits attacking the validity and enforceability of our intellectual property rights, and if such defenses,counterclaims, or countersuits are successful, we could lose valuable intellectual property rights. Further, any changes in law or interpretationof any such laws, particularly intellectual property laws, may impact our ability to protect, register, or enforce our intellectual propertyrights. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation or diversionof our management’s attention and resources, could delay further sales or the implementation of our offerings and capabilities,impair the functionality of our offerings and capabilities, delay introductions of new offerings, result in our substituting inferioror more costly technologies into our offerings, or injure our reputation.

Domainnames generally are regulated by internet regulatory bodies, and the regulation of domain names is subject to change. Regulatory bodieshave and may continue to establish additional top-level domains, appoint additional domain name registrars, or modify therequirements for holding domain names. We may not be able to, or it may not be cost-effective to, acquire or maintain alldomain names that utilize the name “Lucyd Ltd.” or “Innovative Eyewear” in all of the countries in which we currentlyconduct or intend to conduct business. If we lose the ability to use a domain name, we could incur significant additional expenses tomarket our products within that country, including the development of new branding. This could substantially harm our business, resultsof operations, financial condition and prospects.

Wemay incur costs to defend against, face liability or for being vulnerable to intellectual property infringement claims brought againstus by others.

Thirdparties may assert claims against us alleging that we infringe upon, misappropriate, dilute or otherwise violate their intellectual propertyrights, particularly as we expand our business and the number of products we offer. These risks have been amplified by the increase inthird parties whose sole or primary business is to assert such claims. We may be particularly vulnerable to such claims, as companieshaving a substantial online presence are frequently subject to litigation based on allegations of infringement or other violations ofintellectual property rights. As we gain an increasingly high public profile, the possibility of intellectual property rights claims againstus grows. Our competitors and others may now and in the future have significantly larger and more mature patent portfolios than us.

28

Werely on contracts and releases for ownership of copyrighted materials and the right to use images of individuals on our webpage and marketingmaterial, and we may be subject to claims that we did not properly obtain rights, consent, a release, or permission to use certain contentor imagery. Many potential litigants have the ability to dedicate substantial resources to the assertion of their intellectual propertyrights. Any claim of infringement by a third party, even those without merit, could cause us to incur substantial costs defending againstthe claim, could distract our management from our business, could require us to cease use of such intellectual property, and could createongoing obligations if we are subject to agreements or injunctions (stipulated or imposed) preventing us from engaging in certain acts.Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, we risk compromisingour confidential information during this type of litigation. Our defense of any claim, regardless of its merit, could be expensive andtime consuming and could divert management resources. We cannot predict the outcome of lawsuits and cannot ensure that the results ofany such actions will not have an adverse effect on our business, financial condition, or results of operations. Successful infringementclaims against us could result in significant monetary liability or prevent us from selling some of our products. In addition, resolutionof claims may require us to redesign or rebrand our products, license rights from third parties on potentially unfavorable terms, ceaseusing certain brand names or other intellectual property rights altogether, make substantial payments for royalty or license fees, legalfees, settlement payments or other costs or damages, or admit liability. Such outcomes could encourage others to bring claims againstus. To the extent we seek a license to continue offerings or operations found or alleged to infringe third-party intellectualproperty rights, such a license may be non-exclusive, and therefore our competitors may have access to the same technologylicensed to us. In the event we are required to develop alternative, non-infringing technology, this could require significanttime (during which we would be unable to continue to offer our affected offerings), effort and expense, and may ultimately not be successful.Any of these events could harm our business and cause our results of operations, liquidity, and financial condition to suffer.

RisksRelated to Our Dependence on Third Parties

Weface risks associated with suppliers from whom our products are sourced and are dependent on a limited number of suppliers.

Wepurchase all of the inputs for our products, including eyeglass frames, temples with electronics embedded within them, prescription lenses,sun lenses, demo lenses, hinges, packaging materials and other components, parts, and raw materials, directly or indirectly from domesticand international suppliers. For our business to be successful, our suppliers must be willing and able to provide us with inputs in substantialquantities, in compliance with regulatory requirements, at acceptable costs and on a timely basis. Our ability to obtain a sufficientselection or volume of inputs on a timely basis at competitive prices could suffer as a result of any deterioration or change in our supplierrelationships or events that adversely affect our suppliers.

Wetypically do not enter into long-term contracts with our suppliers and, as such, we operate without significant contractualassurances of continued supply, pricing or access to inputs. Any of our suppliers could discontinue supplying us with desired inputs insufficient quantities or offer us less favorable terms on future transactions for a variety of reasons. The benefits we currently experiencefrom our suppliers relationships could be adversely affected if our suppliers:

•        discontinueselling products to us;

•        raisetheir prices;

•        increaselead times for products and/or key components

Wealso source inputs directly from suppliers outside of the United States, including China. Global sourcing and foreign trade involve numerousfactors and uncertainties beyond our control including increased shipping costs, the imposition of additional import or trade restrictions,including legal or economic restrictions on overseas suppliers’ ability to produce and deliver inputs, increased custom duties andtariffs, unforeseen delays in customs clearance of goods, more restrictive quotas, loss of a most favored nation trading status, currencyexchange rates, transportation delays, port of entry issues and foreign government regulations, political instability, and economic uncertaintiesin the countries from which we or our suppliers source our products.

Additionally,sourcing could be impacted by current and future travel restrictions and/or the shut-down of certain businesses globallydue to the COVID-19 pandemic.

29

Werely on a limited number of contract manufacturers and logistics partners for our products. A loss of any of these partners could negativelyaffect our business.

Werely on a limited number of third-party suppliers and contract manufacturers for the components that go into the manufacturingof our products. In particular, our frames are provided by a single supplier. We also assemble and fulfill glasses at a single third-partyoptical laboratory. Our reliance on a limited number of contract manufacturers and logistics partners for our products increases our risksof being unable to deliver our products in a timely and cost-effective manner. In the event of interruption from any of ourcontract manufacturers or our own fulfillment capabilities, we may not be able to increase capacity from other sources or develop alternateor secondary sources without incurring material additional costs and substantial delays.

Ourbusiness could be adversely affected if one or more of our manufacturers is impacted by a natural disaster, an epidemic such as the currentCOVID-19 outbreak, or other interruption at a particular location. In particular, the current COVID-19 outbreakhas caused, and will likely continue to cause, interruptions in the development, manufacturing (including the sourcing of key components),and shipment of our products, which could adversely impact our revenue, gross margins, and operating results.

Additionally,we do not own or operate a warehouse or a warehouse management company or system, and we currently rely on a single third-partywarehouse. Because a significant percentage of our products are stored in and shipped out of the single third-party warehouse,we face significant risks such as, but not limited to: our operations could be disrupted and our inventory could be destroyed by earthquakes,floods, fires or other natural disasters or other events outside of our control, or the control of our third-party warehouse.Our dependence on a single third-party warehouse also exposes us to the risk that the warehouse may experience operationaldisruptions due to security or computer viruses, software and hardware failure, power interruptions and other system failures. If we encounterproblems with our third-party warehouse, we may be unable to meet customer expectations, manage our inventory and fulfillmentcapacity, complete sales, fulfill orders in a timely fashion, and our ability to achieve objectives for operating efficiencies could beadversely affected, all of which could harm our reputation and our relationship with our customers.

Ourprojects could be hindered due to our dependence on third parties to complete many of our contracts.

Inthe current economic environment, third parties may find it difficult to obtain sufficient financing to help fund their operations. Theinability to obtain financing could adversely affect a third party’s ability to provide materials, equipment or services which couldhave a material adverse impact on our business, financial condition, and results of operations. In addition, a failure by a third partysubcontractor, supplier or manufacturer to comply with applicable laws, regulations or client requirements could negatively impact ourbusiness and, for government clients, could result in fines, penalties, suspension or even debarment being imposed on us, which couldhave a material adverse impact on our business, financial condition, and results of operations.

Wedepend on search engines, social media platforms, digital application stores, content-based online advertising, and other online sourcesto attract consumers to and promote our website and our mobile applications, which may be affected by third-party interference beyondour control and as we grow our customer acquisition costs may continue to rise.

Oursuccess depends in part on our ability to attract consumers to our website, mobile applications, and retail partners to convert them intocustomers in a cost-effective manner. We depend, in large part, on search engines, social media platforms, digital applicationstores, content-based online advertising, and other online sources for traffic to our website, mobile applications, and selectapplication partners.

Withrespect to search engines, we are included in search results as a result of both paid search listings, where we purchase specific searchterms that result in the inclusion of our advertisement, and free search listings, which depend on algorithms used by search engines.For paid search listings, if one or more of the search engines or other online sources on which we rely for purchased listings modifiesor terminates its relationship with us, our expenses could rise, we could lose consumers and traffic to our website could decrease, anyof which could have a material adverse effect on our business, financial condition, and results of operations.

30

Weplan to rely primarily on third-party insurance policies to insure our operations-related risks. If our insurance coverage is insufficientfor the needs of our business or our insurance providers are unable to meet their obligations, we may not be able to mitigate the risksfacing our business, which could adversely affect our business, financial condition, and results of operations.

Weprocure third-party insurance policies or plan to procure policies to cover various operations-related risksincluding employment practices liability, workers’ compensation, property and business interruptions, cybersecurity and data breaches,crime, directors’ and officers’ liability, and general business liabilities. We rely on a limited number of insurance providers,and should such providers discontinue or increase the cost of coverage, we cannot guarantee that we would be able to secure replacementcoverage on reasonable terms or at all. If our insurance carriers change the terms of our policies in a manner not favorable to us, ourinsurance costs could increase. Further, if the insurance coverage we maintain is not adequate to cover losses that occur, or if we arerequired to purchase additional insurance for other aspects of our business, we could be liable for significant additional costs. Additionally,if any of our insurance providers becomes insolvent, it would be unable to pay any operations-related claims that we make.

GeneralRisk Factors

Failureto establish and maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverseeffect on our business and stock price.

Weare not currently required to comply with the rules of the SEC implementing Section 404 of the Sarbanes-Oxley Act and thereforeare not required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. Uponbecoming a publicly traded company, we will be required to comply with the SEC’s rules implementing Sections 302 and 404 of theSarbanes-Oxley Act, which will require management to certify financial and other information in our quarterly and annualreports and provide an annual management report on the effectiveness of controls over financial reporting. Though we will be requiredto disclose changes made in our internal controls and procedures on a quarterly basis, we will not be required to make our first annualassessment of our internal control over financial reporting pursuant to Section 404 until the year following our first annual report requiredto be filed with the SEC. As an “emerging growth company,” as defined in the JOBS Act, we may take advantage of certain temporaryexemptions from various reporting requirements, including, but not limited to, not being required to comply with the auditor attestationrequirements of Section 404 of the Sarbanes Oxley Act (and the rules and regulations of the Securities and Exchange Commission thereunder).Once we no longer qualify as an “emerging growth company” under the JOBS Act and lose the ability to rely on the exemptionsrelated thereto discussed above and depending on our status as per Rule 12b-2 of the Securities Exchange Act of 1934, asamended, our independent registered public accounting firm may also need to attest to the effectiveness of our internal control over financialreporting under Section 404.

Basedon the number of personnel available to serve the Company’s accounting function, management believes we are not able to adequatelysegregate responsibility over financial transaction processing and reporting. Further, the Company does not have a formal internal controlenvironment in place and operating effectively. As such, we have identified these issues as material weaknesses in our internal controlover financial reporting and we may identify additional material weaknesses in the future that may cause us to fail to meet our reportingobligations or result in material misstatements of our financial statements. If our remediation of such material weaknesses is not effective,or if we fail to develop and maintain an effective system of internal controls and internal control over financial reporting, our abilityto produce timely and accurate financial statements or comply with applicable laws and regulations could be materially and adversely affectedand the market price of our common stock could be negatively affected, which could require additional financial and management resources.

Changesin tax treatment of companies engaged in e-commerce may adversely affect the commercial use of our sites and our financial results.

Dueto the global nature of the Internet, it is possible that various states or foreign countries might attempt to impose additional or newregulation on our business or levy additional or new sales, income, or other taxes relating to our activities. Tax authorities at theinternational, federal, state, and local levels are currently reviewing the appropriate treatment of companies engaged in e-commerceand digital services. New or revised international, federal, state, or local tax regulations or court decisions may subject us or ourcustomers to additional sales, income and other taxes. For example, on June 21, 2018, the U.S. Supreme Court rendered a 5-4majority decision in South Dakota v. Wayfair Inc.,

31

17-494where the Court held, among other things, that a state may require an out-of-state seller with no physical presence in thestate to collect and remit sales taxes on goods the seller ships to consumers in the state, overturning existing court precedent. Othernew or revised taxes and, in particular, digital taxes, sales taxes, VAT, and similar taxes could increase the cost of doing businessonline and decrease the attractiveness of selling products over the Internet. New taxes and rulings could also create significant increasesin internal costs necessary to capture data and collect and remit taxes. Any of these events could have a material adverse effect on ourbusiness, financial condition, and operating results.

Anoverall decline in the health of the economy and other factors impacting consumer spending, such as recessionary conditions, governmentalinstability, inclement weather, and natural disasters, may affect consumer purchases, which could reduce demand for our products and harmour business, financial conditions, and results of operations.

Ourbusiness depends on consumer demand for our products and, consequently, is sensitive to a number of factors that influence consumer confidenceand spending, such as general economic conditions, consumer disposable income, energy and fuel prices, recession and fears of recession,unemployment, minimum wages, availability of consumer credit, consumer debt levels, conditions in the housing market, interest rates,tax rates and policies, inflation, consumer confidence in future economic conditions and political conditions, war and fears of war, inclementweather, natural disasters, terrorism, outbreak of viruses or widespread illness, and consumer perceptions of personal well-beingand security.

Weare an “emerging growth company,” and we cannot be certain if the reduced reporting and disclosure requirements applicableto emerging growth companies will make our common stock less attractive to investors.

Weare an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from reportingrequirements that are applicable to other public companies that are not “emerging growth companies,” including the auditorattestation requirements of Section 404, reduced disclosure obligations regarding executive compensation in our periodic reports and proxystatements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholderapproval of any golden parachute payments not previously approved. Pursuant to Section 107 of the JOBS Act, as an emerging growth company,we have elected to use the extended transition period for complying with new or revised accounting standards until those standards wouldotherwise apply to private companies. As a result, our financial statements may not be comparable to the financial statements of issuerswho are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies, whichmay make our common stock less attractive to investors. In addition, if we cease to be an emerging growth company, we will no longer beable to use the extended transition period for complying with new or revised accounting standards.

Wewill remain an emerging growth company until the earliest of: (1) the last day of the fiscal year following the fifth anniversary of ourlisting; (2) the last day of the first fiscal year in which our annual gross revenue is $1.07 billion or more; (3) the dateon which we have, during the previous rolling three-year period, issued more than $1 billion in non-convertibledebt securities; and (4) the date on which we are deemed to be a “large accelerated filer” under the rules of the SEC.

Wecannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. For example, if we donot adopt a new or revised accounting standard, our future results of operations may not be comparable to the results of operations ofcertain other companies in our industry that adopted such standards. If some investors find our common stock less attractive as a result,there may be a less active trading market for our common stock, and our stock price may be more volatile.

Ifour estimates or judgments relating to our critical accounting policies prove to be incorrect, our results of operations could be adverselyaffected.

Thepreparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amountsreported in our financial statements and accompanying notes appearing elsewhere in this prospectus. We base our estimates on short durationhistorical experience and on various other assumptions that we believe to be reasonable under the circumstances, as provided in the sectiontitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policiesand Estimates.” The results

32

ofthese estimates form the basis for making judgments about the carrying values of assets, liabilities, and equity, and the amount of revenueand expenses. Significant estimates and judgments involve: revenue recognition, including revenue-related reserves; legalcontingencies; valuation of our common stock and equity awards; income taxes; and sales and indirect tax reserves. Our results of operationsmay be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could causeour results of operations to fall below the expectations of securities analysts and investors, resulting in a decline in the market priceof our common stock.

Ourcurrent insurance coverage may not be adequate, and we may not be able to obtain insurance at acceptable rates, or at all.

Wecurrently have General Liability and Product Liability policies covering our business. These policies may not provide sufficient coveragein the face of significant claims or multiple claims. Claims exceeding our insurance coverage could create significant increases in internalcosts. This even could have a material adverse effect on our business, financial condition, and operating results.

Wemay decide to pursue strategic acquisitions to accelerate our growth. These potential acquisitions may not be successful. We may not beable to successfully integrate future acquisitions or generate sufficient revenues from future acquisitions, which could cause our businessto suffer.

Ifwe buy a company or a division of a company, there can be no assurance that we will be able to profitably manage such business or successfullyintegrate such business without substantial costs, delays or other operational or financial problems. There can be no assurance that thebusinesses we acquire in the future will achieve anticipated revenues and earnings. Additionally:

•        thekey personnel of the acquired business may decide not to work for us;

•        changesin management at an acquired business may impair its relationships with employees and customers;

•        wemay be unable to maintain uniform standards, controls, procedures and policies among acquired businesses;

•        wemay be unable to successfully implement infrastructure, logistics and systems integration;

•        wemay be held liable for legal claims (including environmental claims) arising out of activities of the acquired businesses prior to ouracquisitions, some of which we may not have discovered during our due diligence, and we may not have indemnification claims availableto us or we may not be able to realize on any indemnification claims with respect to those legal claims;

•        wewill assume risks associated with deficiencies in the internal controls of acquired businesses;

•        wemay not be able to realize the cost savings or other financial benefits we anticipated; and

•        ourongoing business may be disrupted or receive insufficient management attention.

Futureacquisitions may require us to obtain additional equity or debt financing, which may not be available on attractive terms. Moreover, tothe extent an acquisition transaction financed by non-equity consideration results in additional goodwill, it will reduceour tangible net worth, which might have an adverse effect on our credit and bonding capacity.

RisksRelating to Our Securities and this Offering

Ourdirectors, executive officers and principal stockholders will continue to have substantial control over our company after this offering,which could limit your ability to influence the outcome of key transactions, including a change of control.

Uponcompletion of this offering, our executive officers, directors and principal stockholders and their affiliates will own               shares of our common stock, or approximately               % ofthe outstanding shares of our common stock, based on the number of shares outstanding as of the date of this prospectus and assuming thesale of                Units in this offering at an assumed initialpublic offering price of $               per Unit, which is themidpoint of the price range set forth on the cover page of this prospectus, and underwriters’ over-allotment option

33

isnot exercised. As a result, these stockholders will be able to exercise a significant level of control over all matters requiring stockholderapproval, including the election of directors and the approval of mergers, acquisitions or other extraordinary transactions. They mayalso have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. Thisconcentration of ownership may have the effect of delaying, preventing or deterring a change of control of our company, could depriveour stockholders of an opportunity to receive a premium for their common stock as part of a sale of our company and might ultimately affectthe market price of our common stock.

Thereis no existing market for our securities and we do not know if one will develop to provide you with adequate liquidity. Even if a marketdoes develop following this offering, the prices in the market may not exceed the offering price.

Priorto this offering, there has not been a public market for our securities. We cannot assure you that an active trading market for our commonstock will develop following this offering, or if it does develop, it may not be maintained. You may not be able to sell your shares quicklyor at the market price if trading in our common stock is not active. There is no established trading market for any of the Warrants, andwe do not expect a market to develop. We do not intend to apply for a listing for any of the Warrants on any securities exchange or othernationally recognized trading system. Without an active trading system, the liquidity of the Warrants will be limited. The initial publicoffering price for the Units will be determined by negotiations between us and representatives of the underwriters and may not be indicativeof prices that will prevail in the trading market following the completion of this offering. Consequently, you may not be able to sellshares of our common stock or Warrants at prices equal to or greater than the price you pay in this offering.

Themarket price of our securitiesis likely to be highly volatile, and you could lose all or part of your investment.

Thetrading price of our common stock and Warrants is likely to be volatile. This volatility may prevent you from being able to sell yourshares of common stock or Warrants at or above the price you paid in this offering. The market price of our securities could be subjectto wide fluctuations in response to a variety of factors, which include:

•        actualor anticipated fluctuations in our quarterly or annual operating results;

•        publicationof research reports by securities analysts about us or our competitors or our industry;

•        thepublic’s reaction to our press releases, our other public announcements and our filings with the SEC;

•        ourfailure or the failure of our competitors to meet analysts’ projections or guidance that we or our competitors may give to the market;

•        additionsand departures of key personnel;

•        strategicdecisions by us or our competitors, such as acquisitions, divestitures, spin-offs, joint ventures, strategic investmentsor changes in business strategy;

•        thepassage of legislation or other regulatory developments affecting us or our industry;

•        speculationin the press or investment community;

•        changesin accounting principles;

•        terroristacts, acts of war or periods of widespread civil unrest;

•        naturaldisasters and other calamities; and

•        changesin general market and economic conditions.

Inaddition, the stock market has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate tothe operating performance of companies. Broad market and industry factors may negatively affect the market price of our common stock andWarrants, regardless of our actual operating performance. In the past, securities class action litigation has often been initiated againstcompanies following periods of volatility in their stock price. This type of litigation could result in substantial costs and divert ourmanagement’s attention and resources, and could also require us to make substantial payments to satisfy judgments or to settle litigation.

34

Ourtrading price and trading volume could decline if securities or industry analysts do not publish research about our business, or if theypublish unfavorable research.

Equityresearch analysts do not currently provide coverage of our common stock, and we cannot assure that any equity research analysts will adequatelyprovide research coverage of our common stock after the listing of our common stock on the NASDAQ. To the extent equity researchanalysts do provide research coverage of our common stock, we will not have any control over the content and opinions included in theirreports. The trading price of our common stock could decline if one or more equity research analysts downgrade our stock or publish otherunfavorable commentary or research. If one or more equity research analysts cease coverage of our company, or fail to regularly publishreports on us, the demand for our common stock could decrease, which in turn could cause our trading price or trading volume to decline.

Wedo not intend to pay dividends for the foreseeable future.

Wehave never declared or paid any cash dividends on our capital stock, and we do not intend to pay any cash dividends in the foreseeablefuture. We expect to retain future earnings, if any, to fund the development and growth of our business. Any future determination to paydividends on our capital stock will be at the discretion of our board of directors. Accordingly, you must rely on the sale of your commonstock after price appreciation, which may never occur, as the only way to realize any future gain on your investment.

Ourquarterly operating results may fluctuate significantly and could fall below the expectations of securities analysts and investors dueto the introduction of technologically more advanced products, seasonality and other factors, some of which are beyond our control, resultingin a decline in our stock price.

Ourquarterly operating results may fluctuate significantly because of several factors, including:

•        laboravailability and costs for hourly and management personnel;

•        changesin interest rates;

•        macroeconomicconditions, both nationally and locally;

•        changesin consumer preferences and competitive conditions;

•        expansionto new markets;

•        weatherconditions in the regions we operate;

•        increasesin infrastructure costs; and

•        fluctuationsin commodity prices.

Unanticipatedfluctuations in our quarterly operating results could result in a decline in our stock price.

Ourfailure to meet the continued listing requirements of NASDAQ could result in a de-listing of our common stock.

Ifafter listing we fail to satisfy the continued listing requirements of NASDAQ, such as the corporate governance requirements or the minimumclosing bid price requirement, NASDAQ may take steps to de-list our common stock. Such a de-listing would likelyhave a negative effect on the price of our common stock and would impair your ability to sell or purchase our common stock when you wishto do so. In the event of a de-listing, we would take actions to restore our compliance with NASDAQ’s listing requirements,but we can provide no assurance that any such action taken by us would allow our common stock to become listed again, stabilize the marketprice or improve the liquidity of our common stock, prevent our common stock from dropping below the NASDAQ minimum bid price requirementor prevent future non-compliance with NASDAQ’s listing requirements.

Ifour shares are delisted from NASDAQ and become subject to the penny stock rules, it would become more difficult to trade our shares.

TheSecurities and Exchange Commission (“SEC”) has adopted rules that regulate broker-dealer practices in connectionwith transactions in penny stocks. Penny stocks are generally equity securities with a price of less than

35

$5.00,other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems,provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system.If we do not obtain or retain a listing on NASDAQ and if the price of our common stock is less than $5.00, our common stock will be deemeda penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exemptfrom those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rulesrequire that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer mustmake a special written determination that the penny stock is a suitable investment for the purchaser and receive (i) the purchaser’swritten acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks;and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing thetrading activity in the secondary market for our common stock, and therefore stockholders may have difficulty selling their shares.

Ourmanagement will have broad discretion in how we use the net proceeds of this offering and might not use them effectively.

Ourmanagement will have considerable discretion over the use of proceeds from this offering. You will not have the opportunity, as part ofyour investment decision, to assess whether the proceeds are being used in a manner which you may consider most appropriate. Our managementmight spend a portion or all of the net proceeds from this offering in ways that our stockholders do not desire or that might not yielda favorable return. The failure by our management to apply these funds effectively could harm our business. Furthermore, you will haveno direct say on how our management allocates the net proceeds of this offering. Until the net proceeds are used, they may be placed ininvestments that do not produce significant income or that may lose value.

Futuresales by our common stockmay adversely affect the marketprice of our securitiesand our ability to raise funds in new offerings.

Salesof our common stock in the public market following this offering or at the conclusion of any required lock-up periods couldlower the market price of our common stock and Warrants. Sales may also make it more difficult for us to sell equity securities or equity-relatedsecurities in the future at a time and price that our management deems acceptable or at all. Of the               shares of common stock outstanding as of               , no sharesare, or will be, freely tradable without restriction immediately after the consummation of this offering, but approximately               of these shares, representing shares not held by our “affiliates,” generally may be resold under SEC Rule 144 beginning 90days from the effectiveness of the registration statement of which this prospectus forms a part, subject to any lock-up agreementsentered into between such stockholder and Maxim Group LLC.

Additionally,we intend to register shares of common stock that are reserved for issuance under our 2021 Equity Incentive Plan. For more information,see the section entitled “Shares Eligible for Future Sale — Registration Statements on Form S-8.”

Salesof substantial amounts of our common stock in the public market after this offering, or the perception that such sales will occur, couldadversely affect the market price of our common stock and make it difficult for us to raise funds through securities offerings in thefuture. Of the shares to be outstanding after this offering, the shares offered by this prospectus will be eligible for immediate salein the public market without restriction by persons other than our affiliates.

TheWarrants offered by this prospectus may not haveany value.

TheWarrants offered by this prospectus will be exercisable for five years from the date of initial issuance at an initial exercise priceof $               per share. There can be no assurance that themarket for shares of our common stock will ever equal or exceed the price of the Warrants. In the event that the price per share of ourcommon stock does not exceed the exercise price of the Warrants during the period when the Warrants are exercisable, the Warrants maynot have any value.

36

AWarrant does not entitle the holder to any rights as a holder of our shares of common stock until the holder exercises the Warrant fora share of common stock.

Untilyou acquire a share of common stock upon exercise of your Warrants, your Warrants will not provide you any rights as a holder of commonstock. Upon exercise of your Warrants, you will be entitled to exercise the rights of a holder of common stock only as to matters forwhich the record date occurs after the exercise date.

Sincethe warrants are executory contracts, they may have no value in a bankruptcy or reorganization proceeding.

Inthe event a bankruptcy or reorganization proceeding is commenced by or against us, a bankruptcy court may hold that any unexercised warrantsare executory contracts that are subject to rejection by us with the approval of the bankruptcy court. As a result, holders of the warrantsmay, even if we have sufficient funds, not be entitled to receive any consideration for their warrants or may receive an amount less thanthey would be entitled to if they had exercised their warrants prior to the commencement of any such bankruptcy or reorganization proceeding.

Wemay amend the terms of the warrants in a way that may be adverse to holders with the approval by the holders of a majority of the thenoutstanding warrants.

Ourwarrants will be issued in physical certificated form under a warrant agreement. The warrant agreement provides that the terms of thewarrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision. All other modificationsor amendments, including any amendment to increase the exercise price of the warrants or shorten the exercise period of the warrants,shall require the written consent of the registered holders of a majority of the then outstanding warrants.

Ouroutstanding warrants may have an adverse effect on the market price of our Common Stock and make it more difficult to effect a businesscombination.

Wewill be issuing warrants to purchase shares of Common Stock as part of this Offering. To the extent we issue shares of Common Stock toeffect a future business combination, the potential for the issuance of a substantial number of additional shares upon exercise of theseWarrants could make us a less attractive acquisition vehicle in the eyes of a target business. Such securities, when exercised, will increasethe number of issued and outstanding shares of common stock and reduce the value of the shares issued to complete the business combination.Accordingly, our Warrants may make it more difficult to effectuate a business combination or increase the cost of acquiring a target business.Additionally, the sale, or even the possibility of sale, of the shares of common stock underlying the Warrants could have an adverse effecton the market price for our securities or on our ability to obtain future financing. If and to the extent these warrants are exercised,you may experience dilution to your holdings.

Youwill experience immediate and substantial dilution as a result of this offering and may experience additional dilution in the future.

Youwill incur immediate and substantial dilution as a result of this offering. After giving effect to the sale by us of               Units in this offering at a public offering price of $              per Unit (the mid-point of the range appearing on the front cover of this prospectus), and after deducting underwriting commissionsand estimated offering expenses payable by us, investors in this offering can expect an immediate dilution of $              per share at the assumed public offering price. Additionally, to the extent that these warrants, or options we will grant to our officers,directors and employees, are ultimately exercised, you will sustain future dilution. We may also acquire new businesses or finance strategicalliances by issuing equity, which may result in additional dilution to our stockholders. Following the completion of this offering, ourboard of directors has the authority, without action or vote of our stockholders, to issue all or any part of our authorized but unissuedshares of common stock, including shares issuable upon the exercise of options, or shares of our authorized but unissued preferred stock.Issuances of common stock or voting preferred stock would reduce your influence over matters on which our stockholders vote and, in thecase of issuances of preferred stock, would likely result in your interest in us being subject to the prior rights of holders of thatpreferred stock. See the section entitled “Dilution.”

37

Wewill incur significant increased costs as a result of operating as a public company and our management will be required to devote substantialtime to new compliance initiatives.

Asa public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. The Sarbanes-OxleyAct, as well as rules subsequently implemented by the SEC and NASDAQ, has imposed various requirements on public companies. Our managementand other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, we anticipate that compliancewith these rules and regulations will increase our legal, accounting and financial compliance costs substantially. A number of those requirementswill require us to carry out activities we have not done previously. For example, we will create new board committees and adopt new internalcontrols and disclosure controls and procedures. In addition, these rules and regulations may make our activities related to legal, accountingand financial compliance more difficult, time-consuming and costly and may also place undue strain on our personnel, systemsand resources. Furthermore, if we identify any issues in complying with those requirements (for example, if we or our auditors identifya material weakness or significant deficiency in our internal control over financial reporting), we could incur additional costs rectifyingthose issues, and the existence of those issues could adversely affect us, our reputation or investor perceptions of us. If these requirementsdivert the attention of our management and personnel from other business concerns, they could have a material adverse effect on our business,financial condition and results of operations. For example, we expect these rules and regulations to make it more difficult and more expensivefor us to obtain director and officer liability insurance, and we may be required to incur substantial costs to maintain our current levelsof such coverage. We estimate the additional costs we may incur to respond to these requirements to range from $              to $               annually, although unforeseen circumstances couldincrease actual costs. These increased costs will require us to divert a significant amount of money that we could otherwise use to expandour business and achieve our strategic objectives. Advocacy efforts by stockholders and third parties may also prompt additional changesin governance and reporting requirements, which could further increase our costs.

Aninvestment in our company may involve tax implications, and you are encouraged to consult your own advisors as neither we nor any relatedparty is offering any tax assurances or guidance regarding our company or your investment.

Aninvestment in our company generally, involves complex federal, state and local income tax considerations. Neither the Internal RevenueService nor any State or local taxing authority has reviewed the transactions described herein, and may take different positions thanthe ones contemplated by management. You are strongly urged to consult your own tax and other advisors prior to investing, as neitherwe nor any of our officers, directors or related parties is offering you tax or similar advice, nor are any such persons making any representationsand warrants regarding such matters.

Unanticipatedchanges in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affectour financial condition and results of operations.

Wewill be subject to income taxes in the United States, and our domestic tax liabilities will be subject to the allocation of expenses indiffering jurisdictions. Our future effective tax rates could be subject to volatility or adversely affected by a number of factors, including:

•        changesin the valuation of our deferred tax assets and liabilities;

•        expectedtiming and amount of the release of any tax valuation allowances;

•        taxeffects of stock-based compensation;

•        costsrelated to intercompany restructurings; or

•        changesin tax laws, regulations or interpretations thereof.

Inaddition, we may be subject to audits of our income, sales and other transaction taxes by federal, state and local authorities. Outcomesfrom these audits could have an adverse effect on our financial condition and results of operations.

38

Anti-takeoverprovisions in our charter documents and Delaware law could discourage, delay or prevent a change in control of our company and may affectthe trading price of our common stock.

Theanti-takeover provisions of the Delaware General Corporation Law may discourage, delay or prevent a change in control byprohibiting us from engaging in a business combination with an interested stockholder for a period of three years after the person becomesan interested stockholder, even if a change in control would be beneficial to our existing stockholders. Our amended and restated certificateof incorporation and our bylaws, upon the consummation of this offering, may discourage, delay or prevent a change in our management orcontrol over us that stockholders may consider favorable. For example, our board of directors has the right to issue preferred stock withoutstockholder approval that could be used to dilute a potential hostile acquirer. As a result, you may lose your ability to sell your stockfor a price in excess of the prevailing market price due to these protective measures, and efforts by stockholders to change the directionor management of the company may be unsuccessful. In addition, our amended and restated certificate of incorporation and bylaws will:

•        providethat vacancies on our board of directors, including newly created directorships, may be filled only by a majority vote of directors thenin office;

•        providethat special meetings of stockholders may only be called by our Chairman and/or President, our board of directors or a super-majority(662/3%) of our stockholders;

•        placerestrictive requirements (including advance notification of stockholder nominations and proposals) on how special meetings of stockholdersmay be called by our stockholders;

•        notprovide stockholders with the ability to cumulate their votes; and

•        providethat only a super-majority of our stockholders (662/3%) may amend our amended and restated bylaws.

39

Useof Proceeds

Weestimate that the net proceeds from the sale of the Units we are offering will be approximately $        million based on an assumed offering price of $         per Unit (which represents the mid-pointof the estimated range of the initial public offering price shown on the front cover of this prospectus). If the underwriters fully exercisethe over-allotment option to purchase additional shares of common stock and/or Warrants, based on an assumed offering priceof $         per Unit, the net proceeds we sell will be approximately $        million. “Net proceeds” is what we expect to receive after deducting the underwriting discount and commission and estimatedoffering expenses payable by us.

Theprincipal purposes of this offering are to increase our financial flexibility, create a public market for our common stock and to facilitateour access to the public equity markets. We intend to use the net proceeds of this offering primarily for (i) sales and marketing,(ii) expanding our inventory, (iii) updating and producing our in-store displays, (iv) development of newstyles and sizes of our smart eyewear and (v) working capital and general purposes.

Weanticipate an approximate allocation of the use of net proceeds as follows:

Use of Net Proceeds

 

$
(in millions)*

 

%

   

 

 

 

   

 

 

 

   

 

 

 

   

 

 

 

Total

       

____________

*        Assumingthe over-allotment option is not exercised.

Whilewe expect to use the net proceeds for the purposes described above, the amounts and timing of our actual expenditures will depend uponnumerous factors, including the aggregate amount raised in this offering. The expected net proceeds from the sale of the shares offeredhereby, if added to our current cash and cash equivalents is anticipated to be sufficient to fund our operations for at least the next12 months. In the event that our plans change, our assumptions change or prove to be inaccurate, or the net proceeds of thisoffering are less than as set forth herein or otherwise prove to be insufficient, it may be necessary or advisable to reallocate proceedsor curtail expansion activities, or we may be required to seek additional financing or curtail our operations. As a result of the foregoing,our success will be affected by our discretion and judgment with respect to the application and allocation of the net proceeds of thisoffering.

Each$1.00 increase (decrease) in the assumed initial public offering price of $         per Unit (themidpoint of the estimated price range set forth on the cover page of this prospectus) would increase (decrease) the net proceeds to usfrom this offering, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us, by approximately$        , assuming that the number of shares offered by us, as set forth on the cover page ofthis prospectus, remains the same. We may also increase or decrease the number of shares we are offering. An increase (decrease) of 1,000,000in the number of Units we are offering would increase (decrease) the net proceeds to us from this offering, after deducting the underwritingdiscounts and commissions and estimated offering expenses payable by us, by approximately $        ,assuming the initial public offering price stays the same. An increase of 1,000,000 in the number of Units we are offering, together witha $1.00 increase in the assumed initial public offering price of $         per Unit (the midpointof the estimated price range set forth on the cover page of this prospectus), would increase the net proceeds to us from this offering,after deducting the underwriting discounts and commissions and estimated offering expenses payable by us, by approximately $        .A decrease of 1,000,000 in the number of Units we are offering, together with a $1.00 decrease in the assumed initial public offeringprice of $        per Unit (the midpoint of the estimated price range set forth on the cover pageof this prospectus), would decrease the net proceeds to us from this offering, after deducting the underwriting discounts and commissionsand estimated offering expenses payable by us, by approximately $        . We do not expect thata change in the offering price or the number of Units by these amounts would have a material effect on our intended uses of the net proceedsfrom this offering, although it may impact the amount of time prior to which we may need to seek additional capital.

Pendingtheir use, we plan to invest the net proceeds from this offering in short- and intermediate-term, interest-bearingobligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the U.S. government.

40

DividendPolicy

Wehave never declared or paid any cash dividends on our equity interests and we do not anticipate paying any cash dividends in the foreseeablefuture. The payment of dividends, if any, in the future is within the discretion of our board of directors and will depend on our earnings,capital requirements and financial condition and other relevant facts. We currently intend to retain all future earnings, if any, to financethe development and growth of our business.

41

Capitalization

Thefollowing table sets forth our cash and equivalents and capitalization as of September 30, 2021:

•        onan actual basis;

•        ona pro forma basis to give effect to (i) the issuance of 253,166 shares of common stock, at a conversion price per shareof $3.56, upon the partial conversion of the Notes in the amount of $901,270.96 on November 16, 2021, (ii) the issuanceof an aggregate of 4,447 shares of common stock, at a price per share of $3.56, pursuant to the Company’sRegulation CF offering, and (iii) the conversion upon the closing of this offering of the remaining outstanding Notes in the principalamount of $         into an aggregate of         shares of common stock at a conversion price of $         pershare; and

•        ona pro forma as adjusted basis to additionally give effect to the sale of         Units in this offering, assuming an initial public offering price of $        per Unit (the mid-point of the price range set forth on the cover page of this prospectus), after deducting estimatedunderwriting discounts and commissions and estimated offering expenses payable by us.

Theinformation set forth in the table below is illustrative only and will be adjusted based on the actual initial public offering price andother terms of this offering as determined at pricing. You should read the information in this table together with our audited financialstatements and related notes and unaudited interim condensed financial statements and related notes and “Management’s Discussionand Analysis of Financial Condition and Results of Operations” appearing elsewhere in this prospectus.

 

As of September 30, 2021

   

Actual

 

Pro Forma

 

Pro Forma,
as adjusted

   

(unaudited)

 

(unaudited)

 

(unaudited)

Cash and cash equivalents

 

$

65,056

 

 

$

 

 

$

 

   

 

 

 

 

 

   

 

 

Stockholders’ equity:

 

 

 

 

 

 

   

 

 

Common stock (10,000,000 shares authorized, 5,801,677 and 4,131,469 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively at par value $0.00001).

 

 

 

 

 

 

   

 

 

50,000,000 shares authorized, issued or outstanding, pro forma (unaudited) to adjust for redomestication.

 

 

58

 

 

 

   

 

 

Preferred stock, $0.00001 par value per share; 0 shares authorized, is          issued or outstanding as of September 30, 2021 and December 31, 2020

 

 

 

 

 

 

   

 

 

15,000,000 preferred stock shares authorized, issued or outstanding shares authorized, issued and outstanding, pro forma (unaudited) to adjust for redomestication.

 

 

 

 

 

   

 

Additional paid-in capital

 

 

3,294,841

 

 

 

   

 

 

Stock subscription receivable

 

 

(25,286

)

 

 

   

 

 

Accumulated deficit

 

 

(3,238,742

)

 

 

   

 

 

Total stockholders’ equity

 

 

30,871

 

 

 

   

 

 

Total capitalization

 

 

95,927

 

 

 

   

 

 

42

Thenumber of shares of our common stock to be outstanding upon completion of this offering is based on 5,801,667 shares of ourcommon stock outstanding as of September 30, 2021, and excludes:

•        2,332,500shares of common stock issuable upon exercise of stock options, at a weighted average exercise price of $2.59 per share;

•                shares of common stock issuable upon the exercise of the warrants to purchase shares of our common stock issued to the underwriters inconnection with this offering; and

•                shares of our common stock reserved for future issuance under our 2021 Equity Incentive Plan (which is equal to 20% of our issuedand outstanding common stock immediately after the consummation of this offering, less the number of outstanding option grants).

Each$1.00 increase (decrease) in the assumed initial public offering price of $         per Unit (themidpoint of the estimated price range set forth on the cover page of this prospectus) would increase (decrease) the amount of cash, additionalpaid-in capital, total stockholders’ equity (deficit) and total capitalization on a pro forma as adjusted basis byapproximately $        , assuming the number of Units, as set forth on the cover page of thisprospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us.Similarly, each increase (decrease) of one million Units offered by us would increase (decrease) cash, total stockholders’ equity(deficit) and total capitalization on a pro forma as adjusted basis by approximately $        ,assuming the assumed initial public offering price of $        per Unit (the midpoint of the estimatedprice range set forth on the cover page of this prospectus) remains the same, and after deducting underwriting discounts and commissionsand estimated offering expenses payable by us. Each one million Unit increase in the number of Units offered by us together with a concomitant$1.00 increase in the assumed initial public offering price of $        per Unit (the midpointof the estimated price range set forth on the cover page of this prospectus) would increase each of cash and total stockholders’(deficit) equity by approximately $        after deducting underwriting discounts and commissionsand any estimated offering expenses payable by us. Conversely, each one million Unit decrease in the number of Units offered by us togetherwith a concomitant $1.00 decrease in the assumed initial public offering price of $        perUnit (the midpoint of the estimated price range set forth on the cover page of this prospectus) would decrease each of cash and totalstockholders’ (deficit) equity by approximately $         after deducting underwriting discountsand commissions and any estimated offering expenses payable by us. The pro forma as adjusted information discussed above is illustrativeonly and will be adjusted based on the actual public offering price and other terms of this offering determined at pricing.

43

Dilution

Ifyou purchase the Units in this offering, your interest will be diluted immediately to the extent of the difference between the assumedpublic offering price of $       per Unit (the mid-point of the range appearing on the frontcover of this prospectus) and the as adjusted net tangible book value per share of our common stock immediately upon the consummationof this offering. As of September 30, 2021, we had a historical net tangible book value of $(108,708), or $(0.019) per shareof common stock. Our historical net tangible book value per share represents total tangible assets less total liabilities, divided bythe number of shares of our common stock outstanding as of September 30, 2021.

Ourpro forma net tangible book value as of September 30, 2021 was $            ,or $             per share of our common stock. Pro forma net tangible bookvalue represents the amount of our total tangible assets less our total liabilities, after giving effect to (i) the issuance of 253,166shares of common stock, at a price per share of $3.56, upon the partial conversion of the Notes on November 16, 2021,(ii) the issuance of an aggregate of 4,447 shares of common stock, at a price per share of $3.56, pursuant to the Company’sRegulation CF offering, and (iii) the conversion upon the closing of this offering of amount remaining on the Notes into an aggregateof              shares of common stock at a conversion price of $        pershare.

Aftergiving effect to our sale of              Units in this offering at an assumedpublic offering price of $             per Unit, and after deducting underwriters’commissions and estimated offering expenses, but assuming no exercise of the Warrants included in the Units offered hereby or the warrantsissued to the Representative of the underwriters, our pro forma as adjusted net tangible book value as of September 30, 2021would have been $             million, or $            per share of common stock. This represents an immediate increase in net tangible book value of $            per share of common stock to existing stockholders and an immediate dilution in net tangible book value of $            per share to purchasers of Units in this offering.

Thefollowing table illustrates this dilution on a per share of common stock basis assuming the underwriters do not exercise their optionto purchase additional shares of common stock:

Assumed public offering price per Unit

 

 

 

 

 

$

 

Net tangible book value per share as of September 30, 2021

 

$

(0.019

)

 

 

 

Increase in net tangible book value per share attributable to new investors

 

$

 

 

 

 

 

Pro forma net tangible book value per share

 

$

 

 

 

 

 

Pro forma as adjusted net tangible book value per share as of September 30, 2021, after giving effect to the offering

 

$

 

 

 

 

 

Dilution per share to new investors in the offering

 

 

 

 

 

$

 

Thedilution information discussed above is illustrative only and may change based on the actual initial public offering price and other termsof this offering.

A$1.00 decrease in the assumed initial public offering price of $        per Unit (the midpointof the price range set forth on the cover page of this prospectus) would decrease our pro forma as adjusted net tangible book value asof September 30, 2021 after this offering by approximately $        , or approximately$        per Unit, and would decrease dilution to investors in this offering by approximately$        per Unit, assuming that the number of Units offered by us, as set forth on the coverpage of this prospectus, remains the same, after deducting the estimated underwriting discount and estimated offering expenses payableby us. A $1.00 increase in the assumed initial public offering price of $        per Unit (themidpoint of the price range set forth on the cover page of this prospectus) would decrease our pro forma as adjusted net tangible bookvalue as of September 30, 2021 after this offering by approximately $        , orapproximately $        per Unit, and would increase dilution to investors in this offering byapproximately $        per Unit, assuming that the number of Units offered by us, as set forthon the cover page of this prospectus, remains the same, after deducting the estimated underwriting discount and estimated offering expensespayable by us. We may also increase or decrease the number of Units we are offering. An increase of 1,000,000 in the number of Units weare offering would increase our pro forma as adjusted net tangible book value as of September 30, 2021 after this offeringby approximately $        , or approximately $        perUnit, and would increase dilution to investors in this offering by approximately $        perUnit, assuming the assumed initial public offering price per Unit remains the same, after deducting the estimated underwriting discountand estimated offering expenses payable by us. A decrease of 1,000,000 in the number of Units we are offering would decrease our pro formaas adjusted net tangible book value as of September 30, 2021 after this offering by approximately $        ,or approximately $        per Unit, and would decrease dilution to investors in this offeringby approximately $        per Unit, assuming the assumed initial

44

publicoffering price per Unit remains the same, after deducting the estimated underwriting discount and estimated offering expenses payableby us. Each one million Unit increase in the number of Units offered by us together with a concomitant $1.00 increase in the assumed initialpublic offering price of $        per Unit (the midpoint of the estimated price range set forthon the cover page of this prospectus) would increase the pro forma as adjusted net tangible book value by $        perUnit and the dilution to new investors by $        per Unit, after deducting underwriting discountsand commissions and any estimated offering expenses payable by us. Conversely, each one million Unit decrease in the number of Units offeredby us together with a concomitant $1.00 decrease in the assumed initial public offering price of $        perUnit (the midpoint of the estimated price range set forth on the cover page of this prospectus) would decrease the pro forma as adjustednet tangible book value by $         per Unit and the dilution to new investors by $        per Unit, after deducting underwriting discounts and commissions and any estimated offering expenses payable by us. The pro forma as adjustedinformation is illustrative only, and we will adjust this information based on the actual initial public offering price and other termsof this offering determined at pricing.

Ifthe underwriters exercise their option in full to purchase              additionalshares of common stock and/or Warrants in this offering at the assumed offering price of $            per Unit, the pro forma net tangible book value per share after this offering would be $            per share of common stock, the increase in the pro forma net tangible book value per share to existing stockholders would be $            per share of common stock and the dilution to new investors purchasing securities in this offering would be $            per share of common stock.

Thefollowing charts illustrate our pro forma proportionate ownership, upon completion of this offering by present stockholders and investorsin this offering, compared to the relative amounts paid by each. The charts reflect payment by present stockholders as of the date theconsideration was received and by investors in this offering at the public offering price. The charts further assume no changes in nettangible book value other than those resulting from the offering.

 

Shares Purchased

 

Total Consideration

 

Average Price

   

Amount
(#)

 

Percent
(%)

 

Amount
($)

 

Percent
(%)

 

Per Share
($)

Existing stockholders

     

%

     

%

 

$

 

New investors

     

%

     

%

 

$

 

Total

     

100.0%

     

100.0%

 

$

 

Thenumber of shares of our common stock outstanding before and after this offering reflected in the tables and discussion above are basedon (i)              shares of common stock outstanding as of the date of thisprospectus (including the issuance of 253,166 shares of common stock, at a price per share of $3.56, upon the partial conversionof the Notes on November 16, 2021, the issuance of an aggregate of 4,447 shares of common stock, at a priceper share of $3.56, pursuant to the Company’s Regulation CF offering, and the conversion upon the closing of this offering of amountremaining on the Notes into an aggregate of              shares of commonstock at a conversion price of $        per share), and (ii)      shares of common stock outstanding on a pro forma as adjusted basis after giving effect to this offering and exclude, as of that date,the following:

•        2,332,500shares of common stock issuable upon exercise of stock options, at a weighted average exercise price of $2.59 per share;

•                    shares of common stock issuable upon the exercise of the warrants to purchase shares of our common stock issued to the underwritersin connection with this offering; and

•                    shares of our common stock reserved for future issuance under our 2021 Equity Incentive Plan (which is equal to 20% of our issued andoutstanding common stock immediately after the consummation of this offering, less the number of outstanding option grants).

45

Thetable below assumes the underwriters’ exercise their over-allotment option in full:

 

Shares Purchased

 

Total Consideration

 

Average Price

   

Amount
(#)

 

Percent
(%)

 

Amount
($)

 

Percent
(%)

 

Per Share
($)

Existing stockholders

     

%

     

%

 

$

 

New investors

     

%

     

%

 

$

 

Total

     

100.0%

     

100.0%

 

$

 

Thenumber of shares of our common stock outstanding before and after this offering reflected in the tables and discussion above are basedon              shares of common stock outstanding as of the date of thisprospectus (including the issuance of 253,166 shares of common stock, at a price per share of $3.56, upon the partial conversionof the Notes on November 16, 2021, the issuance of an aggregate of 4,447 shares of common stock, at a priceper share of $3.56, pursuant to the Company’s Regulation CF offering, and the conversion upon the closing of this offering of amountremaining on the Notes into an aggregate of              shares of commonstock at a conversion price of $        per share), and (ii)       shares of common stock outstanding on a pro forma as adjusted basis after giving effect to this offering and exclude, as of that date,the following:

•        2,332,500shares of common stock issuable upon exercise of stock options, at a weighted average exercise price of $2.59 per share;

•                    shares of common stock issuable upon the exercise of the warrants to purchase shares of our common stock issued to the underwritersin connection with this offering; and

•                    shares of our common stock reserved for future issuance under our 2021 Equity Incentive Plan (which is equal to 20% of our issued andoutstanding common stock immediately after the consummation of this offering, less the number of outstanding option grants).

46

Management’sDiscussion and Analysis of
F
inancial Condition and Results of Operations

Youshould read the following discussion and analysis of our financial condition and results of operations together with the section titled“Summary of Financial Information” and our financial statements and related notes included elsewhere in this prospectus. Dataas of and for the periods ended December 31,2019 and 2020 has been derived from our audited financial statements appearing at the end of this prospectus. Data as of and for the ninemonths ended September 30,2020 and 2021 has been derived from our unaudited condensed financial statements appearing at the end of this prospectus. Results forany interim period should not be construed as an inference of what our results would be for any full fiscal year or future period. Thisdiscussion and other parts of this prospectus contain forward-lookingstatements, such as those relating to our plans, objectives, expectations, intentions, and beliefs, which involve risks and uncertainties.Our actual results could differ materially from those discussed in these forward-lookingstatements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and thosediscussed in the sections titled “Special Note Regarding Forward-LookingStatements” and “Risk Factors” included elsewhere in this prospectus.

Overview

Wedevelop and sell smart eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives,while also offering vision correction and protection. Our flagship product, Lucyd Lyte, enables the wearer to listen to music, take andmake calls, and use voice assistants to perform many common smartphone tasks hands-free. Innovative Eyewear owns the exclusiverights to the Lucyd brand and the Lyte product line.

Ourmission is to Upgrade Your Eyewear. Our smart eyewear is a fusion of headphones with glasses, bringing vision correction and protectiontogether with digital connectivity and clear audio, while also offering a solution for listening to music outdoors (as compared to in-earheadphones). The convenience of having a Bluetooth headset and comfortable glasses in one, especially for those who are already accustomedto all-day eyewear use, offers a lifestyle upgrade at a price similar to traditional prescription eyewear.

Afterthe full launch of Lucyd Lyte in January 2021, we had strong interest and demand from customers in the U.S., and have since soldthousands of our smart eyewear. In order to meet the growing demand for our products, and in an effort to expand our reach, we have engagedover 100 optical resellers. All of our products are designed in Miami, manufactured in Asia, and currently sold through two major saleschannels:

(1)    ecommerceprimarily via our website (Lucyd.co) and Amazon; and,

(2)    agrowing network of independent eyewear stores.

Weapply a manufacturer suggested retail price (“MSRP”) of $149 (for our standard frames) to $179 (for our titanium frames) fornon-prescription, polarized sunglass and blue light blocking glasses across all of our online channels, with our wholesalepricing offering volume discounts to these prices. Please refer to discussion in the Components of Results of Operations for more detailsregarding our pricing structure.

Weare gearing-up to expand these channels with national eyewear chains, big box retail stores (electronics, sporting goods,general merchandise) and specialty retail stores.

Weview this business model as being more efficient with regards to the deployment of capital, by electing not to build our own manufacturingfacilities and Company-owned retail distribution, but rather contract with existing sources of production and consumer facingretail distribution.

Impactof COVID-19 on Our Business

OnMarch 11, 2020, the World Health Organization officially declared the outbreak of the COVID-19 virus a “pandemic.”This contagious disease outbreak has continued to spread across the globe and is impacting worldwide economic activity and financial markets.In light of the uncertain and rapidly evolving situation relating to the spread of COVID-19, we took precautionary measuresintended to minimize the risk of the virus to our employees, by following the CDC guidelines. Specifically, we set up a system that enabledour employees to work remotely when it was beneficial for them or when they felt ill. Additionally, precautionary measures that have beenadopted may negatively affect our ability to sell our products. For example, reducing the marketplace traction at trade shows, and

47

retailstore traffic for our re-sellers, and the fulfillment of customer orders with customized lenses, shipping delays and otheroperations of our suppliers and fulfillment partners. Additionally, our product is manufactured in China and shipped from China on a regularbasis. We have not experienced substantial delays in manufacturing or shipping due to COVID-19, however, we are exposed tosuch risk in the future as a potential impact of COVID-19. More generally, the outbreak of COVID-19 could adverselyaffect economies and financial markets globally, potentially leading to an economic downturn, which could decrease consumer spending andadversely affect demand for our products. It is not possible at this time to estimate the impact that COVID-19 could haveon our business, as the impact will depend on future developments, which are highly uncertain and cannot be predicted.

KeyFactors Affecting Performance

Expansionof retail points of purchase

Ourfuture depends in large part on our ability to place Lucyd Lyte in optical stores as well as sporting goods stores and other specialtystores. To address this we assembled a team with decades of experience in the eyewear industry and are offering a strong co-opmarketing program. We currently have 12 different styles available and plans to continuously increase this number over time.

Retailstore client retention and re-orders

Ourability to sustain and increase revenue depends in large part on our ability to receive re-orders from stores, either directlyor through our wholesale distributors. To support our sales to retail stores directly, we offer a strong co-op marketingprogram that includes free and paid store display materials. As part of this strategy, we are launching a digital try-onkiosk for our resellers to help educate their in-store customers about Lucyd Lyte and enable customers to try them on ina contact-less manner, to mitigate customer contact with viral pathogens.

Investingin business growth

Webelieve that people care about what they wear on their faces, and because we understand that customers have diverse preferences aboutthe shape, size and design of their eyewear, we aim to continuously invest in the design and development of new models in an effort toprovide the consumer with a wide selection of styles, colors and finishes.

Wealso intend to invest in co-op marketing with retail stores, expansion of our sales and marketing team (including influencers)to broaden our brand awareness and online presence. We will also increase our general and administrative expenses in the foreseeable futureto cover the additional costs for finance, compliance, supply chain, quality assurance and investor relations as we grow as a public company.

KeyPerformance Indicators

StoreCount (B2B)

Webelieve that one of the key indicators for our business is the number of retail stores onboarded to sell Lucyd Lyte. We started onboardingour first retail stores in June 2021. Currently, we have over 180 retail stores selling Lucyd Lyte primarily in the United Statesand Canada.

Basedon the existing demand for our products, current distribution and recently consummated supply agreements, we anticipate that our productswill be available in a significant number of new third-party retail locations in 2022.

Re-orderratio (B2B)

Manyof the retail stores that placed initial stocking orders, either directly or through our wholesale distributors, have also placed follow-onorders in the few short months since launching our wholesale business in June 2021. As of September 30, 2021, 58% ofstores have re-ordered our product. We expect this number to gradually increase as we roll out our co-op marketingprogram and introduce our virtual try-on kiosks into retail stores, to facilitate customer education and product sell-through.

48

Numberof online orders (B2C)

Forour ecommerce business, we track the number of online orders as an indicator of the success of our online marketing efforts. Through September30 2021, we received total of over 3000 orders from customers online. We believe that the addition of a virtual try on widget, aswell as further investment in brand awareness, product ambassadors and influencer campaigns, will enable continued growth of online ordersin the foreseeable future. We expect to allocate a significant portion of our advertising expenditures towards influencer marketing programs.

Componentsof Results of Operations

NetRevenue

Ourrevenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses and shipping charges,which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributorsand on our own website Lucyd.co and on Amazon.

Weapply a manufacturer suggested retail price (“MSRP”) of $149 (for our standard frames) to $179 (for our titanium frames) fornon-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Only U.S. consumersenjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website andon Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges. Any costs associatedwith fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers. We charge applicablestate sales taxes in addition to the MSRP for both online channels and all other marketplaces on which sell.

Ourwholesale pricing for eyewear sold to retail store partners and distributors includes volume discounts to the MSRP, due to the natureof large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the natureof wholesale retail orders, no e-commerce fees are applicable.

Ourprescription lens price currently ranges from $35 to $275, which is charged in addition to the MSRP. Glasses with prescription lensesare only available through our website Lucyd.co, while our sales through Amazon and to our retail partners only include non-prescriptionglasses.

Costof Goods Sold

Costof goods sold includes the costs incurred to acquire materials, assemble, and sell our finished products.

Forretail sales placed on one of our eCommerce channels these costs include (i) product costs held at the lesser of cost and net realizablevalue and inclusive of inventory reserves, (ii) freight, import, and inspection costs, (iii) optical laboratory costs for RXglasses, (iv) merchant fees, (v) fees paid to 3rd party eCommerceplatforms (vi) and cost of shipping the product to the consumer.

Forwholesale sales these costs include (i) product costs stated at the lesser of cost and net realizable value and inclusive of inventoryreserves, (ii) freight, import, and inspection costs, (iii) and credit card fees.

Whenconsumers place their orders directly on our online store, our cost of goods sold on a per-unit basis is approximately 8%lower than when consumers place their orders directly from 3rd parties’platforms.

Weexpect our cost of goods sold to fluctuate as a percentage of net revenue primarily due to product mix, customer preferences and resultingdemand, customer shipping costs, and management of our inventory and merchandise mix.

Overtime we expect our total cost of goods sold on a per unit basis to decrease as a result of an increase in scale. Increase in scale isachieved as a result of increase in volumes from both business to consumer and business to business (retail store) orders. We continueto expand our products with line extensions and new models and broaden our presence in retail stores carrying our products.

GrossProfit and Gross Margin

Wedefine gross profit as net revenues less cost of goods sold. Gross margin is gross profit expressed as a percentage of net revenues. Ourgross margin may fluctuate in the future based on a number of factors, including the cost at which we can obtain, transport, and assembleour inventory, the rate at our vendor network expands, and how effective we can be at controlling costs, in any given period.

49

Weanticipate our cost of goods sold, on a per unit basis, will decrease with scale, and this will likely have a positive impact on our grossmargins.

OperatingExpenses

Ouroperating expenses consist primarily of:

•        general &administrative expenses that include primarily consulting and payroll expenses, IT & software, legal, stock compensation expense,postage and non-customer product shipping and other administrative expense;

•        salesand marketing expenses including cost of online and TV advertising, marketing agency fees, influencers, trade shows and other initiatives;

•        relatedparty management fee for a range of back-office services provided by Lucyd Ltd.;

•        researchand development expenses related to (i) development of new styles and features of our smart eyewear (ii) development and improvementof our ecommerce website (iii) development of our Vyrb social media app for wearables.

Interestand Other Income, Net

Interestand other income, net, consists primarily of interest expense paid on convertible note loan due to the Parent.

Provisionfor Income Taxes

Provisionfor income taxes consists of income taxes related to foreign and domestic federal and state jurisdictions in which we conduct business,adjusted for allowable credits, deductions, and valuation allowance against deferred tax assets.

Resultsof Operations

Comparisonof nine months ended September30, 2021 (unaudited) to nine months ended September30, 2020 (unaudited)

 

Nine months ended
September 30,

     

Change
between the
nine months

ended
September 30,
2020 and 2021

   
   

2021

     

2020

       

Revenues, net

 

415,185

 

 

100

%

 

33,592

 

 

100

%

 

381,593

 

 

1,136

%

Less: Cost of Goods Sold

 

(332,378

)

 

80

%

 

(34,783

)

 

104

%

 

(297,595

)

 

856

%

Gross Profit

 

82,807

 

 

20

%

 

(1,191)

 

 

(4

)%

 

83,998

 

 

7,053

%

     

 

   

 

   

 

   

 

   

 

   

 

Operating expenses:

   

 

   

 

   

 

   

 

   

 

   

 

General & administrative

 

(883,356

)

 

213

%

 

(210,509

)

 

627

%

 

(672,847

)

 

320

%

Impairment expense

 

 

 

0

%

 

(112,329

)

 

334

%

 

112,329

 

 

 

Sales and marketing

 

(903,795

)

 

218

%

 

(98,789

)

 

294

%

 

(805,006

)

 

815

%

Related party management fee

 

(84,975

)

 

20

%

 

(102,475

)

 

305

%

 

17,500

 

 

(17

)%

Research and development

 

(36,121

)

 

9

%

 

30,822

)

 

92

%

 

(5,299

)

 

17

%

Total Operating Expenses

 

(1,908,247

)

 

460

%

 

(554,924

)

 

1,652

%

 

(1,353,323

)

 

244

%

     

 

   

 

   

 

   

 

   

 

   

 

Other (Expense):

   

 

   

 

   

 

   

 

   

 

   

 

Interest Expense

 

(33,654

)

 

8

%

 

 

 

0

%

 

(33,654

)

 

 

Total Other (Expense)

 

(33,654

)

 

8

%

 

 

 

0

%

 

(33,654

)

 

 

     

 

   

 

   

 

   

 

   

 

   

 

Net Loss

 

(1,859,094

)

 

448

%

 

(556,115

)

 

1,655

%

 

(1,302,979

)

 

234

%

50

Revenue

Ourrevenues during the nine months ended September 30, 2021 were $415,185 as compared to revenues of $33,592 during the ninemonths ended September 30, 2020. Our revenue is generated entirely from sales of eyewear products, namely smart frames, lensesand accessories. The increase in revenue was due to the launch of Lucyd Lytes, in January 2021, as compared to our limited salesof our beta products, which we do not consider a comparable benchmark to our 2021 sales.

Fornine months ending September 30, 2021, approximately 49% of sales were processed on our online store (Lucyd.co), 32% on Amazonand 19% to retail store partners. This sales channel mix impacted our revenue for the period, due to the fact we charge additional $35to $275 for our prescription lenses available only on Lucyd.co. All sales generated on Amazon.com during the period of $130,841 representnon-prescription frames as we only offer prescription lenses through our website. Out of $201,437 in online sales generatedthrough Lucyd.co, 54% related to frames with prescription lenses with 46% of glasses sold with non-prescription frames. Ourwebsite sales have remained the most material portion of our sales to date, aided by higher price compared to retail store pricing aswell as additional revenue recorded due to sales of prescription lenses.

Weexpect that the online portion of our sales will gradually decrease on a percentage basis, but remain an important component of our totalsales as we onboard more retail stores. We pursued growth in retail store segment in the third quarter of 2021, growing our retail storepresence to over 100 stores as of September 30, 2021.

Costof goods sold

Ourtotal cost of goods sold increased to $332,378 for the nine month period ended September 30, 2021 as compared to $34,783for the nine month period ended September 30, 2020. This increase mirrors the increase in underlying sales and the launchof our Lucyd Lyte in January 2021. These items included, but weren’t limited to, the cost of frames of $173,098, cost of prescriptionlenses incurred with our third-party vendor of $108,451, affiliate referral fees, sales commission expense, ecommerce platformfees of $46,915 and quality assurance costs related to our products sold of $3,600 for the nine month period ended September 30,2021.

Fornine months ending September 30, 2021, approximately 49% of sales were processed on our online store (Lucyd.co), 32% on Amazonand 19% to retail store partners. This sales channel mix impacted our cost of goods sold, as the cost of prescription lenses attributableto our Lucyd.co sales increased our cost of goods sold through Lucyd.co while not impacting cost of goods sold for sales realized throughAmazon or retail store partners.

Overtime, we expect retail stores to become our primary sales channel as we onboard new stores. Consequently, we expect cost of prescriptionlens, offered only as part of our website sales and not to retail stores, to gradually decrease as a percentage of our overall cost ofgoods sold.

Aswe anticipate growth in both wholesale and ecommerce channel sales in our fourth quarter of 2021 and going forward, we also expect correspondinggrowth in total cost of goods sold, primarily from product related costs.

Grossprofit

Ourgross profit increased to $82,807 for the nine month period ended September 30, 2021 as compared to ($1,191) for the ninemonth period ended September 30, 2020. This increase was due to the difference in the price of Lucyd Lytes versus our previousbeta products. We expect that gross profits for the remainder of fiscal year ended 2021 and for fiscal year 2022 to improve slightly,primarily due to economies of scale from large anticipated orders. As we expect retail stores to become our primary sales channel as weonboard new stores, we also expect our overall gross margin to approximate that of the wholesale channel, where no e-commerceplatform fees or prescription lens cost apply and volume related price discounts are included.

Operatingexpenses

Ouroperating expenses increased to $1,908,247 for the nine month period ended September 30, 2021 as compared to $554,924 forthe nine month period ended September 30, 2020. This increase was primarily due to the expansion of our business followinglaunch of Lucyd Lyte in January 2021 and included, but was not limited to, the following:

51

Generaland administrative expenses

Ourgeneral and administrative expenses increased to $883,356 for the nine month period ended September 30, 2021 as comparedto $554,924 for the nine month period ended September 30, 2020. This increase was primarily due to an increase of stock optionawards, resulting from increase in our staffing, from $41,875 to $564,637. Also as a result of Company’s growth and increased usedof consultants, consulting fees increased from $46,943 to $209,330.

Salesand marketing expenses

Oursales and marketing expenses increased to $903,795 for the nine month period ended September 30, 2021 as compared to $98,789for the nine month period ended September 30, 2020. The increase was primarily due to our multi-prong salesand marketing approach, launched in 2021, including the costs of online advertising of $355,780, TV advertising of $111,297, trade showsof $59,956 and SEO management of $59,177. We also hired four sales & marketing staff, and booked $130,137 in related stock compensationexpense for the period.

Weanticipate these costs to further increase as we continue to invest in and build our brand, expand the number of ecommerce platforms wesell our products on and invest in retail store co-op marketing programs to help educate our in-store customersabout Lucyd Lytes, and increase our brand’s physical presence and role in the eyewear industry.

Relatedparty management fee

Ourrelated party management fee was $84,975 for the nine month period ended September 30, 2021 as compared to $102,475 for thenine month period ended September 30, 2020. The management fees are related to the management services agreement betweenus and an affiliate of our Parent.

Researchand development costs

Ourresearch and development costs increased to $36,121 for the nine month period ended September 30, 2021 as compared to $30,822for the nine month period ended September 30, 2020. The increase was attributable entirely to the Company expanding the numberof eyewear designs under development during the nine month period ended September 30, 2021. All expenses recognized as researchand development costs during both periods are related to design of new frames.

ImpairmentExpense

Duringthe nine months period ended September 30, 2021, no impairment charges were required based on management’s analysisof long-lived assets.

Thefollowing tables set forth our statement of operations in dollar amounts and as a percentage of total revenue for each period presented(dollars in millions):

 

Year ended
December 31,
2020

     

Period ended
December 31,
2019

     

2020 vs 2019

   

Revenues, net

 

56,997

 

 

100

%

 

4,821

 

 

100

%

 

52,176

 

 

1,082

%

Less: Cost of Goods Sold

 

(74,266

)

 

130

%

 

(7,735

)

 

160

%

 

(66,531

)

 

862

%

Gross (Deficit)

 

(17,269

)

 

30

%

 

(2,914

)

 

60

%

 

(14,355

)

 

493

%

     

 

   

 

   

 

   

 

   

 

   

 

Operating expenses

   

 

   

 

   

 

   

 

   

 

   

 

General & administrative

 

(316,115

)

 

555

%

 

(43,398

)

 

900

%

 

(272,719

)

 

628

%

Impairment expense

 

(112,329

)

 

197

%

 

 

 

0

%

 

(112,329

)

 

 

Sales and marketing

 

(152,731

)

 

268

%

 

(2,924

)

 

61

%

 

(149,807

)

 

5,124

%

Related party management fee

 

(130,000

)

 

228

%

 

(56,108

)

 

1164

%

 

(73,892

)

 

132

%

Research & Development

 

(36,894

)

 

65

%

 

(4,082

)

 

6

%

 

(32,812

)

 

804

%

Total Operating Expenses

 

(748,070

)

 

1,312

%

 

(106,513

)

 

152

%

 

(641,558

)

 

602

%

     

 

   

 

   

 

   

 

   

 

   

 

Other income

 

2,120

 

 

4

%

 

 

   

 

 

2,121

 

 

 

Interest expense

 

(4,966

)

 

9

%

 

 

   

 

 

(4,966

)

 

 

Total Other Income/(Expense)

 

(2,846

)

 

5

%

 

 

   

 

 

(2,845

)

 

 

     

 

   

 

   

 

   

 

   

 

   

 

Net Loss

 

(768,184

)

 

1,348

%

 

(109,427

)

 

156

%

 

(658,757

)

 

602

%

52

Revenue

Ourrevenue increased to $56,997 for the year ended December 31, 2020 as compared to $4,821 for the period ended December31, 2019. While we consider both years to be largely developmental in nature before launch of Lucyd Lyte in 2021, limited productreleases were made in order to gather customer feedback.

Costof goods sold

Ourcost of sold increased to $74,266 for the year ended December 31, 2020 as compared to $7,735 for the period ended December31, 2019. The increase was primarily due to an increase in related product costs for our increased product sales. Due to the betatesting nature of the sales and related costs, we do not consider the fluctuations to be indicative of the nature of ongoing costs ofgoods sold. We recommend you review “Management’s Discussion and Analysis of Financial Conditionand Results of Operations — Comparison of thesix months ended June 30, 2021 and June30, 2020” for a better indication of our anticipated costs of goods sold inthe future.

Grossprofit (loss)

Ourgross profit (loss) increased to $(17,269) for the year ended December 31, 2020 as compared to $(2,914) for the period endedDecember 31, 2019. The increase was primarily due to the beta testing nature of our limited product releases that were discontinuedin December 2020, before Lucyd Lytes were launched in January 2021.

Operatingexpenses

Ouroperating expenses increased to $748,070 for the year ended December 31, 2020 as compared to $106,513 for the period endedDecember 31, 2019. This increase was primarily due to the expansion of our business in anticipation of our launch of LucydLytes in the beginning of 2021 and included, but was not limited to, the following:

Generaland administrative expenses

Ourgeneral and administrative expenses increased to $316,115 for the year ended December 31, 2020 as compared to $43,398 forthe period ended December 31, 2019. This increase was primarily due to an increase of consulting fees and cash fees paidto our employees of $76,589 and stock compensation expenses of $81,645.

Impairmentexpenses

Werecorded an impairment expense of $112,329 for the year ended December 31, 2020 as compared to $0 for the period ended December31, 2019.

Thelicense agreement subject to the impairment had been originally entered into between the Company’s Parent (Lucyd Ltd) and Universityof Central Florida (“UCF”) and subsequently contributed from Lucyd to the Company as a contribution to capital via an exclusive,irrevocable license of these assets from Lucyd. The impairment charge represented the total net book value of any licenses to intellectualproperty previously held by the Company.

LucydLtd licensed a group of patents from UCF covering augmented reality glasses, specifically enabling the display of information on the lensesof glasses. The UCF patents were subsequently, with UCF’s permission, exclusively licensed to Innovative Eyewear, Inc. by LucydLtd. After conducting significant research on this licensed technology, Innovative Eyewear Inc. determined that the technology was notready for commercialization, so it amicably terminated the license, consistent with its terms and conditions. Innovative Eyewear no longerhas any obligation under the license to UCF nor does Innovative Eyewear have a current business relationship with UCF. UCF has no rightsto any properties currently held by Innovative Eyewear Inc.

Noneof Innovative Eyewear’s current patents and applications are related to the previously licensed patents from UCF. The Company doesnot believe the charge is representative of material trends in the business as following the impairment charge, our patent portfolio includesonly patents developed internally in the last few years.

Salesand marketing expenses

Oursales and marketing expenses increased to $152,731 for the year ended December 31, 2020 as compared to $2,924 for the periodended December 31, 2019. We had immaterial sales and marketing expenses in 2019 and the increase was related to our initialmarket tests of beta versions of our product.

53

Relatedparty management fee

Ourrelated party management fees increased to $130,000 for the year ended December 31, 2020 as compared to $56,108 for the periodended December 31, 2019. The increase was primarily due to ramp up of assistances provided by the affiliate of the Parentin hiring and overall scale up of Company’s operations post formation in 2019.

Researchand development costs

Ourresearch and development costs increased to $36,894 for the year ended December 31, 2020 as compared to $4,082 for the periodended December 31, 2019. The increase was primarily due to our expenditures related to smart eyewear product development,Vyrb app development and website development we incurred in primarily in 2020.

Seasonality

Historically,our business has not experienced material seasonal fluctuations in net revenue. However, we do observe moderately higher seasonal demandduring the months of November and December due in part to holiday shopping.

Liquidityand capital resources

Sinceinception, we have financed our operations primarily from:

•        capitalcontribution from the Parent at the time of inception,

•        issuanceof convertible note held by Parent and,

•        twoequity crowdfunds.

Weexpect that operating losses could continue in the foreseeable future as we continue to invest in the expansion of our business, furtherresearch and development and sales and marketing activities. We believe our existing cash and cash equivalents, proceeds from this offering,funds available under our existing credit facility, and cash flows from operating activities will be sufficient to fund our operationsfor at least the next twelve months. We intend to use proceeds from this offering primarily on (i) sales and marketing, (ii) expandingour inventory, (iii) updating and developing our in-store displays, (iv) development of new smart eyewear stylesand sizes, as well as further development and commercialization of the Vyrb app and (v) working capital and general corporate purposes.

However,our future capital requirements will depend on many factors, including, but not limited to, growth in the number of retail store customers,the needs of our ecommerce business and retail distribution network, expansion of our product and software offerings, and the timing ofinvestments in technology and personnel to support the overall growth of our business. To the extent that current and anticipated futuresources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equityor debt financing. The sale of additional equity would result in additional dilution to our stockholders. The incurrence of debt financingwould result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants thatwould restrict our operations. There can be no assurances that we will be able to raise additional capital. In the event that additionalfinancing is required from outside sources, we may not be able to negotiate terms acceptable to us or at all. In particular, the recentCOVID-19 pandemic has caused disruption in the global financial markets, which could reduce our ability to access capitaland negatively affect our liquidity in the future. If we are unable to raise additional capital when required, or if we cannot expandour operations or otherwise capitalize on our business opportunities because we lack sufficient capital, our business, results of operations,financial condition, and cash flows would be adversely affected.

GoingConcern

TheCompany has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditionsin the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverseconditions may include: recession, downturn or otherwise, changes in regulations or restrictions in imports, competition or changes inconsumer taste including the economic impacts from the COVID-19pandemic. These adverse conditions could affect the Company’s financial condition and the results of its operations.

54

TheCompany meets its day to day working capital requirements through monies raised through sales of eyewear and issues of equity includingcrowdfunding. The Company also has issued a convertible note held by its parent company. Company’sforecasts and projections indicate that the Company expects to have sufficient cash reserves to operate within the level of its currentfacilities. Whilst it is the Company’s intention to rely on the available cash reserves, future income generated from its productsales, a negative variance in the forecasts and projections would make the Company’s ability to continue as a going concern dependenton an additional fund raise. Based on these factors, there is substantial doubt about the Company’s ability to continue as a goingconcern.

Off-Balance sheetarrangements

Asof September 30, 2021, we did not have any off-balance sheet arrangements.

CriticalAccounting Policies and Significant Developments and Estimates

Management’sdiscussion and analysis of our financial condition and results of operations is based on our financial statements, which have been preparedin accordance with GAAP. The preparation of our financial statements requires us to make estimates and assumptions that affect the reportedamounts of assets and liabilities at the date of the financial statements, as well as the reported revenue generated and expenses incurredduring the reporting periods, as well as related disclosures. Our estimates are based on our historical experience and on various otherfactors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carryingvalue of assets and liabilities and the amount of revenue and expenses that are not readily apparent from other sources. Actual resultsmay differ from these estimates under different assumptions or conditions, and any such differences may be material. We believe that theaccounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to themore significant areas involving management’s judgments and estimates.

Webelieve that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically reevaluatethese accounting policies and estimates and make adjustments when facts and circumstances dictate a change. Historically, we have foundour application of accounting policies to be appropriate, and actual results have not differed materially from those determined usingnecessary estimates.

Inventory

Ourinventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a weighted averagefirst-in, first-outbasis. Provisions for excess, obsolete or slow moving inventory are recorded after periodic evaluation of historical sales, current economictrends, forecasted sales, estimated product life cycles and estimated inventory levels. No provisions were determined as needed at September30, 2021.

Inaccordance with our donation policy started in May 2021, we donate an optical frame for every Lucyd Lyte sold. During the nine month periodended September 30, 2021 we donated total of $7,556 of glasses to charity. The amount was recorded at historical cost underGeneral and Administrative Expenses.

Asof September 30, 2021, we recorded an inventory prepayment in the amount of $295,200 related to down payment on eyewear purchasedfrom the manufacturer, prior to shipment of the product that occurred after September 30, 2021. As of December 31,2020, we recorded an inventory prepayment in the amount $85,740 for inventory paid for during 2020 but shipped after December 31,2020.

IntangibleAssets

Intangibleassets relate to:

•        internallydeveloped and licensed utility and design patents. We amortize these assets over the estimated useful life of the patents, and

•        capitalizedsoftware costs incurred due to development of the Vyrb app. We amortize these assets over the estimated useful life of the software application.

Wereview our intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may notbe recoverable.

55

IncomeTaxes

Weare taxed as a C corporation. We comply with Financial Accounting Standards Board (FASB) ASC 740 for accounting for uncertainty in incometaxes recognized in a company’s financial statements, which prescribes a recognition threshold and measurement process for financialstatement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized,a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. FASB ASC 740 also providesguidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based onour evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in our financial statements.We believe that its income tax positions would be sustained on audit and does not anticipate any adjustments that would result in a materialchange to its financial position.

Wehave incurred taxable losses since inception but are current in its tax filing obligations. We are not presently subject to any incometax audit in any taxing jurisdiction.

Stock-BasedCompensation

Weaccount for stock-based compensation to employees and directorsin accordance with FASB ASC Topic 718, which require that compensation expense be recognized in the financial statements for stock-basedawards based on the grant date fair value. For stock option awards, the Black-Scholes-Mertonoption pricing model was used to estimate the fair value of share-basedawards. The Black-Scholes-Merton option pricing model incorporatesvarious and highly subjective assumptions, including expected term and share price volatility. The expected term of the stock optionswas estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

Wenote that the fair value of common stock used in the option pricing model in 2020 and for 9 months ended September30, 2021 (no option grants in 2019) was determined using the most recent price paid by independent investors through RegulationCrowdfund (“REG CF”) securities offering undertaken by the Company. For a majority of the time during which stock option awardswere granted by the Company in 2021 and 2020, the Company had been raising funds from investors under Regulation CF campaigns, with asignificant number of transactions from both accredited and non-accredited investors.

Thepre-money valuation determining price per share was agreed upon each time with the crowdfund platform, who has great dealof experience in setting the proper pre-money valuations for companies that list on their platforms. The determination wasmade using Company’s business progress.

Theshare price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted,using stock prices of comparably profiled public companies. The risk-freeinterest rate assumption is determined using the rates for U.S. Treasury zero-couponbonds with maturities similar to those of the expected term of the award being valued.

RevenueRecognition

Ourrevenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses and shipping charges,which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributorsand on our own website Lucyd.co and on Amazon.

Todetermine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify theperformance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performanceobligations in the contract and (v) recognize revenue when (or as) the entity satisfies a performance obligation. At contract inception,we assess the goods or services promised within each contract and determines those that are performance obligations and assesses whethereach promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respectiveperformance obligation when (or as) the performance obligation is satisfied.

Allrevenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collectedfrom customers on behalf of taxing authorities, returns and discounts.

56

Forsales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewearand transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglassand blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of theperformance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with fasterdelivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free forU.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the onlineplatforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods soldas incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaceson which the company sells products.

Forsales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopifywholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation which is delivery of oureyewear products to retail store or the distributor, and also recorded net of returns and discounts. Our wholesale pricing for eyewearsold to retail store partners and distributors includes volume discounts, due to the nature of large quantity orders. The pricing includesshipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commercefees are applicable.

TheCompany’s sales to both retail store partners and through the e-commerce channels do not contain any variable consideration.

Weallow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reasonwithin the first:

•        7days for sales made through our website (Lucyd.co)

•        30days for sales made through Amazon

•        30days for sales to wholesale retailers and distributors

Forall of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns,which is recorded as a reduction of sales. Additionally, we reviewed all individual returns received in October 2021 pertaining to ordersprocessed prior to September 30, 2021. We had no reserve because the identified amounts were nominal.

Shippingand Handling

Costsincurred for shipping and handling are included in cost of goods sold at the time the related revenue is recognized. Amounts billed toa customer for shipping and handling are reported as revenues.

Earnings/lossper share

Wepresent earnings and loss per share data by calculating the quotient of earnings/(loss) and loss divided by the number of common sharesoutstanding (common shares as of December 31, 2020) as requiredby ASC 260-10-50. As of September30, 2021 all shares underlying the related party convertible debt and common stock options were excludedfrom the earnings per share calculation due to their anti-dilutiveeffect.

InternalControl Over Financial Reporting

Acompany’s internal control over financial reporting is a process designed by, or under the supervision of, that company’sprincipal executive and principal financial officers, or persons performing similar functions, and influenced by that company’sboard of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting andthe preparation of financial statements in accordance with generally accepted accounting principles. Because of its inherent limitations,internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectivenessto future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree ofcompliance with policies or procedures may deteriorate.

57

Asof September 30, 2021, we were a private company and historically had limited accountingand financial reporting personnel and other resources with which to address our internal control over financial reporting. In connectionwith the preparation and audit of our financial statements for the year ended December 31,2020, we identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combinationof deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatementof our annual or interim financial statements will not be prevented or detected on a timely basis.

Wedid not have a sufficient number of personnel with an appropriate degree of accounting and internal controls knowledge, experience, andtraining to appropriately analyze, record and disclose accounting matters commensurate with Innovative Eyewear’s accounting andreporting requirements, which resulted in an inability to consistently establish appropriate authorities and responsibilities in pursuitof their financial reporting objectives. This material weakness contributed to the following additional material weaknesses:

•        Wedid not design and maintain effective controls over the review of journal entries and account reconciliations. Specifically, certain personnelhad the ability to both (i) create and post journal entries within Innovative Eyewear’s general ledger system, and (ii) prepareand review account reconciliations.

•        Wedid not design and maintain effective controls over information technology general controls for information systems that are relevantto the preparation of our financial statements. Specifically, we did not design and maintain: (i) program change management controlsfor the financial systems to ensure that information technology program and data changes affecting financial IT applications and underlyingaccounting records are identified, tested, authorized and implemented appropriately; (ii) appropriate user access controls to ensureappropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs and datato appropriate our personnel; (iii) computer operations controls to ensure data backups are authorized and restorations monitored;and (iv) testing and approval controls for program development to ensure that new software development is aligned with business andIT requirements.

Thesematerial weaknesses could result in a misstatement of substantially all accounts or disclosures that would result in a material misstatementto the annual or interim financial statements that would not be prevented or detected.

Withthe oversight of senior management, we have instituted plans to remediate these material weaknesses and will continue to take remediationsteps, including hiring additional key supporting accounting personnel with public company reporting and accounting operations experience.We are also implementing the required segregation of roles and duties both in manual and systems related processes including for journalentries and account reconciliation, and formalizing the documentation and performance of remaining information technology general controlsfor information systems utilized for financial reporting. We believe the measures described above will remediate the material weaknessidentified and strengthen our internal control over financial reporting. We are committed to continuing to improve our internal controlprocesses and will continue to diligently and vigorously review our financial reporting controls and procedures.

Quantitativeand Qualitative Disclosures about Market Risk

Marketrisk represents the risk of loss that may impact our financial position because of adverse changes in financial market prices and rates.Our market risk exposure is primarily a result of exposure resulting from potential changes in currency rates, interest rates, or inflation.

58

BUSINESS

OurHistory

Wedevelop and sell smart eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives,while also offering prescription eyewear and sun protection. Founded and headquartered in Miami, Florida, we were initially organizedas a Florida limited liability company effective August 15, 2019. We were founded by Lucyd Ltd., the inventor and licensorof the technology that our products are based upon which is a portfolio company of Tekcapital Europe Ltd. (“Tekcapital”).Tekcapital is a U.K. based university intellectual property accelerator. Tekcapital builds portfolio companies around new technologies.On March 26, 2020, we converted from a Florida limited liability company into a Florida corporation. Prior to this offering,we will redomicile from a Florida corporation to a Delaware corporation.

OurProduct

InJanuary 2020, we introduced our first beta product and began market testing.

InJanuary 2021, we officially launched our first commercial product, Lucyd Lyte®(“Lucyd Lyte”). This initial product offering embodies our goal of creating smart eyewear for all day wear that looks likeand is priced similarly to designer eyewear, but is also light weight and comfortable, and enables the wearer to remain connected to theirdigital lives. The product was initially launched with six styles. In September 2021, an additional six styles were added. Thesetwelve styles are each available with 56 different lens types, resulting in 668 variations of products currently available.

Additionally,Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphonetasks hands-free. Some of the many things that can be done with Lucyd Lyte glasses include:

1.      “Senda voice message to (contact)”: this command begins the recording of an audio message to be sent to named contact.

2.      “Senda text to (contact)”: begins recording of a speech-to-text message to be sent by SMS to named contact.

3.      “Call(contact)”: speed-dials the named contact.

4.      “Send$___ to (contact)”: this command allows our user to send money to a contact via Venmo or Apple Pay. Follow the digital assistant’sprompts to confirm.

5.      “Checkmy messages”: this command reads out our user’s latest incoming text messages and offers a prompt to reply to each. Closeout the digital assistant to end the readout.

6.      “Checkmy mailbox”: this command announces the number of unread emails, and reads them out with a prompt to continue after each one. Inthe prompt after each one, our customers can tell their digital assistant “Reply” and dictate an email response to the previousemail.

7.      “Find(cuisine type) food nearby”: this command reads through a list of nearby restaurants and their ratings, and prompts our user fordirections or to call after each one.

8.      “Callme an Uber”: this command prompts our user on which type of Uber ride they want, then asks to confirm to send a car to our user’slocation.

9.      “Whattime is it?”: announces the current time.

10.    “Play(song/album/artist)”: this command begins playing the requested song, album or artist via Apple Music.

11.    “Getme directions to (location)”: this command begins navigating on phone, with audible directions on glasses.

12.    “Takea memo”: this command begins recording a speech-to-text memo in Notes. Say “Read my Notes” to play back.

59

Sincethe launch of Lucyd Lyte, we witnessed interest and demand from customers throughout the United States and have sold thousands ofour smart glasses. Within six months of the launch of Lucyd Lyte, several optical stores in the United States and Canada have on-boarded the product and we have had discussions with several other large eyewear chains (by number of locations) regarding onboardingour product. We believe smart eyewear is a product category whose time has come, and we believe we are well positioned to capitalize onand help develop this exciting new sector–where eyewear meets electronics in a user-friendly, mass market format, pricedsimilarly to designer eyewear.

Additionally,we anticipate introducing our first line of Bluetooth safety glasses, and five new styles of Lucyd Lytes designed specifically for womenand youths in the first quarter of 2022. We plan on expanding our safety glasses line by adding two additional sizes in the second quarterof 2022, along with five new styles of Lucyd Lytes in titanium and acetate. In the third quarter of 2022, we are hoping to introduce foursports frames, five new styles of Lucyd Lytes in titanium and acetate, as well as additional lens packs focused on gamers, boating andfishing, as well as running, cycling and fashion. We anticipate adding five more styles of Lucyd Lytes in the fourth quarter of 2022,along with a rollout of software upgrades to Vyrb.

OurMission

Ourmission is to Upgrade Your Eyewear®. Our smart eyewear is a fusion of headphoneswith glasses, bringing vision correction and protection together with digital connectivity and clear audio, while also offering a safersolution for listening to music outdoors (as compared to in-ear headphones). The convenience of having a Bluetooth headsetand comfortable glasses in one, especially for those who are already accustomed to all-day eyewear use, offers a lifestyleupgrade at a price most consumers can afford.

Ina sense, we view this integration of technology and vison correction/protection as the next evolutionary step in the development of eyewear.Over the entire course of eyewear development and history, many of the innovations have dealt with improving the lenses of the glasses.Notably, eyewear frames have not improved much in the past 400 years, with the exception, in our view, of the utilization of plasticto reduce weight and provide a wider range of designs and finishes, and the introduction of new hinge types. We view the integration ofBluetooth technology into the arms of the glasses as one of the key next steps to Upgrade Your Eyewear®.

60

Ourfocus is to enhance one of the world’s most important wearables: eyewear. The following table describes some of the developmentmilestones in the eyewear industry, with contributions from Innovative Eyewear starting in 2018 highlighted in yellow. Please note thisis not an exhaustive review of all seminal improvements in eyewear over the centuries.

Additionally,as part of our commitment to a great customer experience, we listen to feedback from our customers, and continuously strive to improvecustomer satisfaction and experience with our products. Our customers’ extensive feedback pointed to a need and desire for betterinteraction with social media while on-the-go. We are addressing this need by developing an exciting software applicationcalled Vyrb™, which will enable Lucyd Lyte users to hear and reply to social media posts, with their voice, hands-free,through their glasses (“Vyrb”). Other Vyrb users will be able hear these posts. Additionally, Vyrb will offer Lucyd Lyte usersexternal social media sharing features, which will allow posts made on Vyrb to be exported to other platforms such as Facebook, Twitterand Instagram. We are planning to launch Vyrb in the fourth quarter of 2021 for both iOS and Android, and we believe that Vyrb is oneof the first social applications designed specifically with a focus on smart glasses and other voice enabled wearables. We anticipateexpanding Vyrb’s capabilities through software upgrades that are currently slated for release in Q4 of 2022.

Aspart of our mission to make smart eyewear accessible to the mass market, we are seeking to develop a complete line of Bluetooth eyewearfor nearly every size and style preference, with eighteen styles expected to be available by the end of 2021, and forty styles by theend of 2022. When paired with the Vyrb application, Lucyd Lyte glasses will provide a new and safer wearable user experience suitablefor everyone.

Ourgoal is to become a meaningful player in the smart eyewear market. Innovative Eyewear’s early successes have shown our ability tonot only compete, but to lead in this rapidly changing and expanding technological eyewear market, and our goal is to continue spearheadinginnovation in the field.

GivingBack

Wedonate an optical frame for every Lucyd Lyte sold.

Weare also very active in supporting the various communities we serve through donations and support. From the beginning, Innovative Eyewearhas supported those in need through its donation of glasses frames to New Eyes (https://new-eyes.org/about-us),a charity dedicated to helping children and adults in need of eyewear. We’ve partnered with New Eyes because they fit the Lucydbrand mission: enhancing the vision of people all over the world, and we believe that it simply is the right thing to do.

Additionally,university students, educators, healthcare workers, uniformed service members, and veterans are eligible for an ongoing 18% discount offall frames and lens upgrades on www.lucyd.co.

OurCompetitive Strengths

AUnique Solution to a Common Problem.    While immensely useful, smartphones can present a safety hazard tomotorists, pedestrians and cyclists because smartphones can distract people from the task or activity at hand. In 2018, pedestrian deathswere at a 28-year high and experts believe smartphones were partially to blame. Additionally, recent data from the GovernorsHighway Safety Association indicates that in 2020 there was the largest ever annual increase in the rate at which drivers struckand killed pedestrians. The report mentioned that during the past ten years, the number of drivers striking and killing a pedestrian afterdark increased by 54%, compared to a 16% rise in pedestrian fatalities in daylight. We believethat the distraction created by smartphones originates in two forms: (1) via headphones or earbuds, where the user is deprived offull audible situational awareness; and, (2) via the visual interface of the phone, which distracts the user completely from theirsurroundings. Lucyd Lyte open ear audio helps address this problem by having the speakers mounted at the temples (in the arms) of theglasses. There is nothing in the ear canal and, as a result, individuals can better maintain situational awareness, such as hearing thetraffic around them, as well as nearby sounds. Many of our competitors have relatively bulky speakers enclosed within the temples, whileLucyd Lyte’s speakers and temples are thin, which allows them to look similar to traditional designer glasses. Furthermore, throughthe quick and easy touch controls on the Lucyd Lyte, the wearer can perform many tasks that they would normally pull out their phone for,untethering the eyes of the user from their smartphones throughout the day and enabling them to remain more visually vigilant and awareof the traffic around them.

61

AffordablePrice Point.    Comfortable and affordable Bluetooth audio glassesthat seamlessly integrate vision correction and protection with our customer’s digital life. Our Lucyd Lyte line of smart eyewearenables prescription and sunglass wearers to interact with digital assistants and social media without having to take their eyes off theroad and are nearly hands-free, thereby improving the safety and convenience of taking calls, listening to music and audiblyaccessing digital information on the go. Our Lucyd Lyte eyewear provides both optical-quality glasses and a Bluetooth headsettogether, at roughly the same price as a traditional pair of designer glasses. The Manufacturer’s Suggested Retail Price (“MSRP”)for Lucyd Lyte eyewear starts at $149, with advanced options and customizations available at higher price points, which are at the discretionof the customer, and $35 upcharge for single vision. By comparison, most of our U.S.-based competitors offer products thatare significantly more expensive, starting at approximately $249 or higher.

Quality.    Allof our frames can be outfitted in-house or by optical resellers with any combination of: prescription, sunglass, readersand blue light formats. Our frame fronts are made with what we believe are high quality optical materials to ensure easy lens fittingby any optician.

CustomizableProduct Offering.    There are 56 lens types available for Lucyd Lyte, making it the most customizable smarteyewear in the world. Innovative Eyewear has a partnership with a high-quality optical lab in Boston to produce prescriptionand custom lenses for our frames quickly and affordably. Our contract with a third-party optical lab also allows us to offerdirect fulfillment to our customers.

Comfort.    Atjust 1.0-1.45 ounces, our eyewear has a feather-light fit, suitable for all day vision correction or sun protection(traditional glasses weigh about 1 ounce). This is especially important while on the go. Our 1.0 ounce titanium aviators are among thelightest smart eyewear ever made.

LongBattery Life.    At 6.5-8 hours of playback per charge, Lucyd Lyte glasses outpace most, if notall, of the competition on battery life.

CapitalLight Business Model.    All of our products are sold through multiple ecommerce channels, including on ourwebsite (Lucyd.co), BestBuy.com and Amazon.com, and are distributed through optical or other retailers. We believe this capital lightapproach is highly scalable and efficient in the deployment of resources. We view “capital light” as being more efficientby obviating the need to build factories and retail stores, but rather contract with both.

Multiple-ChannelApproach.    We sell our products both through multiple online channels and multiple categories of brick-and-mortarretail stores. We believe this multi-channel approach provides us with an advantage against our competitors who either solelysell their products online or in brick-and-mortar retail stores.

ExperiencedManagement Team.    We have an experienced board of directors with more than 80 years of combined experiencein the eyewear industry and a management team with substantial experience in operating eyewear and technology companies.

OurBusiness Strategy

Whenwe organized Innovative Eyewear two years ago, there were, in our view, no attractive smart eyewear that addressed the basic consumerneed for good looking designer glasses that were stylish, comfortable, lightweight and provided the functionality of hearables, and pricedaround the same as regular glasses.

Allof our products are designed in Miami, manufactured in China, sold through ecommerce, channels, including on our website (Lucyd.co), BestBuy.comand Amazon.com, or sold by over 100 optical and sporting goods retailers. Additionally, we are pursuing online and in-storebig box retailers, and in-store and online specialty retailers. We believe this capital light approach is highly scalableand efficient in the deployment of resources. We view “capital light” as being more efficient, by obviating the need to buildfactories and retail distribution but rather contracting with both. Based on the existing demand for our products, current distributionand recently consummated supply agreements, we anticipate that our products will be available in a significant number of new third-partyretail locations in 2022.

62

Webelieve that people care about what they wear on their faces, and because we understand that customers have diverse preferences aboutthe shape, size and design of their eyewear, we aim to continuously introduce new models in an effort to offer a wide variety of designs.We continuously present new models of eyewear to our network of followers to vote on those styles they find most appealing. We view thisas community approved design.

Sales

Wehave two major sales channels: (1) ecommerce via Lucyd.co and Amazon and, (2) our ongoing development of a network of eyewear,sporting goods and electronics resellers, including but not limited to, BestBuy.com and Brookstone, to offer our frames in the future.Most of our resellers are experienced opticians who provide valuable feedback that informs the development of our product lines, whichwe would not receive if we were solely direct to consumer. Additionally, we have a robust presence on multiple ecommerce and social mediaplatforms, with more than 160,000 followers and 20,000 email subscribers, which facilitates several customer on-ramps forthe Lucyd brand, and numerous ad campaign strategies. Building on our early successes of driving traffic to Lucyd.co, the website runby a subsidiary of our majority stockholder, from Facebook and TikTok, we deploy high quality content on multiple platforms to continuouslykeep customers engaged and drive brand awareness.

63

Wehave two levels of margins, one for business to consumers (“B2C”), and one for business to business (“B2B”). Themajority of our sales have been through ecommerce with gross margins at approximately 60% and retail sales, which have recently started,have gross margins of approximately 38%. We have an average additional gross profit margin of approximately 20% on custom and prescriptionlenses. We expect that our retail sales will account for the majority of our sales by 2023.

EcommerceChannels

1.      Companywebsite: Lucyd.co

Lucyd.cois our primary ecommerce point of sale. The site offers the most customization options of any of our sales channels and a full prescriptionlens lab, offering a total of 56 different lens combinations (16 key lens tints offered in plano, single prescription and progressivebifocal; seven types of reading lenses; and, a unique lens sold in the 3-lens pack items). Additionally, the Lucyd websiteships worldwide and is used to provide a quick and smooth buying experience.

2.      Amazon

Amazon.com/lucydis our brand shop on Amazon. It drives approximately half of our online sales, but limits the number of variations we can offer on ourframes (e.g., prescription lenses are not permitted on Amazon). However, through Amazon, we are still able to offer color lens sunglassvariants and blue light blocker pairs, in addition to our lens pack accessory item. We are constantly testing traffic flow to Lucyd.covs. Amazon to ensure our online ad spend is fully optimized.

3.      Walmart.com,BestBuy.com, Brookstone.com and eBay

Inaddition to our key online sales channels at Lucyd.co, BestBuy.com and Amazon, we are on these four marketplaces to gain additional brandawareness and drive online sales.

64

4.      SocialSelling

Notonly do we use social media to drive traffic to our main sales channels, we take advantage of intra-social shops as well,and have deployed shopping experiences through Facebook, Instagram and TikTok to gain further brand awareness.

Wealso offer two affiliate platforms via shareasale.com and Shopify for peer-driven sales. The Shareasale program is for professionalaffiliate and deal promotion companies, and increases revenue on Lucyd.co by offering direct commissions in exchange for converting webtraffic. The Shopify affiliate program enables Lucyd brand enthusiasts to get a financial reward for sharing the brand, and operates onsimilar terms as the Shareasale program where we provide a commission rate in exchange for converting web traffic.

RetailChannels

1.      IndependentEyewear Stores

Thecore of our B2B business is formed by our relationship with numerous eyewear store retailers across the United States and Canada,which provide Lucyd Lyte frames directly to their optical customers. Many of these retail stores have placed multiple stocking ordersin the few short months since launching our wholesale business in June 2021. To support our resellers, we offer a strong co-opmarketing program that includes free store display materials. As part of this strategy, we are launching a digital try-onkiosk for our resellers to help educate their in-store customers about Lucyd eyewear, and increase our brand’s physicalpresence in the optical industry. We anticipate introducing our in-store digital try-on kiosk to key retailersin the first quarter of 2022, and are planning on upgrading the kiosk’s capabilities in the second quarter of 2022 to allow forin-store re-ordering.

2.      NationalEyewear Chains

Lucydeyewear is currently being evaluated by multiple leading eyewear chains in the United States for potential inclusion in their brick-and-mortarstores. After the recent introduction of Ray Ban Stories smart eyewear, retailers are keen to include one or more smart eyewear productsin their stores and on their ecommerce platforms. Based on our current discussion with several major optical chains (by store size), webelieve at least one major optical chain will onboard our product line by the end of 2021.

3.      BigBox Retail Stores (Electronics, sporting goods, general merchandise)

Inaddition to mainstream optical channels, we have begun placing our products and are pursuing additional product placements with leadingbig box stores, either in their eyewear or electronics departments. Specifically, we have begun placing our products in Best Buy storesand other notable chains in electronics and sporting goods are testing our products, with positive feedback, and we anticipate havingour product line onboarded on the ecommerce sites of a leading electronics and sporting goods specialty retailers in the next thirty days.

4.      SpecialtyRetail stores (Apparel, travel and more)

Weare leaving no stone unturned in our mission to bring smart eyewear mainstream. We are in talks with several leading fashion brands tolaunch co-branded Lucyd products in their brick-and-mortar retail locations, with a “Powered by Lucyd”designation alongside their brand identity on the packaging. These would be meaningful collaborations, and if successful, could rapidlyexpand Lucyd brand recognition. Additionally, we are pursuing other potential sales outlets such as home shopping channels, airport electronicsshops and boutique retailers.

Manufacturingand Supply Chain

Ourproducts are designed and specified in the United States and subsequently manufactured in China. The products are designed in-house,3-D CAD files are then produced with product renderings. We then subject these rendered images for focus group review, todetermining which designs we should move to the prototype development stage. Pre-production prototypes are developed by ourcontractor in China to our specifications. Our contractor sources components for the smart eyewear in China including plastic and titaniumfor the frames, electronic components, speakers, microphones and batteries. All packaging is designed in Miami and fabricated in China.Once completed, our products are tested in the United States, to assess functionality, fit and finish. Orders received on our eshop,Amazon store and bulk retail orders are aggregated in Miami and then placed and fabricated in China, whereupon they

65

undergoa rigorous eleven-point third party product inspection process. The inspection is conducted on 100% of our manufactured products.Inspections include testing procedures to help ensure our customers receive only functional, high-quality products.

Ifproducts are ordered with non-prescription sunglass lenses, they are manufactured by our third party contractor and shippedto a warehouse in Miami for direct to consumer or retail store shipment. If products are ordered with prescription or specialty lenses,then the smart eyewear frames are sent to an optical contractor laboratory in Boston, Massachusetts, to have the lenses cut, ground andmounted in the frames, whereupon they are directly shipped to customers. If products are ordered from Canada, they are shipped to a Canadiandistributor’s warehouse for subsequent delivery to stores within Canada.

Forour in-store displays, we developed the proprietary software and video for the virtual try-on, in-house,the fixtures are manufactured for us in the United States and the tablets used for the displays are made in China. The displays andthe fixtures are assembled in Miami and then provided to a third-party warehouse in Miami for retail store distribution.

Marketing

Weemploy a 360-degree marketing mix that encompasses both brand and user generated content syndication across earned, ownedand paid platforms (channels where the company pays a fee to have its product advertised). Long form and video content generation area key focus points for the brand, they allow us to better leverage both emerging and critical smart eyewear narratives through persistentsearch engine optimization (SEO); increasing our organic brand awareness across the board, in addition to strategic loyalty, influencerand affiliate marketing campaigns.

Thisstrategy includes, but is not limited to, pay per click advertising, Email, Social and Content marketing, PR and traditional print Ads.Our robust Company-paid Ads span Broadcast TV, Audio, Google (search/video), CTV, Facebook, IG, TikTok, Pinterest, Twitter,Taboola, AI-driven ads and Amazon native ads.

Webelieve we are trendsetters in creating relevant, omni-channel touchpoints that derive meaningful experiences and productsdesigned for our customers.

Froma brand perspective, strategically offering value-added, tangible products and/or services coupled with a well-organizednon-fungible token promotional initiative has become a relevant marketing tool that can potentially rapidly expand brandawareness and revenue. At Innovative Eyewear, we strive to lead and own critical narratives within the Bluetooth and smart eyewear space.

Weseek to create memorable experiences and products that resonate with our customers, coupled with premium content and campaigns designedto expand our brand presence and market share.

Ourinfluencers

Toaccelerate brand awareness and product sales, we are embarking on an influencer strategy to engage leading figures in sports and the arts,who like and enjoy wearing Lucyd Lytes. To date we have onboarded Chris Clark, a PGA golfer, Monique Billings, a WNBA basketball player,and Hadar Adora, an up-and-coming musical artist. We plan to add additional influencers to enhance awareness and sell-throughfor a number of key demographics.

Influencersare a key part of our marketing strategy, as they help our products relate to large, variable audiences. Lucyd Lyte is a perfect fit forthe fitness tech and audio product spaces, so athletes and musicians are a natural fit for our brand and the active lifestyles that Lucydproducts promote. We plan to add A-list musical talent to the brand in the near future, as well as a host of audio contentcreators to support the Vyrb experience.

OurMarket Opportunity

Accordingto Statista, the total addressable market for eyewear in the U.S. is projected to be $28.3 billion in 2021. The market fordigital assistants like Siri, Google Voice, Bixby and Alexa has grown rapidly in North America, and had $2.5 billion in revenuein 2020. In the U.S., our primary market, the hearables market is projected to be $5.1 billion in 2021. We view the popularityof hearables as an important catalyst for the smart eyewear market.

66

Thecommon denominator among markets for the hearables and digital assistant is that they facilitate real-time access to digitaldata, whether it is through music, calls, navigational directions, or information, among other uses. The combination of hearables anddigital assistants provides a transparent, ergonomic interface between the users and their digital lives. At Innovative Eyewear, we arededicated to a touch-free interface and untethering our customers eyes from their smartphone screens, through our smart eyewearproduct.

Thesynergistic fusion of these three markets enables, in our view, an opportunity to create a completely new experience of connected eyewear,which smoothly delivers the functionality of both optical glasses and headphones, eliminating the need for either on its own. Nevertheless,several orthodoxies of the eyewear industry still hold, namely: if you want to sell a lot of eyewear, we believe it should be attractive,stylish, comfortable (e.g., lightweight, which we believe to be approximately 1oz) and cost roughly the same as traditional eyewear. Thisis what we have sought to achieve, and in our view have accomplished with the introduction of Lucyd Lyte eyewear.

IntellectualProperty

Welicense from Lucyd Ltd., a subsidiary of our majority stockholder, an intellectual property portfolio designed to protect our unique eyeweardesigns and certain technological features in current and anticipated future products.

Wehave licensed 41 patents to date, covering all of our current product designs and certain advanced features such as Vyrb, replaceablefront frames, and multi-channel Bluetooth connectivity. The Company will seek to file new IP to protect new styles and featuresof its smart eyewear as they are introduced.

Ourcurrent patent portfolio is as listed below.

Application/Patent Number

 

Title

 

Country

 

Filing/Issue Date

 

Status

 

Grant Date

 

Anticipated
Expiration
Date

10,908,419

 

Smartglasses and Methods and Systems for Using Artificial Intelligence to Control Mobile Devices Used for Displaying and Presenting Tasks and Applications and Enhancing Presentation and Display of Augmented Reality Information

 

US

 

June 28, 2018

 

Issued

 

February 2, 2021

 

October 5, 2038
(Patent Term Adjustment – 99 days)

D899,493

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 20, 2020

 

October 20, 2035

D900,203

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 27, 2020

 

October 27, 2035

D899,494

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 20, 2020

 

October 20, 2035

D899,495

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 20, 2020

 

October 20, 2035

D899,496

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 20, 2020

 

October 20, 2035

D900,204

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 27, 2020

 

October 27, 2035

D900,205

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 27, 2020

 

October 27, 2035

D900,920

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

November 3, 2020

 

November 3, 2035

D900,206

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 27, 2020

 

October 27, 2035

D899,497

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 20, 2020

 

October 20, 2035

D899,498

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 20, 2020

 

October 20, 2035

D899,499

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 20, 2020

 

October 20, 2035

D899,500

 

Smart Glasses

 

US

 

March 22, 2019

 

Issued

 

October 20, 2020

 

October 20, 2035

67

Application/Patent Number

 

Title

 

Country

 

Filing/Issue Date

 

Status

 

Grant Date

 

Anticipated
Expiration
Date

29/716,878

 

Round Smartglasses Having Flat Connector Hinges

 

US

 

December 12, 2019

 

Pending

 

n/a

 

n/a

29/716,882

 

Round Smartglasses Having Pivot Connector Hinges

 

US

 

December 12, 2019

 

Pending

 

n/a

 

n/a

29/716,892

 

Sport Smartglasses Having Flat Connector Hinges

 

US

 

December 12, 2019

 

Pending

 

n/a

 

n/a

29/716,895

 

Wayfarer Smartglasses Having Pivot Connector Hinges

 

US

 

December 12, 2019

 

Pending

 

n/a

 

n/a

62/941,466

 

Wireless Smartglasses with Quick Connect Front Frames

 

US

 

November 27, 2019

 

Non-Provisional Application filed on November 25, 2020; U.S. App. No. 17/104,849

 

n/a

 

November 27, 2020

29/717,878

 

Flat Connector Hinges for Smartglasses Temples

 

US

 

December 19, 2019

 

Pending

 

n/a

 

n/a

29/717,884

 

Pivot Hinges for Smartglasses Temples

 

US

 

December 19, 2019

 

Pending

 

n/a

 

n/a

16/829,841

 

Voice Assistant Management

 

US

 

March 25, 2020

 

Notice of Allowance received 11/30/2021

 

TBD

 

TBD

29/743,256

 

Wayfarer Smartglasses

 

US

 

July 20, 2020

 

Pending

 

n/a

 

n/a

29/743,258

 

Round Smartglasses

 

US

 

July 20, 2020

 

Pending

 

n/a

 

n/a

17/104,849

 

Wireless Smartglasses with Quick Connect Front Frames

 

US

 

November 25, 2020

 

Pending

 

n/a

 

n/a

29/806,200

 

Smartglasses

 

US

 

September 1, 2021

 

Pending

 

n/a

 

n/a

29/806,204

 

Smartglasses

 

US

 

September 1, 2021

 

Pending

 

n/a

 

n/a

29/806,207

 

Smartglasses

 

US

 

September 1, 2021

 

Pending

 

n/a

 

n/a

29/806,209

 

Smartglasses

 

US

 

September 1, 2021

 

Pending

 

n/a

 

n/a

207516

 

Smartglasses

 

Canada

 

October 29, 2021

 

Pending

 

n/a

 

n/a

207517

 

Smartglasses

 

Canada

 

October 29, 2021

 

Pending

 

n/a

 

n/a

207518

 

Smartglasses

 

Canada

 

October 29, 2021

 

Pending

 

n/a

 

n/a

207519

 

Smartglasses

 

Canada

 

October 29, 2021

 

Pending

 

n/a

 

n/a

29/814,016

 

Safety Smartglasses

 

US

 

November 2, 2021

 

Pending

 

n/a

 

n/a

29/814,017

 

Safety Shields

 

US

 

November 2, 2021

 

Pending

 

n/a

 

n/a

63/274,920

 

Safety Glasses

 

US

 

November 2, 2021

 

Pending

 

n/a

 

n/a

29/815,040

 

Charging Cradle

 

US

 

November 10, 2021

 

Pending

 

n/a

 

n/a

207956

 

Safety Smartglasses

 

Canada

 

November 17, 2021

 

Pending

 

n/a

 

n/a

207957

 

Safety Shields

 

Canada

 

November 17, 2021

 

Pending

 

n/a

 

n/a

2021307950576

 

Safety Smartglasses

 

China

 

December 2, 2021

 

Pending

 

n/a

 

n/a

2021307955902

 

Safety Shields

 

China

 

December 2, 2021

 

Pending

 

n/a

 

n/a

68

Additionally,Innovative Eyewear has acquired the exclusive rights to 11 registered trademarks and applications as follows:

Trademark

 

Trademark Number

 

Status

 

Jurisdiction

LUCYD

 

UK00003258030

 

Registered

 

UK

Lucyd Lens

 

UK00003258093

 

Registered

 

UK

Lucyd Loud

 

UK00003400531

 

Registered

 

UK

Upgrade your eyewear

 

UK00003400579

 

Registered

 

UK

GaaS

 

UK00003451728

 

Registered

 

UK

Vyrb

 

UK00003477240

 

Registered

 

UK

Lyte

 

UK00003526151

 

Registered

 

UK

Upgrade your eyewear

 

Application No. 90/407,646

 

Application

 

US

LUCYD

 

Application No. 90/407,723

 

Application

 

US

Lyte

 

Application No. 90/381051

 

Application

 

US

Vyrb

 

Application No. 90/820713

 

Application

 

US

MaterialAgreements

LicenseAgreement between Innovative Eyewear, Inc. and Lucyd Ltd.

OnApril 1, 2020, we entered into an exclusive, worldwide license agreement with Lucyd Ltd. for all fields of use of the Lucyd®brand, and the associated intellectual property and assets (the “License Agreement”). We were founded by Lucyd Ltd., the inventorand licensor of the technology that our products are based upon, which is a portfolio company of Tekcapital, our majority stockholder.The License Agreement is royalty-free, fully paid up, perpetual license, for the exclusive use of the following assets:

1.      AllLucyd intellectual property, including, all patents, patent applications and any continuations of such.

2.      AllLucyd trademarks.

3.      AllLucyd collateral material, artwork, subscriber lists, eyeglass model and frame shots and renders, as well as 3D models.

4.      AllLucyd logos such as, but not limited to: Lucyd® word mark, Lucyd Hexagon,Upgrade Your Eyewear® slogan and the Vyrb™ pending trademark application.

5.      AllLucyd company developed software and any new software developed by Innovative Eyewear, utilizing the Lucyd software, will be owned byInnovative Eyewear.

6.      LucydStore portals through Shopify, Amazon and Walmart.

7.      Relevantwebsites domain names including Lucyd.co, Lucyd.net, Lucyd.eu.

8.      Allsupply and endorsement agreements.

9.      Allcurrent inventory as of the execution date of license.

10.    Allsocial media accounts under the Lucyd name, including, but not limited to: Twitter, Facebook and Instagram.

11.    Alladvertising material and trade show displays, brochures and related materials.

Underthe terms of the License Agreement, we have the exclusive right to effectuate sublicenses, either exclusively or non-exclusively,to any or all of our licensed intellectual property, at its sole discretion. Upon execution of the License Agreement, we paid Lucyd Ltd.£1 for the life of the licensed assets, and the License Agreement shall continue in perpetuity, unless terminated according to theterms of the agreement. Additionally, we issued 3,750,000 shares of our common stock to Lucyd Ltd. as compensation for enteringinto the License Agreement and for the contribution of certain other assets. Lucyd Ltd. may terminate the license with immediate effectby providing written notice to us if, among other things: we commit a material breach, as such is defined by the terms of the agreement;or, if we suspend, or threaten to suspend, payment of our debts or are unable to pay our debts.

69

TheLicense Agreement requires us to indemnify Lucyd against all liabilities, costs, expenses, damages, and losses(including but not limitedto any direct, indirect or consequential losses, loss of profit, loss of reputation and all interest, penalties, and legal costs (calculatedon a full indemnity basis) and all other reasonable professional costs and expenses) suffered or incurred by Lucyd Ltd. arising out ofor in connection with actual or alleged infringement of third party intellectual property rights; our breach or non-performanceof or the enforcement of License Agreement. We have the right to sublicense any of our rights under the License Agreement, provided thatany sublicense also shall enter into a supplemental agreement satisfactory to Lucyd Ltd.

OnOctober 5, 2021, the parties to the License Agreement executed an Addendum, to the exclusive license agreement, which clarifiedthat Innovative Eyewear shall commercialize, continue with any on-going intellectual property prosecutions and pay all maintenanceor other patent fees (the “Addendum”). For all new intellectual property, Innovative Eyewear will own control it and be responsiblefor all prosecution and maintenance costs. The Addendum also confirms that Innovative Eyewear issued Lucyd Ltd. 3,750,000 sharesof its common stock as consideration for the license.

SalesRepresentation Agreement

OnMarch 4, 2021, we entered into a commission-only, sale representation agreement with D. Landstrom Associates,Inc. to provide distribution into big box retailers in the United States (the “Representation Agreement”). The RepresentationAgreement provides for D. Landstrom to act as our commission based, manufacturer’s representative, with the exclusive right to solicitoffers on behalf of us to purchase our products in the United States, for five big box stores. The term of the Representation Agreementis five years. Contract may be terminated for “good cause” with 90 days’ notice by either party. Upon termination,commissions of orders procured will extend 180 days beyond termination date.

DistributionAgreement

OnJune 30, 2021, we entered into a distribution agreement with 8 Points Inc., a subsidiary of Marca Eyewear Group Inc., forexclusive distribution of Lucyd Lyte products in Canada (the “Distribution Agreement”). The Distribution Agreement providesthat 8 Points Inc. will have exclusive purchase and distribution rights and obligations in Canada. The term of the Distribution Agreementis 3.5 years and either party may terminate by providing 180 days’ notice to the other party. The distributor will performservices, which shall include, but shall not be limited to the following):

1.      Salesof our products into retail distribution by servicing potential purchasers and by generating new business within the Territory (as definedin the Distribution Agreement).

2.      Handlingof all account inquiries on sales made pursuant to this Distribution Agreement.

3.      InnovativeEyewear will receive all Canadian returns on a timely basis. Currently, distributor will organize customer returns such that all returnswill be shipped in bulk to Company’s distribution center in Miami, Florida.

4.      Companywill provide marketing activities to support the sales of all the collections sold by the Distributor in the territory.

5.      Distributorwill provide logistic service to distribute the product in the territory covering all provinces and provide internal customer serviceand warehousing and shipping, as well as after purchase care to customer.

6.      Distributorwill provide a minimum purchase of $4.6 million worth of Lucyd Lyte products over 30 months to maintain exclusivityfor sales in Canada.

7.      Monthlyminimum committed purchases increase incrementally over the term of the Distribution Agreement. In the event that 8 Points Inc. does notmeet the minimum monthly purchase requirements then we may convert 8 Points Inc. exclusive contract to a non-exclusive contractor terminate the Distribution Agreement.

70

TheNext Step

Vyrb

Webelieve eyewear should enable customers to freely interact with social media. While digital assistants, once enabled, can provide thebasis for this interaction, we believe that the ability to receive and send social media posts with an individual’s voice may greatlyenhance ease of use of these platforms on the go. To facilitate this, we have been developing Vyrb, our full stack social media applicationthat enables the user to receive and send posts through Lucyd Lyte smart glasses with an individual’s voice. The application isslated to launch out of beta toward the end of the fourth quarter of 2021 and we are aiming to roll out software upgrades to Vyrb in thefourth quarter of 2022, which we anticipate will include new features like: monetization, ad-buying modules, an itemizedupgrade system, and content selling capabilities for social media creators.

Webelieve that Vyrb will enhance the utility of current and future Lucyd Lyte glasses by enabling users to be untethered from their smartphones,yet still be able to hear and make social media posts. A goal of our products is to free our customers from other technologies. As such,we are designing Vyrb with a transparent, voice-centric interface in mind, so that as soon as our customers can say “OkGoogle,” they are connected to a world of engaging audio content and have the ability to create audio posts and messages. We believesocial interaction via smart eyewear will be instrumental in bringing new, youthful customers to our company.

Anumber of companies recently have started to launch voice mediated social media applications, such as Clubhouse, Discord, Audlist, Listenand Riffr. We are designing Vyrb to host audiobooks, podcasts and entire music albums on the platform. With Vyrb, Lucyd Lyte customerswill be able to hear their social media feeds, post messages, hold gatherings and musical performances (by inviting other Vyrb users toconnect with each other at a specific date and time), and enjoy social media with the authenticity of their own voice: all through theireyewear and without taking their phone out of their pocket.

TheProduct and Market for Vyrb

Vyrbis being designed as a full social media experience to enhance voice-based communications on wearables and mobile devices.The sophistication of Vyrb’s interface enables a large array of in-app purchases and subscriptions, as well as easyconnectivity with the Lucyd Lyte line of smart eyewear. In addition to an ad-driven revenue model

71

thatis typical of social media applications, the robust and highly variable selection of planned in-app purchases provide importantimprovements and fine-tuned customizations to help personalize the user experience. We plan to roll out these and other excitingfeatures of Vyrb over the course of several software updates.

TheVyrb app is contemplated to feature an in-app item shop with a number of fun and useful upgrades, such as:

•        LootBoxes — Random packs of multiple upgrade items, a best-selling in-app purchase format frequentlydeployed in online video games.

•        Skins —Items that alter the appearance of the app to help personalize it to the user’s preferences, such as Dark Mode.

•        Accents —Items that change the accent used by the app’s text-to-speech engine, which is employed frequently to vocalize textualcontent.

•        MetalMics — Items that lengthen the maximum allowable verbal post length and image/video sizes per post for users.

•        PostEmbellishments — Items that can be used to animate posts in the feed to make them more prominent.

•        SoundFX Packs — Items that increase the number of audio emojis (Sound FX) available to the user, livening up their posts.

•        AdTokens — Items that can be spent to expand the reach of a feed post to a larger audience.

•        VyrbGold — A premium, monthly subscription to the app that blocks all ads and brings additional benefits like a more prominentusername.

•        VyrbGems — In-app currency that can be spent to tip a user’s favorite content creators, to buy premiumpaywalled content and to buy certain other in-app purchases. Gems can also be traded to other users for their items on theVyrb Marketplace module. Users will also be rewarded Gems for their engagement with ads on the platform, creating a positive feedbackloop that rewards app engagement with premium content and experiences.

•        CommandTokens — Items that can be spent to create new custom voice assistant commands (based on Vyrb’s Voice CommandCreation Interface).

•        Mega-TagTokens — Items that can expand the number of mega-tags available to the user (mega-tags area unique Vyrb feature, they are automatically applied hashtags that make a user’s posts more discoverable to others).

Usersspend approximately 145 minutes per day on social media applications and regularly click on advertisements they view through their applications.We believe Vyrb is strategically positioned to become a prime advertisement space, allowing both visual and audible advertisements tobe purchased. Vyrb ads will be shown in a user’s regular newsfeed, which we believe will create an opportunity and need for a subscriptionin-app purchase (Vyrb Gold) for a premium, ad-free browsing experience. For ease of use, Vyrb ads can be createdby any user through the application in just moments: users will be able to purchase “Ad Token” items from the in-appstore, and then use these tokens to turn standard posts into wide-reaching ads. A rapid-response reportingsystem will be developed and monitored to remove objectionable or illegal content from the platform. With its focus on high quality audio,we are designing Vyrb to lift up professional and creative audio content developers by helping them reach new audiences. To ensure a positiveuser experience, we are developing a system in Vyrb which will automatically promote positively reviewed content, and automatically removecontent that has been reported in a high ratio compared to the number of viewers, providing the basis for user product discovery as wellas a failsafe against any mistake in our manual and algorithmic moderation of the application’s hosted content.

Vyrbusers will be able to purchase and support content from indie and professional creators via an in-app currency (referredto as “gems” in this document, a virtual point the user typically accumulatesby viewing ad content or by purchasing them). Creators will receive gems from typical users as tips during live broadcasts, and in exchangefor access to premium posts. The creators will then be able to cash out these gems at an exchange rate that provides profit to Vyrb. Forexample, users purchase the gems, its in-app loyalty token at a rate of $1 each, but creators only receive $0.75 for eachgem they cash out. A 25% effective platform fee would put the content transaction fees of Vyrb at a lower rate than most digital contentmarketplaces. In the case of typical livestreaming applications, a functionality Vyrb supports, they are often exorbitant, taking as muchas 50% in effective fees on in-app currency transactions.

72

Toacquire the gems, users must buy them in the Vyrb Shop or gain them by engaging with sufficient ad content (e.g., using the applicationfor an hour, or an amount of time that effectively pays for the gem).  While Vyrb allows users the flexibility of choice of eitherbuying or earning these gems, we believe that there is a huge revenue stream potential for us through a strategic implementation of theVyrb Shop and peer-to-peer content transactions.

Also,we plan for users to be able to charge a fixed price to be able to access particular audio posts. For example, this feature could be usedby a podcaster to sell their premium episodes, or by a recording artist to sell their music albums. In tandem with this feature, audioposts will be divisible into tracks to support long form content such as albums and audiobooks. Vyrb will take a flat percentage fee onall sales of premium content within the application by allowing creators to cash out gems they receive for selling their content. We believethe major benefit of this system is that it will provide audio content creators a new platform for rapidly creating, listing and sellingtheir content, and help create an environment full of rich, unique and interactive audio experiences such as live “radio shows,”indie content and virtual concerts for typical Vyrb users.

Webelieve that Vyrb will effectively leverage multiple successful gamification models from the world of social media to provide a flexibleand highly interactive user experience that can potentially draw high-value content creators. A fundamental aspiration ofVyrb is to provide a new platform and source of revenue for high quality audio content creators in particular; to that end, we designedVyrb with a goal of providing a rapid, user-friendly platform for creators and consumers to share, sell and enjoy the bestaudio the web has to offer. We believe that through Vyrb, we can make the interaction between our users and our product a fun andrewarding experience, which can also be monetized by the company and content creators alike. By putting audio front and center, we hopeto provide a new meeting ground for audio content creators and those who enjoy lots of music, podcasts and talk shows. We hope to providea mutually beneficial relationship, where Vyrb takes a reasonable fee on the transacting of these parties in exchange for bringing themtogether.

Competition

Thesmart eyewear industry in which we operate is competitive and subject to changes in practice. While we believe that our products are hybridof eyeglasses and audio technology, which gives us a unique product that provides us with competitive advantages, we may face competitionfrom many different entities now and in the future. As of now, we face competition from the following products:

•        BoseCorporation’s Bose Frames.    These are a Bluetooth eyewear product, but in a bulkier form factor andwith what we believe to be comparable models at a higher price ($199 to $249 MSRP) than Lucyd Lyte.

•        Amazon’sEcho Glasses.    Another entry in the Bluetooth eyewear space. Not available directly from the manufacturerin prescription with a limited number of frame styles. The cost of the Amazon Echo Glasses is higher than Lucyd Lyte. While lightweightlike Lucyd Lyte glasses, Amazon Echo Glasses have, in our view, a muted form factor, and the battery life is about half of that of LucydLyte.

•        SnapchatSpectacles.    This is a camera-focused smart eyewear product and, in our view, not a direct competitoras to its style, weight, pricing and suitability for all-day wear, as compared with our products; however, Snapchat Spectaclesmay introduce further entries in the space that may directly compete with Lucyd Lyte. Snapchat Spectacles Version 3 have an MSRP of $380.

•        Ray-BanStories Glasses.    Developed in association with Facebook, are a camera-focused smart eyewearproduct, and despite the fact they are available in prescription, in our view not a direct competitor; Ray-Ban may, however,introduce further entries in the space that may directly compete with Lucyd Lyte. Ray-Ban Spectacles have a well-knownand respected brand, and an MSRP starting $299, which makes them twice as expensive as Lucyd Lyte. They weigh considerably more (20-70%depending upon the Lyte model) than Lucyd Lyte glasses, have a shorter battery life, thicker temple profiles and are not water resistant.

Allof the competitors discussed above have substantially greater manufacturing, financial, research and development, personnel and marketingresources than we do. As a result, although we believe our products are currently superior, our competitors may be able to develop superiorproducts, and compete more aggressively and sustain their competitive advantage over a longer period of time than us. Our products maybe rendered obsolete in the face of competition.

73

GovernmentRegulation

Weare subject to a wide variety of laws and regulations in the United States and other jurisdictions in which we operate. The lawsand regulations govern many issues related to our business practices, including but not limited to those regarding contact lens prescriptions,worker classification, wage and hour, sick pay and leaves of absence, anti-discrimination and harassment, whistleblower protections,privacy, data security, intellectual property, product liability and taxation.

Theselaws and regulations are constantly evolving and may be interpreted, applied, created, superseded, or amended in a manner that could harmour business. These changes may occur immediately or develop over time through judicial decisions or as new guidance or interpretationsare provided by regulatory and governing bodies, such as federal, state, and local administrative agencies. As we expand our businessinto new markets or introduce new products, features, or offerings into existing markets, regulatory bodies or courts may claim that weare subject to additional requirements, or that we are prohibited from conducting business in certain jurisdictions.

FDARegulations

Oureyewear is considered a medical device by the FDA and regulated as such, and we are subject to the requirements set by the Consumer ProductSafety Commission (the “CPSC”). Prescription eyeglasses are regulated as medical devices in the United States by theFood and Drug Administration (the “FDA”), and under the Food, Drug, and Cosmetic Act (the “FDCA”), such medicaldevices must meet a number of regulatory requirements. Regulatory changes could result in restrictions on our ability to carry on or expandour operations, higher than anticipated costs, or lower than anticipated sales. Failure to comply with applicable regulations could jeopardizeour contract manufacturers’ ability to manufacture and result in FDA enforcement actions against the Company.

DataPrivacy and Security

Additionally,because we receive, use, store, and transmit personal data, relating to our customers, we are subject to numerous laws and regulationsin the United States, as well as industry standards, relating to privacy, data security and data protection. Such laws, regulations,and industry standards include, but are not limited to, Section 5(a) of the Federal Trade Commission Act, the California ConsumerPrivacy Act of 2018, the California Online Privacy Protection Act, and HIPAA, as amended by the Health Information Technology for Economicand Clinical Health Act, or HITECH, and its implementing regulations, that impose requirements on covered entities, including certainhealthcare providers, health plans, and healthcare clearinghouses, and their respective business associates that create, receive, maintain,or transmit individually identifiable health information for or on behalf of a covered entity as well as their covered subcontractorsrelating to the privacy, security, and transmission of individually identifiable health information. Enforcement activity with respectto one or more breaches of data privacy and security can result in financial liability and reputational harm, and responses to such enforcementactivity can consume significant internal resources.

Employeesand Human Capital Resources

Asof the date of this prospectus, we have eight (8) full time employees with two in product development, two in sales, one in finance,one in customer service, one in marketing and one in graphic design. Employees are supported by a number of consultants and part timeemployees.

Ourexperienced employees and management team are our most valuable resources and we are committed to attracting, motivating, and retainingtop professionals going forward. We have been able to locate and engage highly qualified employees as needed and do not expect our growthefforts to be constrained by a lack of qualified personnel. We consider our employee relations to be good.

Oursuccess is directly related to the satisfaction, growth, and development of our employees. We strive to offer a work environment whereemployee opinions are valued and one that provides our employees the opportunities to use and augment their professional skills. To achieveour human capital goals, we intend to remain focused on providing our key personnel with raises as appropriate, a 401(k) program, andcompany stock options. We continue to search out well qualified highly skilled individuals to help us expand and grow our operations.

74

LegalProceedings

Weare not currently subject to any material legal proceedings. However, we may from time to time become a party to various legal proceedingsarising in the ordinary course of our business.

Facilities

Ourexecutive offices are located at 8101 Biscayne Blvd., Miami, Florida 33138. Our executive offices are provided to us by the parent ofour majority stockholder, Tekcapital. Since, June 1, 2020, we have paid Tekcapital $25,000 per fiscal quarter for officespace, utilities, advisory services and any other services. We consider our current office space adequate for our current operations.To accommodate our anticipated growth, Tekcapital signed a lease for an additional facility for the Company, located at 11900 BiscayneBlvd., Miami, Florida 33181, which lease will commence on February 1, 2022.

75

Management

Directorsand Officers

Thefollowing table sets forth certain information regarding our board of directors, our executive officers, and some of our key employees,as of the date of this prospectus.

Name

 

Age

 

Position

Harrison R. Gross

 

29

 

Chief Executive Officer and Director

Konrad Dabrowski

 

38

 

Chief Financial Officer

Frank Rescigna

 

61

 

Vice President of Global Sales and Director

David Cohen

 

49

 

Chief Technology Officer

Kristen Mclaughlin

 

49

 

Director

Louis Castro

 

63

 

Director

Olivia C. Bartlett

 

63

 

Director

HarrisonGross is one of the founders of Innovative Eyewear and has served as our Chief Executive Officer and as a director since August 2019,where he guides the company’s product and brand development. Prior to his employment at Innovative Eyewear,from August 2017 to August 2019, Mr. Gross served in various positions, including chief executive officerand media & UX lead, of Lucyd Ltd., our largest stockholder and the licensor of our technology which is also a smart eyeweardevelopment company where he developed the company’s brand identity and oversaw general operations and product development. Additionally,from November 2015 to August 2021, Mr. Gross served as the Digital Media Manager of Tekcapital PLC (“Tekcapital”)(LON: TEK), a university intellectual property investment firm that is the parent company of Tekcapital Europe Limited, and Lucyd Ltd,the holding company for Tekcapital’s shares in Innovative Eyewear, where he created, developed and marketed for the company’slicensed properties. Prior to that, from October 2013 to September 2014, Mr. Gross worked as a credit analyst fora Verizon, Inc. contractor, where he managed credit systems and provided support to Verizon agents. Mr. Gross is a graduateof Columbia University with a BA in Writing and received a BA in Jewish Studies from the Jewish Theological Seminary. Mr. Grossis well qualified to serve as a director due to his substantial knowledge of our product and his experience in marketing, product andapp development.

KonradDabrowski has served as our Chief Financial Officer on a part-time basis since August 2019. Since June 2017,Mr. Dabrowski has also served as the group controller and chief financial officer of Tekcapital PLC (“Tekcapital”),where he co-manages the group’s investment strategy and oversees financial reporting for all of its portfolio companies.Prior to his employment at Tekcapital, from  March 2016 to June 2017, Mr. Dabrowski was a Global AccountingManager for Restaurant Brands International (NYSE:QSR), a multinational fast food holding company, where he oversaw accounting and taxprojects for Burger King within the Europe Middle East and Africa (EMEA) market. Prior to his employment at Restaurant Brands International,Mr. Dabrowski was an Audit Manager at Deloitte, where he managed end-to-end accounting audits for a portfolioof public and private corporate clients. Mr. Dabrowski has a Master’s in Finance and Banking from the Warsaw Schoolof Economics and is a Certified Public Accountant.

FrankRescigna has served as our Vice President of Global Sales and a director since August 2021. Mr. Rescigna hasmore than 25 years of brand building and sales experience in the eyewear industry. Prior to his employment at Innovative Eyewear,from October 2019 to May 2021, Mr. Rescigna was the Director of Global Sales at House of Wu, a global wholesaleluxury bridal and evening dress distributor, where he led the company’s sales strategy throughout the world. Prior to his employmentat House of Wu, from September 2018 to September 2019, Mr. Rescigna was the President of Teka Eyewear, a boutiqueglobal wholesale luxury eyewear distributor specializing in exotic materials, where he managed all aspects of its sales organization andoperations. Prior to his employment at Teka Eyewear, from March 2015 to August 2018, Mr. Rescigna was the SeniorVice President of Global Sales at Wiley X, a multi-brand global eyewear company that designs and distributes sunglasses,where he managed the company’s sales activities at the corporate and sales level. Prior to his employment at Wiley X, from February 2011to February 2015, Mr. Rescigna was the President of Jewelry & Global Brand Licensing for Guess Inc. (NYSE:GES), a global fashion/lifestyle company with varying business models, distribution models and products, where he assisted the companywith the expansion of its brand and new brands/products. Prior to his employment at Guess, from February 2004 to January 2011,Mr. Rescigna was the President of Viva International Group, a large eyewear company that designs, manufactures and distributescore

76

andluxury global brands, where he led the company’s expansion and integration with its parent company Highmark Vision Holding Company.He received a degree in Opticianry from Middlesex College. Mr. Rescigna is well qualified to serve as a director due hissubstantial brand and sales experience and his experience in the eyewear industry.

DavidCohen is one of the founders of Innovative Eyewear and has served as our Chief Technology Officer since September 2019.Prior to his employment at Innovative Eyewear, from August 2017to August 2019, Mr. Cohen served as the chief technology officer of Lucyd Ltd., a smart eyewear development company,where he led the company’s technological advancements and digital ad campaigns. Also, prior to his employment at Innovative Eyewear,from September 2009 to October 2019, Mr. Cohen served as President of Emaze Design Agency, a digital design agency,where he led the development of web and applications for e-commerce, web performance monitoring, website design and mobileapplications. Prior to his employment at Emaze Design Agency, Mr. Cohen was lead Business Intelligence Specialist at JewishGeneral Hospital where he assisted with the data solutions and business processes and requirements. He received a BS in Computer Sciencefrom the Academy of Bordeaux and an MS in Advanced Technician & Information Systems Management from Hadassah University.

KristenMclaughlin has served as one of our directors since August 2021. Ms. Mclaughlin has 20 years’ experience launching,managing and developing products in the eyewear, accessories, cosmetics and skincare industries. From March 2019 to April 2020,Ms. Mclaughlin served as the Global Marketing Director at DePasquale Companies, a skincare, hair care and cosmetics manufacturer,where she led the global marketing strategy and new product development. Prior to her employment at DePasquale Companies, from March 2000to January 2019, Ms. Mclaughlin was employed at Silhouette International, an eyewear manufacturer, where she served as the Directorof Marketing: Eyewear Manufacturer, Regional Sales Manager, and Brand Manager: Daniel Swarovski Crystal Eyewear. While at Silhouette International,Ms. Mclaughlin led the company’s brand portfolio in the U.S. and its brand direction, product development and campaign content.She has a BS and MBA from Ramapo College of New Jersey. Ms. Mclaughlin is well qualified to serve as a director due to her substantialexperience in the eyewear industry and her experience in brand and product development.

LouisCastro has served as one of our directors since August 2021. Mr. Castro is an experienced public company directorand chartered accountant. Mr. Castro is currently on the board of directors of the following public companies (1) Tekcapitalwhere he has been a director since December 2019, (2) Orosur Mining Inc. (TSE:OMI), a company exploring for minerals in South America,where he has been chairman of the board since April 2020, (3) Stanley Gibbons Group plc (LON:SGI), a company that specializes inthe retailing of collectable stamps and similar products, where he has been a director since June 2016, (4) Tomco Energy plc (LON:TOM),an oil exploration and technology company, where he has been a director since April 2021, (5) Predator Oil & Gas Holdingsplc (LON:PRD), an oil and gas exploration company, where he has been a director since July 2020, and (6) Veteran Capital Corp.(TSX-V:VCC), a capital pool company, where he has been a director since January 2021. From September 2012 to June 2016,Mr. Castro was a director and, from September 2014 to June 2016 served as the Chief Financial Officer, of ElandOil & Gas plc, a Nigerian focused upstream oil and natural gas exploration and production company, where he was responsible forthe company’s finance, legal and corporate finance activities. Prior to his employment at Eland, from May 2011 to May 2014,Mr. Castro served as Head of Capital Markets and then as Chief Executive Officer of Northland Capital Partners, an investmentbank, where he was responsible for the investment banks day-to-day activities. He is a fellow of the Institute of CharteredAccountants of England & Wales, has a double degree in Engineering Production and Economics from Birmingham University and attendedthe Postgraduate Advanced Course in Production Management and Methods at Cambridge University. Mr. Castro is well qualifiedto serve as a director due to his substantial experience as a director of public companies and his distinction as chartered accountant.

OliviaC. Bartlett has served as one of our directors since August 2021. Ms. Bartlett has been in the eyewear industry for over40 years holding various roles including optician, optical manager, marketing manager and operations management. Since September 2015,Ms. Bartlett has been the Chief Operating Officer of Todd Rogers Eyewear, a specialty eyewear company, where she manages the day-to-dayoperations of the company. Prior to her time at Todd Rogers Eyewear, from March 2010 to May 2015, Ms. Bartlett was thesales representative for eyewear sales in the northeast of Massachusetts for Safilo USA, a specialty eyewear company. Additionally, fromSeptember 2013 to May 2018, Ms. Bartlett was an Adjunct Professor at Benjamin Franklin Institute of Technology in Boston,Massachusetts. Since February 2020 Ms. Bartlett has been the President of the Opticians Association of America, a national organizationrepresenting the professional, business, educational, legislative and regulatory interests of opticianry. Prior to that, Ms. Bartlettwas a director for ten years for the Opticians Association of Massachusetts.

77

Ms. Bartletthas received a number of awards through her time in the industry, including but not limited to, the 2020 Eyecare Business Game ChangerAward and the 2020 and 2018 Vision Monday Most Influential Woman Executive. Ms. Bartlett received her Massachusetts Opticians licensein 1987 and is ABO certified. Ms. Bartlett received her BA in Political Science from Clark University. Ms. Bartlett is wellqualified to serve as a director due to her substantial experience in the optical industry.

Numberand Terms of Office of Officers and Directors

Uponthe effectiveness of the registration statement of which this prospectus forms a part, we expect that our board of directors will continueto consist of five members. Our directors are appointed for one year terms to hold office until the next annual general meeting of ourstockholders or until removed from office in accordance with our amended and restated bylaws, which will be in effect upon the consummationof this offering.

Ourofficers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific termsof office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated bylaws, whichwill be in effect upon the consummation of this offering, as it deems appropriate.

DirectorIndependence and Committees of the Board of Directors

DirectorIndependence

Ofour directors, we have determined that Mr. Louis Castro and Mss. Kristen Mclaughlin and Olivia Bartlett are “independent”directors under NASDAQ listing standards, while Messrs. Harrison Gross and Frank Rescigna are not independent under such standards. Wehave also determined that each of the three prospective members of the Audit Committee is “independent” for purposes of Section 10A(m)(3)of the Exchange Act and the rules promulgated thereunder and under the NASDAQ listing standards. Further, the Board has determined thateach of the two members of both the Compensation Committee and the Nominating and Corporate Governance Committee is “independent”under NASDAQ listing standards.

BoardCommittees

Priorto the consummation of this offering, we will have three standing committees of the Board: the Audit Committee, Compensation Committeeand Nominating and Corporate Governance Committee. Each of the board committees will act pursuant to a separate written charter adoptedby our board of directors, each of which is available on our website at www.lucyd.co. Our boardof directors may at any time or from time to time appoint certain other committees in its sole discretion as it deems necessary or appropriateto carry out its functions.

AuditCommittee

TheAudit Committee will consist of Mr. Louis Castro (Chairman) and Mss. Kristen Mclaughlin and Olivia Bartlett. The Board hasdetermined that all of the prospective members of the Audit Committee are “independent,” as defined by NASDAQ listing standardsand by applicable SEC rules. In addition, the Board has determined that Mr. Castro is an audit committee financial expert,as that term is defined by the SEC rules, by virtue of having the following attributes through relevant experience: (i) an understandingof generally accepted accounting principles and financial statements; (ii) the ability to assess the general application of suchprinciples in connection with the accounting for estimates, accruals, and reserves; (iii) experience preparing, auditing, analyzing,or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable tothe breadth and complexity of issues that can reasonably be expected to be raised by the Company’s financial statements, or experienceactively supervising one or more persons engaged in such activities; (iv) an understanding of internal controls and procedures forfinancial reporting; and (v) an understanding of audit committee functions.

Thefunction of the Audit Committee relates to oversight of the auditors, the auditing, accounting, and financial reporting processes, andthe review of the Company’s financial reports and information. In addition, the functions of the Audit Committee will include, amongother things, recommending to the Board the engagement or discharge of independent auditors, discussing with the auditors their reviewof the Company’s quarterly results and the results of their audit, and reviewing the Company’s internal accounting controls.

78

CompensationCommittee

TheCompensation Committee will consist of Ms. Kristen Mclaughlin (Chairman) and Mr. Louis Castro. The Board has determinedthat all of the prospective members of the Compensation Committee are “independent,” as defined by NASDAQ listing standards.The responsibility of the Compensation Committee is to review and approve the compensation and other terms of employment of our Presidentand Chief Executive Officer and our other executive officers, including all of the executive officers named in the Summary CompensationTable under the heading “Executive Compensation” below (the “named executive officers”). Among its other duties,the Compensation Committee oversees all significant aspects of the Company’s compensation plans and benefit programs. The CompensationCommittee annually reviews and approves corporate goals and objectives for the President and Chief Executive Officer’s compensationand evaluates the Chief Executive Officer’s performance in light of those goals and objectives. The Compensation Committee alsorecommends to the Board the compensation and benefits for members of the Board. The Compensation Committee has also been appointed bythe Board to administer our 2021 Equity Incentive Plan. The Compensation Committee does not delegate any of its authority to other persons.

Nominatingand Corporate Governance Committee

TheNominating and Corporate Governance Committee will be comprised of Mss. Olivia Bartlett (Chairman) and Kristen Mclaughlin and Mr.Harrison Gross. The majority of committee members are independent under applicable NASDAQ rules and regulations. The Nominatingand Corporate Governance Committee is responsible for, among other things, considering potential board members, making recommendationsto the full board as to nominees for election to the board, assessing the effectiveness of the board and implementing our corporate governanceguidelines.

CompensationCommittee Interlocks and Insider Participation

Noneof our officers currently serves, and in the past year have not served, as a member of the compensation committee of any entity that hasone or more officers serving on our board of directors.

Codeof Business Conduct and Ethics and Insider Trading Policy

Effectiveupon consummation of this offering, our Board of Directors will adopt a Code of Ethical Conduct and an Insider Trading Policy. We willfile a copy of our Code of Ethics as an exhibit to the registration statement filed in connection with our initial public offering. Oncefiled, you can review these documents by accessing our public filings at the SEC’s web site at www.sec.gov.The Code of Ethics will also be available on our website at www.lucyd.co. In addition, a copyof the Code of Ethics will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certainprovisions of our Code of Ethics in a Current Report on Form 8-K.

Limitationof Directors Liability and Indemnification

TheDelaware General Corporation Law authorizes corporations to limit or eliminate, subject to certain conditions, the personal liabilityof directors to corporations and their stockholders for monetary damages for breach of their fiduciary duties. Our amended and restatedcertificate of incorporation, which will become effective upon the completion of this offering, limits the liability of our directorsto the fullest extent permitted by Delaware law. In addition, upon the closing of this offering, we will enter into indemnification agreementswith all of our directors and named executive officers whereby we will agree to indemnify those directors and officers to the fullestextent permitted by law, including indemnification against expenses and liabilities incurred in legal proceedings to which the directoror officer was, or is threatened to be made, a party by reason of the fact that such director or officer is or was a director, officer,employee or agent of ours, provided that such director or officer acted in good faith and in a manner that the director or officer reasonablybelieved to be in, or not opposed to, our best interests.

Priorto the consummation of this offering, we will obtain director and officer liability insurance to cover liabilities our directors and officersmay incur in connection with their services to us, including matters arising under the Securities Act. Our certificate of incorporationand bylaws also provide that we will indemnify our directors and officers who, by reason of the fact that he or she is or was one of ourofficers or directors of our Company, is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigativerelated to their board role with us.

Thereis no pending litigation or proceeding involving any of our directors, officers, employees or agents in which indemnification will berequired or permitted. We are not aware of any threatened litigation or proceeding that may result in a claim for such indemnification.

79

ExecutiveCompensation

Thefollowing table sets forth the aggregate compensation paid to our named executive officers for the fiscal years ended December 31,2020 and 2019. Individuals we refer to as our “named executive officers” include our Chief Executive Officer, our Chief FinancialOfficer and our V.P. of Global Sales.

SummaryCompensation Table

Name and Principal Position

 

Year

 

Salary
($)

 

Bonus
($)

 

Option
Awards ($)

 

Non-Equity
Incentive Plan
Compensation
($)

 

Nonqualified
Deferred
Compensation
Earnings
($)

 

All Other
Compensation
($)

 

Total
($)

Harrison Gross,

 

2020

 

42,000

 

 

199,688

 

 

 

 

241,688

Chief Executive Officer(1)

 

2019

 

42,000

                     

42,000

Konrad Dabrowski,

 

2020

 

27,000

 

 

 

 

 

 

27,000

Chief Financial Officer

 

2019

 

35,000

                     

35,000

Frank Rescigna,

 

2020

 

 

 

 

 

 

 

V.P. of Global Sales(2)

 

2019

 

 

 

 

 

 

 

____________

(1)      Includes375,000 options to purchase common stock of the Company issued to Mr. Gross for services rendered to the Company for thefiscal year ended December 31, 2020.

(2)      Mr.Rescigna began his employment on May 1, 2021 and received no compensation for the fiscal years ended December 31, 2020 and2019. Please see “Employment Agreements—Frank Rescigna” for a description of the compensation he will receive in thefiscal year ended December 31, 2021.

EmploymentArrangements with our Executive Officers

HarrisonGross

OnAugust 11, 2021, we entered into an employment agreement with Harrison Gross to serve in the capacity of the Chief ExecutiveOfficer of the Company. We agreed to pay Mr. Gross an annual base salary of $85,800 for the remainder of 2021, and we alsoagreed that on January 1, 2022 we will increase the base salary to $150,000 per year. Pursuant to the terms of the employmentagreement, our Board may exercise its sole discretion to grant Mr. Gross an annual bonus, the amount of which bonus shallbe determined in the sole discretion of our Board. Additionally, we granted Mr. Gross an option to purchase 100,000shares of our common stock.

Theagreement has an initial term of three years, and will terminate on the third anniversary of the effective date unless Mr. Grossand the Company agree otherwise in writing. If we terminate the employment agreement for any reason other than for cause (as such is definedin the agreement) or Mr. Gross terminates his employment for good reason (as such is defined in the agreement): (1) Mr.Gross shall be entitled to payment of his base salary for the balance of the agreement’s term; (2) if Mr. Grosselects to continue group health insurance benefits, we shall reimburse Mr. Gross for any COBRA premiums he pays for the durationof COBRA’s coverage; and, (3) we shall provide Mr. Gross with payment of all accrued amounts (as defined in theagreement).

KonradDabrowski

OnAugust 11, 2021, we entered into an employment agreement with Konrad Dabrowski to serve as the Chief Financial Officer ofthe Company on a part-time basis, which agreement became effective on September 1, 2021. Mr. Dabrowskidevotes 50% of his business time to our Company. We agreed to pay Mr. Dabrowski an annual base salary of $100,000. Pursuantto the terms of the employment agreement, we may exercise our discretion to grant Mr. Dabrowski an annual bonus, the amountof which bonus shall be determined in the sole discretion of the Company. Additionally, we granted Mr. Dabrowski an optionto purchase 60,000 shares of our common stock.

Followingthe effective date, the employment agreement shall continue, unless terminated by Mr. Dabrowski or the Company. Mr.Dabrowski’s employment is at-will, which may be terminated by the Company or by Mr. Dabrowski atany time and for any reason. Pursuant to the terms of the employment agreement, a sixty days’ written notice of

80

terminationor resignation is required. If Mr. Dabrowski notifies us of his resignation, or if we terminate Mr. Dabrowski’semployment agreement, the Company reserves the right to determine, in its sole discretion, whether Mr. Dabrowski will berequired to actively work during the sixty day notice period; however, Mr. Dabrowski will be entitled to receive his basesalary for the duration of the sixty day notice period. The Company has the right to terminate Mr. Dabrowski’s employmentagreement for cause (as defined in the agreement), which termination shall be effective immediately.

FrankRescigna

OnMay 1, 2021, we entered into a consulting services agreement with Frank Rescigna. The initial term of the agreement is effectivethrough December 31, 2021, and may be extended for additional twelve month periods. Pursuant to the consulting agreement,we agreed to pay Mr. Rescigna a monthly consulting fee of $6,000 and a commission of 3.5% on any wholesale sales generatedand received for the duration of his agreement. The consulting agreement may be terminated for any reason either by Mr. Rescignaor the Company, with fifteen days’ notice.

Underthe terms of the consulting agreement, Mr. Rescigna will receive a $50,000 bonus upon successful completion of a sales quotaof $8,000,000. Additionally, we granted Mr. Rescigna an option to purchase 100,000 shares of our common stock,which will vest upon reaching this sales quota.

Compensationof Directors

Therewas no cash or equity compensation paid to our directors for the year ended December 31, 2020.

OliviaC. Bartlett

OnJuly 29, 2021, we entered into an agreement with Olivia C. Bartlett to serve as a member of the Company’s Board. Weagreed to pay Ms. Bartlett compensation of $10,000 per calendar year, with the annual retainer becoming effective upon consummationof the IPO. The Company agreed to pay Ms. Bartlett $200 per meeting she attends pre-IPO. Additionally, for the firstyear of services to the Company, we granted Ms. Bartlett an option to purchase 25,000 shares of our common stock.

LouisCastro

OnJuly 29, 2021, we entered into an agreement with Louis Castro to serve as a member of the Company’s Board. We agreedto pay Mr. Castro compensation of $30,000 per calendar year, with the annual retainer becoming effective upon consummationof the IPO. Additionally, for the first year of services to the Company, we granted Mr. Castro an option to purchase 25,000shares of our common stock.

KristenMclaughlin

OnAugust 20, 2021, we entered into an agreement with Kristen Mclaughlin to serve as a member of the Company’s Board.We agreed to pay Ms. Mclaughlin compensation of $20,000 per calendar year, with the annual retainer becoming effective upon consummationof the IPO. Additionally, for the first year of services to the Company, we granted Ms. Mclaughlin an option to purchase 25,000shares of our common stock.

FrankRescigna

OnJuly 29, 2021, we entered into an agreement with Frank Rescigna to serve as a member of the Company’s Board. We agreedto pay Mr. Rescigna compensation of $5,000 per calendar year, with the annual retainer becoming effective upon consummationof the IPO. Additionally, for the first year of services to the Company, we granted Mr. Rescigna an option to purchase 25,000shares of our common stock.

81

OutstandingEquity Awards

Thefollowing table sets forth outstanding equity awards to our named executive officers as of December 31, 2020.

 

Option awards

 

Stock awards

Name

 

Number of
securities
underlying
unexercised
options
(#)
exercisable

 

Number of
securities
underlying
unexercised
options
(#)
unexercisable

 

Equity
incentive
plan
awards:
Number of
securities
underlying
unexercised
unearned
options
(#)

 

Option
exercise
price
($)

 

Option
expiration
date

 

Number
of shares
or units
of stock
that
have not
vested
(#)

 

Market
value of
shares
of units
of stock
that
have not
vested
($)

 

Equity
incentive
plan
awards:
Number of
unearned
shares,
units or
other
rights that
have not
vested
(#
)

 

Equity
incentive
plan awards:
Market or
payout value
of unearned
shares, units
or other
rights that
have not
vested
($)

Harrison Gross

 

187,500

 

187,500

 

 

$

1.00

 

04/01/2024

 

 

 

 

Konrad Dabrowski

 

 

 

 

 

 

 

 

 

 

Frank Rescigna

 

 

 

 

 

 

 

 

 

 

Our2021 Equity Incentive Plan was adopted by the Board and approved by our shareholders on July 1, 2021, under which: (i) Mr.Gross was issued stock options on May 5, 2021 to purchase an additional 600,000 shares of our commonstock; (ii) Mr. Gross was also issued stock options on August 11, 2021, to purchase an additional 100,000shares of our common stock; (iii) Konrad Dabrowski was issued stock options on August 11, 2021, to purchase 60,000shares of our common stock; (iv) Frank Rescigna was issued stock options on May 1, 2021, to purchase 100,000shares of our common stock; (v) Mr. Rescigna was also issued stock options on July 29, 2021, topurchase an additional 25,000 shares of our common stock; (vi) Olivia Bartlett was issued stock options on July29, 2021, to purchase 25,000 shares of our common stock; (vii) Louis Castro was issued stock options on July21, 2021, to purchase 20,000 shares of our common stock; (viii) Mr. Castro was also issued stockoptions on July 29, 2021, to purchase an additional 25,000 shares of our common stock; (ix) Kristen Mclaughlinwas issued stock options on August 20, 2021, to purchase 25,000 shares of our common stock. All stock optionswere issued under our Equity Incentive Plan and are subject to time-based vesting, except for Mr. Rescigna’sMay 5, 2021 option grant that vests upon successful completion of the $8 million sales quota and Mr. Castro’sJuly 21, 2021 option grant that vests upon an acquisition or flotation at a valuation greater than or equal to four time(400%) of the most recent published annual Company valuation (2020: $2.7 million). See “Note 9 Stock Based Compensation”to our financial statement for more information.

Employeebenefits plans

Wecurrently do not provide retirement, health or welfare benefits to any of our employees.

Limitationof Directors Liability and Indemnification

TheDelaware General Corporation Law authorizes corporations to limit or eliminate, subject to certain conditions, the personal liabilityof directors to corporations and their stockholder for monetary damages for breach of their fiduciary duties. The amended and restatedcertificate of incorporation to be adopted upon the closing of this offering limits the liability of our directors to the fullest extentpermitted by Delaware law. In addition, upon closing of this offering we will enter into indemnification agreements with all of our directorsand named executive officers whereby we will agreed to indemnify those directors and officers to the fullest extent permitted by law,including indemnification against expenses and liabilities incurred in legal proceedings to which the director or officer was, or is threatenedto be made, a party by reason of the fact that such director or officer is or was a director, officer, employee or agent of ours, providedthat such director or officer acted in good faith and in a manner that the director or officer reasonably believed to be in, or not opposedto, our best interests.

Priorto the consummation of this offering, we will obtain director and officer liability insurance to cover liabilities our directors and officersmay incur in connection with their services to us, including matters arising under the Securities Act. The amended and restated certificateof incorporation and amended and restated bylaws that will be adopted upon closing of this offering will also provide that we will indemnifyour directors and officers who, by reason of the fact that he or she is or was one of our officers or directors of our Company, is involvedin any action, suit or proceeding, whether civil, criminal, administrative or investigative related to their board role with us.

82

Thereis no pending litigation or proceeding involving any of our directors, officers, employees or agents in which indemnification will berequired or permitted. We are not aware of any threatened litigation or proceeding that may result in a claim for such indemnification.

2021Equity Incentive Plan

General

Our2021 Equity Incentive Plan was adopted by the Board and approved by our shareholders on July 1, 2021. The general purposesof the 2021 Equity Incentive Plan are to (i) enable the Company and its subsidiaries to attract and retain the types of employees,consultants, and directors who will contribute to the Company’s long range success; (ii) provide incentives that align theinterests of employees, consultants, and directors with those of our shareholders; and (iii) promote the success of the Company’sbusiness.

Descriptionof the 2021 Equity Incentive Plan

Thefollowing description of the principal terms of the 2021 Equity Incentive Plan is a summary and is qualified in its entirety by the fulltext of the 2021 Equity Incentive Plan.

Administration.    The2021 Equity Incentive Plan is administered by a committee appointed by our Board, or in the Board’s discretion, by the Board (asapplicable, the “Incentive Plan Administrator”). Subject to the terms of the 2021 Equity Incentive Plan, the Incentive PlanAdministrator has the authority to (a) determine the eligible individuals who are to receive awards, (b) determine the termsand conditions of each award, including exercise price, vesting or performance criteria, performance period, and terms of the award, (c) determinewhether vesting and performance criteria have been achieved, (d) accelerate the vesting or exercisability of, payment for or lapseof restrictions on, or otherwise modify or amend awards, (e) construe and interpret the 2021 Equity Incentive Plan, including theability to reconcile any inconsistency in, correct any defect in and/or supply any omission in the plan and award agreement; any instrumentor agreement, (f) promulgate, amend, and rescind rules and regulations relating to the administration of the 2021 Equity IncentivePlan, and (g) exercise discretion to make any and all other determinations which it determines to be necessary or advisable for theadministration of the 2021 Equity Incentive Plan and awards granted thereunder. The Incentive Plan Administrator may also delegate itsauthority to a subcommittee or to one or more officers of the Company, subject to terms and conditions determined by the Incentive PlanAdministrator. All decisions made by the Incentive Plan Administrator are final and binding on the Company and the participants.

Typesof Awards.    The 2021 Equity Incentive Plan provides for the grant of stock options, which may be incentivestock options (“ISOs”) or nonqualified stock options (“NSOs”), stock appreciation rights (“SARs”),restricted stock, restricted stock units (“RSUs”), performance share awards, and other cash-based or equity-basedawards, or collectively, awards.

ShareReserve.    A total equal to 20% of our issued and outstanding common stock shall be available for the grantof awards under the 2021 Equity Incentive Plan.

Ifoptions, stock appreciation rights, restricted stock units or any other awards are forfeited, cancelled or expire before being exercisedor settled in full, the shares subject to such awards will again be available for issuance under the 2021 Equity Incentive Plan. If restrictedstock or shares issued upon exercise of an option are reacquired by the Company pursuant to a forfeiture provision, repurchase right orfor any other reason, then such shares will again be available for issuance under the 2021 Equity Incentive Plan. Notwithstanding theforegoing, shares applied to pay the exercise price of an option or satisfy withholding taxes related to any award will not become availablefor issuance under the 2021 Equity Incentive Plan.

Sharesissued under the 2021 Equity Incentive Plan may be authorized but unissued shares or treasury shares. As of the date hereof, awards covering2,263,500 shares of common stock have been granted under the 2021 Equity Incentive Plan.

IncentiveStock Option Limit.    No more than 25,000,000 shares of Common Stock may be issued under the2021 Equity Incentive Plan upon the exercise of ISOs.

83

Eligibility.    Employees(including officers), non-employee directors and consultants who render services to the Company or a parent or subsidiarythereof (whether now existing or subsequently established) are eligible to receive awards under the 2021 Equity Incentive Plan. ISOs mayonly be granted to employees of the Company or a parent or subsidiary thereof (whether now existing or subsequently established).

StockOptions.    A stock option is the right to purchase a certain number of shares of stock at a fixed exerciseprice which, pursuant to the 2021 Equity Incentive Plan, may not be less than 100% of the fair market value of Common Stock on the dateof grant. Subject to limited exceptions, an option may have a term of up to 10 years and will generally expire sooner if the optionholder’sservice terminates. Options will vest at the rate determined by the Incentive Plan Administrator. An optionholder may pay the exerciseprice of an option in cash, or, with the Incentive Plan Administrator’s consent, with shares of stock the optionholder already owns,with proceeds from an immediate sale of the option shares, through a net exercise procedure or by any other method permitted by applicablelaw.

TaxLimitations on Incentive Stock Options.    The aggregate fair market value, determined at the time of grant,of the Common Stock with respect to ISOs that are exercisable for the first time by an optionholder during any calendar year under allof the Company’s stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treatedas NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% ofthe Company’s total combined voting power or that of any of the Company’s affiliates unless (a) the option exercise priceis at least 110% of the fair market value of Common Stock on the date of grant and (b) the term of the ISO does not exceed five yearsfrom the date of grant.

StockAppreciation Rights.    A stock appreciation right provides the recipient with the right to the appreciationin a specified number of shares of stock. The Incentive Plan Administrator determines the exercise price of stock appreciation rightsgranted under the 2021 Equity Incentive Plan, which may not be less than 100% of the fair market value of Common Stock on the date ofgrant. A stock appreciation right may have a term of up to 10 years and will generally expire sooner if the recipient’s serviceterminates. SARs will vest at the rate determined by the Incentive Plan Administrator. Upon exercise of a SAR, the recipient will receivean amount in cash, stock, or a combination of stock and cash determined by the Incentive Plan Administrator, equal to the excess of thefair market value of the shares being exercised over their exercise price.

RestrictedStock Awards.    Shares of restricted stock may be issued under the 2021 Equity Incentive Plan and may be subjectto vesting, as determined by the Incentive Plan Administrator. Recipients of restricted stock generally have all of the rights of a shareholderwith respect to those shares, including voting rights and dividends, except as provided in the award agreement.

RestrictedStock Units.    A restricted stock unit is a right to receive a share, at no cost to the recipient, upon satisfactionof certain conditions, including vesting conditions, established by the Incentive Plan Administrator. RSUs vest at the rate determinedby the Incentive Plan Administrator and any unvested RSUs will generally be forfeited upon termination of the recipient’s service.Settlement of restricted stock units may be made in the form of cash, stock or a combination of cash and stock, as provided in the awardagreement and as determined by the Incentive Plan Administrator. Recipients of restricted stock units generally will have no voting ordividend rights prior to the time the vesting conditions are satisfied and the award is settled.

PerformanceShare Award.    A performance share award is a right to receive a share or share units based upon the Company’sperformance during a specified performance period, as determined by the Incentive Plan Administrator. The Incentive Plan Administratorhas the discretion to determine: (i) the number of shares or stock-denominated units subject to a Performance ShareAward granted to any recipient; (ii) the performance period applicable to any award; (iii) the conditions that must be satisfiedfor a recipient to earn an award; and, (iv) the other terms, conditions and restrictions of the award.

CashAwards and Other Equity-Based Awards.    TheIncentive Plan Administrator may grant cash awards and other awards based in whole or in part by reference to Common Stock, either aloneor in tandem with other awards. The Incentive Plan Administrator will determine the terms and conditions of any such awards.

Changesto Capital Structure.    In the event of certain changes in capitalization, including a stock split, reversestock split, stock dividend, or an extraordinary corporate transaction such as any recapitalization, reorganization, merger, consolidation,combination, or exchange, proportionate adjustments will be made in the number and kind of shares

84

availablefor issuance under the 2021 Equity Incentive Plan, the limit on the number of shares that may be issued under the 2021 Equity IncentivePlan as ISOs, the number and kind of shares subject to each outstanding award and/or the exercise price of each outstanding award.

Changein Control.    If the Company is party to certain change in control transactions, each outstanding award willbe treated as the Incentive Plan Administrator determines, which may include the continuation, assumption or substitution of an outstandingaward, the cancellation of an outstanding award after an opportunity to exercise or the cancellation of an outstanding award in exchangefor a payment equal to the value of the shares subject to such award less any applicable exercise price.

Transferabilityof Awards.    Unless the Incentive Plan Administrator determines otherwise, an award generally will not betransferable other than by beneficiary designation, a will or the laws of descent and distribution. The Incentive Plan Administrator maypermit transfer of an award in a manner consistent with applicable law.

Amendmentand Termination.    The Board may amend or terminate the 2021 Equity Incentive Plan at any time. Any such amendmentor termination will not affect outstanding awards. If not sooner terminated, the 2021 Equity Incentive Plan will terminate automatically10 years after its adoption by the Board. Shareholder approval is not required for any amendment of the 2021 Equity Incentive Plan,unless required by applicable law, government regulation or exchange listing standards.

CertainFederal Income Tax Aspects of Awards Under the 2021 Equity Incentive Plan

Thisis a brief summary of the U.S. federal income tax aspects of awards that may be made under the 2021 Equity Incentive Plan based on existingU.S. federal income tax laws as of the date of this prospectus. This summary covers only the basic tax rules. It does not describe a numberof special tax rules, including the alternative minimum tax and various elections that may be applicable under certain circumstances.It also does not reflect provisions of the income tax laws of any municipality, state or foreign country in which a holder may reside,nor does it reflect the tax consequences of a holder’s death. Therefore, no one should rely on this summary for individual tax compliance,planning or decisions. Participants in the 2021 Equity Incentive Plan should consult their own professional tax advisors concerning taxaspects of awards under the 2021 Equity Incentive Plan. The discussion below concerning tax deductions that may become available to theCompany under U.S. federal tax law is not intended to imply that the Company will necessarily obtain a tax benefit or asset from thosedeductions. The tax consequences of awards under the 2021 Equity Incentive Plan depend upon the type of award. Changes to tax laws followingthe date of this prospectus could alter the tax consequences described below.

IncentiveStock Options.    No taxable income is recognized by an optionholder upon the grant or vesting of an ISO, andno taxable income is recognized at the time an ISO is exercised unless the optionholder is subject to the alternative minimum tax. Theexcess of the fair market value of the purchased shares on the exercise date over the exercise price paid for the shares is includablein alternative minimum taxable income.

Ifthe optionholder holds the purchased shares for more than one year after the date the ISO was exercised and more than two years afterthe ISO was granted (the “required ISO holding periods”), then the optionholder will generally recognize long-termcapital gain or loss upon disposition of such shares. The gain or loss will equal the difference between the amount realized upon thedisposition of the shares and the exercise price paid for such shares. If the optionholder disposes of the purchased shares before satisfyingeither of the required ISO holding periods, then the optionholder will recognize ordinary income equal to the fair market value of theshares on the date the ISO was exercised over the exercise price paid for the shares (or, if less, the amount realized on a sale of suchshares). Any additional gain will be a capital gain and will be treated as short-term or long-term capital gaindepending on how long the shares were held by the optionholder.

NonqualifiedStock Options.    No taxable income is recognized by an optionholder upon the grant or vesting of an NSO, providedthe NSO does not have a readily ascertainable fair market value. If the NSO does not have a readily ascertainable fair market value, theoptionholder will generally recognize ordinary income in the year in which the option is exercised equal to the excess of the fair marketvalue of the purchased shares on the exercise date over the exercise price paid for the shares. If the optionholder is an employee orformer employee, the optionholder will be required to satisfy the tax withholding requirements applicable to such income. Upon resaleof the purchased shares, any subsequent appreciation or depreciation in the value of the shares will be treated as short-termor long-term capital gain or loss depending on how long the shares were held by the optionholder.

85

StockAppreciation Rights.    In general, no taxable income results upon the grant of a SAR. A participant will generallyrecognize ordinary income in the year of exercise equal to the value of the shares or other consideration received. In the case of a currentor former employee, this amount is subject to income tax withholding. Upon resale of the shares acquired pursuant to a SAR, any subsequentappreciation or depreciation in the value of the shares will be treated as a short-term or long-term capitalgain or loss, depending on how long the shares were held by the recipient.

RestrictedStock.    A participant who receives an award of restricted stock generally does not recognize taxable incomeat the time of the award. Instead, the participant recognizes ordinary income when the shares vest, subject to withholding if the participantis an employee or former employee. The amount of taxable income is equal to the fair market value of the shares on the vesting date(s)less the amount, if any, paid for the shares. Alternatively, a participant may make a one-time election to recognize incomeat the time the participant receives restricted stock in an amount equal to the fair market value of the restricted stock (less any amountpaid for the shares) on the date of the award by making an election under Section 83(b) of the Code. Upon resale of the shares acquiredpursuant to a restricted stock award, any subsequent appreciation or depreciation in the value of the shares will be treated as short-termor long-term capital gain or loss, depending on how long the shares were held by the recipient.

RestrictedStock Units.    In general, no taxable income results upon the grant of an RSU. The recipient will generallyrecognize ordinary income, subject to withholding if the recipient is an employee or former employee, equal to the fair market value ofthe shares that are delivered to the recipient upon settlement of the RSU. Upon resale of the shares acquired pursuant to an RSU, anysubsequent appreciation or depreciation in the value of the shares will be treated as short-term or long-termcapital gain or loss depending on how long the shares were held by the recipient.

PerformanceShare Award, Cash Award, or Other Equity-BasedAward.    A participant who receives a performance share award, cash award, or other equity-basedaward generally does not recognize taxable income at the time of the award. Instead, the participant recognizes ordinary income when theaward vests or is otherwise no longer subject to a substantial risk of forfeiture, subject to withholding if the participant is an employeeor former employee. The amount of taxable income is equal to the cash paid or fair market value of the shares on the vesting date(s) lessthe amount, if any, paid for the shares. Upon resale of the shares acquired pursuant to a performance share award or other equity-basedaward, any subsequent appreciation or depreciation in the value of the shares will be treated as short-term or long-termcapital gain or loss, depending on how long the shares were held by the recipient.

Section 409A.    Theforegoing description assumes that Section 409A of the Code does not apply to an award. In general, options and stock appreciationrights are exempt from Section 409A if the exercise price per share is at least equal to the fair market value per share of the underlyingstock at the time the option or stock appreciation right was granted. RSUs are subject to Section 409A unless they are settled withintwo and one half months after the end of the later of (a) the end of the Company’s fiscal year in which vesting occurs or (b) theend of the calendar year in which vesting occurs. Restricted stock awards are not generally subject to Section 409A. If an awardis subject to Section 409A and the provisions for the exercise or settlement of that award do not comply with Section 409A,then the participant would be required to recognize ordinary income whenever a portion of the award vested (regardless of whether it hadbeen exercised or settled). This amount would also be subject to a 20% U.S. federal tax and premium interest, inaddition to the U.S. federal income tax at the participant’s usual marginal rate for ordinary income.

TaxTreatment for the Company.    The Company will generally be entitled to an income tax deduction at the timeand to the extent a participant recognizes ordinary income as a result of an award granted under the 2021 Equity Incentive Plan. However,Section 162(m) of the Code may limit the deductibility of certain awards granted under the 2021 Equity Incentive Plan. Although theIncentive Plan Administrator considers the deductibility of compensation as one factor in determining executive compensation, the IncentivePlan Administrator retains the discretion to award and pay compensation that is not deductible as it believes that it is in the shareholders’best interests to maintain flexibility in the approach to executive compensation and to structure a program that the Company considersto be the most effective in attracting, motivating and retaining key employees.

86

PrincipalStockholders

Basedsolely upon information made available to us, the following table sets forth information as of , 2021 regarding the beneficial ownershipof our common stock:

•        eachperson known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;

•        eachof our named executive officers and directors; and

•        allour executive officers and directors as a group.

Thepercentage ownership information shown in the table is based upon 6,059,290 shares of common stock outstanding as of thedate hereof, which gives into effect the conversion of the Note. In addition, the number of shares and percentage of shares beneficiallyowned after the offering gives effect to the issuance by us of             shares of common stock in this offering assuming an initial public offering price of $            per share (the mid-point of the price range set forth on the cover page of this prospectus). The percentage ownership informationassumes no exercise of the underwriters’ over-allotment option.

Beneficialownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities.Except as otherwise indicated, each person or entity named in the table has sole voting and investment power with respect to all sharesof our capital shown as beneficially owned, subject to applicable community property laws.

Incomputing the number and percentage of shares beneficially owned by a person, shares that may be acquired by such person (for example,upon the exercise of options or warrants) within 60 days of the date of this prospectus are counted as outstanding, while these sharesare not counted as outstanding for computing the percentage ownership of any other person.

Theaddress of each holder listed below, except as otherwise indicated, is 8101 Biscayne Blvd., Suite 705, Miami, Florida, 33138.

Name of Beneficial Owner

 

Shares of
Common Stock
Beneficially
Owned
(1)

 

Percent of
Common Stock
Beneficially
Owned Before
Offering

 

Percent of
Common Stock
Beneficially
Owned After
Offering

Named Executive Officers and Directors

       

 

   

 

Harrison Gross(2)

 

204,162

 

3.37

%

 

    %

 

Konrad Dabrowski(3)

 

9,996

 

1.65

%

 

    %

 

Frank Rescigna

 

 

%

 

    %

 

Kristen McLaughlin

 

 

 

 

             —

 

Louis Castro(4)

 

20,000

 

3.3

%

 

             —

 

Olivia Bartlett

 

 

 

 

             —

 

All directors and executive officers as a group (7 persons)

 

234,158

 

3.86

%

 

    %

 

5% Stockholders

       

 

   

 

Lucyd Ltd.(5)(6)

 

4,922,115

 

81.2

%

 

    %

 

____________

*        Lessthan 1%.

Percentageownership is based on 6,059,290 sharesof our common stock outstanding and options exercisable into 2,332,500 sharesof our common stock outstanding prior to this offering and              sharesof our common stock outstanding after this offering.

(1)      Wehave determined beneficial ownership in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended,which is generally determined by voting power and/or dispositive power with respect to securities. Unless otherwise noted, the sharesof common stock listed above are owned as of the date of this prospectus, and are owned of record by each individual named as beneficialowner and such individual has sole voting and dispositive power with respect to the shares of common stock owned by each of them.

87

(2)      Includes204,162 shares of common stock issuable upon exercise of stock options held by Mr. Gross exercisable within60 days of the date of this prospectus.

(3)      Includes9,996 shares of common stock issuable upon exercise of stock options held by Mr. Dabrowski exercisable within60 days of the date of this prospectus.

(4)      Includes20,000 shares of common stock issuable upon exercise of stock options held by Mr. Castro exercisable within60 days of the date of this prospectus.

(5)      Tekcapitalplc, a public company listed on the London Stock Exchange, owns all issued and outstanding securities of Tekcapital Europe Ltd., whichowns all issued and outstanding securities of Lucyd Ltd. As such, Tekcapital plc may be deemed to beneficially own the shares held byLucyd Ltd. by virtue of their control over Lucyd Ltd. Tekcapital plc disclaims beneficial ownership of the shares held by Lucyd Ltd. Mr.Clifford Gross, the Chief Executive Officer of Tekcapital plc, is the father of Mr. Harrison Gross, our Chief ExecutiveOfficer.

(6)      Includes4,922,115 shares of common stock issuable to Lucyd Ltd. upon conversion of the outstanding Notes.

88

CertainRelationships and Related Party Transactions

Onoccasion we may engage in certain related party transactions. All prior related party transactions were approved by our board of directorsand a majority of our issued and outstanding shares of capital stock. Upon the consummation of offering, our policy is that all relatedparty transactions will be reviewed and approved by the Audit Committee of our Board of Directors prior to our entering into any relatedparty transactions.

LicenseAgreement

OnApril 1, 2020, we entered into an exclusive, worldwide license agreement with Lucyd Ltd., the majority stockholder of theCompany, for the use of the Lucyd brand, and the associated intellectual property and assets (the “License Agreement”). TheLicense Agreement is royalty-free, fully paid up, and perpetual license for the exclusive use of certain assets of LucydLtd. related to Innovative Eyewear current products and trademarks. As compensation for entrance into the License Agreement, we issuedLucyd Ltd. 3,750,000 shares of our common stock. On October 5, 2021, the parties to the License Agreement executedan Addendum, to the exclusive license agreement, which clarified that Innovative Eyewear shall commercialize, continue with any on-goingintellectual property prosecutions and pay all maintenance or other patent fees (the “Addendum”). For all new intellectualproperty, Innovative Eyewear will own control it and be responsible for all prosecution and maintenance costs. The Addendum also confirmsthat Innovative Eyewear issued Lucyd Ltd. 3,750,000 shares of its common stock as consideration for the license. Please see“Business — Material Agreements” for a more complete description of the License Agreement and Addendum.

ManagementAgreement

OnJune 1, 2020, we entered into a management agreement with Tekcapital Europe Ltd., an affiliate of our majority stockholder,Lucyd Ltd., who’s Chief Executive Officer is the father of our Chief Executive Officer, pursuant to which we have agreed to payTekcapital Europe Ltd. $25,000 per fiscal quarter for office space, utilities, advisory services and any other services in accordancewith Tekcapital Europe Ltd.’s areas of expertise. The management agreement shall be in force perpetually, with the right of eitherparty to terminate for any reason with 30 days’ notice.

Additionally,the Tekcapital Europe Ltd. incurred $100,000 in 2019 and $80,000 in 2020 in management fee charges on behalf of the Company. These payableswere assigned to the Company based on the related party convertible debt agreement, dated June 1, 2021 and included in theNotes balance discussed above. Tekcapital Europe Ltd. incurred $9,975 in management fee charges on behalf of the Company for the ninemonths ended September 30, 2021.

ConvertibleNote Financing

OnDecember 1, 2020, we issued a convertible note for an aggregate principal amount of up to $2,000,000 to Lucyd Ltd., the majoritystockholder of the Company (the “Note”). On June 1, 2021, we completed the partial conversion of an aggregateof $778,500 of the outstanding balance on the Note, at $1.00 per share, into an aggregate of 778,500 shares of common stock.On September 5, 2021, we completed the partial conversion of an aggregate of $500,002 of the outstanding balance on the Note,at $3.56 per share, into an aggregate of 140,449 shares of common stock. As of September 30, 2021, $420,104remained outstanding on the Note. On November 16, 2021, we completed the partial conversion of an aggregate of $901,270.96of the outstanding balance of the Note, at $3.56 per share, into an aggregate of 253,166 shares of common stock. As of November30, 2021, $28,209 remains outstanding on the Note.

TheNote has an interest rate of 10.0% per annum, is unsecured, matures on December 1, 2023 and provides for conversion, at theelection of Lucyd Ltd., into our common stock upon the earlier of (i) the Company consummating an equity financing pursuant to whichit raises an aggregate amount of not less than $750,000, (ii) the Company entering into a transaction pursuant to which the Companysells not less than 10% of the Company’s shares, excluding any and all convertible notes which are convertible into shares, (iii) theCompany lists its shares on a national securities exchange or (iv) the holder determines to convert the Note. The Note can be convertedby the Holder using the price of either (i) the per share purchase price paid for by investors under the terms of recent equity financing,(ii) the closing price of the Company’s trading shares on the relevant public exchange for the day immediately preceding the dateof conversion of the Note or (iii) the valuation of the last equity investment. If not converted earlier, upon the closing of this offering,the Notes will convert into              shares of our common stock at a conversionprice equal to $             per share. The principal amount and accrued butunpaid interest under each note will automatically convert into shares of our common stock at the stated conversion price per share.

89

IntercompanyLoan and Debt Transfer Agreements

OnJune 1, 2021, we entered into an intercompany loan and debt transfer agreement, whereby Lucyd Ltd, Tekcapital plc, TekcapitalEurope Ltd or Tekcapital LLC incurred a debt on behalf of the Company in the amount of $387,328. Pursuant to the terms of the agreement,there is no interest payable on the amount of the debt outstanding, unless we agree otherwise with Lucyd Ltd. The debt, along with anyaccrued interest and other amounts that may be due in connection with the debt, is repayable by the Company upon demand from Lucyd Ltd,at any time, unless we agree otherwise with Lucyd Ltd. The Company may prepay the whole or any part of the debt at any time, unless weagree otherwise.

OnSeptember 5, 2021, we entered into an intercompany loan and debt transfer agreement, whereby Lucyd Ltd, Tekcapital plc, TekcapitalEurope Ltd or Tekcapital LLC incurred a debt on behalf of the Company in the amount of $500,002. Pursuant to the terms of the agreement,there is no interest payable on the amount of the debt outstanding, unless we agree otherwise with Lucyd Ltd. The debt, along with anyaccrued interest and other amounts that may be due in connection with the debt, is repayable by the Company upon demand from Lucyd Ltd,at any time, unless we agree otherwise with Lucyd Ltd. The Company may prepay the whole or any part of the debt at any time, unless weagree otherwise.

Statementof Policy

Allfuture transactions between us and our officers, directors or five percent stockholders, and respective affiliates will be on terms noless favorable than could be obtained from unaffiliated third parties and will be approved by a majority of our independent directorswho do not have an interest in the transactions and who had access, at our expense, to our legal counsel or independent legal counsel.

Tothe best of our knowledge, during the past three fiscal years, other than as set forth above, there were no material transactions, orseries of similar transactions, or any currently proposed transactions, or series of similar transactions, to which we were or are tobe a party, in which the amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at year-endfor the last two completed financial years, and in which any director or executive officer, or any security holder who is known by usto own of record or beneficially more than 5% of any class of our common stock, or any member of the immediate family of any of the foregoingpersons, has an interest (other than compensation to our officers and directors in the ordinary course of business).

90

Descriptionof Capital Stock

General

Pursuantto our amended and restated certificate of incorporation, our authorized capital stock will consist of shares of Common Stock, $0.00001par value and              shares of preferred stock, $0.00001 par value.As of the date of this prospectus, after giving effect to the conversion of our outstanding Notes into an aggregate of             shares of common stock upon the closing of this offering, there are             shares of common stock outstanding. In addition, as of the date of this prospectus, we had outstanding options to purchase an aggregateof 2,332,500 shares of our common stock under the 2021 Equity Incentive Plan, at a weighted average exercise price equalto $2.59 per share. Our authorized but unissued shares of common stock and preferred stock are available for issuance without furtheraction by our stockholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotationsystem on which our securities may be listed or traded in the future. The following description summarizes the material terms of our capitalstock. Because it is only a summary, it may not contain all the information that is important to you.

CommonStock

Asof ____, 2021, ____ shares of common stock were issued and outstanding held by ___ stockholders of record. Holders of our common stockare entitled to one vote for each share held on all matters submitted to a vote of stockholders and are not entitled to cumulative votingrights.

Holdersof our common stock are entitled to receive ratably such dividends, if any, as may be declared by our Board of Directors out of fundslegally available therefor, subject to any preferential distribution rights of third parties. Upon our liquidation, dissolution or windingup, the holders of our common stock are entitled to receive ratably our net assets available after the payment of all debts and otherliabilities.

Holdersof our common stock have no preemptive, subscription, redemption or conversion rights. There are no redemption or sinking fund provisionsapplicable to the common stock. All of the outstanding shares of our common stock are fully-paid and nonassessable. The rights,preferences and privileges of holders of our common stock are subject to, and may be adversely affected by, the rights of the holdersof any indebtedness of our company.

StockOptions

Asof the date of this prospectus, we had reserved the following shares of common stock for issuance pursuant to stock options under the2021 Equity Incentive Plan described below:

•        2,332,500shares of our common stock reserved for issuance under stock option agreements issued pursuant to the 2021 Equity Incentive Planwith a weighted average exercise price of $2.59 per share; and

•                      shares of our common stock reserved for future issuance under the 2021 Equity Incentive Plan (which is equal to 20% of our issued andoutstanding common stock immediately after the consummation of this offering, less the number of outstanding option grants).

ConvertiblePromissory Notes

Asof the date of this prospectus, we had outstanding Notes in an aggregate principal amount of approximately $             with an interest rate of 10% per annum.

Ifnot converted earlier, at the closing of this offering the aggregate principal amount and any accrued but unpaid interest on all noteswill automatically convert into an aggregate of              shares of ourcommon stock at a conversion price of $             per share. Please see“Certain Relationships and Related Party Transactions” for a more complete description of the Notes.

91

WarrantsOffered in this Offering

Thefollowing summary of certain terms and provisions of the Warrants offered hereby is not complete and is subject to, and qualified in itsentirety by the provisions of the form of Warrant, which is filed as an exhibit to the registration statement of which this prospectusis a part. Prospective investors should carefully review the terms and provisions set forth in the form of Warrant.

TheWarrants issued in this offering entitle the registered holders to purchase common stock at a price equal to $[__] per share, subjectto adjustment as discussed below, immediately following the issuance of such Warrants and terminating at 5:00 p.m., New York City time,five years after the closing of this offering.

Theexercise price and number of shares of common stock issuable upon exercise of the Warrants may be adjusted in certain circumstances, includingin the event of a stock dividend or recapitalization, reorganization, merger or consolidation. However, the Warrants will not be adjustedfor issuances of shares of common stock at prices below its exercise price.

Exercisability.    TheWarrants are exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance. The Warrantswill be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice accompaniedby payment in full for the number of shares of common stock purchased upon such exercise. Each Warrant entitles the holder thereof topurchase one share of common stock. Warrants are not exercisable for a fraction of a share and may only be exercised into whole numbersof shares. In lieu of fractional shares, we will, pay the holder an amount in cash equal to the fractional amount multiplied by the exerciseprice and round down to the nearest whole share. Unless otherwise specified in the Warrant, the holder will not have the right to exercisethe Warrants, in whole or in part, if the holder (together with its affiliates) would beneficially own in excess of 4.99% (or 9.99% atthe holder’s election) of the number of our shares of common stock outstanding immediately after giving effect to the exercise,as such percentage is determined in accordance with the terms of the Warrant. However, any holder may increase or decrease such percentageto any other percentage not in excess of 9.99% upon at least 61 days’ prior notice from the holder to us.

ExercisePrice.    The exercise price per share of common stock purchasable upon exercise of the Warrants is $ per share,or             % of the public offering price per Unit, and is subject toadjustments for stock splits, reclassifications, subdivisions, and other similar transactions. In addition to the exercise price per shareof common stock, and other applicable charges and taxes are due and payable upon exercise.

WarrantAgent; Global Certificate.    The Warrants will be issued in registered form under a warrant agency agreementbetween a warrant agent and us. The Warrants will initially be represented only by one or more global warrants deposited with the warrantagent, as custodian on behalf of The Depository Trust Company, or DTC, and registered in the name of Cede & Co., a nominee of DTC,or as otherwise directed by DTC.

Listing;Transferability.    There is no established trading market for any of the Warrants, and we do not expect amarket to develop. We do not intend to apply for a listing for any of the Warrants on any securities exchange or other nationally recognizedtrading system. Without an active trading market, the liquidity of the Warrants will be limited. We intend to have the Warrants issuedin registered form under the warrant agency agreement between us and the warrant agent. Subject to applicable laws, the Warrants may betransferred at the option of the holders upon surrender of the Warrants to the warrant agent, together with the appropriate instrumentsof transfer.

Adjustments;Fundamental Transaction.    The exercise price and the number of shares underlying the Warrants are subjectto appropriate adjustment in the event of stock splits, stock dividends on our shares of common stock, stock combinations or similar eventsaffecting our shares of common stock. In addition, in the event we consummate a merger or consolidation with or into another person orother reorganization event in which our shares of common stock are converted or exchanged for securities, cash or other property, or wesell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of our assets or we or another personacquire 50% or more of our outstanding shares of common stock (each, a Fundamental Transaction), then following such Fundamental Transactionthe holders of the Warrants will be entitled to receive upon exercise of the Warrants the same kind and amount of securities, cash orproperty which the holders would have received had they exercised the Warrants immediately prior to such Fundamental Transaction. Anysuccessor to us or surviving entity will assume the obligations under the Warrants.

92

Rightsas a Shareholder.    Except by virtue of such holder’s ownership of our common stock, the holder of aWarrant does not have rights or privileges of a shareholder, including any voting rights, until the holder exercises such Warrant.

Representative’sWarrants

Wehave agreed to sell to the representative of the underwriters of this offering, or its permitted designees, for nominal consideration,warrants to purchase              shares of our common stock as additionalconsideration to the underwriters in this offering. The representative’s warrants will have an exercise price equal to 110.0% ofthe public offering price in this offering and shall be exercisable during the five (5) year period commencing 180 days followingthe commencement of sales of the securities in this offering, which is also the effective date of the registration statement of whichthis prospectus is a part, and will contain customary “cashless” exercise and registration rights provisions. The warrantsshall not be exercisable for a period of 180 days following the commencement of sale of the securities in this offering, which is alsothe date of effectiveness of the registration statement of which this prospectus forms a part. See “Underwriting — Representative’sWarrants.”

DelawareLaw and Certain Charter and Bylaw Provisions

DelawareAnti-Takeover Law.    Uponthe consummation of this offering, we will be subject to Section 203 of the Delaware General Corporation Law. Section 203 generallyprohibits a public Delaware corporation from engaging in a “business combination” with an “interested stockholder”for a period of three years after the date of the transaction in which the person became an interested stockholder, unless:

•        priorto the date of the transaction, the board of directors of the corporation approved either the business combination or the transactionwhich resulted in the stockholder becoming an interested stockholder;

•        uponconsummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder ownedat least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding specified shares; or

•        ator subsequent to the date of the transaction, the business combination is approved by the board of directors and authorized at an annualor special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 and 2/3% of the outstanding votingstock which is not owned by the interested stockholder.

Section 203defines a “business combination” to include:

•        anymerger or consolidation involving the corporation and the interested stockholder;

•        anysale, lease, exchange, mortgage, pledge, transfer or other disposition of 10% or more of the assets of the corporation to or with theinterested stockholder;

•        subjectto exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interestedstockholder;

•        subjectto exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of anyclass or series of the corporation beneficially owned by the interested stockholder; or

•        thereceipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits providedby or through the corporation.

Ingeneral, Section 203 defines an “interested stockholder” as any person that is:

•        theowner of 15% or more of the outstanding voting stock of the corporation;

•        anaffiliate or associate of the corporation who was the owner of 15% or more of the outstanding voting stock of the corporation at any timewithin three years immediately prior to the relevant date; or

•        theaffiliates and associates of the above.

93

Underspecific circumstances, Section 203 makes it more difficult for an “interested stockholder” to effect various businesscombinations with a corporation for a three-year period, although the stockholders may, by adopting an amendment to the corporation’samended and restated certificate of incorporation or amended and restated bylaws, which will be in effect upon the consummation of thisoffering, elect not to be governed by this section, effective 12 months after adoption.

Ouramended and restated certificate of incorporation and bylaws, which will be in effect upon the consummation of this offering, do not excludeus from the restrictions of Section 203. We anticipate that the provisions of Section 203 might encourage companies interestedin acquiring us to negotiate in advance with our Board of Directors since the stockholder approval requirement would be avoided if a majorityof the directors then in office approve either the business combination or the transaction that resulted in the stockholder becoming aninterested stockholder.

Amendedand Restated Certificate of Incorporation and Bylaws.    Our amended and restated certificate of incorporationand amended and restated bylaws, which will be in effect upon the consummation of this offering, contain provisions that could have theeffect of discouraging potential acquisition proposals or tender offers or delaying or preventing a change of control of our company,such as:

•        Authorizedbut Unissued Capital Stock;

•        UndesignatedPreferred Stock;

•        Requirementsfor Advance Notification of Stockholder Nominations and Special Meetings;

•        Stockholdersnot Entitled to Cumulative Voting; and

•        Limitationon Liability and Indemnification Matters.

Theseprovisions affect your rights as a stockholder since they permit our Board of Directors to make it more difficult for common stockholdersto replace members of the Board or undertake other significant corporate actions. Because our Board of Directors is responsible for appointingthe members of our management team, these provisions could in turn affect any attempt to replace our current management team.

Eliminationof Monetary Liability for Officers and Directors

Ouramended and restated certificate of incorporation incorporates certain provisions permitted under the Delaware General Corporation Lawrelating to the liability of directors. The provisions eliminate a director’s liability for monetary damages for a breach of fiduciaryduty, including gross negligence, except in circumstances involving certain wrongful acts, such as the breach of director’s dutyof loyalty or acts or omissions, which involve intentional misconduct or a knowing violation of law. These provisions do not eliminatea director’s duty of care. Moreover, these provisions do not apply to claims against a director for certain violations of law, includingknowing violations of federal securities law. Our amended and restated certificate of incorporation to be adopted at the time of our anticipatedcorporate conversion also contains provisions to indemnify the directors, officers, employees or other agents to the fullest extent permittedby the Delaware General Corporation Law. We believe that these provisions will assist us in attracting and retaining qualified individualto serve as directors.

Indemnificationof Officers and Directors

Ouramended and restated certificate of incorporation contains provisions to indemnify the directors, officers, employees or other agentsto the fullest extent permitted by the Delaware General Corporation Law. These provisions may have the practical effect in certain casesof eliminating the ability of shareholders to collect monetary damages from directors. We are also a party to indemnification agreementswith each of our directors. We believe that these provisions will assist us in attracting or retaining qualified individuals to serveas our directors.

Disclosureof Commission Position on Indemnification for Securities Act Liabilities

Insofaras indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling personspursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policyas expressed in the Securities Act and is, therefore, unenforceable.

94

TransferAgent and Registrar

Thetransfer agent and registrar of our common stock is             .

Listing

Wehave applied to have our common stock listed on NASDAQ under the symbol “LUCY”. There is no established trading market forany of the Warrants, and we do not expect a market to develop. We do not intend to apply for a listing for any of the Warrants on anysecurities exchange or other nationally recognized trading system. Without an active trading market, the liquidity of the Warrants willbe limited.

95

SharesEligible For Future Sale

Immediatelyprior to this offering, there was no public market for our common stock or Warrants. Future sales of substantial amounts of our commonstock in the public market could adversely affect prevailing market prices. Furthermore, since only a limited number of shares will beavailable for sale shortly after this offering because of contractual and legal restrictions on resale described below, sales of substantialamounts of common stock in the public market after the restrictions lapse could adversely affect the prevailing market price for our commonstock as well as our ability to raise equity capital in the future.

Uponthe closing of this offering, approximately              million shares ofcommon stock will be outstanding, assuming an initial public offering price of $            per Unit (the mid-point of the price range set forth on the cover page of this prospectus), no exercise of the Warrants includedin the Units offered hereby and further assuming no exercise of the underwriters’ over-allotment option. All of theshares sold in this offering will be freely tradable unless held by an affiliate of ours. The remaining             shares of common stock outstanding after this offering will be restricted as a result of securities laws or lock-up agreements.These remaining shares will generally become available for sale in the public market as follows: approximately             restricted shares held by non-affiliates will be eligible for sale under Rule 144 or Rule 701 upon expiration oflock-up agreements at least 180 days after the date of this offering.

Rule 144

Ingeneral, under Rule 144 as currently in effect, beginning 90 days after the effective date of the registration statement ofwhich this prospectus is a part, any person who is not an affiliate of ours and has held their shares for at least six months, as measuredby SEC rule, including the holding period of any prior owner other than one of our affiliates, may sell shares without restriction, providedcurrent public information about us is available. In addition, under Rule 144, any person who is not an affiliate of ours and hasheld their shares for at least one year, as measured by SEC rule, including the holding period of any prior owner other than one of ouraffiliates, would be entitled to sell an unlimited number of shares immediately upon the closing of this offering without regard to whethercurrent public information about us is available. Beginning 90 days after the effective date of the registration statement of whichthis prospectus is a part, a person who is an affiliate of ours and who has beneficially owned restricted securities for at least sixmonths, as measured by SEC rule, including the holding period of any prior owner other than one of our affiliates, is entitled to sella number of restricted shares within any three-month period that does not exceed the greater of:

•        1%of the number of shares of our common stock then outstanding, which will equal approximately             shares immediately after this offering; and

•        theaverage weekly trading volume of our common stock on NASDAQ during the four calendar weeks preceding the filing of a notice on Form 144with respect to the sale.

Salesof restricted shares under Rule 144 held by our affiliates are also subject to requirements regarding the manner of sale, noticeand the availability of current public information about us. Rule 144 also provides that affiliates relying on Rule 144 to sellshares of our common stock that are not restricted shares must nonetheless comply with the same restrictions applicable to restrictedshares, other than the holding period requirement. Notwithstanding the availability of Rule 144, the holders of             of our restricted shares have entered into lock-up agreements as described below and their restricted shares will becomeeligible for sale at the expiration of the restrictions set forth in those agreements.

Rule 701

UnderRule 701, shares of our common stock acquired upon the exercise of currently outstanding options or pursuant to other rights grantedunder our stock plans may be resold, by:

•        personsother than affiliates, beginning 90 days after the effective date of the registration statement of which this prospectus is a part,subject only to the manner-of-sale provisions of Rule 144; and

•        ouraffiliates, beginning 90 days after the effective date of the registration statement of which this prospectus is a part, subjectto the manner-of-sale and volume limitations, current public information and filing requirements of Rule 144, in eachcase, without compliance with the six-month holding period requirement of Rule 144.

96

Lock-upAgreements

We,all of our directors, officers, employees and the holders of 1.0% or more of the outstanding shares of our Common Stock as of the effectivedate of the registration statement of which this prospectus is a part have entered into lock-up agreements with respect tothe disposition of their shares. See “Underwriting — Lock-Up Agreements” for additional information.

EquityIncentive Plans

Weintend to file registration statements on Form S-8 under the Securities Act after the closing of this offering to registerthe shares of our common stock that are issuable pursuant to our 2021 Equity Incentive Plan. The registration statement is expected tobe filed and become effective as soon as practicable after the completion of this offering, but in no event prior to the six months afterthe date of this prospectus. Accordingly, shares registered under the registration statements will be available for sale in the open marketfollowing their effective dates, subject to Rule 144 volume limitations and the lock-up arrangement described above,if applicable.

97

CERTAINU.S. FEDERAL INCOME TAX CONSIDERATIONS

Thefollowing discussion summarizes certain U.S. federal income tax considerations generally applicable to the acquisition, ownership anddisposition of our units (each consisting of one share of our common stock one warrant) that are purchased in this offering by U.S. Holders(as defined below) and Non-U.S. Holders (as defined below). Because the components of a unit are separable, the holder ofa unit generally should be treated, for U.S. federal income tax purposes, as the owner of the underlying share of our common stock andone warrant components of the unit. As a result, the discussion below with respect to holders of shares of our common stock and warrantsshould also apply to holders of units (as the deemed owners of the underlying share of our common stock and warrants that constitute theunits).

Thisdiscussion is limited to certain U.S. federal income tax considerations to beneficial owners of our securities who are initial purchasersof a unit pursuant to this offering and hold the unit and each component of the unit as capital assets within the meaning of Section 1221(a)of the U.S. Internal Revenue Code of 1986, as amended (the “Code”) (generally, property held for investment). This discussionassumes that the shares of our common stock and warrants will trade separately and that any distributions made (or deemed made) by uson the shares of our common stock and any consideration received (or deemed received) by a holder in consideration for the sale or otherdisposition of our securities will be in U.S. dollars. This discussion is a summary only and does not consider all aspects of U.S. federalincome taxation that may be relevant to the acquisition, ownership and disposition of a unit by a prospective investor in light of itsparticular circumstances or that is subject to special rules under the U.S. federal income tax laws, including, but not limited to:

•        ourofficers, directors or other holders of our common stock or private placement warrants;

•        banksand other financial institutions or financial services entities;

•        broker-dealers;

•        mutualfunds;

•        retirementplans, individual retirement accounts or other tax-deferred accounts;

•        taxpayersthat are subject to the mark-to-market tax accounting rules;

•        tax-exemptentities;

•        S-corporations,partnerships or other flow-through entities and investors therein;

•        governmentsor agencies or instrumentalities thereof;

•        insurancecompanies;

•        regulatedinvestment companies;

•        realestate investment trusts;

•        passiveforeign investment companies;

•        controlledforeign corporations;

•        qualifiedforeign pension funds;

•        expatriatesor former long-term residents of the United States;

•        personsthat actually or constructively own five percent or more of our voting shares;

•        personsthat acquired our securities pursuant to an exercise of employee share options, in connection with employee share incentive plans or otherwiseas compensation or in connection with services;

•        personsrequired for U.S. federal income tax purposes to conform the timing of income accruals to their financial statements under Section 451of the Code;

•        personssubject to the alternative minimum tax;

98

•        personsthat hold our securities as part of a straddle, constructive sale, hedging, conversion or other integrated or similar transaction; or

•        U.S.Holders (as defined below) whose functional currency is not the U.S. dollar.

Thediscussion below is based upon current provisions of the Code, applicable U.S. Treasury regulations promulgated under the Code (“TreasuryRegulations”), judicial decisions and administrative rulings of the IRS, all as in effect on the date hereof, and all of which aresubject to differing interpretations or change, possibly on a retroactive basis. Any such differing interpretations or change could alterthe U.S. federal income tax consequences discussed below. Furthermore, this discussion does not address any aspect of U.S. federal non-incometax laws, such as gift, estate or Medicare contribution tax laws, or state, local or non-U.S. tax laws.

Wehave not sought, and will not seek, a ruling from the IRS as to any U.S. federal income tax consequence described herein. The IRS maydisagree with the discussion herein, and its determination may be upheld by a court. Moreover, there can be no assurance that future legislation,regulations, administrative rulings or court decisions will not adversely affect the accuracy of the statements in this discussion.

Asused herein, the term “U.S. Holder” means a beneficial owner of units, shares of our common stock or warrants that is forU.S. federal income tax purposes:

(i)     anindividual who is a citizen or resident of the United States,

(ii)    acorporation (or other entity treated as a corporation for U.S. federal income tax purposes) that is created or organized (or treated ascreated or organized) in or under the laws of the United States, any state thereof or the District of Columbia,

(iii)   anestate the income of which is subject to U.S. federal income taxation regardless of its source or

(iv)   atrust if (A) a court within the United States is able to exercise primary supervision over the administration of the trust andone or more United States persons have the authority to control all substantial decisions of the trust, or (B) it has in effecta valid election under Treasury Regulations to be treated as a United States person.

Thisdiscussion does not consider the tax treatment of partnerships or other pass-through entities (including branches) or personswho hold our securities through such entities. If a partnership (or other entity or arrangement classified as a partnership for U.S. federalincome tax purposes) is the beneficial owner of our securities, the U.S. federal income tax treatment of a partner in the partnershipgenerally will depend on the status of the partner and the activities of the partner and the partnership. If you are a partner or a partnershipholding our securities, we urge you to consult your own tax advisor.

THISDISCUSSION IS ONLY A SUMMARY OF CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS ASSOCIATED WITH THE ACQUISITION, OWNERSHIP AND DISPOSITIONOF OUR UNITS. EACH PROSPECTIVE INVESTOR IN OUR UNITS IS URGED TO CONSULT ITS OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCESTO SUCH INVESTOR OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR UNITS, INCLUDING THE APPLICABILITY AND EFFECT OF ANY STATE, LOCAL,AND NON-UNITED STATES TAX LAWS

PersonalHolding Company Status

Wecould be subject to a second level of U.S. federal income tax on a portion of our income if we are determined to be a personal holdingcompany (a “PHC”) for U.S. federal income tax purposes. A U.S. corporation generally would be classified as a PHC for U.S.federal income tax purposes in a given taxable year if (i) at any time during the last half of such taxable year, five or fewer individuals(without regard to their citizenship or residency and including as individuals for this purpose certain entities such as certain tax-exemptorganizations, pension funds and charitable trusts) own or are deemed to own (pursuant to certain constructive ownership rules) more than50% of the stock of the corporation by value and (ii) at least 60% of the corporation’s adjusted ordinary gross income, asdetermined for U.S. federal income tax purposes, for such taxable year consists of PHC income (which includes, among other things, dividends,interest, certain royalties, annuities and, under certain circumstances, rents). If we are or were to become a PHC in a given taxableyear, we would be subject to an additional PHC tax, currently 20%, on our undistributed PHC income, which generally includes our taxableincome, subject to certain adjustments.

99

Allocationof Purchase Price and Characterization of a Unit

Nostatutory, administrative or judicial authority directly addresses the treatment of a unit or instruments similar to a unit for U.S. federalincome tax purposes, and therefore, that treatment is not entirely clear. The acquisition of a unit should be treated for U.S. federalincome tax purposes as the acquisition of one share of our common stock and one warrant, with each warrant exercisable to acquire oneshare of our common stock, and we intend to treat the acquisition of a unit in this manner. For U.S. federal income tax purposes, eachholder of a unit must allocate the purchase price paid by such holder for such unit between the one share of our common stock and theone warrant based on the relative fair market value of each at the time of issuance. Under U.S. federal income tax law, each investormust make its own determination of such value based on all the relevant facts and circumstances. Therefore, we strongly urge each investorto consult its tax advisor regarding the determination of value for these purposes. The price allocated to each share of our common stockand each warrant should constitute the holder’s initial tax basis in such share and such warrant, respectively. Any dispositionof a unit should be treated for U.S. federal income tax purposes as a disposition of the share of our common stock and warrant comprisingthe unit, and the amount realized on the disposition should be allocated between the share of our common stock and warrant based on theirrespective relative fair market values at the time of disposition. The separation of the share of our common stock and the warrant constitutinga unit should not be a taxable event for U.S. federal income tax purposes.

Theforegoing treatment of the shares of our common stock and warrants and a holder’s purchase price allocation are not binding on theIRS or the courts. Because there are no authorities that directly address instruments that are similar to the units, no assurance canbe given that the IRS or the courts will agree with the characterization described above or the discussion below. Accordingly, each prospectiveinvestor is urged to consult its tax advisor regarding the tax consequences of an investment in a unit (including alternative characterizationsof a unit). The balance of this discussion assumes that the characterization of the units described above is respected for U.S. federalincome tax purposes.

U.S.Holders

Taxationof Distributions

Ifwe pay distributions in cash or other property (other than certain distributions of our stock or rights to acquire our stock) to U.S.Holders of our common stock, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid fromour current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Distributions in excess of currentand accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero)the U.S. Holder’s adjusted tax basis in our shares of our common stock. Any remaining excess will be treated as gain realized onthe sale or other disposition of the shares of our common stock and will be treated as described under “U.S. Holders —Gain or Loss on Sale, Taxable Exchange or Other Taxable Disposition of Our Common Stock and Warrants” below.

Dividendswe pay to a corporate U.S. Holder generally will qualify for the dividends received deduction if certain holding period requirements aremet. With certain exceptions (including, but not limited to, dividends treated as investment income for purposes of investment interestdeduction limitations), and provided certain holding period requirements are met, dividends we pay to a non-corporate U.S.Holder will generally be taxed as qualified dividend income at the preferential tax rate for long-term capital gains. Ifthe holding period requirements are not met, then a corporation may not be able to qualify for the dividends received deduction and wouldhave taxable income equal to the entire dividend amount, and non-corporate holders may be subject to tax on such dividendat regular ordinary income tax rates instead of the preferential rate that applies to qualified dividend income.

Gainor Loss on Sale, Taxable Exchange or Other Taxable Disposition of Our Common Stock and Warrants

AU.S. Holder generally will recognize capital gain or loss on a sale or other taxable disposition of our shares of common stock or warrants.Any such capital gain or loss generally will be long-term capital gain or loss if the U.S. Holder’s holding periodfor such shares of our common stock or warrants exceeds one year. Long-term capital gains recognized by a non-corporateU.S. Holder are currently eligible to be taxed preferential rates. The deductibility of capital losses is subject to limitations.

100

Theamount of gain or loss recognized on a sale or other taxable disposition generally will be equal to the difference between (i) thesum of the amount of cash and the fair market value of any property received in such disposition (or, if the shares of our common stockor warrants are held as part of units at the time of the disposition, the portion of the amount realized on such disposition that is allocatedto the shares of our common stock or warrants based upon the then relative fair market values of the shares of our common stock and thewarrants included in the units) and (ii) the U.S. Holder’s adjusted tax basis in its shares of our common stock or warrantsso disposed of. A U.S. Holder’s adjusted tax basis in its shares of our common stock and warrants generally will equal the U.S.Holder’s acquisition cost (that is, the portion of the purchase price of a unit allocated to a share of our common stock or warrant,as described above under “— Allocation of Purchase Price and Characterization of a Unit”) reduced, in the case of ashare of our common stock, by any prior distributions treated as a return of capital. See “U.S. Holders — Exercise, Lapseor Redemption of a Warrant” below for a discussion regarding a U.S. Holder’s tax basis in a share of our common stock acquiredpursuant to the exercise of a warrant.

Redemptionof Our Common Stock

Inthe event that a U.S. Holder’s shares of our common stock are redeemed or if we purchase a U.S. Holder’s shares of our commonstock in an open market transaction (each referred to herein as a “redemption”), the treatment of the redemption for U.S.federal income tax purposes will depend on whether it qualifies as a sale or exchange of the shares of our common stock under Section 302of the Code. If the redemption qualifies as a sale or exchange of the shares of our common stock under the tests described below, theU.S. Holder will be treated as described under “U.S. Holders — Gain or Loss on Sale, Taxable Exchange or Other Taxable Dispositionof Our Common Stock and Warrants” above. If the redemption does not qualify as a sale or exchange of the shares of our common stock,the U.S. Holder will be treated as receiving a corporate distribution with the tax consequences described above under “U.S. Holders— Taxation of Distributions.” Whether a redemption qualifies for sale or exchange treatment will depend largely on the totalnumber of our shares treated as held by the U.S. Holder (including any shares constructively owned by the U.S. Holder as described inthe following paragraph) relative to all of our shares outstanding both before and after such redemption. The redemption of our commonstock generally will be treated as a sale or exchange of the shares of our common stock (rather than as a corporate distribution) if,within the meaning of Section 302 of the Code, such redemption (i) is “substantially disproportionate” with respectto the U.S. Holder, (ii) results in a “complete termination” of the U.S. Holder’s interest in us or (iii) is“not essentially equivalent to a dividend” with respect to the U.S. Holder.

Indetermining whether any of the foregoing tests are satisfied, a U.S. Holder must take into account not only shares of our stock actuallyowned by the U.S. Holder, but also shares of our stock that are constructively owned by it. A U.S. Holder may constructively own, in additionto stock owned directly, stock owned by certain related individuals and entities in which the U.S. Holder has an interest or that havean interest in such U.S. Holder, as well as any stock the U.S. Holder has a right to acquire by exercise of an option, which would generallyinclude shares of our common stock which could be acquired pursuant to the exercise of the warrants. In order to meet the “substantiallydisproportionate” test, the percentage of our outstanding voting shares actually and constructively owned by the U.S. Holder immediatelyfollowing the redemption of shares of our common stock must, among other requirements, be less than 80% of the percentage of our outstandingvoting stock actually and constructively owned by the U.S. Holder immediately before the redemption. The shares of our common stock maynot be treated as voting shares for this purpose and, consequently, this substantially disproportionate test may not be applicable. Therewill be a complete termination of a U.S. Holder’s interest if either (i) all of our shares actually and constructively ownedby the U.S. Holder are redeemed or (ii) all of our shares actually owned by the U.S. Holder are redeemed and the U.S. Holder is eligibleto waive, and effectively waives in accordance with specific rules, the attribution of shares owned by certain family members and theU.S. Holder does not constructively own any other shares of our stock. The redemption of the shares of our common stock will not be essentiallyequivalent to a dividend with respect to a U.S. Holder if it results in a “meaningful reduction” of the U.S. Holder’sproportionate interest in us. Whether the redemption will result in a meaningful reduction in a U.S. Holder’s proportionate interestin us will depend on the particular facts and circumstances. However, the IRS has indicated in a published ruling that even a small reductionin the proportionate interest of a small minority stockholder in a publicly-held corporation who exercises no control overcorporate affairs may constitute such a “meaningful reduction.” A U.S. Holder should consult with its own tax advisors asto the tax consequences of a redemption.

101

Ifnone of the foregoing tests are satisfied, then the redemption will be treated as a corporate distribution and the tax effects will beas described under “U.S. Holders — Taxation of Distributions” above. After the application of those rules, any remainingtax basis of the U.S. Holder in the redeemed shares of our common stock will be added to the U.S. Holder’s adjusted tax basis inits remaining shares, or, if it has none, to the U.S. Holder’s adjusted tax basis in its warrants or possibly in other stock constructivelyowned by it.

Exercise,Lapse or Redemption of a Warrant

Exceptas discussed below with respect to the cashless exercise of a warrant, a U.S. Holder generally will not recognize gain or loss upon theacquisition of a share of our common stock on the exercise of a warrant for cash. A U.S. Holder’s initial tax basis in a share ofour common stock received upon exercise of the warrant generally will equal the sum of the U.S. Holder’s initial investment in thewarrant (that is, the portion of the U.S. Holder’s purchase price for the units that is allocated to the warrant, as described aboveunder “— Allocation of Purchase Price and Characterization of a Unit”) and the exercise price of such warrant. It isunclear whether a U.S. Holder’s holding period for the share of our common stock received upon exercise of the warrants will commenceon the date of exercise of the warrant or the day following the date of exercise of the warrant; in either case, the holding period willnot include the period during which the U.S. Holder held the warrant. If a warrant is allowed to lapse unexercised, a U.S. Holder generallywill recognize a capital loss equal to such holder’s tax basis in the warrant.

Thetax consequences of a cashless exercise of a warrant are not clear under current law. A cashless exercise may not be taxable, either becausethe exercise is not a realization event or because the exercise is treated as a “recapitalization” for U.S. federal incometax purposes. In either situation, a U.S. Holder’s tax basis in the shares of our common stock received generally would equal theU.S. Holder’s tax basis in the warrants exercised therefor. If the cashless exercise were not a realization event, it is unclearwhether a U.S. Holder’s holding period for the shares of our common stock will commence on the date of exercise of the warrant orthe day following the date of exercise of the warrant. If the cashless exercise were treated as a recapitalization, the holding periodof the shares of our common stock would include the holding period of the warrants exercised therefor.

Itis also possible that a cashless exercise could be treated in whole or in part as a taxable exchange in which gain or loss would be recognized.In such event, a U.S. Holder could be deemed to have surrendered a number of warrants having an aggregate value (as measured by the excessof the fair market value of our common stock over the exercise price of the warrants) equal to the exercise price for the total numberof warrants to be exercised (i.e., the warrants underlying the number of shares of our commonstock actually received by the U.S. Holder pursuant to the cashless exercise). The U.S. Holder would recognize capital gain or loss inan amount equal to the difference between the value of the warrants deemed surrendered and the U.S. Holder’s tax basis in such warrants.Such gain or loss would be long-term or short-term, depending on the U.S. Holder’s holding period in thewarrants deemed surrendered. In this case, a U.S. Holder’s tax basis in the common stock received would equal the sum of the U.S.Holder’s tax basis in the warrants exercised and the exercise price of such warrants. It is unclear whether a U.S. Holder’sholding period for the common stock would commence on the date following the date of exercise or on the date of exercise of the warrant;in either case, the holding period would not include the period during which the U.S. Holder held the warrant.

Alternativecharacterizations are also possible (including as a taxable exchange of all of the warrants surrendered by the U.S. Holder for sharesof our common stock received upon exercise). Due to the absence of authority on the U.S. federal income tax treatment of a cashless exercise,including when a U.S. Holder’s holding period would commence with respect to the common stock received, there can be no assurancewhich, if any, of the alternative tax consequences and holding periods described above would be adopted by the IRS or a court of law.Accordingly, U.S. Holders should consult their tax advisors regarding the tax consequences of a cashless exercise.

Ifwe redeem warrants for cash or if we purchase warrants in an open market transaction, such redemption or purchase generally will be treatedas a taxable disposition to the U.S. Holder, taxed as described above under “U.S. Holders — Gain or Loss on Sale, TaxableExchange or Other Taxable Disposition of Our Common Stock and Warrants.”

PossibleConstructive Distributions

Theterms of each warrant provide for an adjustment to the number of shares of our common stock for which the warrant may be exercised orto the exercise price of the warrant in certain events. Depending on the circumstances, such adjustments may be treated as constructivedistributions. An adjustment which has the effect of preventing

102

dilutionpursuant to a bona fide reasonable adjustment formula generally is not taxable. The U.S. Holders of the warrants would, however, be treatedas receiving a constructive distribution from us if, for example, the adjustment increases the warrant holders’ proportionate interestin our assets or earnings and profits (e.g., through an increase in the number of shares of our common stock that would be obtained uponexercise or through a decrease to the exercise price) as a result of a taxable distribution of cash or other property to the holders ofshares of our common stock. Any such constructive distribution would generally be subject to tax as described under “U.S. Holders— Taxation of Distributions” above in the same manner as if the U.S. Holders of the warrants received a cash distributionfrom us equal to the fair market value of such increased interest resulting from the adjustment.

Non-U.S.Holders

Thissection applies to “Non-U.S. Holders.” As used herein, the term “Non-U.S. Holder” meansa beneficial owner of our units, common stock or warrants that is not a U.S. Holder and is not a partnership or other entity classifiedas a partnership for U.S. federal income tax purposes, but such term generally does not include an individual who is present in the United Statesfor 183 days or more in the taxable year of disposition. If you are such an individual, you should consult your tax advisor regardingthe U.S. federal income tax consequences of the acquisition, ownership or sale or other disposition of our securities.

Taxationof Distributions

Ingeneral, any distributions (including constructive distributions) we make to a Non-U.S. Holder of shares of our common stock,to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles), willconstitute dividends for U.S. federal income tax purposes. Provided such dividends are not effectively connected with the Non-U.S.Holder’s conduct of a trade or business within the United States (or, if required pursuant to an applicable income tax treaty,are not attributable to a permanent establishment of fixed base maintained by the Non-U.S. Holder in the United States),we will be required to withhold tax from the gross amount of the dividend at a rate of 30%, unless such Non-U.S. Holder iseligible for a reduced rate of withholding tax under an applicable income tax treaty and provides proper certification of its eligibilityfor such reduced rate (usually on an IRS Form W-8BEN or W-8BEN-E, as applicable). In the case of any constructivedividend, it is possible that this tax would be withheld from any amount owed to a Non-U.S. Holder by the applicable withholdingagent, including cash distributions on other property or sale proceeds from warrants or other property subsequently paid or credited tosuch holder. Any distribution not constituting a dividend will be treated first as reducing (but not below zero) the Non-U.S.Holder’s adjusted tax basis in its shares of our common stock and, to the extent such distribution exceeds the Non-U.S.Holder’s adjusted tax basis, as gain realized from the sale or other disposition of the shares of our common stock, which will betreated as described under “Non-U.S. Holders — Gain on Sale, Taxable Exchange or Other Taxable Dispositionof Our Common Stock and Warrants” below. In addition, if we determine that we are or are likely to be classified as a “United Statesreal property holding corporation” (see “Non-U.S. Holders — Gain on Sale, Taxable Exchange or OtherTaxable Disposition of Our Common Stock and Warrants” below), we will withhold 15% of any distribution that exceeds our currentand accumulated earnings and profits, including a distribution in redemption of shares of our common stock. See also “Non-U.S.Holders — Possible Constructive Distributions” for potential U.S. federal tax consequences with respect to constructivedistributions.

Dividendsthat we pay to a Non-U.S. Holder that are effectively connected with such Non-U.S. Holder’s conduct ofa trade or business within the United States (and, if a tax treaty applies, are attributable to a permanent establishment or fixedbase maintained by the Non-U.S. Holder in the United States) will not be subject to U.S. withholding tax, provided suchNon-U.S. Holder complies with certain certification and disclosure requirements (usually by providing an IRS Form W-8ECI).Instead, the effectively connected dividends will be subject to regular U.S. federal income tax as if the Non-U.S. Holderwere a U.S. resident, unless an applicable income tax treaty provides otherwise. A Non-U.S. Holder that is a foreign corporationreceiving effectively connected dividends may also be subject to an additional “branch profits tax” imposed at a rate of 30%(or a lower treaty rate).

Exercise,Lapse or Redemption of a Warrant

TheU.S. federal income tax treatment of a Non-U.S. Holder’s exercise of a warrant, or the lapse of a warrant held by aNon-U.S. Holder, generally will correspond to the U.S. federal income tax treatment of the exercise or lapse of a warrantby a U.S. Holder, as described under “U.S. Holders — Exercise, Lapse or Redemption of a Warrant” above,

103

althoughto the extent a cashless exercise results in a taxable exchange, the consequences would be similar to those described below under “Non-U.S.Holders — Gain on Sale, Taxable Exchange or Other Taxable Disposition of Our Common Stock and Warrants.” The U.S. federalincome tax treatment for a Non-U.S. Holder of a redemption of warrants for cash (or if we purchase warrants in an open markettransaction) would be similar to that described below in “Non-U.S. Holders — Gain on Sale, Taxable Exchangeor Other Taxable Disposition of Our Common Stock and Warrants.”

Gainon Sale, Taxable Exchange or Other Taxable Disposition of Our Common Stock and Warrants

Subjectto the discussion of FATCA and backup withholding below, a Non-U.S. Holder generally will not be subject to U.S. federalincome or withholding tax in respect of gain recognized on a sale, taxable exchange or other taxable disposition of shares of our commonstock or warrants (including an expiration or redemption of our warrants), in each case without regard to whether such securities wereheld as part of a unit, unless:

•        thegain is effectively connected with the conduct of a trade or business by the Non-U.S. Holder within the United States(and, under certain income tax treaties, is attributable to a permanent establishment or fixed base maintained by the Non-U.S.Holder in the United States); or

•        weare or have been a “United States real property holding corporation” for U.S. federal income tax purposes at any timeduring the shorter of the five-year period ending on the date of disposition or the period that the Non-U.S.Holder held our common stock, and, in the case where shares of our common stock are regularly traded on an established securities market,the Non-U.S. Holder has owned, directly or constructively, more than 5% of our common stock at any time within the shorterof the five-year period preceding the disposition or such Non-U.S. Holder’s holding period for the sharesof our common stock. There can be no assurance that our common stock will be treated as regularly traded on an established securitiesmarket for this purpose. These rules may be modified for Non-U.S. Holders of warrants. If we are or have been a “United Statesreal property holding corporation” and you own warrants, you are urged to consult your own tax advisor regarding the applicationof these rules.

Unlessan applicable treaty provides otherwise, gain described in the first bullet point above will generally be subject to tax at the applicableU.S. federal income tax rates as if the Non-U.S. Holder were a U.S. resident. Any gains described in the first bullet pointabove of a Non-U.S. Holder that is a foreign corporation may also be subject to an additional “branch profits tax”at a 30% rate (or lower treaty rate).

Ifthe second bullet point above applies to a Non-U.S. Holder, gain recognized by such holder on the sale, exchange or otherdisposition of our common stock or warrants will generally be subject to tax at applicable U.S. federal income tax rates as if the Non-U.S.Holder were a U.S. resident. In addition, a buyer of our common stock or warrants from such holder may be required to withhold U.S. federalincome tax at a rate of 15% of the amount realized upon such disposition. In general, we would be classified as a United States realproperty holding corporation if the fair market value of our “United States real property interests” equals or exceeds50% of the sum of the fair market value of our worldwide real property interests plus our other assets used or held for use in a tradeor business, as determined for U.S. federal income tax purposes.

Redemptionof Our Common Stock

Thecharacterization for U.S. federal income tax purposes of any redemption of a Non-U.S. Holder’s shares of our commonstock will generally correspond to the U.S. federal income tax characterization of such a redemption of a U.S. Holder’s shares ofour common stock, as described under “U.S. Holders — Redemption of Our Common Stock” above, and the consequencesof the redemption to the Non-U.S. Holder will be as described above under “Non-U.S. Holders —Taxation of Distributions” and “Non-U.S. Holders — Gain on Sale, Taxable Exchange or Other TaxableDisposition of Our Common Stock and Warrants,” as applicable.

PossibleConstructive Distributions

Theterms of each warrant provide for an adjustment to the number of shares of our common stock for which the warrant may be exercised orto the exercise price of the warrant in certain events. Depending on the circumstances, such adjustments may be treated as constructivedistributions. An adjustment which has the effect of preventing dilution pursuant to a bona fide reasonable adjustment formula generallyis not taxable. The Non-U.S. Holders of the

104

warrantswould, however, be treated as receiving a constructive distribution from us if, for example, the adjustment increases the warrant holders’proportionate interest in our assets or earnings and profits (e.g., through an increase in the number of shares of our common stock thatwould be obtained upon exercise or through a decrease to the exercise price) as a result of a taxable distribution of cash or other propertyto the holders of shares of our common stock. Any such constructive distribution would generally be taxed as described under “Non-U.S.Holders — Taxation of Distributions” above, in the same manner as if the Non-U.S. Holders of the warrantsreceived a cash distribution from us equal to the fair market value of such increased interest resulting from the adjustment.

InformationReporting and Backup Withholding

Dividendpayments (including constructive dividends) with respect to our common stock and proceeds from the sale, exchange or redemption of sharesof our common stock or warrants may be subject to information reporting to the IRS and possible United States backup withholding.Backup withholding will not apply, however, to payments made to a U.S. Holder who furnishes a correct taxpayer identification number andmakes other required certifications, or who is otherwise exempt from backup withholding and establishes such exempt status. Payments madeto a Non-U.S. Holder generally will not be subject to backup withholding if the Non-U.S. Holder provides certificationof its foreign status, under penalties of perjury, on a duly executed applicable IRS Form W-8 or by otherwise establishingan exemption.

Backupwithholding is not an additional tax. Amounts withheld under the backup withholding rules may be credited against a holder’s U.S.federal income tax liability, and a holder generally may obtain a refund of any excess amounts withheld by timely filing the appropriateclaim for refund with the IRS and furnishing any required information. All holders should consult their tax advisors regarding the applicationof information reporting and backup withholding to them.

FATCAWithholding Taxes

Sections 1471through 1474 of the Code and the Treasury Regulations and administrative guidance promulgated thereunder (commonly referred to as the“Foreign Account Tax Compliance Act” or “FATCA”) generally impose withholding of 30% in certain circumstanceson payments of dividends (including constructive dividends) and, subject to the proposed Treasury Regulations discussed below, on proceedsfrom sales or other disposition of our securities paid to “foreign financial institutions” (which is broadly defined for thispurpose and includes investment vehicles) and certain other non-U.S. entities unless various U.S. information reporting anddue diligence requirements (relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfiedor an exemption applies (typically certified as to by the delivery of a properly completed IRS Form W-8BEN-E). If FATCAwithholding is imposed, a beneficial owner that is not a foreign financial institution will be entitled to a refund of any amounts withheldby filing a U.S. federal income tax return (which may entail significant administrative burden). Foreign financial institutions locatedin jurisdictions that have an intergovernmental agreement with the United States governing FATCA may be subject to different rules.Similarly, dividends and, subject to the proposed Treasury Regulations discussed below, proceeds from sales or other disposition in respectof our units held by an investor that is a non-financial non-U.S. entity that does not qualify under certainexceptions generally will be subject to withholding at a rate of 30%, unless such entity either (i) certifies to us or the applicablewithholding agent that such entity does not have any “substantial United States owners” or (ii) provides certaininformation regarding the entity’s “substantial United States owners,” which will in turn be provided to the U.S.Department of the Treasury. The U.S. Department of the Treasury has proposed regulations which eliminate the federal withholding tax of30% applicable to the gross proceeds of a sale or other disposition of our securities. Withholding agents may rely on the proposed TreasuryRegulations until final regulations are issued. Prospective investors should consult their tax advisors regarding the possible effectsof FATCA on their investment in our securities.

THEU.S. FEDERAL INCOME TAX DISCUSSION SET FORTH ABOVE IS INCLUDED FOR GENERAL INFORMATION ONLY AND MAY NOT BE APPLICABLE DEPENDING UPON AHOLDER’S PARTICULAR SITUATION. HOLDERS ARE URGED TO CONSULT THEIR OWN TAX ADVISORS WITH RESPECT TO THE TAX CONSEQUENCES TO THEMOF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK AND WARRANTS, INCLUDING THE TAX CONSEQUENCES UNDER STATE, LOCAL, ESTATE,NON-U.S. AND OTHER TAX LAWS AND TAX TREATIESAND THE POSSIBLE EFFECTS OF CHANGES IN U.S. OR OTHER TAX LAWS.

105

Underwriting

MaximGroup LLC is acting as the representative of the underwriters of the offering (the “Representative”). We have entered intoan underwriting agreement dated             , 2022 with the Representative,with respect to the Units being offered. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell toeach underwriter named below and each underwriter named below has severally and not jointly agreed to purchase from us, at the publicoffering price per Unit, less the underwriting discounts set forth on the cover page of this prospectus, the number of Units listed nextto its name in the following table:

Underwriter

 

Number of
Units

Maxim Group LLC

 

Total

 

Theunderwriters are committed to purchase all the Units offered by us other than those covered by the over-allotment optiondescribed below, if any, are purchased. The underwriting agreement also provides that if an underwriter defaults, the purchase commitmentsof non-defaulting underwriters may be increased, or the offering may be terminated. The underwriters are not obligatedto purchase the securities covered by the underwriters’ over-allotment option described below. The underwritersare offering the Units, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters bytheir counsel, and other conditions contained in the underwriting agreement, such as the receipt by the underwriters of officer’scertificates and legal opinions. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject ordersin whole or in part.

Over-AllotmentOption

Wehave granted to the Representative an option, exercisable one or more times in whole or in part, not later than 45 days after thedate of this prospectus, to purchase from us up to an additional               shares of our Common Stock at a price of $           per (which is the public offeringprice of $            per Unit minus $0.01) and/or up to an additional               Warrants to purchase up to                shares of Common Stockat a price of $0.01 per Warrant, in each case, less the underwriting discounts and commissions set forth on the cover of this prospectus,in any combination thereof, to cover over-allotments, if any. To the extent that the Representative exercises this option,each of the underwriters will become obligated, subject to conditions, to purchase approximately the same percentage of these additionalshares of Common Stock and/or Warrants as the number of Units to be purchased by it in the above table bears to the total number of Unitsoffered by this prospectus. We will be obligated, pursuant to the option, to sell these additional shares of Common Stock and/or Warrantsto the underwriters to the extent the option is exercised. If any additional shares of Common Stock and/or Warrants are purchased, theunderwriters will offer the additional shares of Common Stock and/or Warrants on the same terms as those on which the other shares ofCommon Stock and/or Warrants are being offered hereunder. If this option is exercised in full, the total offering price to the publicwill be $           and the total net proceeds, before expenses and after the creditto the underwriting commissions described below, to us will be $          .

Discountsand Commissions; Expenses

Thefollowing table shows the public offering price, underwriting discount and proceeds, before expenses, to us. The information assumes eitherno exercise or full exercise by the Representative of the over-allotment option.

 

Per Unit

 

Total Without
Over-allotment
Option

 

Total With Full
Over-allotment
Option

Public offering price

 

$

   

$

   

$

 

Underwriting discounts and commissions (7.0%)

 

$

   

$

   

$

 

Proceeds, before expenses, to us

 

$

   

$

   

$

 

Non-accountable expense allowance (1.0%)(1)

 

$

   

$

   

$

 

____________

(1)      Thenon-accountable expense allowance will not be payable with respect to the representative’s exercise of the over-allotmentoption, if any.

106

Wehave agreed to pay a non-accountable expense allowance to the representative of the underwriters equal to 1.0% of the grossproceeds received at the completion of the offering. The non-accountable expense allowance of 1.0% is not payable with respectto any shares sold upon exercise of the representative’s over-allotment option.

Wehave also paid an expense deposit of $25,000 to the Representative and will pay an additional $25,000 expense deposit to the Representativeconcurrently with the filing with the Commission of the registration statement of which this prospectus forms a part, which will be appliedagainst the accountable expenses that will be paid by us to the Representative in connection with this offering. The combined $50,000expense deposit will be returned to us to the extent not actually incurred. The underwriting agreement also provides that in the eventthe offering is terminated, the combined $50,000 expense deposit paid to the Representative will be returned to us to the extent thatoffering expenses are not actually incurred by the Representative in accordance with Financial Industry Regulation Authority (“FINRA”)Rule 5110(g)(4)(A).

Theunderwriters propose to offer the Units offered by us to the public at the public offering price per Unit set forth on the cover of thisprospectus. In addition, the underwriters may offer some of the Units to other securities dealers at such price less a concession of $              per Unit. After the initial offering, the public offering price and concession to dealers may be changed.

Wehave also agreed to reimburse the Representative for reasonable out-of-pocket expenses not to exceed $150,000 in the aggregate.We estimate that total expenses payable by us in connection with this offering, other than the underwriting discount, will be approximately$              .

DiscretionaryAccounts

Theunderwriters do not intend to confirm sales of the shares of Common Stock and/or Warrants offered hereby to any accounts over which theyhave discretionary authority.

Indemnification

Wehave agreed to indemnify the underwriters against specified liabilities, including liabilities under the Securities Act, and to contributeto payments the underwriters may be required to make in respect thereof.

Lock-UpAgreements

Weand our officers and directors, and the holders of 1.0% or more of the outstanding shares of our Common Stock as of the effective dateof the registration statement of which this prospectus is a part, have agreed, subject to limited exceptions, for a period of six (6) monthsafter the closing of this offering, not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale orotherwise dispose of, directly or indirectly any shares of our Common Stock or any securities convertible into or exchangeable for ourCommon Stock either owned as of the date of the underwriting agreement or thereafter acquired without the prior written consent of theRepresentative. The Representative may, in its sole discretion and at any time or from time to time before the termination of the lock-upperiod, without notice, release all or any portion of the securities subject to lock-up agreements.

Pricingof this Offering; Market Information

Priorto this offering, there has been no public market for our Common Stock. The initial public offering price was determined through negotiationsbetween us and the Representative. In addition to prevailing market conditions, the factors considered in determining the initial publicoffering price included the following:

•        theinformation included in this prospectus and otherwise available to the Representative;

•        thevaluation multiples of publicly traded companies that the Representative believes to be comparable to us;

•        ourfinancial information;

•        ourprospects and the history and the prospects of the industry in which we compete;

•        anassessment of our management, its past and present operations, and the prospects for, and timing of, our future revenues;

107

•        thepresent state of our development; and

•        theabove factors in relation to market values and various valuation measures of other companies engaged in activities similar to ours.

Anactive trading market for our Common Stock may not develop. It is also possible that after the offering our Common Stock will not tradein the public market at or above the public offering price. There is no established trading market for any of the Warrants, and we donot expect a market to develop. We do not intend to apply for a listing for any of the Warrants on any securities exchange or other nationallyrecognized trading system. Without an active trading system, the liquidity of the Warrants will be limited.

Representative’sWarrants

Wehave agreed to issue to the Representative (or its permitted designees) warrants to purchase up to a total of               shares of Common Stock (6.0% of the shares of Common Stock issued in this offering, including the over-allotment, if any).The representative’s warrants will be exercisable at any time, and from time to time, in whole or in part, during the five (5) yearperiod commencing 180 days from the commencement of sales of the Common Stock and the Warrants in this offering, which is also theeffective date of the registration statement of which this prospectus is a part, which period is in compliance with applicable FINRA rules.The representative’s warrants are exercisable at a per share price equal to $              per share, or 110% of the public offering price per share of Common Stock issued in this offering (based on the assumed public offeringprice of $               per share). The representative’swarrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(e)(1)(A)of FINRA. The Representative (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecatethese representative’s warrants or the securities underlying these representative’s warrants, nor will they engage in anyhedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the representative’swarrants or the underlying securities for a period commencing 180 days from the commencement of sales of the Common Stock in thisoffering. In addition, the representative’s warrants provide for cashless exercise and registration rights upon request, incertain cases. The unlimited piggyback registration rights provided will not be greater than three (3) years from the closing date ofthe offering in compliance with applicable FINRA rules (provided such registration rights will not apply to any universal shelf registrationstatement). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the representative’swarrants. The exercise price and number of shares issuable upon exercise of the representative’s warrants may be adjusted in certaincircumstances including in the event of a stock dividend, extraordinary cash dividend or our recapitalization, reorganization, merger,or consolidation. However, the exercise price of the representative’s warrants or underlying shares of Common Stock will not beadjusted for issuances of shares of Common Stock at a price below the warrant exercise price.

Rightof First Refusal

Subjectto the closing of this offering, for a period of eighteen (18) months after the closing of the offering, Maxim Group LLC (“Maxim”)shall have a right of first refusal to act as underwriter and book-running manager and/or placement agent for any and allfuture public or private equity and debt (excluding commercial bank debt and other customary exceptions) offerings undertaken during suchperiod by us, or any of our successors or subsidiaries. We and Maxim agree that the provisions of the preceding sentence shall not beapplicable to financing provided by or solicited from any person or entity who is a holder of our debt or equity as of July 29,2021.

NasdaqCapital Market Listing

Wehave applied to have our Common Stock listed on Nasdaq under the symbol “LUCY”. No assurance can be given that our listingapplication will be approved by the Nasdaq Capital Market. There is no established trading market for any of the Warrants, and we do notexpect a market to develop. We do not intend to apply for a listing for any of the Warrants on any securities exchange or other nationallyrecognized trading system. Without an active trading market, the liquidity of the Warrants will be limited.

TransferAgent and Registrar

Thename, address and telephone number of our stock transfer agent is VStock Transfer, LLC, 18 Lafayette Pl, Woodmere, New York 11598, (212)828-8436.

108

PriceStabilization, Short Positions and Penalty Bids

Inconnection with this offering the underwriters may engage in stabilizing transactions, over-allotment transactions, syndicatecovering transactions and penalty bids in accordance with Regulation M under the Exchange Act:

•        Stabilizingtransactions permit bids to purchase securities so long as the stabilizing bids do not exceed a specified maximum.

•        Over-allotmentinvolves sales by the underwriters of securities in excess of the number of securities the underwriters are obligated to purchase, whichcreates a syndicate short position. The short position may be either a covered short position or a naked short position. In a coveredshort position, the number of securities over-allotted by the underwriters is not greater than the number of securities thatthey may purchase in the over-allotment option. In a naked short position, the number of securities involved is greater thanthe number of securities in the over-allotment option. The underwriters may close out any covered short position by eitherexercising their over-allotment option and/or purchasing securities in the open market.

•        Syndicatecovering transactions involve purchases of the securities in the open market after the distribution has been completed in order to coversyndicate short positions. In determining the source of securities to close out the short position, the underwriters will consider, amongother things, the price of securities available for purchase in the open market as compared to the price at which they may purchase securitiesthrough the over-allotment option. A naked short position occurs if the underwriters sell more securities than could be coveredby the over-allotment option. This position can only be closed out by buying securities in the open market. A naked shortposition is more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the securitiesin the open market after pricing that could adversely affect investors who purchase in this offering.

•        Penaltybids permit the underwriters to reclaim a selling concession from a syndicate member when securities originally sold by the syndicatemember is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions.

Thesestabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market priceof our securities or preventing or retarding a decline in the market price of the securities. As a result, the price of our shares ofCommon Stock and Warrants may be higher than the price that might otherwise exist in the open market. These transactions may be discontinuedat any time.

Neitherwe nor the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions describedabove may have on the price of our shares of Common Stock and Warrants. In addition, neither we nor the underwriters make any representationthat the underwriters will engage in these transactions or that any transaction, if commenced, will not be discontinued without notice.

PassiveMarket Making

Inconnection with this offering, the underwriters and selling group members may also engage in passive market making transactions in ourCommon Stock. Passive market making consists of displaying bids limited by the prices of independent market makers and effecting purchaseslimited by those prices in response to order flow. Rule 103 of Regulation M promulgated by the SEC limits the amount of net purchasesthat each passive market maker may make and the displayed size of each bid. Passive market making may stabilize the market price of theCommon Stock at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.

ElectronicDistribution

Thisprospectus in electronic format may be made available on websites or through other online services maintained by the underwriters, orby their affiliates. Other than this prospectus in electronic format, the information on the underwriters’ websites and any informationcontained in any other websites maintained by the underwriters is not part of this prospectus or the registration statement of which thisprospectus forms a part, has not been approved and/or endorsed by us or the underwriters in their capacity as underwriters, and shouldnot be relied upon by investors.

109

Other

Fromtime to time, the underwriters and/or their affiliates have provided, and may in the future provide, various investment banking and otherfinancial services for us for which services it has received and, may in the future receive, customary fees. Except for the services providedin connection with this offering and other than as described below, the underwriters have not provided any investment banking or otherfinancial services during the 180-day period preceding the date of this prospectus.

Noticeto Prospective Investors in Canada

Thisprospectus constitutes an “exempt offering document” as defined in and for the purposes of applicable Canadian securitieslaws. No prospectus has been filed with any securities commission or similar regulatory authority in Canada in connection with the offerand sale of the securities. No securities commission or similar regulatory authority in Canada has reviewed or in any way passed uponthis prospectus or on the merits of the securities and any representation to the contrary is an offence.

Canadianinvestors are advised that this prospectus has been prepared in reliance on section 3A.3 of National Instrument 33-105Underwriting Conflicts (“NI 33-105”).Pursuant to section 3A.3 of NI 33-105, thisprospectus is exempt from the requirement that the Company and the underwriter(s) provide Canadian investors with certain conflicts ofinterest disclosure pertaining to “connected issuer” and/or “related issuer” relationships that may exist betweenthe Company and the underwriter(s) as would otherwise be required pursuant to subsection 2.1(1) of NI 33-105.

ResaleRestrictions

Theoffer and sale of the securities in Canada is being made on a private placement basis only and is exempt from the requirement that theCompany prepares and files a prospectus under applicable Canadian securities laws. Any resale of securities acquired by a Canadian investorin this offering must be made in accordance with applicable Canadian securities laws, which may vary depending on the relevant jurisdiction,and which may require resales to be made in accordance with Canadian prospectus requirements, pursuant to a statutory exemption from theprospectus requirements, in a transaction exempt from the prospectus requirements or otherwise under a discretionary exemption from theprospectus requirements granted by the applicable local Canadian securities regulatory authority. These resale restrictions may undercertain circumstances apply to resales of the securities outside of Canada.

Representationsof Purchasers

EachCanadian investor who purchases securities will be deemed to have represented to the Company, the underwriters and to each dealer fromwhom a purchase confirmation is received, as applicable, that the investor is (i) purchasing as principal, or is deemed to be purchasingas principal in accordance with applicable Canadian securities laws, for investment only and not with a view to resale or redistribution;(ii) an “accredited investor” as such term is defined in section 1.1 of National Instrument 45-106 ProspectusExemptions or, in Ontario, as such term is defined in section 73.3(1) of the Securities Act (Ontario); and (iii) is a “permittedclient” as such term is defined in section 1.1 of National Instrument 31-103 Registration Requirements, Exemptionsand Ongoing Registrant Obligations.

Taxationand Eligibility for Investment

Anydiscussion of taxation and related matters contained in this prospectus does not purport to be a comprehensive description of all of thetax considerations that may be relevant to a Canadian investor when deciding to purchase the securities and, in particular, does not addressany Canadian tax considerations. No representation or warranty is hereby made as to the tax consequences to a resident, or deemed resident,of Canada of an investment in the securities or with respect to the eligibility of the securities for investment by such investor underrelevant Canadian federal and provincial legislation and regulations.

110

Rightsof Action for Damages or Rescission

Securitieslegislation in certain of the Canadian jurisdictions provides certain purchasers of securities pursuant to an offering memorandum (suchas this prospectus), including where the distribution involves an “eligible foreign security” as such term is defined in OntarioSecurities Commission Rule 45-501 Ontario Prospectus and Registration Exemptions and in Multilateral Instrument 45-107Listing Representation and Statutory Rights of Action Disclosure Exemptions, as applicable, with a remedy for damages or rescission, orboth, in addition to any other rights they may have at law, where the offering memorandum, or other offering document that constitutesan offering memorandum, and any amendment thereto, contains a “misrepresentation” as defined under applicable Canadian securitieslaws. These remedies, or notice with respect to these remedies, must be exercised or delivered, as the case may be, by the purchaser withinthe time limits prescribed under, and are subject to limitations and defenses under, applicable Canadian securities legislation. In addition,these remedies are in addition to and without derogation from any other right or remedy available at law to the investor.

Languageof Documents

Uponreceipt of this document, each Canadian investor hereby confirms that it has expressly requested that all documents evidencing or relatingin any way to the sale of the securities described herein (including for greater certainty any purchase confirmation or any notice) bedrawn up in the English language only. Par la réception de ce document, chaque investisseurcanadien confirme par les présentes qu’il a expressément exigé que tous les documents faisant foi ou se rapportantde quelque manière que ce soit à la vente des valeurs mobilières décrites aux présentes (incluant,pour plus de certitude, toute confirmation d’achat ou tout avis) soient rédigés en anglais seulement.

EuropeanEconomic Area and United Kingdom

Inrelation to each Member State of the European Economic Area and the United Kingdom (each a “Relevant State”), no CommonStock has been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of aprospectus in relation to the Common Stock which has been approved by the competent authority in that Relevant State or, where appropriate,approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the ProspectusRegulation, except that offers of shares may be made to the public in that Relevant State at any time under the following exemptions underthe Prospectus Regulation:

•        tolegal entities which are qualified investors as defined under the Prospectus Regulation;

•        bythe underwriters to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Regulation),subject to obtaining the prior consent of the representatives of the underwriters for any such offer; or

•        inany other circumstances falling within Article 1(4) of the Prospectus Regulation, provided that no such offer of Common Stock shall resultin a requirement for us or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Regulation or supplement aprospectus pursuant to Article 23 of the Prospectus Regulation.

Forthe purposes of this provision, the expression an “offer of Common Stock to the public” in relation to any Common Stock inany Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any CommonStock to be offered so as to enable an investor to decide to purchase or subscribe for our Common Stock, and the expression “ProspectusRegulation” means Regulation (EU) 2017/1129.

United Kingdom

Thisprospectus has only been communicated or caused to have been communicated and will only be communicated or caused to be communicated asan invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and MarketsAct of 2000, or the FSMA) as received in connection with the issue or sale of our Common Stock in circumstances in which Section 21(1)of the FSMA does not apply to us. All applicable provisions of the FSMA will be complied with in respect to anything done in relationto our Common Stock in, from or otherwise involving the United Kingdom.

111

OffersOutside the United States

Otherthan in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securitiesoffered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus maynot be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connectionwith the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will resultin compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes areadvised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. Thisprospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in anyjurisdiction in which such an offer or a solicitation is unlawful.

112

Experts

Thefinancial statements of Innovative Eyewear, Inc. as of December 31, 2020 and 2019 and for each of the periods then endedincluded in this Registration Statement, of which this Prospectus forms a part, have been so included in reliance on the report of CherryBekaert LLP, an independent registered public accounting firm (the report on the financial statements contains an explanatory paragraphregarding the Company’s ability to continue as a going concern) appearing elsewhere herein, given on the authority of said firmas experts in auditing and accounting.

LegalMatters

EllenoffGrossman & Schole LLP, New York, New York, is acting as counsel in connection with the registration of our common stockand warrants under the Securities Act, and as such, will pass upon the validity of the securities offered hereby. Certain matters arebeing passed on for the underwriters by Gracin & Marlow, LLP, New York, New York.

WhereYou Can Find More Information

Wehave filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares ofcommon stock offered hereby. This prospectus, which constitutes a part of the registration statement, does not contain all of the informationset forth in the registration statement or the exhibits and schedules filed with the registration statement. For further information aboutus and the common stock offered hereby, we refer you to the registration statement and the exhibits filed with the registration statement.Statements contained in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to theregistration statement are not necessarily complete, and each such statement is qualified in all respects by reference to the full textof such contract or other document filed as an exhibit to the registration statement. The SEC also maintains an internet website thatcontains reports, proxy statements and other information about registrants, like us, that file electronically with the SEC. The addressof that website is www.sec.gov.

Uponthe closing of this offering, we will be required to file periodic reports, proxy statements, and other information with the SEC pursuantto the Exchange Act. These reports, proxy statements, and other information will be available on the website of the SEC referred to above.

Wealso maintain a website at www.lucyd.co, through which you may access these materials free ofcharge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained onor accessed through our website is not a part of this prospectus and the inclusion of our website address in this prospectus is an inactivetextual reference only.

113

INDEXTO FINANCIAL STATEMENTS

 

Page

Audited Financial Statements

   

Report of Independent Registered Public Accounting Firm

 

F-2

Balance Sheets as of December 31, 2020 and 2019

 

F-3

Statements of Operations for the year ended December 31, 2020 and the period from August 15, 2019 (inception) through December 31, 2019

 

F-4

Statements of Stockholders’ (Deficit) for the year ended December 31, 2020 and the period from August 15, 2019 (inception) through December 31, 2019

 

F-5

Statements of Cash Flows for the year ended December 31, 2020 and the period from August 15, 2019 (inception) through December 31, 2019

 

F-6

Notes to Financial Statements

 

F-7

Interim Unaudited Financial Statements

   

Condensed Balance Sheets as of September 30, 2021 and December 31, 2020 (Unaudited)

 

F-16

Condensed Statements of Operations for the nine months ended September 30, 2021 and September 30, 2020 (Unaudited)

 

F-17

Condensed Statements of Changes in Stockholders’ Equity (Deficit) for the nine months ended September 30, 2021 and 2020 (Unaudited)

 

F-18

Condensed Statements of Cash Flows for the nine months ended September 30, 2021 and 2020 (Unaudited)

 

F-19

Notes to Condensed Financial Statements (Unaudited)

 

F-20

F-1

REPORTOF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Tothe Board of Directors and Stockholders
Innovative Eyewear, Inc.
Miami, Florida

Opinionon the Financial Statements

Wehave audited the accompanying balance sheets of Innovative Eyewear, Inc. (the “Company”) as of December 31, 2020and 2019, and the related statements of operations, changes in stockholders’ deficit, and cash flows for the year ended December31, 2020 and for the period from August 15, 2019 (inception) through December 31, 2019, and the relatednotes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, inall material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operationsand its cash flows for each of the periods then ended, in conformity with accounting principles generally accepted in the United Statesof America.

SubstantialDoubt about the Company’s Ability to Continue as a Going Concern

Theaccompanying financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 3 tothe financial statements, the Company has recurring losses and negative cash flows from operations that raise substantial doubt aboutits ability to continue as a going concern. Management’s evaluations of the events and conditions and management’s plans regardingthose matters are also described in Note 3. The financial statements do not include any adjustments that might result from the outcomeof this uncertainty.

Basisfor Opinion

Thesefinancial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’sfinancial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securitieslaws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

Weconducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtainreasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Companyis not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinionon the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Ouraudits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error orfraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regardingthe amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significantestimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits providea reasonable basis for our opinion.

Wehave served as the Company’s auditor since 2021.

/s/CHERRY BEKAERT LLP

Tampa,Florida
October 12, 2021

F-2

INNOVATIVEEYEWEAR, INC.
BALANCE SHEETS
December 31, 2020 and 2019

 

2020

 

2019

TOTAL ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

27,023

 

 

$

 

Prepaid expenses

 

 

25,000

 

 

 

 

 

Inventory prepayment

 

 

85,740

 

 

 

 

Inventory

 

 

4,040

 

 

 

 

Total Current Assets

 

 

141,803

 

 

 

 

   

 

 

 

 

 

 

 

Non-Current Assets

 

 

 

 

 

 

 

 

Patent costs, net

 

 

69,213

 

 

 

 

TOTAL ASSETS

 

$

211,016

 

 

$

 

   

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ (DEFICIT)

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

51,410

 

 

$

 

Due to parent and affiliates

 

 

114,901

 

 

 

483,825

 

Related party convertible debt

 

 

599,542

 

 

 

 

   

 

 

 

 

 

 

 

Total Current Liabilities

 

 

765,853

 

 

 

483,825

 

   

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

765,853

 

 

 

483,825

 

   

 

 

 

 

 

 

 

Stockholders’ (Deficit)

 

 

 

 

 

 

 

 

Common stock (10,000,000 shares authorized, 4,131,469 and 0 shares issued and outstanding as of December 31, 2020 and 2019, respectively at par value $0.00001)

 

 

41

 

 

 

 

Additional paid-in capital

 

 

845,417

 

 

 

127,639

 

Stock Subscription Receivable

 

 

(20,647

)

 

 

 

Accumulated deficit

 

 

(1,379,648

)

 

 

(611,464

)

TOTAL STOCKHOLDERS’ (DEFICIT)

 

 

(554,837

)

 

 

(483,825

)

   

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT)

 

$

211,016

 

 

$

 

F-3

INNOVATIVEEYEWEAR, INC.
STATEMENTS OF OPERATIONS
For the year ended December 31, 2020 and
period from August 15, 2019 (inception) throughDecember 31, 2019

 

2020

 

2019

Revenues, net

 

$

56,997

 

 

$

4,821

 

Less: Cost of Goods Sold

 

 

(74,266

)

 

 

(7,735

)

Gross (loss)

 

 

(17,269

)

 

 

(2,914

)

   

 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

 

 

 

General and administrative

 

 

(316,115

)

 

 

(43,398

)

Sales and marketing

 

 

(152,731

)

 

 

(2,924

)

Research & development

 

 

(36,894

)

 

 

(4,082

)

Related party management fee

 

 

(130,000

)

 

 

(56,108

)

Impairment expense

 

 

(112,329

)

 

 

 

Total Operating Expenses

 

 

(748,070

)

 

 

(106,513

)

   

 

 

 

 

 

 

 

Other Income

 

 

2,120

 

 

 

 

Interest Expense

 

 

(4,966

)

 

 

 

Total Other Income/(Expense)

 

 

(2,846

)

 

 

 

   

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

Net Loss

 

$

(768,184

)

 

$

(109,427

)

   

 

 

 

 

 

 

 

Weighted average number of shares outstanding

 

 

2,960,289

 

 

 

 

Earnings per share, basic and diluted

 

$

(0.26

)

 

$

0.00

 

F-4

INNOVATIVEEYEWEAR, INC.
STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT)
For the year ended December 31, 2020 and
period from August15, 2019 (inception) through December 31, 2019

 

Common Stock (LLC
Units until
March 26, 2020)

 

Additional
Paid-in
Capital

 

Stock
Subscription
Receivable

 

Accumulated
Deficit

 

Total
Stockholders’
(Deficit)

   

Shares

 

Amount

 

Balance, August 15, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net expenses incurred by parent and affiliates pre-formation

 

 

 

 

 

 

 

 

 

 

(502,037

)

 

 

(502,037

)

Forgiveness of amounts due to related party

 

 

 

 

 

127,639

 

 

 

 

 

 

 

 

127,639

 

Net loss

 

 

 

 

 

 

 

 

 

 

(109,427

)

 

 

(109,427

)

Balances, December 31, 2019

 

 

$

 

$

127,639

 

$

 

 

$

(611,464

)

 

$

(483,825

)

Shares issued for contribution of assets from Parent and Affiliates

 

3,750,000

 

 

38

 

 

395,143

 

 

 

 

 

 

 

 

395,181

 

Issuance of shares, net of offering expenses of $222,962

 

381,469

 

 

3

 

 

146,969

 

 

(20,647

)

 

 

 

 

 

126,325

 

Forgiveness of amounts due to related party

 

 

 

 

 

94,021

 

 

 

 

 

 

 

 

94,021

 

Stock based compensation

 

 

 

 

 

81,645

 

 

 

 

 

 

 

 

81,645

 

Net loss

 

 

 

 

 

 

 

 

 

 

(768,184

)

 

 

(768,184

)

Balances, December 31, 2020

 

4,131,469

 

$

41

 

$

845,417

 

$

(20,647

)

 

$

(1,379,648

)

 

$

(554,837

)

F-5

INNOVATIVEEYEWEAR, INC.
STATEMENTS OF CASH FLOWS
For the year ended December 31, 2020 and
period from August 15, 2019 (inception) throughDecember 31, 2019

 

2020

 

2019

Operating Activities

 

 

 

 

 

 

 

 

Net loss

 

$

(768,184

)

 

$

(109,427

)

Adjustments to reconcile net loss to operating activities:

 

 

 

 

 

 

 

 

Impairment

 

 

112,329

 

 

 

 

Amortization

 

 

994

 

 

 

 

Non-Cash interest expense

 

 

4,966

 

 

 

 

 

Stock based compensation

 

 

81,645

 

 

 

 

Expenses paid by Parent and Affiliates

 

 

536,211

 

 

 

109,427

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

 

46,444

 

 

 

 

Prepaid expenses

 

 

(25,000

)

 

 

 

Inventory

 

 

(29,668

)

 

 

 

Net cash flows from operating activities

 

 

(40,263

)

 

 

 

   

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

Patent costs

 

 

(59,039

)

 

 

 

Net cash flows from investing activities

 

 

(59,039

)

 

 

 

   

 

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

Proceeds from issuance of shares, net of offering expenses

 

 

126,325

 

 

 

 

Net cash flows from financing activities

 

 

126,325

 

 

 

 

   

 

 

 

 

 

 

 

Net Change In Cash

 

$

27,023

 

 

 

 

   

 

 

 

 

 

 

 

Cash at Beginning of Period

 

 

 

 

 

 

Cash at End of Period

 

$

27,023

 

 

 

 

   

 

 

 

 

 

 

 

Non-Cash Transactions

 

 

 

 

 

 

 

 

   

 

 

 

 

 

 

 

Expenses paid for by Parent and Affiliates, pre-formation, recorded as a decrease in accumulated deficit

 

$

 

 

$

502,037

 

Forgiveness of amounts due to related party recorded as an increase in Additional Paid in Capital

 

 

94,021

 

 

 

127,639

 

Expenses paid for by Parent and Affiliates recorded as an increase in Due to Parent and Affiliates and Related Party Convertible Debt

 

 

536,211

 

 

 

109,427

 

Shares issued for contribution of assets from Parent and Affiliates (intangible assets)

 

 

123,497

 

 

 

 

 

Shares issued for contribution of assets from Parent and Affiliates
(inventory)

 

 

60,112

 

 

 

 

Shares issued for settlement of Due to Parent and Affiliates

 

 

211,572

 

 

 

 

F-6

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
As of December 31, 2020 and 2019

NOTE1 — GENERAL INFORMATION AND INITIAL CAPITALIZATION

GeneralInformation — INNOVATIVE EYEWEAR, INC. (f/k/a Innovative Eyewear LLC) (“the Company”) is a corporation organizedunder the laws of the State of Florida. The principal activity of the Company is designing, manufacturing and selling smart eyewear throughits e-commerce channels and retail distribution.

TheCompany was formed as a limited liability company in Florida on August 15, 2019, but converted from a Florida limited liabilitycompany to a Florida Corporation on March 26, 2020. The Company is a subsidiary of Lucyd, Ltd. (the “Parent”or “Lucyd”), who is a wholly-owned subsidiary of Tekcapital Plc, through Tekcapital Europe, Ltd (collectivelythe “Parent and Affiliates”).

Initialcapitalization — Upon conversion to Innovative Eyewear Inc. and in consideration of contributed assets (as discussed below) andreimbursement of pre-formation costs, the Company issued 3,750,000 shares of common stock to its sole stockholderand Parent, Lucyd.

Duringthe year ended December 31, 2020, the Company received intangible assets from Lucyd as its sole shareholder as a contributionto capital. The Company received $123,497 net book value of trademark and license costs via an exclusive, irrevocable license of theseassets from Lucyd. Additionally, the Company received $60,112 of inventory. These amounts have been recorded on the balance sheet at thehistorical book value of Lucyd as an addition to additional paid-in capital based on the related party nature of the transaction.Upon contribution, these amounts were originally recorded as capitalized license costs and trademark under intangible assets and inventoryon the balance sheet of the Company. Subsequently, during the year ended December 31, 2020, we recorded an impairment expenseof $112,329 related to capitalized license costs and reclassified trademark amounts to Statement of Operations. For more detailed discussions,please refer to Intangible Assets section of Note 2.

Additionally,the Parent and Affiliates incurred a number of costs on behalf of the Company both prior to its legal formation and for both of the yearsended December 31, 2020 and 2019, as summarized below:

Company

 

2020*

 

2019*

Expenses paid for by Parent and Affiliates, pre-formation, recorded as an increase in accumulated deficit

 

$

 

 

$

502,037

 

Expenses paid for by Parent and Affiliates recorded as increase in due to Parent and Affiliates and Related Party Convertible debt

 

 

442,190

 

 

 

109,427

 

   

 

442,190

*

 

 

611,464

*

____________

*        offsetby $94,021 and $127,639 in amounts forgiven by the Parent and Affiliates for the year and period ended December 31, 2020 and December31, 2019 respectively, recorded as increase in Additional Paid in Capital.

Keyexpenses paid by Parent and Affiliates in the period prior to the Company’s formation, from 2017 to August 2019, included:

 

Amount

General & Administrative expenses

 

$

607,479

 

Advertising & Marketing

 

 

401,046

 

Management fees

 

 

54,354

 

Cost of Sales

 

 

10,819

 

R&D expenses

 

 

27,076

 

Sales

 

 

(21,684

)

Forgiveness of amounts due from Parent and Affiliates

 

 

(577,053

)

   

$

502,037

 

Theseexpenses paid for by Parent and Affiliates provided support crucial to the Company’s ability to significantly advance product development,assemble a team of capable individuals, build a portfolio of intellectual property, as well as provide other operational support.

F-7

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
As of December 31, 2020 and 2019

NOTE2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basisof Presentation

Theaccounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America(“GAAP”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statementsfor the years presented have been included. The Company has adopted December 31 as its year end for accounting purposes. These financialsstatements present the available period since inception (August 15,2019).

Useof Estimates

Thepreparation of financial statements in conformity with accounting principles generally accepted in the United States of America requiresmanagement to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assetsand liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.Actual results could differ from those estimates, particularly given the significant social and economic disruptions and uncertaintiesassociated with the ongoing coronavirus pandemic (“COVID-19”)and COVID-19 control responses.

Cashand Cash Equivalents

TheCompany considers short-term, highly liquid investments withoriginal maturities of three months or less at the time of purchase to be cash equivalents. Cash consists of funds held in the Company’schecking account. The Company maintains its cash with a major financial institution located in the United States of America, whichit believes to be credit worthy. The Federal Deposit Insurance Corporation insures balances up to $250,000. At times, the Company maymaintain balances in excess of the federally insured limits.

Receivablesand Credit Policy

Tradereceivables from customers are uncollateralized customer obligations due under normal trade terms, primarily requiring payment beforeproduct is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated tothe specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice.The Company, by policy, routinely assesses the financial strength of its customers. As a result, the Company believes that itsaccounts receivable credit risk exposure is limited and it has not experienced any significant write-downs in its accountsreceivable balances. As of December 31,2020, the Company had no accounts receivable nor allowance for bad debt.

SalesTaxes

Variousstates impose a sales tax on the Company’s sales to non-exemptcustomers. The Company collects the sales tax from customers and remits the entire amount to each respective state. The Company’saccounting policy is to exclude the tax collected and remitted to the states from revenue and cost of sales.

Inventory

Company’sinventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a weighted averagefirst-in, first-outbasis. Provisions for excess, obsolete or slow moving inventory are recorded after periodic evaluation of historical sales, current economictrends, forecasted sales, estimated product life cycles and estimated inventory levels. No provisions were determined as needed at December31, 2020.

TheCompany recorded an inventory prepayment in the amount of $85,740 related to down payment on eyewear purchase from the manufacturer, priorto shipment of the product that occurred in January 2021.

F-8

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
As of December 31, 2020 and 2019

NOTE2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

IntangibleAssets

Intangibleassets relate to a license agreement and patent costs received in conjunction with the initial capitalization of the Company, as describedin Note 1. The Company amortizes the license agreement over the estimated useful life of the license agreement.

Intangibleassets also related to internally developed utility and design patents. The Company amortizes these assets over the estimated useful lifeof the patents.

TheCompany reviews its intangibles assets for impairment whenever changes in circumstances indicate that the carrying amount of the assetsmay not be recoverable. We recorded an impairment expense of $112,329 for the year ended December 31, 2020 as compared to$0 for the period ended December 31, 2019.

Thelicense agreement subject to the impairment had been originally entered into between Company’s Parent (Lucyd Ltd) and Universityof Central Florida (“UCF”) and subsequently contributed from Lucyd to Company as a contribution to capital via an exclusive,irrevocable license of these assets from Lucyd. The impairment charge represented the total net book value of any licenses to intellectualproperty previously held by the Company.

LucydLtd licensed a group of patents from UCF covering augmented reality glasses, specifically enabling the display of information on the lensesof glasses. The UCF patents were subsequently, with UCF’s permission, exclusively licensed to Innovative Eyewear, Inc. by LucydLtd. After conducting significant research on this licensed technology, Innovative Eyewear Inc. determined that the technology was notready for commercialization, so it amicably terminated the license, consistent with its terms and conditions. Innovative Eyewear no longerhas any obligation under the license to UCF nor does Innovative Eyewear have a current business relationship with UCF. UCF has no rightsto any properties currently held by Innovative Eyewear Inc.

Allof Innovative Eyewear’s current patents and applications are not related to the previously licensed patents from UCF. The Companydoes not believe the charge is representative of material trends in the business as following the impairment charge, our patent portfolioincludes only patents developed internally in the last few years.

IncomeTaxes

TheCompany is taxed as a C corporation. The Company complies with Financial Accounting Standards Board (FASB) ASC 740 for accounting foruncertainty in income taxes recognized in a company’s financial statements, which prescribes a recognition threshold and measurementprocess for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For thosebenefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.FASB ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosureand transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiringrecognition in the Company’s financial statements. The Company believes that its income tax positions would be sustained on auditand does not anticipate any adjustments that would result in a material change to its financial position.

TheCompany has incurred taxable losses since inception but is current in its tax filing obligations. The Company is not presently subjectto any income tax audit in any taxing jurisdiction.

Stock-BasedCompensation

TheCompany accounts for stock-based compensation to employees anddirectors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statementsfor stock-based awards based on the grant date fair value. Forstock option awards, the Black-Scholes-Merton option pricingmodel was used to estimate the fair value of share-based awards.The Black-Scholes-Merton option pricing model incorporates variousand highly subjective assumptions, including expected term and share price volatility. The expected term of the stock options was estimatedbased on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107). The share price volatility at the

F-9

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
As of December 31, 2020 and 2019

NOTE2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

grantdate is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparablyprofiled public companies. The risk-free interest rate assumptionis determined using the rates for U.S. Treasury zero-couponbonds with maturities similar to those of the expected term of the award being valued.

RevenueRecognition

Ourrevenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses and shipping charges,which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributorsand on our own website Lucyd.co and on Amazon.

Todetermine revenue recognition, we perform the following steps: (i) identify the contract(s)with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocatethe transaction price to the performance obligations in the contract and (v) recognize revenue when (or as) the entity satisfiesa performance obligation.

Atcontract inception, we assess the goods or services promised within each contract and determines those that are performance obligationsand assesses whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price thatis allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

Allrevenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collectedfrom customers on behalf of taxing authorities, returns and discounts.

Forsales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewearand transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglassand blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of theperformance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with fasterdelivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free forU.S. consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the onlineplatforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods soldas incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaceson which the company sells products.

Forsales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopifywholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation which is delivery of thecompany’s eyewear products to retail store or the distributor, and also recorded net of returns and discounts. Our wholesale pricingfor eyewear sold to retail store partners and distributors includes volume discounts, due to the nature of large quantity orders. Thepricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders,no e-commerce fees are applicable.

TheCompany’s sales to both retail store partners and through the e-commerce channels do not contain any variable consideration.

Weallow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reasonwithin the first:

•        7days for sales made through our website (Lucyd.co)

•        30days for sales made through Amazon

•        30days for sales to wholesale retailers and distributors

Forall of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns,which is recorded as a reduction of sales.

F-10

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
As of December 31, 2020 and 2019

NOTE2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

Shippingand Handling

Costsincurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to acustomer for shipping and handling are reported as revenues.

Earnings/lossper share

TheCompany presents earnings and loss per share data by calculating the quotient of earnings/(loss) and loss divided by the number of commonshares outstanding (common shares as of December 31, 2020) asrequired by ASC 260-10-50. As of December31, 2020, all shares underlying the related party convertible debt and common stock options wereexcluded from the earnings per share calculation due to their anti-dilutiveeffect.

Salesand Marketing Expenses

TheCompany expenses advertising costs as they are incurred.

RecentAccounting Pronouncements

InFebruary 2017, FASB issued ASU No. 2017-02, “Leases(Topic 842),” that requires organizations that lease assets, referred to as “lessees,” to recognize on the balance sheetthe assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12months. ASU 2017-02 willalso require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertaintyof cash flows arising from leases and will include qualitative and quantitative requirements. The Company plans to adopt ASU 2017-02as of January 1, 2022 and does not believe it will have a material impact on the Company’s financial statements.

InMay 2018, FASB issued ASU 2020-06, “Debt –Debt with Conversion and Other Options (Subtopic 470-20), andDerivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40):Accounting for Convertible Instruments and Contract’s in Entity’s Own Equity. The guidance in ASU 2020-06simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20,Debt: Debt with Conversion and Other Options, that requires entities to account for beneficialconversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. In addition,the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instrumentsand embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removingcertain criteria required for equity classification. The amendments in ASU 2020-06 further revise the guidance in ASC 260,Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-convertedmethod. The Company plans to adopt ASU 2020-06 as of January 1, 2021 and does not believe it will have a materialimpact on the Company’s financial statements.

NOTE3 — GOING CONCERN

TheCompany has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditionsin the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverseconditions may include: recession, downturn or otherwise, changes in regulations or restrictions in imports, competition or changes inconsumer taste including the economic impacts from the COVID-19pandemic. These adverse conditions could affect the Company’s financial condition and the results of its operations.

TheCompany meets its day to day working capital requirements through monies raised through sales of eyewear and issues of equity includingcrowdfunding. The Company also has issued a convertible note held by its parent company. Company’sforecasts and projections indicate that the Company expects to have sufficient cash reserves to operate within the level of its currentfacilities. Whilst it is the Company’s intention to rely on the available cash reserves, future income generated from its productsales, a negative variance in the forecasts and projections would make the Company’s ability to continue as a going concern dependenton an additional fund raise. Based on these factors, there is substantial doubt about the Company’s ability to continue as a goingconcern.

F-11

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
As of December 31, 2020 and 2019

NOTE4 — INCOME TAX PROVISION

Asdiscussed above, the Company is a C corporation for federal income tax purposes. The Company has incurred tax losses since inception,however valuation allowances has been established against the deferred tax assets associated with the carryforwards of those losses asthere does not yet exist evidence the deferred tax assets created by those losses will ever by utilized.

 

2020

 

2019

Current tax expense

 

$

 

 

$

Deferred tax benefit

 

 

181,891

 

 

 

Increase in valuation allowance

 

 

(181,891

)

 

 

Total provision for income taxes

 

$

 

 

$

AtDecember 31, 2020 and 2019, the Company had temporary differences between the carrying amount of assets and liabilitiesfor financial reporting purposes and their respective income tax bases, measured by enacted state and federal tax rates, as follows:

 

2020

 

2019

Deferred tax assets (liabilities)

 

$

 

 

 

 

Net Operating Loss carryforward

 

 

181,891

 

 

$

Less: valuation allowance

 

 

(181,891

)

 

 

Total net deferred tax assets

 

$

 

 

$

Thefollowing is a reconciliation of tax computed at the statutory federal rate to the income tax benefit in the statements of operations:

 

2020

 

2019

Income tax benefit at the statutory federal rate

 

$

149,208

 

 

$

State income tax benefits, net of federal benefit

 

 

32,683

 

 

 

Change in valuation allowance

 

 

(181,891

)

 

 

Total

 

$

 

 

$

Taxreturns once filed which will remain subject to examination by the Internal Revenue Service under the statute of limitations for a periodof three years from the date it is filed.

NOTE5 — INTANGIBLE ASSETS

Cost

 

Patents
$

 

Total
$

At December 31, 2019

 

 

At December 31, 2020

 

70,207

 

70,207

         

Accumulated amortization

       

At December 31, 2019

 

 

At December 31, 2020

 

994

 

994

         

Net book value

       

At December 31, 2019

 

 

At December 31, 2020

 

69,213

 

69,213

F-12

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
As of December 31, 2020 and 2019

NOTE6 — RELATED PARTY ADVANCES AND OTHER INTERCOMPANY AGREEMENTS

ConvertibleNote and Due to Parent and Affiliates

Duringthe year, the Company had availability, but not the contractual right, to additional intercompany financing from the Parent and Affiliatesin the form of cash advances. As of December 31, 2020, the Company had an outstanding balance of $714,443 due to relatedparties, as shown on the accompany balance sheet of $114,901 in due to Parent and Affiliates and $599,542 of related party convertibledebt.

OnDecember 1, 2020, the Company issued a convertible note to its Parent and Affiliates for up to $2,000,000 that bear interestat 10% per annum, which includes the option to convert the debt into shares at market price. The note can be converted into shares ofcommon stock of the Company upon occurrence of certain conversion events, as defined. Subsequently to issuing the note, the Company reclassifiedits existing payable due to Parent and Affiliates of $599,542 to related party convertible note on its balance sheet and incurred $4,966in interest expense which is included in Trade and other payables in the accompanying December 31, 2020 balance sheet.

ManagementService Agreement

In2020, The Company entered into a Management services agreement with a related party (related through common ownership). The Company isbilled $25,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar dayswritten notice by any party. The related party provides the following services:

•        Provisionof support and advise to the Company in accordance with their area of expertise

•        Undertakeresearch, technical review, legal review, recruitment, software development, marketing, public relations and advertisement

•        Provideadvice, assistance and consultation services to support the Company or in relation to any other related matter

•        Rent-freeoffice space.

Asof December 31, 2020 the balance related to this agreement is $50,000 and is included in the related party convertible notebalance on the accompanying December 31, 2020 balance sheet.

Additionally,the Company’s Parent and Affiliates incurred $100,000 in 2019 and $80,000 in 2020 in management fee charges on behalf of the Company.These payables were assigned to the Company based on the related party convertible debt agreement with the Company’s Parent andAffiliates, dated June 1, 2021 and included in the Convertible Note balances discussed above.

NOTE7 — COMMITMENTS AND CONTINGENCIES

LegalMatters

TheCompany is not currently involved in or aware of threats of any litigation.

Commitments

Seerelated party management services agreement discussed in Note 6.

F-13

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
As of December 31, 2020 and 2019

NOTE8 — SHAREHOLDERS’ EQUITY

Conversionto Corporation

OnMarch 26, 2020, the Company converted from a limited liabilitycompany into a corporation. The Company had not issued LLC units nor had any commercial activity prior to the conversion.

CrowdfundedOffering

In2020, the Company offered securities in a Regulation CF campaign and raised $369,930 through the issuance of 381,469 shares.The Company incurred $222,962 in offering costs associated with the Crowdfunded Offering and has reduced the additional paid-incapital by the amount of the offering costs. Terms of the crowdfund investment round included pricing discounts on the Company’sproducts and access to an exclusive investors club.

NOTE9 — STOCK BASED COMPENSATION

TheDirector and CEO, Harrison Gross, received a grant of 375,000 stock options on April 1,2020. These share options vest over 36 months, with 1/6 vestingevery six months from the date of the agreement, April 1, 2020.The exercise price for the options is $1 for each share, based upon fair market value of shares at the time of the grant. Calvin Peters,Company’s Marketing Director, received a grant of 270,000 stock options on October 5,2020. These share options are vesting over 36 months, with 1/6vesting every six months from the date of the agreement, October 5,2020. The exercise price for the options is $1 for each share, based upon fair market value of shares at the time of the grant.

Bothoption grants terminate three years from date of issuance.

Thefair value options granted is expensed over the vesting period and is calculated using the Black-Scholes model. The assumptionsinherent in the use of this model for the above grants are as follows:

Attribute

 

Input

Share price at date of grant

 

$

1.00

 

Options life in years

 

 

3

 

Risk free rate

 

 

0.36

%

Expected volatility

 

 

112

%

Expected dividend yield

 

 

0

 

Grant date fair value of options

 

$

0.71

 

Theweighted average fair value of each option outstanding was $0.71. Volatility was calculated using historical share price performance ofpeer companies in the 3 year period prior to December 31,2020.

Detailsof the number of share options and the weighted average exercise price outstanding during the year as follows (the Company did not grantany share options until year ended December 31, 2020):

Company

 

Av. Exercise
price per share
$

 

Options
(Number)

As at January 1, 2020

 

 

Granted

 

1.00

 

645,000

Exercised

 

 

Forfeited

 

 

As at December 31, 2020

 

1.00

 

645,000

Exercisable as at December 31, 2020

 

1.00

 

62,500

Theweighted average remaining contractual life is 2.5 years. The weighted average exercise price of options granted during the yearwas $1.00. The range of exercise prices for options outstanding at the end of the year was $1.00. Unrecognized stock compensation expenseat December 31, 2020 was $375,134 to be taken over 2.5 years.

F-14

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
As of December 31, 2020 and 2019

NOTE10 — SUBSEQUENT EVENTS

CrowdfundedOffering

During2021, the Company continued its first Crowdfunded Offering and raised $683,662 in gross proceeds in a securities offering considered exemptfrom registration under Regulation CF. The Crowdfunded Offering was facilitated by StartEngine, a FINRA-approved RegulationCF funding portal (the “Intermediary”), resulting in issuance of 710,248 shares.

InJuly 2021, the Company launched its second Crowdfunded offering of common stock in a securities in which it raised $163,886, correspondingto 47,986 shares to be issued in a securities offering to be considered exempt from registration under Regulation CF (40,011issued as of September 30, 2021). The Crowdfunded Offering was facilitated by StartEngine, a FINRA-approvedRegulation CF funding portal. The crowdfund was completed on September 24, 2021.

ConvertibleNote

OnJune 1, 2021, the Company converted borrowings totaling $778,500 into 778,500 shares of common stock at $1.00each.

OnSeptember 5, 2021, the Company converted borrowings totaling $500,002 into 140,449 shares at $3.56 each.

StockOption Issuances

During2021, the Company issued total of 1,657,500 stock options to its employees and directors, with grant price ranging from $1 to $3.56.

OnJuly 1, 2021, an Equity Incentive Plan was approved, allowing for total of 20%, or 1,124,043, of total issued shares to beavailable for the grant of awards under the Plan.

Amendedand Restated Articles of Incorporation

Pursuantto a resolution on July 1, 2021, the Company authorized 15,000,000 preferred stock shares and 50,000,000 common stock shares.

F-15

INNOVATIVEEYEWEAR, INC.
CONDENSED BALANCE SHEETS
September 30, 2021 and December 31, 2020

 

Unaudited
2021

 

Audited
2020

TOTAL ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

65,056

 

 

$

27,023

 

Accounts receivable

 

 

27,069

 

 

 

 

Prepaid expenses

 

 

51,000

 

 

 

25,000

 

Deferred offering costs

 

 

50,000

 

 

 

 

Inventory prepayment

 

 

295,200

 

 

 

85,740

 

Inventory

 

 

37,833

 

 

 

4,040

 

Other current assets

 

 

20,065

 

 

 

 

Total Current Assets

 

 

546,223

 

 

 

141,803

 

   

 

 

 

 

 

 

 

Non-Current Assets

 

 

 

 

 

 

 

 

Patent costs, net

 

 

76,579

 

 

 

69,213

 

Capitalized software costs

 

 

63,000

 

 

 

 

Property and equipment, net

 

 

10,662

 

 

 

 

TOTAL ASSETS

 

$

696,464

 

 

$

211,016

 

   

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

115,738

 

 

$

51,410

 

Deferred revenue

 

 

17,950

 

 

 

 

Due to Parent and Affiliates

 

 

111,801

 

 

 

114,901

 

Related party convertible debt

 

 

420,104

 

 

 

599,542

 

Total Current Liabilities

 

 

665,593

 

 

 

765,853

 

   

 

665,593

 

 

 

765,853

 

   

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

 

 

 

 

 

 

Stockholders’ Equity (Deficit)

 

 

 

 

 

 

 

 

Common stock (10,000,000 shares authorized, 5,801,677 and 4,131,469 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively at par value $0.00001)

 

 

58

 

 

 

41

 

Additional paid-in capital

 

 

3,294,841

 

 

 

845,417

 

Stock subscription receivable

 

 

(25,286

)

 

 

(20,647

)

Accumulated deficit

 

 

(3,238,742

)

 

 

(1,379,648

)

TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

30,871

 

 

 

(554,837

)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

$

696,464

 

 

$

211,016

 

F-16

INNOVATIVEEYEWEAR, INC.
CONDENSED STATEMENTS OF OPERATIONS
For the nine months ended September 30, 2021 and September 30, 2020
(Unaudited)

 

9 months ended
September 30,

   

2021

 

2020

Revenues, net

 

$

415,185

 

 

$

33,592

 

Less: Cost of Goods Sold

 

 

(332,378

)

 

 

(34,783

)

Gross Profit (Loss)

 

 

82,807

 

 

 

(1,191

)

   

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

General & administrative

 

 

(883,356

)

 

 

(210,509

)

Impairment expense

 

 

 

 

 

(112,329

)

Sales and marketing

 

 

(903,795

)

 

 

(98,789

)

Related party management fee

 

 

(84,975

)

 

 

(102,475

)

Research and development

 

 

(36,121

)

 

 

(30,822

)

Total Operating Expenses

 

 

(1,908,247

)

 

 

(554,924

)

   

 

 

 

 

 

 

 

Other (Expense):

 

 

 

 

 

 

 

 

Interest Expense

 

 

(33,654

)

 

 

 

Total Other (Expense)

 

 

(33,654

)

 

 

 

   

 

 

 

 

 

 

 

Net Loss

 

$

(1,859,094

)

 

$

(556,115

)

   

 

 

 

 

 

 

 

Weighted average number of shares outstanding

 

 

5,033,823

 

 

 

2,602,987

 

Earnings per share, basic and diluted

 

 

(0.37

)

 

 

(0.21

)

F-17

INNOVATIVEEYEWEAR, INC.
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
For the nine months ended September 30, 2021and 2020
(Unaudited)

 

Common Stock

 

Additional
Paid-in
Capital

 

Stock
Subscription
Receivable

 

Accumulated
Deficit

 

Total
Stockholders’
Equity
(Deficit)

Shares

 

Amount

 

Balance – January 1, 2021

 

4,131,469

 

$

41

 

$

845,417

 

$

(20,647

)

 

$

(1,379,648

)

 

$

(554,837

)

Shares issued for conversion of related party convertible note

 

918,949

 

 

9

 

 

1,278,493

 

 

 

 

 

 

 

 

1,278,502

 

Issuance of shares,
net of offering
expenses of $339,529

 

751,259

 

 

8

 

 

476,157

 

 

(45,404

)

 

 

 

 

 

430,761

 

Collection of stock subscription receivable

 

 

 

 

 

 

 

40,765

 

 

 

 

 

 

40,765

 

Stock based compensation

 

 

 

 

 

694,774

 

 

 

 

 

 

 

 

694,774

 

Net loss

 

 

 

 

 

 

 

 

 

 

(1,859,094

)

 

 

(1,859,094

)

Balance – September 30, 2021

 

5,801,677

 

$

58

 

$

3,294,841

 

$

(25,286

)

 

$

(3,238,742

)

 

$

30,871

 

 

Common Stock

 

Additional Paid-in Capital

 

Stock Subscription Receivable

 

Accumulated Deficit

 

Total Stockholders’ Equity (Deficit)

Shares

 

Amount

 

Balance – January 1, 2020

 

 

 

 

$

127,639

 

 

 

$

(611,464

)

 

$

(483,825

)

Shares issued for contribution of assets from Parent and Affiliates

 

3,750,000

 

 

38

 

 

395,143

 

 

 

 

 

 

 

395,181

 

Issuance of shares,
net of offering
expenses of $72,900

 

180,727

 

 

2

 

 

72,426

 

(9,659

)

 

 

 

 

 

 

62,769

 

Forgiveness of amounts due to related party

 

 

 

 

 

94,021

 

 

 

 

 

 

 

94,021

 

Stock based compensation

 

 

 

 

 

41,875

 

 

 

 

 

 

 

41,875

 

Net loss

 

 

 

 

 

 

 

 

 

(556,115

)

 

 

(556,115

)

Balance – September 30, 2020

 

3,930,727

 

$

40

 

$

731,104

 

(9,659

)

 

$

(1,167,579

)

 

$

(446,094

)

F-18

INNOVATIVEEYEWEAR, INC.
CONDENSED STATEMENTS OF CASH FLOWS
For the nine months ended September 30, 2021 and 2020
(Unaudited)

 

2021

 

2020

Operating Activities

 

 

 

 

 

 

 

 

Net (Loss)

 

$

(1,859,094

)

 

 

(556,115

)

Adjustments to reconcile net loss to net cash flows from operating activities:

 

 

 

 

 

 

 

 

Amortization

 

 

6,218

 

 

 

 

Impairment

 

 

 

 

 

112,329

 

Non-cash interest expense

 

 

38,621

 

 

 

 

Stock based compensation

 

 

694,774

 

 

 

41,875

 

Expenses paid by Parent and Affiliates

 

 

631,765

 

 

 

364,391

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(27,069

)

 

 

 

Accounts payable and Accrued Expenses

 

 

25,707

 

 

 

108,047

 

Prepaid expenses

 

 

(26,000

)

 

 

 

Inventory

 

 

(243,253

)

 

 

(74,199

)

Other current assets

 

 

(20,065

)

 

 

 

Deferred revenue

 

 

17,950

 

 

 

 

Deferred offering costs

 

 

(50,000

)

 

 

 

Net cash flows from operating activities

 

 

(810,446

)

 

 

(3,672

)

   

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

Patent costs

 

 

(13,584

)

 

 

(29,634

)

Purchases of equipment and fixtures

 

 

(10,662

)

 

 

 

Capitalized software costs

 

 

(63,000

)

 

 

 

Net cash flows from investing activities

 

 

(87,246

)

 

 

(29,634

)

   

 

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

Proceeds from issuance of shares net of offering expenses

 

 

430,761

 

 

 

62,769

 

Collection of stock subscription receivable

 

 

40,765

 

 

 

 

Proceeds from related party convertible debt

 

 

521,000

 

 

 

 

Repayments of related party convertible debt

 

 

(52,801

)

 

 

 

Repayments of Amounts Due to Parent and Affiliates

 

 

(4,000

)

 

 

 

Net cash flows from financing activities

 

 

935,725

 

 

 

62,769

 

   

 

 

 

 

 

 

 

Net Change In Cash

 

 

38,033

 

 

 

29,463

 

   

 

 

 

 

 

 

 

Cash at Beginning of Period

 

$

27,023

 

 

 

 

Cash at End of Period

 

$

65,056

 

 

$

29,463

 

   

 

 

 

 

 

 

 

Significant Non-Cash Transaction

 

 

 

 

 

 

 

 

Expenses paid for by Parent reported as increase in Due to
Parent and Affiliates and related party convertible debt

 

 

631,765

 

 

 

364,391

 

Increase in amounts Due to Parent and Affiliates reported as decrease in Additional Paid in Capital

 

 

 

 

 

94,021

 

Shares issued for contribution of assets from Parent and
Affiliates (intangible assets)

 

 

 

 

 

123,497

 

Shares issued for contribution of assets from Parent and Affiliates (inventory)

 

 

 

 

 

60,112

 

Shares issued for settlement of Due to Parent and Affiliates

 

 

 

 

 

211,572

 

Shares issued from conversion of related party convertible debt

 

 

1,278,502

 

 

 

 

F-19

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
September30, 2021 and December 31, 2020

NOTE1 — GENERAL INFORMATION

GeneralInformation — INNOVATIVE EYEWEAR, INC. (f/k/a Innovative Eyewear LLC) (“the Company”) is a corporation organizedunder the laws of the State of Florida. The principal activity of the Company is designing, manufacturing and selling smart eyewear throughits e-commerce channels and retail distribution.

NOTE2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basisof Presentation

Theaccounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America(“GAAP”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statementsfor the years presented have been included. The results of operations for the nine months ended September 30, 2021 are notnecessarily indicative of the results to be expected for future periods or the full year.

Useof Estimates

Thepreparation of financial statements in conformity with accounting principles generally accepted in the United States of America requiresmanagement to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assetsand liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.Actual results could differ from those estimates, particularly given the significant social and economic disruptions and uncertaintiesassociated with the ongoing coronavirus pandemic (“COVID-19”) and COVID-19 control responses.

Receivablesand Credit Policy

Tradereceivables from customers are uncollateralized customer obligations due under normal trade terms, primarily requiring payment beforeproduct is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated tothe specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice.The Company, by policy, routinely assesses the financial strength of its customers. As a result, the Company believes that its accountsreceivable credit risk exposure is limited and it has not experienced any significant write-downs in its accounts receivablebalances. As of September 30, 2021 and December 31, 2020, the Company had no allowance for bad debt.

SalesTaxes

Variousstates impose a sales tax on the Company’s sales to non-exempt customers. The Company collects the sales tax from customersand remits the entire amount to each respective state. The Company’s accounting policy is to exclude the tax collected and remittedto the states from revenue and cost of sales.

CapitalizedSoftware

TheCompany incurred software development costs related to development of the Vyrb app. The Company capitalized these costs in accordancewith ASC 985-20, Software — Costs of Software to be Sold, Leased, or Marketed, considering it is Company’sintention to market and sell the software externally. Planning, designing, coding and testing occurred necessary to meet Vyrb’sdesign specifications. As such, all coding, development and testing costs incurred subsequent to establishing technical feasibility werecapitalized.

F-20

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
September30, 2021 and December 31, 2020

NOTE2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

Inventory

Ourinventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a weighted averagefirst-in, first-out basis. Provisions for excess, obsolete or slow moving inventory are recorded after periodicevaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles and estimated inventory levels.No provisions were determined as needed at September 30, 2021.

Inaccordance with the donation policy started in May 2021, we donate an optical frame for every Lucyd Lyte sold. During the nine monthperiod ended September 30, 2021 we donated total of $7,556 of glasses to charity. The amount was recorded at historical costunder General and Administrative Expenses.

Asof September 30, 2021, the Company recorded an inventory prepayment in the amount of $295,200 related to down payment oneyewear purchase from the manufacturer, prior to shipment of the product that occurred after September 30, 2021. As of December31, 2020, the Company recorded an inventory prepayment in the amount $85,740 for inventory paid for during 2020 but shipped afterDecember 31, 2020.

IncomeTaxes

TheCompany is taxed as a C corporation. The Company complies with FASB ASC 740 for accounting for uncertainty in income taxes recognizedin a company’s financial statements, which prescribes a recognition threshold and measurement process for financial statement recognitionand measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position mustbe more-likely-than-not to be sustained upon examination by taxing authorities. FASB ASC 740 also provides guidance on derecognition,classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation,it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements.The Company believes that its income tax positions would be sustained on audit and does not anticipate any adjustments that would resultin a material change to its financial position.

TheCompany has incurred taxable losses since inception but is current in its tax filing obligations. The Company is not presently subjectto any income tax audit in any taxing jurisdiction.

Stock-BasedCompensation

TheCompany accounts for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requiresthat compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value.For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-basedawards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expectedterm and share price volatility. The expected term of the stock options was estimated based on the simplified method as allowed by StaffAccounting Bulletin 107 (SAB 107).

Theshare price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted,using stock prices of comparably profiled public companies. The risk-free interest rate assumption is determined using therates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.The expected term is calculate using the vesting term of 3 years and contractual term of 3 years, resulting in a holding periodof 3 years.

Wenote that the fair value of common stock used in the option pricing model in 2020 and for 9 months ended September30, 2021 (no option grants in 2019) was determined using the most recent price paid by independent investors through RegulationCrowdfund (“REG CF”) securities offering undertaken by the Company. For majority of time during which stock option awardswere granted by the Company in 2021 and 2020, the Company has been raising funds from investors under Regulation CF campaigns, with significantnumber of transactions from both accredited and non-accredited investors.

F-21

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
September30, 2021 and December 31, 2020

NOTE2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

Thepre-money valuation determining price per share was agreed upon each time with the crowdfund platform, who has great dealof experience in setting the proper pre-money valuations for companies that list on their platforms. The determination wasmade using Company’s business progress.

RevenueRecognition

Ourrevenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses and shipping charges,which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributorsand on our own website Lucyd.co and on Amazon.

Todetermine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify theperformance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performanceobligations in the contract and (v) recognize revenue when (or as) the entity satisfies a performance obligation. At contract inception,we assess the goods or services promised within each contract and determines those that are performance obligations and assesses whethereach promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respectiveperformance obligation when (or as) the performance obligation is satisfied.

Allrevenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collectedfrom customers on behalf of taxing authorities, returns and discounts.

Forsales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewearand transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglassand blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of theperformance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with fasterdelivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free forU.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the onlineplatforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods soldas incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaceson which the company sells products.

Forsales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopifywholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation which is delivery of thecompany’s eyewear products to retail store or the distributor, and also recorded net of returns and discounts. Our wholesale pricingfor eyewear sold to retail store partners and distributors includes volume discounts, due to the nature of large quantity orders. Thepricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders,no e-commerce fees are applicable.

TheCompany’s sales to both retail store partners and through the e-commerce channels do not contain any variable consideration.

Weallow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reasonwithin the first:

•        7 daysfor sales made through our website (Lucyd.co)

•        30 daysfor sales made through Amazon

•        30 daysfor sales to wholesale retailers and distributors

Forall of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns,which is recorded as a reduction of sales. Additionally, we reviewed all individual returns received in October 2021 pertaining toorders processed prior to September 30, 2021. The identified amounts were nominal.

F-22

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
September30, 2021 and December 31, 2020

NOTE2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (cont.)

Shippingand Handling

Costsincurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to acustomer for shipping and handling are reported as revenues.

Earnings/lossper share

TheCompany presents earnings and loss per share data by calculating the quotient of earnings/(loss) and loss divided by the number of commonshares outstanding (common shares as of September 30, 2021) as required by ASC 260-10-50. As of September30, 2021, all shares underlying the related party convertible debt and common stock options were excluded from the earnings pershare calculation due to their anti-dilutive effect.

RecentAccounting Pronouncements

InFebruary 2017, FASB issued ASU No. 2017-02, “Leases (Topic 842),” that requires organizations thatlease assets, referred to as “lessees,” to recognize on the balance sheet the assets and liabilities for the rights and obligationscreated by those leases with lease terms of more than 12 months. ASU 2017-02 will also require disclosures tohelp investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leasesand will include qualitative and quantitative requirements. The Company adopted ASU 2017-02 as of January 1,2021. Company’s management determined it had no material impact on financial statements due to the lack of long-termleasing arrangements.

InMay 2018, FASB issued ASU 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20),and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for ConvertibleInstruments and Contract’s in Entity’s Own Equity. The guidance in ASU 2020-06 simplifies the accounting forconvertible debt instruments and convertible preferred stock by removing the existing guidance in ASC 470-20, Debt:Debt with Conversion and Other Options,that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the hostconvertible debt or preferred stock. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’equity, by removing certain criteria required for equity classification. The amendments in ASU 2020-06 further revise theguidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instrumentsby using the if-converted method. The Company adopted ASU 2020-06 as of January 1, 2021. Company’smanagement determined it had no material impact on financial statements due to the lack of beneficial conversion features.

NOTE3 — GOING CONCERN

TheCompany has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditionsin the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverseconditions may include: recession, downturn or otherwise, changes in regulations or restrictions in imports, competition or changes inconsumer taste including the economic impacts from the COVID-19 pandemic. These adverse conditions could affect the Company’sfinancial condition and the results of its operations.

TheCompany meets its day to day working capital requirements through monies raised through sales of eyewear and issues of equity includingcrowdfunding. The Company also has issued a convertible note held by its parent company. Company’s forecasts and projections indicatethat the Company expects to have sufficient cash reserves to operate within the level of its current facilities. Whilst it is the Company’sintention to rely on the available cash reserves, future income generated from its product sales, a negative variance in the forecastsand projections would make the Company’s ability to continue as a going concern dependent on an additional fund raise. Based onthese factors, there is substantial doubt about the Company’s ability to continue as a going concern.

F-23

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
September30, 2021 and December 31, 2020

NOTE4 — RELATED PARTY ADVANCES AND OTHER INTERCOMPANY AGREEMENTS

ConvertibleNote

OnDecember 1, 2020, the Company issued a convertible note to its Parent and Affiliates for up to $2,000,000 that bear interestat 10% per annum, which includes the option to convert the debt into shares at market price.

OnJune 1, 2021, the Company converted related party borrowings totaling $778,500 into 778,500 shares of commonstock at $1 each. On September 5, 2021, the Company converted related party borrowings totaling $500,002 into 140,449shares of common stock at $3.56 each. The Company had an outstanding balance of $420,104 as of September 30, 2021.

ManagementService Agreement

Duringnine months ended September 30, 2021, the Company incurred $75,000 under its agreement with Tekcapital Europe Ltd. Additionally,the Company’s Parent and Affiliates incurred $9,975 in management charges on behalf of the Company.

Theoutstanding unpaid balance of $74,943 as of September 30, 2021 was included in the Convertible Note balances discussed above.

NOTE5 — COMMITMENTS AND CONTINGENCIES

LegalMatters

TheCompany is not currently involved in or aware of threats of any litigation.

Commitments

Seerelated party management services agreement discussed in Note 4.

NOTE6 — SHAREHOLDERS’ EQUITY

CrowdfundedOffering

InApril 2021, the Company concluded its crowdfund launched in 2020, with the Company raising additional $770,290 in the nine monthsperiod ended September 30, 2021, offset by $339,529 in offering costs.

InJuly 2021, the Company launched its second Crowdfunded offering of common stock in which it raised $154,712, amounting to 44,458shares (40,011 issued as of September 30, 2021), offset by $93,341 in offering costs.

NOTE7 — STOCK BASED COMPENSATION

OnJuly 1, 2021, an Equity Incentive Plan was approved, allowing for total of 20%, or 1,124,043, of total issued shares to beavailable for the grant of awards under the Plan. 1,685,000 option awards were granted by the Company prior to the approval of the Plan,while 647,500 option awards were granted subject to the Plan.

Duringthe nine-month period ended September 30, 2021, the Company, granted 1,687,500 option awards, of which 1,347,500vest ratably over time and 340,000 vest based on certain performance conditions, which the Company believes are probable of occurring.

F-24

INNOVATIVEEYEWEAR, INC.
NOTES TO THE FINANCIAL STATEMENTS
September30, 2021 and December 31, 2020

NOTE7 — STOCK BASED COMPENSATION (cont.)

Thefair value of options granted is expensed over the vesting period and is calculated using the Black-Scholes model. The assumptionsinherent in the use of this model for the current period option grants are as follows:

Attribute

 

Input

Share price at date of grant

 

$1.00 – $3.56

Options life in years

 

3

Risk free rate

 

0.46% – 0.53%

Expected volatility

 

122% – 130%

Expected dividend yield

 

0

Grant date fair value of options

 

$0.71 – $2.64

Theweighted average grant date fair value of options outstanding was $1.87. Volatility was calculated using historical share price performanceof peer companies in the 3 year period prior to option grant.

Detailsof the number of share options and the weighted average exercise price outstanding during the nine months ended September 30,2021 are as follows:

Company

 

Av. Exercise
price per share
$

 

Options
(Number)

As at January 1, 2021

 

1.00

 

645,00

Granted

 

3.19

 

1,687,500

Exercised

 

 

Forfeited

 

 

As at September 30, 2021

 

2.59

 

2,332,500

Exercisable as at September 30, 2021

 

1.40

 

170,000

Theweighted average remaining contractual life is 2 years. The weighted average exercise price of options granted during the year was$3.19. The range of exercise prices for options outstanding at the end of the year was $1.00-$3.56. Unrecognized stock compensation expenseof $3,318,597 remains to be recognized over next 2 years related to options granted during nine months ended September 30,2021 and $242,265 remains to be recognized over next 2 years related to options granted prior to January 1, 2021.

NOTE8 — SUBSEQUENT EVENTS

ConvertibleNote

OnNovember 1, 2021, the Company executed an addendum for its December 1, 2020 convertible note agreement withParent and Affiliates, increasing the amount of available financing from $2,000,000 to $3,000,000.

OnNovember 16, 2021, the Company converted related party borrowings totaling $901,270.96 into 253,166 shares ofcommon stock at $3.56 per share.

OnNovember 18, 2021, the Company, previously domiciled as a Florida corporation, underwent redomestication, becoming a Delawarecorporation. Upon incorporation as a Delaware corporation, the Company is authorized to issue 50,000,000 shares of commonstock with par value of $0.0001 per share and 15,000,000 shares of preferred stock with a par value of $0.00001.

F-25

 

             Units consisting of
            Shares of Common Stock
and

Warrantsto Purchase
         Sharesof Common Stock

InnovativeEyewear, Inc.

_______________________________

PROSPECTUS

_______________________________

            ,2022

SoleBook-Running Manager

MaximGroup LLC

Throughand including         , 2022 (the 25thday after the date of this offering), all dealers effecting transactions in these securities, whether or not participating in this offering,may be required to deliver a prospectus. This is in addition to a dealer’s obligation to deliver a prospectus when acting as anunderwriter and with respect to an unsold allotment or subscription.

 

 

PARTII — INFORMATION NOT REQUIRED IN PROSPECTUS

Item 13.Other Expenses of Issuance and Distribution

Thefollowing table sets forth the expenses in connection with this registration statement. All of such expenses are estimates, other thanthe filing fees payable to the Securities and Exchange Commission and to FINRA.

 

Amount
to be paid

SEC registration fee

 

$

 

FINRA filing fee

 

$

 

NASDAQ initial listing fee

 

$

 

Transfer agent and registrar fees

 

$

 

Accounting fees and expenses

 

$

 

Legal fees and expenses

 

$

 

Printing expenses

 

$

 

Total

 

$

 

____________

*        Tobe completed by amendment

Item 14.Indemnification of Directors and Officers

Section 145of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers as well as other employees andindividuals against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonablyincurred by such person in connection with any threatened, pending or completed actions, suits or proceedings in which such person ismade a party by reason of such person being or having been a director, officer, employee or agent of the corporation. Section 145of the Delaware General Corporation Law also provides that expenses (including attorneys’ fees) incurred by a director or officerin defending an action may be paid by a corporation in advance of the final disposition of an action if the director or officer undertakesto repay the advanced amounts if it is determined such person is not entitled to be indemnified by the corporation. The Delaware GeneralCorporation Law provides that Section 145 is not exclusive of other rights to which those seeking indemnification may be entitledunder any bylaw, agreement, vote of stockholders or disinterested directors or otherwise. Our bylaws, which will be in effect upon theconsummation of this offering, provide that, to the fullest extent permitted by law, we shall indemnify and hold harmless any person whowas or is made or is threatened to be made a party or is otherwise involved in any threatened, pending or completed action, suit or proceeding,whether civil, criminal, administrative or investigative by reason of the fact that such person, or the person for whom he is the legallyrepresentative, is or was a director or officer of ours, against all liabilities, losses, expenses (including attorney’s fees),judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such proceeding.

Section 102(b)(7)of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director of the corporationshall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director,except for liability (i) for any breach of the director’s duty of loyalty to the corporation or its stockholders, (ii) foracts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) for unlawful paymentsof dividends or unlawful stock repurchases, redemptions or other distributions, or (iv) for any transaction from which the directorderived an improper personal benefit. Our amended and restated certificate of incorporation includes this provision.

Additionally,our amended and restated certificate of incorporation provides that we shall, to the maximum extent permitted from time to time underthe law of the State of Delaware, indemnify and upon request shall advance expenses to any person who is or was a party or is threatenedto be made a party to any threatened, pending or completed action, suit, proceeding or claim, whether civil, criminal, administrativeor investigative, by reason of the fact that such person is or was or has agreed to be a director or officer of ours or while a directoror officer is or was serving at our request as a director, officer, partner, trustee, employee or agent of any corporation, partnership,joint venture, trust or other enterprise, including service with respect to employee benefit plans, against expenses (including attorneys’fees and expenses), judgments, fines, penalties and amounts paid in settlement incurred in connection with the investigation, preparationto defend or defense of such action, suit, proceeding or claim; provided, however, that the foregoing shall

II-1

notrequire us to indemnify or advance expenses to any person in connection with any action, suit, proceeding or claim initiated by or onbehalf of such person or any counterclaim against us initiated by or on behalf of such person. Such indemnification shall not be exclusiveof other indemnification rights arising under any by-law, agreement, vote of directors or stockholders or otherwise and shallinure to the benefit of the heirs and legal representatives of such person. Any person seeking indemnification shall be deemed to havemet the standard of conduct required for such indemnification unless the contrary shall be established. Any repeal or modification ofour amended and restated certificate of incorporation shall not adversely affect any right or protection of a director or officer of ourswith respect to any acts or omissions of such director or officer occurring prior to such repeal or modification.

Expensesincurred by such a person in defending a civil or criminal action, suit or proceeding by reason of the fact that such person is or was,or has agreed to become, a director or officer of ours, or is or was serving, or has agreed to serve, at our request, as a director, officeror trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, including anyemployee benefit plan, or by reason of any action alleged to have been taken or omitted in such capacity shall be paid by us in advanceof the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such person to repay suchamount if it shall ultimately be determined that he is not entitled to be indemnified by us as authorized by relevant sections of theDelaware General Corporation Law. Notwithstanding the foregoing, we shall not be required to advance such expenses to a person who isa party to an action, suit or proceeding brought by us and approved by a majority of our Board of Directors that alleges willful misappropriationof corporate assets by such person, disclosure of confidential information in violation of such person’s fiduciary or contractualobligations to us or any other willful and deliberate breach in bad faith of such person’s duty to us or our stockholders.

Weshall not indemnify any such person seeking indemnification in connection with a proceeding (or part thereof) initiated by such personunless the initiation thereof was approved by our Board of Directors.

Theindemnification rights provided in our bylaws, which will be in effect upon the consummation of this offering, shall not be deemed exclusiveof any other rights to which those indemnified may be entitled under any by-law, agreement or vote of stockholders or disinteresteddirectors or otherwise, both as to action in their official capacities and as to action in another capacity while holding such office,continue as to such person who has ceased to be a director or officer, and inure to the benefit of the heirs, executors and administratorsof such a person.

Ifthe Delaware General Corporation Law is amended to expand further the indemnification permitted to indemnitees, then we shall indemnifysuch persons to the fullest extent permitted by the Delaware General Corporation Law, as so amended.

Wemay, to the extent authorized from time to time by our Board of Directors, grant indemnification rights to other employees or agents ofours or other persons serving us and such rights may be equivalent to, or greater or less than, those set forth in our bylaws, which willbe in effect upon the consummation of this offering.

Ourobligation to provide indemnification under our bylaws, which will be in effect upon the consummation of this offering, shall be offsetto the extent of any other source of indemnification or any otherwise applicable insurance coverage under a policy maintained by us orany other person.

Toassure indemnification under our bylaws, which will be in effect upon the consummation of this offering, of all directors, officers, employeesor agents who are determined by us or otherwise to be or to have been “fiduciaries” of any employee benefit plan of ours thatmay exist from time to time, Section 145 of the Delaware General Corporation Law shall, for the purposes of our bylaws, which willbe in effect upon the consummation of this offering, be interpreted as follows: an “other enterprise” shall be deemed to includesuch an employee benefit plan, including without limitation, any plan of ours that is governed by the Act of Congress entitled “EmployeeRetirement Income Security Act of 1974,” as amended from time to time; we shall be deemed to have requested a person to serve anemployee benefit plan where the performance by such person of his duties to us also imposes duties on, or otherwise involves servicesby, such person to the plan or participants or beneficiaries of the plan; and excise taxes assessed on a person with respect to an employeebenefit plan pursuant to such Act of Congress shall be deemed “fines.”

Ourbylaws, which will be in effect upon the consummation of this offering, shall be deemed to be a contract between us and each person whowas or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil,criminal, administrative or investigative, by reason of the fact that person is or was, or has agreed to become, a director or officerof ours, or is or was serving, or has agreed to serve, at our request,

II-2

asa director, officer or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise,including any employee benefit plan, or by reason of any action alleged to have been taken or omitted in such capacity, at any time whilethis by-law is in effect, and any repeal or modification thereof shall not affect any rights or obligations then existingwith respect to any state of facts then or theretofore existing or any action, suit or proceeding theretofore or thereafter brought basedin whole or in part upon any such state of facts.

Theindemnification provision of our bylaws, which will be in effect upon the consummation of this offering, does not affect directors’responsibilities under any other laws, such as the federal securities laws or state or federal environmental laws.

Wemay purchase and maintain insurance on behalf of any person who is or was a director, officer or employee of ours, or is or was servingat our request as a director, officer, employee or agent of another company, partnership, joint venture, trust or other enterprise againstliability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or not we wouldhave the power to indemnify him against liability under the provisions of this section. We currently maintain such insurance.

Theright of any person to be indemnified is subject to our right, in lieu of such indemnity, to settle any such claim, action, suit or proceedingat our expense of by the payment of the amount of such settlement and the costs and expenses incurred in connection therewith.

Insofaras indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling ourcompany pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the Securities and Exchange Commission,such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

Inthe event that a claim for indemnification against such liabilities (other than the payment of expenses incurred or paid by a director,officer or controlling person in a successful defense of any action, suit or proceeding) is asserted by such director, officer or controllingperson in connection with the securities being registered herewith, we will, unless in the opinion of our counsel the matter has beensettled by controlling precedent, submit to the court of appropriate jurisdiction the question whether such indemnification by us is againstpublic policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

TheRegistrant plans to enter into an underwriting agreement, which provides that the underwriters are obligated, under some circumstances,to indemnify the Registrant’s directors, officers and controlling persons against specified liabilities, including liabilities underthe Securities Act.

Item 15.Recent Sales of Unregistered Securities

Duringthe last three years, the Company has not issued unregistered securities to any person, except as described below. None of these transactionsinvolved any underwriters, underwriting discounts or commissions, except as specified below, or any public offering, and, unless otherwiseindicated below, the Company believes that each transaction was exempt from the registration requirements of the Securities Act by virtueof Section 4(a)(2) thereof and/or Rule 506 of Regulation D promulgated thereunder, and/or Regulation S promulgated thereunderregarding offshore offers and sales. All recipients had adequate access, though their relationships with the Company, to information aboutthe Company.

OriginalIssuance of Stock

OnMarch 26, 2020, the Company issued an aggregate of 3,750,000 shares of common stock to Lucyd Ltd. as part ofthe consideration for the Company entering into an exclusive licensing agreement with Lucyd Ltd.

ConvertiblePromissory Notes

OnDecember 1, 2020, we issued a convertible note for an aggregate principal amount of up to $2,000,000 to Lucyd Ltd., the majoritystockholder of the Company (the “Note”). On June 1, 2021, we completed the partial conversion of $778,500 ofthe outstanding balance on the Note into an aggregate of 778,500 shares of common stock. On September 5, 2021,we completed the partial conversion of an aggregate of $500,002 of the outstanding balance on the

II-3

Note,at $3.56 per share, into an aggregate of 140,449 shares of common stock. On November 16, 2021, we completedthe partial conversion of an aggregate of $901,270.96 of the outstanding balance on the Note, at $3.56 per share, into an aggregate of253,166 shares of common stock. As of November 30, 2021, $28,209 remains outstanding on the Note.

TheNote has an interest rate of 10.0 % per annum, is unsecured, matures on December 1, 2023 and provide for conversion, at theelection of Lucyd Ltd., into our common stock upon the earlier of (i) the Company consummating an equity financing pursuant to whichit raises an aggregate amount of not less than $750,000, (ii) the Company entering into a transaction pursuant to which the Companysells not less than 10% of the Company’s shares, excluding any and all convertible notes which are convertible into shares, (iii) theCompany lists its shares on a national securities exchange or (iv) the holder determines to convert the Note. If not converted earlier,upon the closing of this offering, the Notes will convert into             shares of our common stock at a conversion price equal to $             pershare. The principal amount and accrued but unpaid interest under each note will automatically convert into shares of our common stockat the stated conversion price per share.

RegulationCF Offerings

InJune 2020, the Company commenced an offering pursuant to Regulation CF of the Securities Act, through the intermediary portal, StartEngine.com,pursuant to which we offered shares of our common stock for $1.00 per share. The offering was terminated in April 2021 and we issued1,091,717 shares of common stock for aggregate gross proceeds of $1,091,717.

OnJuly 12, 2021, the Company issued an aggregate of 1,000 shares of common stock for $1.00 per share to an individualinvestor, pursuant to a subscription agreement with the Company, for aggregate gross proceeds of $1,000.

InJuly 2021, the Company launched its second Crowdfunded offering of common stock in which it raised $154,712, amounting to 44,458shares (40,011 issued as of September 30, 2021), offset by $93,341 in offering costs.

StockOptions

Sinceour inception, we have issued options exercisable for an aggregate of 2,332,500 shares of common stock. These options havea weighted average exercise price of $2.59 per share.

II-4

Item 16.Exhibits

Thefollowing is a list of exhibits filed as a part of this registration statement:

Exhibit Number

 

Description of Document

1.1

 

Form of Underwriting Agreement*

3.1

 

Certificate of Incorporation of Innovative Eyewear, Inc.*

3.2

 

Amended and Restated Certificate of Incorporation of Innovative Eyewear, Inc.*

3.3

 

Bylaws of Innovative Eyewear, Inc.*

4.1

 

Form of Representative’s Warrant*

5.1

 

Opinion of Ellenoff Grossman & Schole LLP*

10.1

 

License Agreement between Innovative Eyewear, Inc. and Lucyd Ltd.*

10.2

 

Addendum to the License Agreement between Innovative Eyewear, Inc. and Lucyd Ltd.*

10.3

 

Management Agreement between Innovative Eyewear, Inc. and Tekcapital Europe Ltd.*#

10.4

 

Convertible Note, dated December 1, 2020, issued to Lucyd Ltd.*

10.5

 

Intercompany Loan and Debt Transfer Agreement, dated June 1, 2021, by and among Innovative Eyewear, Inc., Lucyd Ltd., Tekcapital pk, Tekcapital Europe Ltd. and Tekcapital LLC*

10.6

 

Employment Agreement by and between Innovative Eyewear, Inc. and Harrison Gross*#

10.7

 

Employment Agreement by and between Innovative Eyewear, Inc. and Konrad Dabrowksi*#

10.8

 

Consulting Agreement by and between Innovative Eyewear, Inc. and Frank Rescigna*#

10.9

 

Innovative Eyewear, Inc. 2021 Equity Incentive Plan*

10.10

 

Sale Representation Agreement by and between Innovative Eyewear, Inc. and D. Landstrom Associates, Inc.*

10.11

 

Distribution Agreement by and between Innovative Eyewear, Inc. and 8 Points Inc.*

14.1

 

Form of Code of Ethics of Innovative Eyewear, Inc.*

21.1

 

List of Subsidiaries*

23.1

 

Consent of Cherry Bekaert LLP, Independent Registered Public Accounting Firm

23.2

 

Consent of Ellenoff Grossman & Schole LLP (contained in Exhibit 5.1)*

24.1

 

Powers of Attorney (included on signature page to Registration Statement filed on December 13, 2021)

99.1

 

Form of Audit Committee Charter*

99.2

 

Form of Compensation Committee Charter*

99.3

 

Form of Nominating and Corporate Governance Committee Charter*

____________

*        Tobe filed by amendment.

#        Indicatesmanagement contract or compensatory plan.

II-5

Item 17.Undertakings

Theundersigned registrant hereby undertakes:

(1)    Tofile, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i)     Toinclude any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

(ii)    Toreflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effectiveamendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registrationstatement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securitiesoffered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering rangemay be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate,the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculationof Registration Fee” table in the effective registration statement; and

(iii)   Toinclude any material information with respect to the plan of distribution not previously disclosed in the registration statement or anymaterial change to such information in the registration statement;

(2)    That,for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall bedeemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that timeshall be deemed to be the initial bona fide offering thereof.

(3)    Toremove from registration by means of a post-effective amendment any of the securities being registered which remain unsoldat the termination of the offering.

(4)    That,for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b)as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other thanprospectuses filed in reliance on Rule 430A (§230.430A of this chapter), shall be deemed to be part of and included in the registrationstatement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement orprospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into theregistration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of saleprior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part ofthe registration statement or made in any such document immediately prior to such date of first use.

(5)    That,for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distributionof the securities:

Theundersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registrationstatement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold tosuch purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and willbe considered to offer or sell such securities to such purchaser:

(i)     Anypreliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

(ii)    Anyfree writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by theundersigned registrant;

(iii)   Theportion of any other free writing prospectus relating to the offering containing material information about the undersigned registrantor its securities provided by or on behalf of the undersigned registrant; and

(iv)   Anyother communication that is an offer in the offering made by the undersigned registrant to the purchaser.

II-6

(6)    Insofaras indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling personsof the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securitiesand Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable.In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurredor paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) isasserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unlessin the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction thequestion whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed bythe final adjudication of such issue.

(7)    Theundersigned registrant hereby undertakes to provide to the underwriter at the closing specified in the underwriting agreements certificatesin such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser.

(8)    Theundersigned Registrant hereby undertakes that:

(i)     Forpurposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of thisregistration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1)or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declaredeffective.

(ii)    Forthe purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form ofprospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securitiesat that time shall be deemed to be the initial bona fide offering thereof.

II-7

Signatures

Pursuantto the requirements of the Securities Act, the registrant has duly caused this registration statement to be signed on its behalf by theundersigned, thereunto duly authorized, in the City of Miami, State of Florida, on December 13, 2021.

 

Innovative Eyewear, Inc.

   

By:

 

/s/ Harrison Gross

       

Name: Harrison Gross

       

Title: Chief Executive Officer

POWEROF ATTORNEY

KNOWALL BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Harrison Gross as his true and lawful attorney-in-factand agent, with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to signany and all amendments to this registration statement (including post-effective amendments), and to sign any registrationstatement for the same offering covered by this registration statement that is to be effective upon filing pursuant to Rule 462(b)promulgated under the Securities Act, and all post-effective amendments thereto, and to file the same, with exhibits theretoand other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-factand agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be donein and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirmingall that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtuehereof.

Pursuantto the requirements of the Securities Act, this registration statement has been signed below by the following persons in the capacitiesand on the dates indicated.

Person

 

Capacity

 

Date

/s/ Harrison Gross

 

Chief Executive Officer and Director

 

December 13, 2021

Harrison Gross

 

(Principal Executive Officer)

   

/s/ Konrad Dabrowski

 

Chief Financial Officer

 

December 13, 2021

Konrad Dabrowski

 

(Principal Financial and Accounting Officer)

   

/s/ Frank Rescigna

 

Vice President of Global Sales and Director

 

December 13, 2021

Frank Rescigna

       

/s/ Kristen Mclaughlin

 

Director

 

December 13, 2021

Kristen Mclaughlin

       

/s/ Louis Castro

 

Director

 

December 13, 2021

Louis Castro

       

/s/ Olivia C. Bartlett

 

Director

 

December 13, 2021

Olivia C. Bartlett

       

II-8

Stock View